{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# BioMedGraphica Metabolite"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 1. Data Access  \n",
    "### Direct Download Links  \n",
    "**HMDB**: Can be downloaded directly via the link without the need for registration. [Link](https://hmdb.ca/downloads)  \n",
    "**ChEBI**: Can be downloaded directly via the link without the need for registration. [Link1](https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=77746); [Link2](https://ftp.ebi.ac.uk/pub/databases/chebi/Flat_file_tab_delimited/database_accession.tsv)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### HMDB Pre-Process"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import xml.etree.ElementTree as ET\n",
    "import csv\n",
    "\n",
    "tree = ET.parse('hmdb_metabolites.xml')\n",
    "root = tree.getroot()\n",
    "\n",
    "# Extract the relevant fields\n",
    "namespace = {'hmdb': 'http://www.hmdb.ca'}\n",
    "metabolites = []\n",
    "for metabolite in root.findall('hmdb:metabolite', namespace):\n",
    "    data = {\n",
    "        'accession': metabolite.find('hmdb:accession', namespace).text,\n",
    "        'name': metabolite.find('hmdb:name', namespace).text,\n",
    "        'iupac_name': metabolite.find('hmdb:iupac_name', namespace).text if metabolite.find('hmdb:iupac_name', namespace) is not None else None,\n",
    "        'cas_registry_number': metabolite.find('hmdb:cas_registry_number', namespace).text if metabolite.find('hmdb:cas_registry_number', namespace) is not None else None,\n",
    "        'smiles': metabolite.find('hmdb:smiles', namespace).text if metabolite.find('hmdb:smiles', namespace) is not None else None,\n",
    "        'inchi': metabolite.find('hmdb:inchi', namespace).text if metabolite.find('hmdb:inchi', namespace) is not None else None,\n",
    "        'inchikey': metabolite.find('hmdb:inchikey', namespace).text if metabolite.find('hmdb:inchikey', namespace) is not None else None,\n",
    "        'chemspider_id': metabolite.find('hmdb:chemspider_id', namespace).text if metabolite.find('hmdb:chemspider_id', namespace) is not None else None,\n",
    "        'drugbank_id': metabolite.find('hmdb:drugbank_id', namespace).text if metabolite.find('hmdb:drugbank_id', namespace) is not None else None,\n",
    "        'pubchem_compound_id': metabolite.find('hmdb:pubchem_compound_id', namespace).text if metabolite.find('hmdb:pubchem_compound_id', namespace) is not None else None,\n",
    "        'pdb_id': metabolite.find('hmdb:pdb_id', namespace).text if metabolite.find('hmdb:pdb_id', namespace) is not None else None,\n",
    "        'chebi_id': metabolite.find('hmdb:chebi_id', namespace).text if metabolite.find('hmdb:chebi_id', namespace) is not None else None,\n",
    "        'kegg_id': metabolite.find('hmdb:kegg_id', namespace).text if metabolite.find('hmdb:kegg_id', namespace) is not None else None\n",
    "    }\n",
    "    metabolites.append(data)\n",
    "\n",
    "# Convert the data to a DataFrame\n",
    "hmdb = pd.DataFrame(metabolites)  # Correctly create DataFrame from metabolites\n",
    "hmdb.to_csv('hmdb.csv', index=False)  # Save DataFrame to CSV file"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 2. Load Data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 2.1 HMDB"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "accession",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "name",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "iupac_name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "cas_registry_number",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "smiles",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "inchi",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "inchikey",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chemspider_id",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "drugbank_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "pubchem_compound_id",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "pdb_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chebi_id",
         "rawType": "float64",
         "type": "float"
        },
        {
         "name": "kegg_id",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "9128b3ec-c4d3-46c6-a833-eef24282530c",
       "rows": [
        [
         "0",
         "HMDB0000001",
         "1-Methylhistidine",
         "(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid",
         "332-80-9",
         "CN1C=NC(C[C@H](N)C(O)=O)=C1",
         "InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1",
         "BRMWTNUJHUMWMS-LURJTMIESA-N",
         "83153.0",
         "DB04151",
         "92105.0",
         null,
         "50599.0",
         "C01152"
        ],
        [
         "1",
         "HMDB0000002",
         "1,3-Diaminopropane",
         "propane-1,3-diamine",
         "109-76-2",
         "NCCCN",
         "InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2",
         "XFNJVJPLKCPIBV-UHFFFAOYSA-N",
         "415.0",
         null,
         "428.0",
         null,
         "15725.0",
         "C00986"
        ],
        [
         "2",
         "HMDB0000005",
         "2-Ketobutyric acid",
         "2-oxobutanoic acid",
         "600-18-0",
         "CCC(=O)C(O)=O",
         "InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)",
         "TYEYBOSBBBHJIV-UHFFFAOYSA-N",
         "57.0",
         "DB04553",
         "58.0",
         null,
         "30831.0",
         "C00109"
        ],
        [
         "3",
         "HMDB0000008",
         "2-Hydroxybutyric acid",
         "(2S)-2-hydroxybutanoic acid",
         "3347-90-8",
         "CC[C@H](O)C(O)=O",
         "InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1",
         "AFENDNXGAFYKQO-VKHMYHEASA-N",
         "389701.0",
         null,
         "440864.0",
         null,
         "50613.0",
         "C05984"
        ],
        [
         "4",
         "HMDB0000010",
         "2-Methoxyestrone",
         "(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one",
         "362-08-3",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3",
         "InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1",
         "WHEUWNKSCXYKBU-QPWUGHHJSA-N",
         "389515.0",
         null,
         "440624.0",
         null,
         "1189.0",
         "C05299"
        ],
        [
         "5",
         "HMDB0000011",
         "3-Hydroxybutyric acid",
         "(3R)-3-hydroxybutanoic acid",
         "625-72-9",
         "C[C@@H](O)CC(O)=O",
         "InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1",
         "WHBMMWSBFZVSSR-GSVOUGTGSA-N",
         "83181.0",
         null,
         "92135.0",
         null,
         "17066.0",
         "C01089"
        ],
        [
         "6",
         "HMDB0000012",
         "Deoxyuridine",
         "1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione",
         "951-78-0",
         "OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O",
         "InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1",
         "MXHRCPNRJAMMIM-SHYZEUOFSA-N",
         "13118.0",
         "DB02256",
         "13712.0",
         null,
         "16450.0",
         "C00526"
        ],
        [
         "7",
         "HMDB0000014",
         "Deoxycytidine",
         "4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",
         "951-77-9",
         "NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1",
         "InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",
         "CKTSBUTUHBMZGZ-SHYZEUOFSA-N",
         "13117.0",
         "DB02594",
         "13711.0",
         null,
         "15698.0",
         "C00881"
        ],
        [
         "8",
         "HMDB0000015",
         "Cortexolone",
         "(1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "152-58-9",
         "[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1",
         "WHBHBVVOGNECLV-OBQKJFGGSA-N",
         "389582.0",
         null,
         "440707.0",
         null,
         "28324.0",
         "C05488"
        ],
        [
         "9",
         "HMDB0000016",
         "Deoxycorticosterone",
         "(1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "64-85-7",
         "[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1",
         "ZESRJSPZRDMNHY-YFWFAHHUSA-N",
         "5932.0",
         null,
         "6166.0",
         null,
         "16973.0",
         "C03205"
        ],
        [
         "10",
         "HMDB0000017",
         "4-Pyridoxic acid",
         "3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid",
         "82-82-6",
         "CC1=NC=C(CO)C(C(O)=O)=C1O",
         "InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)",
         "HXACOUQIXZGNBF-UHFFFAOYSA-N",
         "6467.0",
         null,
         "6723.0",
         null,
         "17405.0",
         "C00847"
        ],
        [
         "11",
         "HMDB0000019",
         "alpha-Ketoisovaleric acid",
         "3-methyl-2-oxobutanoic acid",
         "759-05-7",
         "CC(C)C(=O)C(O)=O",
         "InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)",
         "QHKABHOOEWYVLI-UHFFFAOYSA-N",
         "48.0",
         "DB04074",
         "49.0",
         null,
         "16530.0",
         "C00141"
        ],
        [
         "12",
         "HMDB0000020",
         "p-Hydroxyphenylacetic acid",
         "2-(4-hydroxyphenyl)acetic acid",
         "156-38-7",
         "OC(=O)CC1=CC=C(O)C=C1",
         "InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)",
         "XQXPVVBIMDBYFF-UHFFFAOYSA-N",
         "124.0",
         null,
         "127.0",
         null,
         "18101.0",
         "C00642"
        ],
        [
         "13",
         "HMDB0000021",
         "Iodotyrosine",
         "(2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid",
         "70-78-0",
         "N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O",
         "InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1",
         "UQTZMGFTRHFAAM-ZETCQYMHSA-N",
         "388804.0",
         "DB01758",
         "439744.0",
         null,
         "27847.0",
         "C02515"
        ],
        [
         "14",
         "HMDB0000022",
         "3-Methoxytyramine",
         "4-(2-aminoethyl)-2-methoxyphenol",
         "554-52-9",
         "COC1=C(O)C=CC(CCN)=C1",
         "InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3",
         "DIVQKHQLANKJQO-UHFFFAOYSA-N",
         "1606.0",
         null,
         "1669.0",
         null,
         "742324.0",
         "C05587"
        ],
        [
         "15",
         "HMDB0000023",
         "(S)-3-Hydroxyisobutyric acid",
         "(2S)-3-hydroxy-2-methylpropanoic acid",
         "26543-05-5",
         "C[C@@H](CO)C(O)=O",
         "InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1",
         "DBXBTMSZEOQQDU-VKHMYHEASA-N",
         "389707.0",
         null,
         "440873.0",
         null,
         "37373.0",
         "C06001"
        ],
        [
         "16",
         "HMDB0000024",
         "3-O-Sulfogalactosylceramide (d18:1/24:0)",
         "[(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid",
         "151122-71-3",
         "[H][C@@](CO[C@@H]1O[C@H](CO)[C@H](O)C(OS(O)(=O)=O)C1O)(NC(=O)CCCCCCCCCCCCCCCCCCCCCCC)[C@]([H])(O)\\C=C\\CCCCCCCCCCCCC",
         "InChI=1S/C48H93NO11S/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2)40-58-48-46(54)47(60-61(55,56)57)45(53)43(39-50)59-48/h35,37,41-43,45-48,50-51,53-54H,3-34,36,38-40H2,1-2H3,(H,49,52)(H,55,56,57)/b37-35+/t41-,42+,43+,45-,46?,47?,48+/m0/s1",
         "MEAZTWJVOWHKJM-YQTIZROBSA-N",
         "24823255.0",
         null,
         "24779585.0",
         null,
         null,
         null
        ],
        [
         "17",
         "HMDB0000026",
         "Ureidopropionic acid",
         "3-(carbamoylamino)propanoic acid",
         "462-88-4",
         "NC(=O)NCCC(O)=O",
         "InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9)",
         "JSJWCHRYRHKBBW-UHFFFAOYSA-N",
         "109.0",
         null,
         null,
         null,
         "18261.0",
         "C02642"
        ],
        [
         "18",
         "HMDB0000027",
         "Tetrahydrobiopterin",
         "(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,5,6,7,8-hexahydropteridin-4-one",
         "62989-33-7",
         "[H][C@@]1(CNC2=C(N1)C(=O)N=C(N)N2)[C@@H](O)[C@H](C)O",
         "InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1",
         "FNKQXYHWGSIFBK-RPDRRWSUSA-N",
         "40270.0",
         "DB00360",
         "44257.0",
         null,
         "59560.0",
         "C00272"
        ],
        [
         "19",
         "HMDB0000030",
         "Biotin",
         "5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid",
         "58-85-5",
         "[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2",
         "InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",
         "YBJHBAHKTGYVGT-ZKWXMUAHSA-N",
         "149962.0",
         "DB00121",
         "171548.0",
         null,
         "15956.0",
         "C00120"
        ],
        [
         "20",
         "HMDB0000031",
         "Androsterone",
         "(1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one",
         "53-41-8",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)CC[C@]12C",
         "InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,18-,19-/m0/s1",
         "QGXBDMJGAMFCBF-HLUDHZFRSA-N",
         "5668.0",
         null,
         "5879.0",
         null,
         "16032.0",
         "C00523"
        ],
        [
         "21",
         "HMDB0000032",
         "7-Dehydrocholesterol",
         "(1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,9-dien-5-ol",
         "434-16-2",
         "[H][C@@]1(CC[C@@]2([H])C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C",
         "InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1",
         "UCTLRSWJYQTBFZ-DDPQNLDTSA-N",
         null,
         null,
         "439423.0",
         null,
         "17759.0",
         "C01164"
        ],
        [
         "22",
         "HMDB0000033",
         "Carnosine",
         "(2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid",
         "305-84-0",
         "NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O",
         "InChI=1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1",
         "CQOVPNPJLQNMDC-ZETCQYMHSA-N",
         "388363.0",
         "DB11695",
         "439224.0",
         null,
         "15727.0",
         "C00386"
        ],
        [
         "23",
         "HMDB0000034",
         "Adenine",
         "7H-purin-6-amine",
         "73-24-5",
         "NC1=C2NC=NC2=NC=N1",
         "InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)",
         "GFFGJBXGBJISGV-UHFFFAOYSA-N",
         "185.0",
         "DB00173",
         "190.0",
         null,
         "16708.0",
         "C00147"
        ],
        [
         "24",
         "HMDB0000036",
         "Taurocholic acid",
         "2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid",
         "81-24-3",
         "[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O",
         "InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1",
         "WBWWGRHZICKQGZ-HZAMXZRMSA-N",
         "6423.0",
         "DB04348",
         "6675.0",
         null,
         "28865.0",
         "C05122"
        ],
        [
         "25",
         "HMDB0000037",
         "Aldosterone",
         "(1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde",
         "52-39-1",
         "[H][C@@]12CC[C@H](C(=O)CO)[C@]1(C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C)C=O",
         "InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",
         "PQSUYGKTWSAVDQ-ZVIOFETBSA-N",
         "5633.0",
         "DB04630",
         "5839.0",
         null,
         "27584.0",
         "C01780"
        ],
        [
         "26",
         "HMDB0000038",
         "Dihydrobiopterin",
         "2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,7,8-tetrahydropteridin-4-one",
         "6779-87-9",
         "C[C@H](O)[C@H](O)C1=NC2=C(NC1)NC(N)=NC2=O",
         "InChI=1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3,6,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,6-/m0/s1",
         "FEMXZDUTFRTWPE-DZSWIPIPSA-N",
         "106382.0",
         "DB04400",
         "119055.0",
         null,
         "43029.0",
         "C02953"
        ],
        [
         "27",
         "HMDB0000039",
         "Butyric acid",
         "butanoic acid",
         "107-92-6",
         "CCCC(O)=O",
         "InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)",
         "FERIUCNNQQJTOY-UHFFFAOYSA-N",
         "259.0",
         "DB03568",
         "264.0",
         null,
         "30772.0",
         "C00246"
        ],
        [
         "28",
         "HMDB0000042",
         "Acetic acid",
         "acetic acid",
         "64-19-7",
         "CC(O)=O",
         "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)",
         "QTBSBXVTEAMEQO-UHFFFAOYSA-N",
         "171.0",
         "DB03166",
         "176.0",
         null,
         "15366.0",
         "C00033"
        ],
        [
         "29",
         "HMDB0000043",
         "Betaine",
         "(carboxymethyl)trimethylazanium",
         "6915-17-9",
         "C[N+](C)(C)CC(O)=O",
         "InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3/p+1",
         "KWIUHFFTVRNATP-UHFFFAOYSA-O",
         "243.0",
         "DB04455",
         "248.0",
         null,
         "41139.0",
         null
        ],
        [
         "30",
         "HMDB0000044",
         "Ascorbic acid",
         "(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one",
         "50-81-7",
         "[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO",
         "InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1",
         "CIWBSHSKHKDKBQ-JLAZNSOCSA-N",
         "10189562.0",
         "DB00126",
         null,
         null,
         "29073.0",
         "C01041"
        ],
        [
         "31",
         "HMDB0000045",
         "Adenosine monophosphate",
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid",
         "61-19-8",
         "NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
         "UDMBCSSLTHHNCD-KQYNXXCUSA-N",
         "5858.0",
         "DB00131",
         "6083.0",
         null,
         "16027.0",
         "C00020"
        ],
        [
         "32",
         "HMDB0000048",
         "Melibiose",
         "(2S,3R,4S,5S,6R)-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol",
         "13299-20-2",
         "OC[C@H]1O[C@H](OC[C@H]2O[C@H](O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O",
         "InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2/t3-,4-,5+,6-,7+,8+,9-,10-,11+,12+/m1/s1",
         "DLRVVLDZNNYCBX-CQHUIXDMSA-N",
         null,
         null,
         "6602503.0",
         null,
         null,
         null
        ],
        [
         "33",
         "HMDB0000050",
         "Adenosine",
         "(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",
         "58-61-7",
         "NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
         "OIRDTQYFTABQOQ-KQYNXXCUSA-N",
         "54923.0",
         "DB00640",
         "60961.0",
         null,
         "16335.0",
         "C00212"
        ],
        [
         "34",
         "HMDB0000051",
         "Ammonia",
         "ammonia",
         "7664-41-7",
         "N",
         "InChI=1S/H3N/h1H3",
         "QGZKDVFQNNGYKY-UHFFFAOYSA-N",
         "217.0",
         "DBMET01482",
         "222.0",
         null,
         "16134.0",
         "C00014"
        ],
        [
         "35",
         "HMDB0000052",
         "Argininosuccinic acid",
         "(2S)-2-{N'-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid",
         "2387-71-5",
         "N[C@@H](CCCNC(=N)N[C@@H](CC(O)=O)C(O)=O)C(O)=O",
         "InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/t5-,6-/m0/s1",
         "KDZOASGQNOPSCU-WDSKDSINSA-N",
         "16059.0",
         null,
         "16950.0",
         null,
         "15682.0",
         "C03406"
        ],
        [
         "36",
         "HMDB0000053",
         "Androstenedione",
         "(1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,14-dione",
         "63-05-8",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",
         "AEMFNILZOJDQLW-QAGGRKNESA-N",
         "5898.0",
         "DB01536",
         "6128.0",
         null,
         "16422.0",
         "C00280"
        ],
        [
         "37",
         "HMDB0000054",
         "Bilirubin",
         "3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",
         "635-65-4",
         "CC1=C(C=C)\\C(NC1=O)=C\\C1=C(C)C(CCC(O)=O)=C(CC2=C(CCC(O)=O)C(C)=C(N2)\\C=C2/NC(=O)C(C=C)=C2C)N1",
         "InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-",
         "BPYKTIZUTYGOLE-IFADSCNNSA-N",
         "4444055.0",
         null,
         "5280352.0",
         null,
         "16990.0",
         "C00486"
        ],
        [
         "38",
         "HMDB0000055",
         "Cellobiose",
         "(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol",
         "528-50-7",
         "OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O",
         "InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11-,12+/m1/s1",
         "GUBGYTABKSRVRQ-QRZGKKJRSA-N",
         "10261.0",
         null,
         "10712.0",
         null,
         "36217.0",
         "C06422"
        ],
        [
         "39",
         "HMDB0000056",
         "beta-Alanine",
         "3-aminopropanoic acid",
         "107-95-9",
         "NCCC(O)=O",
         "InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)",
         "UCMIRNVEIXFBKS-UHFFFAOYSA-N",
         "234.0",
         "DB03107",
         "239.0",
         null,
         "16958.0",
         "C00099"
        ],
        [
         "40",
         "HMDB0000058",
         "Cyclic AMP",
         "(4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one",
         "60-92-4",
         "[H][C@@]12COP(O)(=O)O[C@@]1([H])[C@@H](O)[C@@H](O2)N1C=NC2=C1N=CN=C2N",
         "InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
         "IVOMOUWHDPKRLL-KQYNXXCUSA-N",
         "5851.0",
         "DB02527",
         "6076.0",
         null,
         "17489.0",
         "C00575"
        ],
        [
         "41",
         "HMDB0000060",
         "Acetoacetic acid",
         "3-oxobutanoic acid",
         "541-50-4",
         "CC(=O)CC(O)=O",
         "InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7)",
         "WDJHALXBUFZDSR-UHFFFAOYSA-N",
         "94.0",
         "DB01762",
         "96.0",
         null,
         "15344.0",
         "C00164"
        ],
        [
         "42",
         "HMDB0000061",
         "Adenosine 3',5'-diphosphate",
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}phosphonic acid",
         "1053-73-2",
         "NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1",
         "WHTCPDAXWFLDIH-KQYNXXCUSA-N",
         "140102.0",
         "DB01812",
         "159296.0",
         null,
         "17985.0",
         "C00054"
        ],
        [
         "43",
         "HMDB0000062",
         "L-Carnitine",
         "(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate",
         "541-15-1",
         "C[N+](C)(C)C[C@H](O)CC(O)=O",
         "InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/p+1/t6-/m1/s1",
         "PHIQHXFUZVPYII-ZCFIWIBFSA-O",
         "2006614.0",
         "DB00583",
         "10917.0",
         null,
         "16347.0",
         "C00318"
        ],
        [
         "44",
         "HMDB0000063",
         "Cortisol",
         "(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "50-23-7",
         "[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",
         "JYGXADMDTFJGBT-VWUMJDOOSA-N",
         null,
         "DB00741",
         "5754.0",
         null,
         "17650.0",
         "C00735"
        ],
        [
         "45",
         "HMDB0000064",
         "Creatine",
         "2-(N-methylcarbamimidamido)acetic acid",
         "57-00-1",
         "CN(CC(O)=O)C(N)=N",
         "InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)",
         "CVSVTCORWBXHQV-UHFFFAOYSA-N",
         "566.0",
         "DB00148",
         "586.0",
         null,
         "16919.0",
         "C00300"
        ],
        [
         "46",
         "HMDB0000067",
         "Cholesterol",
         "(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",
         "57-88-5",
         "[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C",
         "InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1",
         "HVYWMOMLDIMFJA-DPAQBDIFSA-N",
         null,
         "DB04540",
         "5997.0",
         null,
         "16113.0",
         "C00187"
        ],
        [
         "47",
         "HMDB0000068",
         "Epinephrine",
         "4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol",
         "51-43-4",
         "CNC[C@H](O)C1=CC(O)=C(O)C=C1",
         "InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",
         "UCTWMZQNUQWSLP-VIFPVBQESA-N",
         "5611.0",
         "DB00668",
         "5816.0",
         null,
         "28918.0",
         "C00788"
        ],
        [
         "48",
         "HMDB0000070",
         "Pipecolic acid",
         "piperidine-2-carboxylic acid",
         "535-75-1",
         "OC(=O)C1CCCCN1",
         "InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)",
         "HXEACLLIILLPRG-UHFFFAOYSA-N",
         "826.0",
         null,
         "849.0",
         null,
         "17964.0",
         "C00408"
        ],
        [
         "49",
         "HMDB0000071",
         "Deoxyinosine",
         "9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-ol",
         "890-38-0",
         "OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC2=O",
         "InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1",
         "VGONTNSXDCQUGY-RRKCRQDMSA-N",
         "58569.0",
         "DB02380",
         "65058.0",
         null,
         "28997.0",
         "C05512"
        ]
       ],
       "shape": {
        "columns": 13,
        "rows": 217920
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>accession</th>\n",
       "      <th>name</th>\n",
       "      <th>iupac_name</th>\n",
       "      <th>cas_registry_number</th>\n",
       "      <th>smiles</th>\n",
       "      <th>inchi</th>\n",
       "      <th>inchikey</th>\n",
       "      <th>chemspider_id</th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>pubchem_compound_id</th>\n",
       "      <th>pdb_id</th>\n",
       "      <th>chebi_id</th>\n",
       "      <th>kegg_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>HMDB0000001</td>\n",
       "      <td>1-Methylhistidine</td>\n",
       "      <td>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...</td>\n",
       "      <td>332-80-9</td>\n",
       "      <td>CN1C=NC(C[C@H](N)C(O)=O)=C1</td>\n",
       "      <td>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11...</td>\n",
       "      <td>BRMWTNUJHUMWMS-LURJTMIESA-N</td>\n",
       "      <td>83153.0</td>\n",
       "      <td>DB04151</td>\n",
       "      <td>92105.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50599.0</td>\n",
       "      <td>C01152</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HMDB0000002</td>\n",
       "      <td>1,3-Diaminopropane</td>\n",
       "      <td>propane-1,3-diamine</td>\n",
       "      <td>109-76-2</td>\n",
       "      <td>NCCCN</td>\n",
       "      <td>InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2</td>\n",
       "      <td>XFNJVJPLKCPIBV-UHFFFAOYSA-N</td>\n",
       "      <td>415.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>428.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15725.0</td>\n",
       "      <td>C00986</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HMDB0000005</td>\n",
       "      <td>2-Ketobutyric acid</td>\n",
       "      <td>2-oxobutanoic acid</td>\n",
       "      <td>600-18-0</td>\n",
       "      <td>CCC(=O)C(O)=O</td>\n",
       "      <td>InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)</td>\n",
       "      <td>TYEYBOSBBBHJIV-UHFFFAOYSA-N</td>\n",
       "      <td>57.0</td>\n",
       "      <td>DB04553</td>\n",
       "      <td>58.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30831.0</td>\n",
       "      <td>C00109</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>HMDB0000008</td>\n",
       "      <td>2-Hydroxybutyric acid</td>\n",
       "      <td>(2S)-2-hydroxybutanoic acid</td>\n",
       "      <td>3347-90-8</td>\n",
       "      <td>CC[C@H](O)C(O)=O</td>\n",
       "      <td>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(...</td>\n",
       "      <td>AFENDNXGAFYKQO-VKHMYHEASA-N</td>\n",
       "      <td>389701.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>440864.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50613.0</td>\n",
       "      <td>C05984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>HMDB0000010</td>\n",
       "      <td>2-Methoxyestrone</td>\n",
       "      <td>(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyl...</td>\n",
       "      <td>362-08-3</td>\n",
       "      <td>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[...</td>\n",
       "      <td>InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18...</td>\n",
       "      <td>WHEUWNKSCXYKBU-QPWUGHHJSA-N</td>\n",
       "      <td>389515.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>440624.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1189.0</td>\n",
       "      <td>C05299</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217915</th>\n",
       "      <td>HMDB0304947</td>\n",
       "      <td>Nordeoxycholic acid</td>\n",
       "      <td>3-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7....</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CC(CC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C</td>\n",
       "      <td>InChI=1S/C23H38O4/c1-13(10-21(26)27)17-6-7-18-...</td>\n",
       "      <td>PLRQOCVIINWCFA-UHFFFAOYSA-N</td>\n",
       "      <td>278117.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>314374.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217916</th>\n",
       "      <td>HMDB0304950</td>\n",
       "      <td>3-Oxo-5beta-cholanoic acid</td>\n",
       "      <td>4-{2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CC(CCC(O)=O)C1CCC2C3CCC4CC(=O)CCC4(C)C3CCC12C</td>\n",
       "      <td>InChI=1S/C24H38O3/c1-15(4-9-22(26)27)19-7-8-20...</td>\n",
       "      <td>KIQFUORWRVZTHT-UHFFFAOYSA-N</td>\n",
       "      <td>473110.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>543448.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217917</th>\n",
       "      <td>HMDB0304951</td>\n",
       "      <td>Glycerol 1-myristate</td>\n",
       "      <td>2,3-dihydroxypropyl tetradecanoate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCCCCCCCCCCCCC(=O)OCC(O)CO</td>\n",
       "      <td>InChI=1S/C17H34O4/c1-2-3-4-5-6-7-8-9-10-11-12-...</td>\n",
       "      <td>DCBSHORRWZKAKO-UHFFFAOYSA-N</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>79050.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>75562.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217918</th>\n",
       "      <td>HMDB0304953</td>\n",
       "      <td>O-Phenolsulfonic acid</td>\n",
       "      <td>2-hydroxybenzene-1-sulfonic acid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OC1=CC=CC=C1S(O)(=O)=O</td>\n",
       "      <td>InChI=1S/C6H6O4S/c7-5-3-1-2-4-6(5)11(8,9)10/h1...</td>\n",
       "      <td>IULJSGIJJZZUMF-UHFFFAOYSA-N</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>11867.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>71049.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217919</th>\n",
       "      <td>HMDB0304954</td>\n",
       "      <td>d-Fucitol</td>\n",
       "      <td>(2R,3S,4R,5S)-hexane-1,2,3,4,5-pentol</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[H][C@@](C)(O)[C@@]([H])(O)[C@@]([H])(O)[C@]([...</td>\n",
       "      <td>InChI=1S/C6H14O5/c1-3(8)5(10)6(11)4(9)2-7/h3-1...</td>\n",
       "      <td>SKCKOFZKJLZSFA-KCDKBNATSA-N</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DB03815</td>\n",
       "      <td>445724.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>217920 rows Ã— 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          accession                        name  \\\n",
       "0       HMDB0000001           1-Methylhistidine   \n",
       "1       HMDB0000002          1,3-Diaminopropane   \n",
       "2       HMDB0000005          2-Ketobutyric acid   \n",
       "3       HMDB0000008       2-Hydroxybutyric acid   \n",
       "4       HMDB0000010            2-Methoxyestrone   \n",
       "...             ...                         ...   \n",
       "217915  HMDB0304947         Nordeoxycholic acid   \n",
       "217916  HMDB0304950  3-Oxo-5beta-cholanoic acid   \n",
       "217917  HMDB0304951        Glycerol 1-myristate   \n",
       "217918  HMDB0304953       O-Phenolsulfonic acid   \n",
       "217919  HMDB0304954                   d-Fucitol   \n",
       "\n",
       "                                               iupac_name cas_registry_number  \\\n",
       "0       (2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...            332-80-9   \n",
       "1                                     propane-1,3-diamine            109-76-2   \n",
       "2                                      2-oxobutanoic acid            600-18-0   \n",
       "3                             (2S)-2-hydroxybutanoic acid           3347-90-8   \n",
       "4       (1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyl...            362-08-3   \n",
       "...                                                   ...                 ...   \n",
       "217915  3-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7....                 NaN   \n",
       "217916  4-{2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}...                 NaN   \n",
       "217917                 2,3-dihydroxypropyl tetradecanoate                 NaN   \n",
       "217918                   2-hydroxybenzene-1-sulfonic acid                 NaN   \n",
       "217919              (2R,3S,4R,5S)-hexane-1,2,3,4,5-pentol                 NaN   \n",
       "\n",
       "                                                   smiles  \\\n",
       "0                             CN1C=NC(C[C@H](N)C(O)=O)=C1   \n",
       "1                                                   NCCCN   \n",
       "2                                           CCC(=O)C(O)=O   \n",
       "3                                        CC[C@H](O)C(O)=O   \n",
       "4       [H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[...   \n",
       "...                                                   ...   \n",
       "217915     CC(CC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C   \n",
       "217916      CC(CCC(O)=O)C1CCC2C3CCC4CC(=O)CCC4(C)C3CCC12C   \n",
       "217917                         CCCCCCCCCCCCCC(=O)OCC(O)CO   \n",
       "217918                             OC1=CC=CC=C1S(O)(=O)=O   \n",
       "217919  [H][C@@](C)(O)[C@@]([H])(O)[C@@]([H])(O)[C@]([...   \n",
       "\n",
       "                                                    inchi  \\\n",
       "0       InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11...   \n",
       "1                      InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2   \n",
       "2         InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)   \n",
       "3       InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(...   \n",
       "4       InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18...   \n",
       "...                                                   ...   \n",
       "217915  InChI=1S/C23H38O4/c1-13(10-21(26)27)17-6-7-18-...   \n",
       "217916  InChI=1S/C24H38O3/c1-15(4-9-22(26)27)19-7-8-20...   \n",
       "217917  InChI=1S/C17H34O4/c1-2-3-4-5-6-7-8-9-10-11-12-...   \n",
       "217918  InChI=1S/C6H6O4S/c7-5-3-1-2-4-6(5)11(8,9)10/h1...   \n",
       "217919  InChI=1S/C6H14O5/c1-3(8)5(10)6(11)4(9)2-7/h3-1...   \n",
       "\n",
       "                           inchikey  chemspider_id drugbank_id  \\\n",
       "0       BRMWTNUJHUMWMS-LURJTMIESA-N        83153.0     DB04151   \n",
       "1       XFNJVJPLKCPIBV-UHFFFAOYSA-N          415.0         NaN   \n",
       "2       TYEYBOSBBBHJIV-UHFFFAOYSA-N           57.0     DB04553   \n",
       "3       AFENDNXGAFYKQO-VKHMYHEASA-N       389701.0         NaN   \n",
       "4       WHEUWNKSCXYKBU-QPWUGHHJSA-N       389515.0         NaN   \n",
       "...                             ...            ...         ...   \n",
       "217915  PLRQOCVIINWCFA-UHFFFAOYSA-N       278117.0         NaN   \n",
       "217916  KIQFUORWRVZTHT-UHFFFAOYSA-N       473110.0         NaN   \n",
       "217917  DCBSHORRWZKAKO-UHFFFAOYSA-N            NaN         NaN   \n",
       "217918  IULJSGIJJZZUMF-UHFFFAOYSA-N            NaN         NaN   \n",
       "217919  SKCKOFZKJLZSFA-KCDKBNATSA-N            NaN     DB03815   \n",
       "\n",
       "        pubchem_compound_id pdb_id  chebi_id kegg_id  \n",
       "0                   92105.0    NaN   50599.0  C01152  \n",
       "1                     428.0    NaN   15725.0  C00986  \n",
       "2                      58.0    NaN   30831.0  C00109  \n",
       "3                  440864.0    NaN   50613.0  C05984  \n",
       "4                  440624.0    NaN    1189.0  C05299  \n",
       "...                     ...    ...       ...     ...  \n",
       "217915             314374.0    NaN       NaN     NaN  \n",
       "217916             543448.0    NaN       NaN     NaN  \n",
       "217917              79050.0    NaN   75562.0     NaN  \n",
       "217918              11867.0    NaN   71049.0     NaN  \n",
       "217919             445724.0    NaN       NaN     NaN  \n",
       "\n",
       "[217920 rows x 13 columns]"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "\n",
    "hmdb = pd.read_csv('hmdb.csv')  # Load the CSV file into a DataFrame\n",
    "hmdb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "accession",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "name",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "iupac_name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "cas_registry_number",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "smiles",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "inchi",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "inchikey",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chemspider_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "drugbank_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "pubchem_compound_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "pdb_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chebi_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "kegg_id",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "c335fa60-feba-41be-b30b-2cda212a3516",
       "rows": [
        [
         "0",
         "HMDB0000001",
         "1-Methylhistidine",
         "(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid",
         "332-80-9",
         "CN1C=NC(C[C@H](N)C(O)=O)=C1",
         "InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1",
         "BRMWTNUJHUMWMS-LURJTMIESA-N",
         "83153",
         "DB04151",
         "92105",
         null,
         "50599",
         "C01152"
        ],
        [
         "1",
         "HMDB0000002",
         "1,3-Diaminopropane",
         "propane-1,3-diamine",
         "109-76-2",
         "NCCCN",
         "InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2",
         "XFNJVJPLKCPIBV-UHFFFAOYSA-N",
         "415",
         null,
         "428",
         null,
         "15725",
         "C00986"
        ],
        [
         "2",
         "HMDB0000005",
         "2-Ketobutyric acid",
         "2-oxobutanoic acid",
         "600-18-0",
         "CCC(=O)C(O)=O",
         "InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)",
         "TYEYBOSBBBHJIV-UHFFFAOYSA-N",
         "57",
         "DB04553",
         "58",
         null,
         "30831",
         "C00109"
        ],
        [
         "3",
         "HMDB0000008",
         "2-Hydroxybutyric acid",
         "(2S)-2-hydroxybutanoic acid",
         "3347-90-8",
         "CC[C@H](O)C(O)=O",
         "InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1",
         "AFENDNXGAFYKQO-VKHMYHEASA-N",
         "389701",
         null,
         "440864",
         null,
         "50613",
         "C05984"
        ],
        [
         "4",
         "HMDB0000010",
         "2-Methoxyestrone",
         "(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one",
         "362-08-3",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3",
         "InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1",
         "WHEUWNKSCXYKBU-QPWUGHHJSA-N",
         "389515",
         null,
         "440624",
         null,
         "1189",
         "C05299"
        ],
        [
         "5",
         "HMDB0000011",
         "3-Hydroxybutyric acid",
         "(3R)-3-hydroxybutanoic acid",
         "625-72-9",
         "C[C@@H](O)CC(O)=O",
         "InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1",
         "WHBMMWSBFZVSSR-GSVOUGTGSA-N",
         "83181",
         null,
         "92135",
         null,
         "17066",
         "C01089"
        ],
        [
         "6",
         "HMDB0000012",
         "Deoxyuridine",
         "1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione",
         "951-78-0",
         "OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O",
         "InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1",
         "MXHRCPNRJAMMIM-SHYZEUOFSA-N",
         "13118",
         "DB02256",
         "13712",
         null,
         "16450",
         "C00526"
        ],
        [
         "7",
         "HMDB0000014",
         "Deoxycytidine",
         "4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",
         "951-77-9",
         "NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1",
         "InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",
         "CKTSBUTUHBMZGZ-SHYZEUOFSA-N",
         "13117",
         "DB02594",
         "13711",
         null,
         "15698",
         "C00881"
        ],
        [
         "8",
         "HMDB0000015",
         "Cortexolone",
         "(1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "152-58-9",
         "[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1",
         "WHBHBVVOGNECLV-OBQKJFGGSA-N",
         "389582",
         null,
         "440707",
         null,
         "28324",
         "C05488"
        ],
        [
         "9",
         "HMDB0000016",
         "Deoxycorticosterone",
         "(1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "64-85-7",
         "[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1",
         "ZESRJSPZRDMNHY-YFWFAHHUSA-N",
         "5932",
         null,
         "6166",
         null,
         "16973",
         "C03205"
        ],
        [
         "10",
         "HMDB0000017",
         "4-Pyridoxic acid",
         "3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid",
         "82-82-6",
         "CC1=NC=C(CO)C(C(O)=O)=C1O",
         "InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)",
         "HXACOUQIXZGNBF-UHFFFAOYSA-N",
         "6467",
         null,
         "6723",
         null,
         "17405",
         "C00847"
        ],
        [
         "11",
         "HMDB0000019",
         "alpha-Ketoisovaleric acid",
         "3-methyl-2-oxobutanoic acid",
         "759-05-7",
         "CC(C)C(=O)C(O)=O",
         "InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)",
         "QHKABHOOEWYVLI-UHFFFAOYSA-N",
         "48",
         "DB04074",
         "49",
         null,
         "16530",
         "C00141"
        ],
        [
         "12",
         "HMDB0000020",
         "p-Hydroxyphenylacetic acid",
         "2-(4-hydroxyphenyl)acetic acid",
         "156-38-7",
         "OC(=O)CC1=CC=C(O)C=C1",
         "InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)",
         "XQXPVVBIMDBYFF-UHFFFAOYSA-N",
         "124",
         null,
         "127",
         null,
         "18101",
         "C00642"
        ],
        [
         "13",
         "HMDB0000021",
         "Iodotyrosine",
         "(2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid",
         "70-78-0",
         "N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O",
         "InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1",
         "UQTZMGFTRHFAAM-ZETCQYMHSA-N",
         "388804",
         "DB01758",
         "439744",
         null,
         "27847",
         "C02515"
        ],
        [
         "14",
         "HMDB0000022",
         "3-Methoxytyramine",
         "4-(2-aminoethyl)-2-methoxyphenol",
         "554-52-9",
         "COC1=C(O)C=CC(CCN)=C1",
         "InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3",
         "DIVQKHQLANKJQO-UHFFFAOYSA-N",
         "1606",
         null,
         "1669",
         null,
         "742324",
         "C05587"
        ],
        [
         "15",
         "HMDB0000023",
         "(S)-3-Hydroxyisobutyric acid",
         "(2S)-3-hydroxy-2-methylpropanoic acid",
         "26543-05-5",
         "C[C@@H](CO)C(O)=O",
         "InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1",
         "DBXBTMSZEOQQDU-VKHMYHEASA-N",
         "389707",
         null,
         "440873",
         null,
         "37373",
         "C06001"
        ],
        [
         "16",
         "HMDB0000024",
         "3-O-Sulfogalactosylceramide (d18:1/24:0)",
         "[(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid",
         "151122-71-3",
         "[H][C@@](CO[C@@H]1O[C@H](CO)[C@H](O)C(OS(O)(=O)=O)C1O)(NC(=O)CCCCCCCCCCCCCCCCCCCCCCC)[C@]([H])(O)\\C=C\\CCCCCCCCCCCCC",
         "InChI=1S/C48H93NO11S/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2)40-58-48-46(54)47(60-61(55,56)57)45(53)43(39-50)59-48/h35,37,41-43,45-48,50-51,53-54H,3-34,36,38-40H2,1-2H3,(H,49,52)(H,55,56,57)/b37-35+/t41-,42+,43+,45-,46?,47?,48+/m0/s1",
         "MEAZTWJVOWHKJM-YQTIZROBSA-N",
         "24823255",
         null,
         "24779585",
         null,
         null,
         null
        ],
        [
         "17",
         "HMDB0000026",
         "Ureidopropionic acid",
         "3-(carbamoylamino)propanoic acid",
         "462-88-4",
         "NC(=O)NCCC(O)=O",
         "InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9)",
         "JSJWCHRYRHKBBW-UHFFFAOYSA-N",
         "109",
         null,
         null,
         null,
         "18261",
         "C02642"
        ],
        [
         "18",
         "HMDB0000027",
         "Tetrahydrobiopterin",
         "(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,5,6,7,8-hexahydropteridin-4-one",
         "62989-33-7",
         "[H][C@@]1(CNC2=C(N1)C(=O)N=C(N)N2)[C@@H](O)[C@H](C)O",
         "InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1",
         "FNKQXYHWGSIFBK-RPDRRWSUSA-N",
         "40270",
         "DB00360",
         "44257",
         null,
         "59560",
         "C00272"
        ],
        [
         "19",
         "HMDB0000030",
         "Biotin",
         "5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid",
         "58-85-5",
         "[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2",
         "InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",
         "YBJHBAHKTGYVGT-ZKWXMUAHSA-N",
         "149962",
         "DB00121",
         "171548",
         null,
         "15956",
         "C00120"
        ],
        [
         "20",
         "HMDB0000031",
         "Androsterone",
         "(1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one",
         "53-41-8",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)CC[C@]12C",
         "InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,18-,19-/m0/s1",
         "QGXBDMJGAMFCBF-HLUDHZFRSA-N",
         "5668",
         null,
         "5879",
         null,
         "16032",
         "C00523"
        ],
        [
         "21",
         "HMDB0000032",
         "7-Dehydrocholesterol",
         "(1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,9-dien-5-ol",
         "434-16-2",
         "[H][C@@]1(CC[C@@]2([H])C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C",
         "InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1",
         "UCTLRSWJYQTBFZ-DDPQNLDTSA-N",
         null,
         null,
         "439423",
         null,
         "17759",
         "C01164"
        ],
        [
         "22",
         "HMDB0000033",
         "Carnosine",
         "(2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid",
         "305-84-0",
         "NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O",
         "InChI=1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1",
         "CQOVPNPJLQNMDC-ZETCQYMHSA-N",
         "388363",
         "DB11695",
         "439224",
         null,
         "15727",
         "C00386"
        ],
        [
         "23",
         "HMDB0000034",
         "Adenine",
         "7H-purin-6-amine",
         "73-24-5",
         "NC1=C2NC=NC2=NC=N1",
         "InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)",
         "GFFGJBXGBJISGV-UHFFFAOYSA-N",
         "185",
         "DB00173",
         "190",
         null,
         "16708",
         "C00147"
        ],
        [
         "24",
         "HMDB0000036",
         "Taurocholic acid",
         "2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid",
         "81-24-3",
         "[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O",
         "InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1",
         "WBWWGRHZICKQGZ-HZAMXZRMSA-N",
         "6423",
         "DB04348",
         "6675",
         null,
         "28865",
         "C05122"
        ],
        [
         "25",
         "HMDB0000037",
         "Aldosterone",
         "(1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde",
         "52-39-1",
         "[H][C@@]12CC[C@H](C(=O)CO)[C@]1(C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C)C=O",
         "InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",
         "PQSUYGKTWSAVDQ-ZVIOFETBSA-N",
         "5633",
         "DB04630",
         "5839",
         null,
         "27584",
         "C01780"
        ],
        [
         "26",
         "HMDB0000038",
         "Dihydrobiopterin",
         "2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,7,8-tetrahydropteridin-4-one",
         "6779-87-9",
         "C[C@H](O)[C@H](O)C1=NC2=C(NC1)NC(N)=NC2=O",
         "InChI=1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3,6,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,6-/m0/s1",
         "FEMXZDUTFRTWPE-DZSWIPIPSA-N",
         "106382",
         "DB04400",
         "119055",
         null,
         "43029",
         "C02953"
        ],
        [
         "27",
         "HMDB0000039",
         "Butyric acid",
         "butanoic acid",
         "107-92-6",
         "CCCC(O)=O",
         "InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)",
         "FERIUCNNQQJTOY-UHFFFAOYSA-N",
         "259",
         "DB03568",
         "264",
         null,
         "30772",
         "C00246"
        ],
        [
         "28",
         "HMDB0000042",
         "Acetic acid",
         "acetic acid",
         "64-19-7",
         "CC(O)=O",
         "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)",
         "QTBSBXVTEAMEQO-UHFFFAOYSA-N",
         "171",
         "DB03166",
         "176",
         null,
         "15366",
         "C00033"
        ],
        [
         "29",
         "HMDB0000043",
         "Betaine",
         "(carboxymethyl)trimethylazanium",
         "6915-17-9",
         "C[N+](C)(C)CC(O)=O",
         "InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3/p+1",
         "KWIUHFFTVRNATP-UHFFFAOYSA-O",
         "243",
         "DB04455",
         "248",
         null,
         "41139",
         null
        ],
        [
         "30",
         "HMDB0000044",
         "Ascorbic acid",
         "(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one",
         "50-81-7",
         "[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO",
         "InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1",
         "CIWBSHSKHKDKBQ-JLAZNSOCSA-N",
         "10189562",
         "DB00126",
         null,
         null,
         "29073",
         "C01041"
        ],
        [
         "31",
         "HMDB0000045",
         "Adenosine monophosphate",
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid",
         "61-19-8",
         "NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
         "UDMBCSSLTHHNCD-KQYNXXCUSA-N",
         "5858",
         "DB00131",
         "6083",
         null,
         "16027",
         "C00020"
        ],
        [
         "32",
         "HMDB0000048",
         "Melibiose",
         "(2S,3R,4S,5S,6R)-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol",
         "13299-20-2",
         "OC[C@H]1O[C@H](OC[C@H]2O[C@H](O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O",
         "InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2/t3-,4-,5+,6-,7+,8+,9-,10-,11+,12+/m1/s1",
         "DLRVVLDZNNYCBX-CQHUIXDMSA-N",
         null,
         null,
         "6602503",
         null,
         null,
         null
        ],
        [
         "33",
         "HMDB0000050",
         "Adenosine",
         "(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",
         "58-61-7",
         "NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
         "OIRDTQYFTABQOQ-KQYNXXCUSA-N",
         "54923",
         "DB00640",
         "60961",
         null,
         "16335",
         "C00212"
        ],
        [
         "34",
         "HMDB0000051",
         "Ammonia",
         "ammonia",
         "7664-41-7",
         "N",
         "InChI=1S/H3N/h1H3",
         "QGZKDVFQNNGYKY-UHFFFAOYSA-N",
         "217",
         "DBMET01482",
         "222",
         null,
         "16134",
         "C00014"
        ],
        [
         "35",
         "HMDB0000052",
         "Argininosuccinic acid",
         "(2S)-2-{N'-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid",
         "2387-71-5",
         "N[C@@H](CCCNC(=N)N[C@@H](CC(O)=O)C(O)=O)C(O)=O",
         "InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/t5-,6-/m0/s1",
         "KDZOASGQNOPSCU-WDSKDSINSA-N",
         "16059",
         null,
         "16950",
         null,
         "15682",
         "C03406"
        ],
        [
         "36",
         "HMDB0000053",
         "Androstenedione",
         "(1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,14-dione",
         "63-05-8",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",
         "AEMFNILZOJDQLW-QAGGRKNESA-N",
         "5898",
         "DB01536",
         "6128",
         null,
         "16422",
         "C00280"
        ],
        [
         "37",
         "HMDB0000054",
         "Bilirubin",
         "3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",
         "635-65-4",
         "CC1=C(C=C)\\C(NC1=O)=C\\C1=C(C)C(CCC(O)=O)=C(CC2=C(CCC(O)=O)C(C)=C(N2)\\C=C2/NC(=O)C(C=C)=C2C)N1",
         "InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-",
         "BPYKTIZUTYGOLE-IFADSCNNSA-N",
         "4444055",
         null,
         "5280352",
         null,
         "16990",
         "C00486"
        ],
        [
         "38",
         "HMDB0000055",
         "Cellobiose",
         "(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol",
         "528-50-7",
         "OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O",
         "InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11-,12+/m1/s1",
         "GUBGYTABKSRVRQ-QRZGKKJRSA-N",
         "10261",
         null,
         "10712",
         null,
         "36217",
         "C06422"
        ],
        [
         "39",
         "HMDB0000056",
         "beta-Alanine",
         "3-aminopropanoic acid",
         "107-95-9",
         "NCCC(O)=O",
         "InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)",
         "UCMIRNVEIXFBKS-UHFFFAOYSA-N",
         "234",
         "DB03107",
         "239",
         null,
         "16958",
         "C00099"
        ],
        [
         "40",
         "HMDB0000058",
         "Cyclic AMP",
         "(4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one",
         "60-92-4",
         "[H][C@@]12COP(O)(=O)O[C@@]1([H])[C@@H](O)[C@@H](O2)N1C=NC2=C1N=CN=C2N",
         "InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
         "IVOMOUWHDPKRLL-KQYNXXCUSA-N",
         "5851",
         "DB02527",
         "6076",
         null,
         "17489",
         "C00575"
        ],
        [
         "41",
         "HMDB0000060",
         "Acetoacetic acid",
         "3-oxobutanoic acid",
         "541-50-4",
         "CC(=O)CC(O)=O",
         "InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7)",
         "WDJHALXBUFZDSR-UHFFFAOYSA-N",
         "94",
         "DB01762",
         "96",
         null,
         "15344",
         "C00164"
        ],
        [
         "42",
         "HMDB0000061",
         "Adenosine 3',5'-diphosphate",
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}phosphonic acid",
         "1053-73-2",
         "NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1",
         "WHTCPDAXWFLDIH-KQYNXXCUSA-N",
         "140102",
         "DB01812",
         "159296",
         null,
         "17985",
         "C00054"
        ],
        [
         "43",
         "HMDB0000062",
         "L-Carnitine",
         "(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate",
         "541-15-1",
         "C[N+](C)(C)C[C@H](O)CC(O)=O",
         "InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/p+1/t6-/m1/s1",
         "PHIQHXFUZVPYII-ZCFIWIBFSA-O",
         "2006614",
         "DB00583",
         "10917",
         null,
         "16347",
         "C00318"
        ],
        [
         "44",
         "HMDB0000063",
         "Cortisol",
         "(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "50-23-7",
         "[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",
         "JYGXADMDTFJGBT-VWUMJDOOSA-N",
         null,
         "DB00741",
         "5754",
         null,
         "17650",
         "C00735"
        ],
        [
         "45",
         "HMDB0000064",
         "Creatine",
         "2-(N-methylcarbamimidamido)acetic acid",
         "57-00-1",
         "CN(CC(O)=O)C(N)=N",
         "InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)",
         "CVSVTCORWBXHQV-UHFFFAOYSA-N",
         "566",
         "DB00148",
         "586",
         null,
         "16919",
         "C00300"
        ],
        [
         "46",
         "HMDB0000067",
         "Cholesterol",
         "(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",
         "57-88-5",
         "[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C",
         "InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1",
         "HVYWMOMLDIMFJA-DPAQBDIFSA-N",
         null,
         "DB04540",
         "5997",
         null,
         "16113",
         "C00187"
        ],
        [
         "47",
         "HMDB0000068",
         "Epinephrine",
         "4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol",
         "51-43-4",
         "CNC[C@H](O)C1=CC(O)=C(O)C=C1",
         "InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",
         "UCTWMZQNUQWSLP-VIFPVBQESA-N",
         "5611",
         "DB00668",
         "5816",
         null,
         "28918",
         "C00788"
        ],
        [
         "48",
         "HMDB0000070",
         "Pipecolic acid",
         "piperidine-2-carboxylic acid",
         "535-75-1",
         "OC(=O)C1CCCCN1",
         "InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)",
         "HXEACLLIILLPRG-UHFFFAOYSA-N",
         "826",
         null,
         "849",
         null,
         "17964",
         "C00408"
        ],
        [
         "49",
         "HMDB0000071",
         "Deoxyinosine",
         "9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-ol",
         "890-38-0",
         "OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC2=O",
         "InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1",
         "VGONTNSXDCQUGY-RRKCRQDMSA-N",
         "58569",
         "DB02380",
         "65058",
         null,
         "28997",
         "C05512"
        ]
       ],
       "shape": {
        "columns": 13,
        "rows": 217920
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>accession</th>\n",
       "      <th>name</th>\n",
       "      <th>iupac_name</th>\n",
       "      <th>cas_registry_number</th>\n",
       "      <th>smiles</th>\n",
       "      <th>inchi</th>\n",
       "      <th>inchikey</th>\n",
       "      <th>chemspider_id</th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>pubchem_compound_id</th>\n",
       "      <th>pdb_id</th>\n",
       "      <th>chebi_id</th>\n",
       "      <th>kegg_id</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>HMDB0000001</td>\n",
       "      <td>1-Methylhistidine</td>\n",
       "      <td>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...</td>\n",
       "      <td>332-80-9</td>\n",
       "      <td>CN1C=NC(C[C@H](N)C(O)=O)=C1</td>\n",
       "      <td>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11...</td>\n",
       "      <td>BRMWTNUJHUMWMS-LURJTMIESA-N</td>\n",
       "      <td>83153</td>\n",
       "      <td>DB04151</td>\n",
       "      <td>92105</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50599</td>\n",
       "      <td>C01152</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HMDB0000002</td>\n",
       "      <td>1,3-Diaminopropane</td>\n",
       "      <td>propane-1,3-diamine</td>\n",
       "      <td>109-76-2</td>\n",
       "      <td>NCCCN</td>\n",
       "      <td>InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2</td>\n",
       "      <td>XFNJVJPLKCPIBV-UHFFFAOYSA-N</td>\n",
       "      <td>415</td>\n",
       "      <td>NaN</td>\n",
       "      <td>428</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15725</td>\n",
       "      <td>C00986</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HMDB0000005</td>\n",
       "      <td>2-Ketobutyric acid</td>\n",
       "      <td>2-oxobutanoic acid</td>\n",
       "      <td>600-18-0</td>\n",
       "      <td>CCC(=O)C(O)=O</td>\n",
       "      <td>InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)</td>\n",
       "      <td>TYEYBOSBBBHJIV-UHFFFAOYSA-N</td>\n",
       "      <td>57</td>\n",
       "      <td>DB04553</td>\n",
       "      <td>58</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30831</td>\n",
       "      <td>C00109</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>HMDB0000008</td>\n",
       "      <td>2-Hydroxybutyric acid</td>\n",
       "      <td>(2S)-2-hydroxybutanoic acid</td>\n",
       "      <td>3347-90-8</td>\n",
       "      <td>CC[C@H](O)C(O)=O</td>\n",
       "      <td>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(...</td>\n",
       "      <td>AFENDNXGAFYKQO-VKHMYHEASA-N</td>\n",
       "      <td>389701</td>\n",
       "      <td>NaN</td>\n",
       "      <td>440864</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50613</td>\n",
       "      <td>C05984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>HMDB0000010</td>\n",
       "      <td>2-Methoxyestrone</td>\n",
       "      <td>(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyl...</td>\n",
       "      <td>362-08-3</td>\n",
       "      <td>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[...</td>\n",
       "      <td>InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18...</td>\n",
       "      <td>WHEUWNKSCXYKBU-QPWUGHHJSA-N</td>\n",
       "      <td>389515</td>\n",
       "      <td>NaN</td>\n",
       "      <td>440624</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1189</td>\n",
       "      <td>C05299</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217915</th>\n",
       "      <td>HMDB0304947</td>\n",
       "      <td>Nordeoxycholic acid</td>\n",
       "      <td>3-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7....</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CC(CC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C</td>\n",
       "      <td>InChI=1S/C23H38O4/c1-13(10-21(26)27)17-6-7-18-...</td>\n",
       "      <td>PLRQOCVIINWCFA-UHFFFAOYSA-N</td>\n",
       "      <td>278117</td>\n",
       "      <td>NaN</td>\n",
       "      <td>314374</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217916</th>\n",
       "      <td>HMDB0304950</td>\n",
       "      <td>3-Oxo-5beta-cholanoic acid</td>\n",
       "      <td>4-{2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CC(CCC(O)=O)C1CCC2C3CCC4CC(=O)CCC4(C)C3CCC12C</td>\n",
       "      <td>InChI=1S/C24H38O3/c1-15(4-9-22(26)27)19-7-8-20...</td>\n",
       "      <td>KIQFUORWRVZTHT-UHFFFAOYSA-N</td>\n",
       "      <td>473110</td>\n",
       "      <td>NaN</td>\n",
       "      <td>543448</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217917</th>\n",
       "      <td>HMDB0304951</td>\n",
       "      <td>Glycerol 1-myristate</td>\n",
       "      <td>2,3-dihydroxypropyl tetradecanoate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CCCCCCCCCCCCCC(=O)OCC(O)CO</td>\n",
       "      <td>InChI=1S/C17H34O4/c1-2-3-4-5-6-7-8-9-10-11-12-...</td>\n",
       "      <td>DCBSHORRWZKAKO-UHFFFAOYSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>79050</td>\n",
       "      <td>NaN</td>\n",
       "      <td>75562</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217918</th>\n",
       "      <td>HMDB0304953</td>\n",
       "      <td>O-Phenolsulfonic acid</td>\n",
       "      <td>2-hydroxybenzene-1-sulfonic acid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>OC1=CC=CC=C1S(O)(=O)=O</td>\n",
       "      <td>InChI=1S/C6H6O4S/c7-5-3-1-2-4-6(5)11(8,9)10/h1...</td>\n",
       "      <td>IULJSGIJJZZUMF-UHFFFAOYSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>11867</td>\n",
       "      <td>NaN</td>\n",
       "      <td>71049</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217919</th>\n",
       "      <td>HMDB0304954</td>\n",
       "      <td>d-Fucitol</td>\n",
       "      <td>(2R,3S,4R,5S)-hexane-1,2,3,4,5-pentol</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[H][C@@](C)(O)[C@@]([H])(O)[C@@]([H])(O)[C@]([...</td>\n",
       "      <td>InChI=1S/C6H14O5/c1-3(8)5(10)6(11)4(9)2-7/h3-1...</td>\n",
       "      <td>SKCKOFZKJLZSFA-KCDKBNATSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>DB03815</td>\n",
       "      <td>445724</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>217920 rows Ã— 13 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          accession                        name  \\\n",
       "0       HMDB0000001           1-Methylhistidine   \n",
       "1       HMDB0000002          1,3-Diaminopropane   \n",
       "2       HMDB0000005          2-Ketobutyric acid   \n",
       "3       HMDB0000008       2-Hydroxybutyric acid   \n",
       "4       HMDB0000010            2-Methoxyestrone   \n",
       "...             ...                         ...   \n",
       "217915  HMDB0304947         Nordeoxycholic acid   \n",
       "217916  HMDB0304950  3-Oxo-5beta-cholanoic acid   \n",
       "217917  HMDB0304951        Glycerol 1-myristate   \n",
       "217918  HMDB0304953       O-Phenolsulfonic acid   \n",
       "217919  HMDB0304954                   d-Fucitol   \n",
       "\n",
       "                                               iupac_name cas_registry_number  \\\n",
       "0       (2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...            332-80-9   \n",
       "1                                     propane-1,3-diamine            109-76-2   \n",
       "2                                      2-oxobutanoic acid            600-18-0   \n",
       "3                             (2S)-2-hydroxybutanoic acid           3347-90-8   \n",
       "4       (1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyl...            362-08-3   \n",
       "...                                                   ...                 ...   \n",
       "217915  3-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7....                 NaN   \n",
       "217916  4-{2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}...                 NaN   \n",
       "217917                 2,3-dihydroxypropyl tetradecanoate                 NaN   \n",
       "217918                   2-hydroxybenzene-1-sulfonic acid                 NaN   \n",
       "217919              (2R,3S,4R,5S)-hexane-1,2,3,4,5-pentol                 NaN   \n",
       "\n",
       "                                                   smiles  \\\n",
       "0                             CN1C=NC(C[C@H](N)C(O)=O)=C1   \n",
       "1                                                   NCCCN   \n",
       "2                                           CCC(=O)C(O)=O   \n",
       "3                                        CC[C@H](O)C(O)=O   \n",
       "4       [H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[...   \n",
       "...                                                   ...   \n",
       "217915     CC(CC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C   \n",
       "217916      CC(CCC(O)=O)C1CCC2C3CCC4CC(=O)CCC4(C)C3CCC12C   \n",
       "217917                         CCCCCCCCCCCCCC(=O)OCC(O)CO   \n",
       "217918                             OC1=CC=CC=C1S(O)(=O)=O   \n",
       "217919  [H][C@@](C)(O)[C@@]([H])(O)[C@@]([H])(O)[C@]([...   \n",
       "\n",
       "                                                    inchi  \\\n",
       "0       InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11...   \n",
       "1                      InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2   \n",
       "2         InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)   \n",
       "3       InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(...   \n",
       "4       InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18...   \n",
       "...                                                   ...   \n",
       "217915  InChI=1S/C23H38O4/c1-13(10-21(26)27)17-6-7-18-...   \n",
       "217916  InChI=1S/C24H38O3/c1-15(4-9-22(26)27)19-7-8-20...   \n",
       "217917  InChI=1S/C17H34O4/c1-2-3-4-5-6-7-8-9-10-11-12-...   \n",
       "217918  InChI=1S/C6H6O4S/c7-5-3-1-2-4-6(5)11(8,9)10/h1...   \n",
       "217919  InChI=1S/C6H14O5/c1-3(8)5(10)6(11)4(9)2-7/h3-1...   \n",
       "\n",
       "                           inchikey chemspider_id drugbank_id  \\\n",
       "0       BRMWTNUJHUMWMS-LURJTMIESA-N         83153     DB04151   \n",
       "1       XFNJVJPLKCPIBV-UHFFFAOYSA-N           415         NaN   \n",
       "2       TYEYBOSBBBHJIV-UHFFFAOYSA-N            57     DB04553   \n",
       "3       AFENDNXGAFYKQO-VKHMYHEASA-N        389701         NaN   \n",
       "4       WHEUWNKSCXYKBU-QPWUGHHJSA-N        389515         NaN   \n",
       "...                             ...           ...         ...   \n",
       "217915  PLRQOCVIINWCFA-UHFFFAOYSA-N        278117         NaN   \n",
       "217916  KIQFUORWRVZTHT-UHFFFAOYSA-N        473110         NaN   \n",
       "217917  DCBSHORRWZKAKO-UHFFFAOYSA-N          <NA>         NaN   \n",
       "217918  IULJSGIJJZZUMF-UHFFFAOYSA-N          <NA>         NaN   \n",
       "217919  SKCKOFZKJLZSFA-KCDKBNATSA-N          <NA>     DB03815   \n",
       "\n",
       "       pubchem_compound_id pdb_id chebi_id kegg_id  \n",
       "0                    92105    NaN    50599  C01152  \n",
       "1                      428    NaN    15725  C00986  \n",
       "2                       58    NaN    30831  C00109  \n",
       "3                   440864    NaN    50613  C05984  \n",
       "4                   440624    NaN     1189  C05299  \n",
       "...                    ...    ...      ...     ...  \n",
       "217915              314374    NaN     <NA>     NaN  \n",
       "217916              543448    NaN     <NA>     NaN  \n",
       "217917               79050    NaN    75562     NaN  \n",
       "217918               11867    NaN    71049     NaN  \n",
       "217919              445724    NaN     <NA>     NaN  \n",
       "\n",
       "[217920 rows x 13 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hmdb['chemspider_id'] = hmdb['chemspider_id'].apply(lambda x: str(int(x)) if pd.notnull(x) else '')  # Convert the 'chemspider_id' column to a string\n",
    "hmdb['pubchem_compound_id'] = hmdb['pubchem_compound_id'].apply(lambda x: str(int(x)) if pd.notnull(x) else '')  # Convert the 'pubchem_compound_id' column to a string\n",
    "hmdb['chebi_id'] = hmdb['chebi_id'].apply(lambda x: str(int(x)) if pd.notnull(x) else '')  # Convert the 'pdb_id' column to a string\n",
    "hmdb.replace('', pd.NA, inplace=True)  # Replace empty strings with missing values\n",
    "hmdb"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 2.2 ChEBI"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Metabolome ChEBI"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "chebi_id",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "chebi_name",
         "rawType": "object",
         "type": "string"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "7a4d701d-703b-459d-949d-4f9f9ff72e53",
       "rows": [
        [
         "0",
         "10983",
         "(R)-3-hydroxybutyrate"
        ],
        [
         "1",
         "17771",
         "trans-urocanate"
        ],
        [
         "2",
         "18703",
         "D-pipecolate"
        ],
        [
         "3",
         "45479",
         "13-cis-retinol"
        ],
        [
         "4",
         "45487",
         "13-cis-retinal"
        ],
        [
         "5",
         "64559",
         "lysophosphatidylcholine 20:5"
        ],
        [
         "6",
         "67056",
         "lysophosphatidylcholine 20:2"
        ],
        [
         "7",
         "76076",
         "2-stearoyl-sn-glycero-3-phosphocholine"
        ],
        [
         "8",
         "84834",
         "O-hexanoyl-L-carnitine"
        ],
        [
         "9",
         "84838",
         "O-isobutyryl-L-carnitine"
        ],
        [
         "10",
         "85349",
         "CDP-1-stearoyl-2-arachidonoyl-sn-glycerol(2-)"
        ],
        [
         "11",
         "85350",
         "CDP-1-palmitoyl-2-arachidonoyl-sn-glycerol(2-)"
        ],
        [
         "12",
         "85352",
         "CDP-1-stearoyl-2-linoleoyl-sn-glycerol(2-)"
        ],
        [
         "13",
         "85353",
         "CDP-1-stearoyl-2-oleoyl-sn-glycerol(2-)"
        ],
        [
         "14",
         "85963",
         "1,2-dioleoyl-sn-glycero-3-phospho-N,N-dimethylethanolamine"
        ],
        [
         "15",
         "86514",
         "N-hexacosahexaenoylsphingosine"
        ],
        [
         "16",
         "91297",
         "lysophosphatidylcholine(0:0/16:0)"
        ],
        [
         "17",
         "91298",
         "lysophosphatidylcholine(0:0/16:1)"
        ],
        [
         "18",
         "91299",
         "lysophosphatidylcholine(0:0/18:0)"
        ],
        [
         "19",
         "91302",
         "lysophosphatidylcholine(0:0/18:2)"
        ],
        [
         "20",
         "91303",
         "lysophosphatidylcholine(0:0/20:4)"
        ],
        [
         "21",
         "91304",
         "lysophosphatidylcholine(0:0/20:5)"
        ],
        [
         "22",
         "91305",
         "lysophosphatidylcholine(16:1/0:0)"
        ],
        [
         "23",
         "91309",
         "lysophosphatidylcholine(18:2/0:0)"
        ],
        [
         "24",
         "91310",
         "lysophosphatidylcholine(20:4/0:0)"
        ],
        [
         "25",
         "91311",
         "1-icosapentaenoyl-sn-glycero-3-phosphocholine"
        ],
        [
         "26",
         "91312",
         "lysophosphatidylcholine 22:4"
        ],
        [
         "27",
         "91313",
         "lysophosphatidylcholine(18:0/0:0)"
        ],
        [
         "28",
         "113",
         "(S)-salsolinol"
        ],
        [
         "29",
         "766",
         "estriol 16-O-(beta-D-glucuronide)"
        ],
        [
         "30",
         "771",
         "16alpha-hydroxypregnenolone"
        ],
        [
         "31",
         "783",
         "(20R)-17alpha,20-dihydroxycholesterol"
        ],
        [
         "32",
         "799",
         "3,17-dioxoandrost-4-en-19-al"
        ],
        [
         "33",
         "1156",
         "2-hydroxyestrone"
        ],
        [
         "34",
         "1157",
         "isethionic acid"
        ],
        [
         "35",
         "1189",
         "2-methoxyestrone"
        ],
        [
         "36",
         "1294",
         "(20R,22R)-20,22-dihydroxycholesterol"
        ],
        [
         "37",
         "1296",
         "20-hydroxycholesterol"
        ],
        [
         "38",
         "1463",
         "3-carboxy-1-hydroxypropylthiamine diphosphate"
        ],
        [
         "39",
         "1604",
         "3-methylguanine"
        ],
        [
         "40",
         "1905",
         "4-methylumbelliferone sulfate"
        ],
        [
         "41",
         "2274",
         "7-methylguanine"
        ],
        [
         "42",
         "2288",
         "7alpha,12alpha-dihydroxy-5beta-cholestan-3-one"
        ],
        [
         "43",
         "2290",
         "7alpha-hydroxy-5beta-cholestan-3-one"
        ],
        [
         "44",
         "3110",
         "biotinyl-5'-AMP"
        ],
        [
         "45",
         "3424",
         "carnitinium"
        ],
        [
         "46",
         "3663",
         "cholesteryl palmitate"
        ],
        [
         "47",
         "4251",
         "D-tagatofuranose 6-phosphate"
        ],
        [
         "48",
         "4705",
         "double-stranded DNA"
        ],
        [
         "49",
         "6220",
         "alpha-L-fucose 1-phosphate"
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 5757
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>chebi_id</th>\n",
       "      <th>chebi_name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10983</td>\n",
       "      <td>(R)-3-hydroxybutyrate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>17771</td>\n",
       "      <td>trans-urocanate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>18703</td>\n",
       "      <td>D-pipecolate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>45479</td>\n",
       "      <td>13-cis-retinol</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>45487</td>\n",
       "      <td>13-cis-retinal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5752</th>\n",
       "      <td>192078</td>\n",
       "      <td>L-citrulline-d2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5753</th>\n",
       "      <td>192080</td>\n",
       "      <td>L-methionine-d3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5754</th>\n",
       "      <td>192086</td>\n",
       "      <td>L-valine-d8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5755</th>\n",
       "      <td>192088</td>\n",
       "      <td>L-proline-d7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5756</th>\n",
       "      <td>192084</td>\n",
       "      <td>L-phenylalanine-d5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5757 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     chebi_id             chebi_name\n",
       "0       10983  (R)-3-hydroxybutyrate\n",
       "1       17771        trans-urocanate\n",
       "2       18703           D-pipecolate\n",
       "3       45479         13-cis-retinol\n",
       "4       45487         13-cis-retinal\n",
       "...       ...                    ...\n",
       "5752   192078        L-citrulline-d2\n",
       "5753   192080        L-methionine-d3\n",
       "5754   192086            L-valine-d8\n",
       "5755   192088           L-proline-d7\n",
       "5756   192084     L-phenylalanine-d5\n",
       "\n",
       "[5757 rows x 2 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Since there seems to be misalignment in the data, I'll read the file line by line, and split manually\n",
    "with open('ChEBI_Results.tsv', 'r') as file:\n",
    "    lines = file.readlines()\n",
    "\n",
    "# Split each line by tab and manually build the dataframe\n",
    "data = [line.strip().split('\\t') for line in lines]\n",
    "\n",
    "# Create a DataFrame from the split data\n",
    "chebi = pd.DataFrame(data[1:], columns=[\"ID\", \"NAME\"])\n",
    "chebi['ID'] = chebi['ID'].apply(lambda x: x.split(':')[-1])  # Extract the ChEBI ID from the 'ID' column\n",
    "chebi = chebi.rename(columns={'ID': 'chebi_id', 'NAME': 'chebi_name'})  # Rename the columns\n",
    "chebi"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Xref"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "chebi_id",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Agricola citation",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "BPDB accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Beilstein Registry Number",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "CAS Registry Number",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "COMe accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ChemIDplus accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Chemspider accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Chinese Abstracts citation",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "CiteXplore citation",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Drug Central accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "DrugBank accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ECMDB accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "FAO/WHO standards accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "FooDB accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "GlyGen accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "GlyTouCan accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Gmelin Registry Number",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "HMDB accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "KEGG COMPOUND accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "KEGG DRUG accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "KEGG GLYCAN accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "KNApSAcK accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "LINCS accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "LIPID MAPS class accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "LIPID MAPS instance accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "MetaCyc accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "MolBase accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PDB accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PDBeChem accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PPDB accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PPR",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Patent accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Pesticides accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PubMed Central citation",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PubMed citation",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Pubchem accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "RESID accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Reaxys Registry Number",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "SMID accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "UM-BBD compID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "VSDB accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "WebElements accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "Wikipedia accession",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "YMDB accession",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "bbdc1adb-52ac-4f4f-9507-cbc870d01ae2",
       "rows": [
        [
         "0",
         "10",
         null,
         null,
         null,
         "21008-67-3",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "C11141",
         null,
         null,
         "C00001814",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "1",
         "100",
         null,
         null,
         "1257009",
         "32383-76-9;32383-76-9",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "C10503",
         null,
         null,
         "C00002547",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "2",
         "10000",
         null,
         null,
         null,
         "87605-72-9",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "C09977",
         null,
         null,
         "C00003022",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "3",
         "100000",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11379",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "4",
         "100001",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11380",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "5",
         "100002",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11381",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "6",
         "100003",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11382",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "7",
         "100004",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11383",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "8",
         "100005",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11384",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "9",
         "100006",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11385",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "10",
         "100007",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11386",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "11",
         "100008",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11387",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "12",
         "100009",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11388",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "13",
         "10001",
         null,
         null,
         null,
         "477-32-7",
         null,
         null,
         null,
         null,
         null,
         "3649",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "C09316",
         "D08735",
         null,
         "C00002504",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "14",
         "100010",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11389",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "15",
         "100011",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11390",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "16",
         "100012",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11391",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "17",
         "100013",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11392",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "18",
         "100014",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11393",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "19",
         "100015",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11394",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "20",
         "100016",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11395",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "21",
         "100017",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11396",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "22",
         "100018",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11397",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "23",
         "100019",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11398",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "24",
         "10002",
         null,
         null,
         null,
         "82-57-5;82-57-5",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "C09049",
         null,
         null,
         "C00002447",
         "LSM-25873",
         null,
         "LMPK13110003",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "27004212;27936681;25504881;24069365;22085634;21165322;23096256;21116788;21069311;19188097;20036111;10705731;9175638;8605947;9487797;25111086;9888257",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "Visnagin",
         null
        ],
        [
         "25",
         "100020",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11399",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "26",
         "100021",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11400",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "27",
         "100022",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11401",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "28",
         "100023",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11402",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "29",
         "100024",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11403",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "30",
         "100025",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11404",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "31",
         "100026",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11405",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "32",
         "100027",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11406",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "33",
         "100028",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11407",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "34",
         "100029",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11408",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "35",
         "10003",
         null,
         null,
         null,
         "53797-35-6;53797-35-6",
         null,
         null,
         null,
         null,
         null,
         null,
         "DB03615",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "D02209",
         null,
         null,
         null,
         null,
         null,
         "CPD-14143",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "8820400",
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "36",
         "100030",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11409",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "37",
         "100031",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11410",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "38",
         "100032",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11411",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "39",
         "100033",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11412",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "40",
         "100034",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11413",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "41",
         "100035",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11414",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "42",
         "100036",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11415",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "43",
         "100037",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11416",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "44",
         "100038",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11417",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "45",
         "100039",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11418",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "46",
         "100040",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11419",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "47",
         "100041",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11420",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "48",
         "100042",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11421",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ],
        [
         "49",
         "100043",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         "LSM-11422",
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null,
         null
        ]
       ],
       "shape": {
        "columns": 45,
        "rows": 161983
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>TYPE</th>\n",
       "      <th>chebi_id</th>\n",
       "      <th>Agricola citation</th>\n",
       "      <th>BPDB accession</th>\n",
       "      <th>Beilstein Registry Number</th>\n",
       "      <th>CAS Registry Number</th>\n",
       "      <th>COMe accession</th>\n",
       "      <th>ChemIDplus accession</th>\n",
       "      <th>Chemspider accession</th>\n",
       "      <th>Chinese Abstracts citation</th>\n",
       "      <th>CiteXplore citation</th>\n",
       "      <th>...</th>\n",
       "      <th>PubMed citation</th>\n",
       "      <th>Pubchem accession</th>\n",
       "      <th>RESID accession</th>\n",
       "      <th>Reaxys Registry Number</th>\n",
       "      <th>SMID accession</th>\n",
       "      <th>UM-BBD compID</th>\n",
       "      <th>VSDB accession</th>\n",
       "      <th>WebElements accession</th>\n",
       "      <th>Wikipedia accession</th>\n",
       "      <th>YMDB accession</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>21008-67-3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>100</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1257009</td>\n",
       "      <td>32383-76-9;32383-76-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>87605-72-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>100000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>100001</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161978</th>\n",
       "      <td>99995</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161979</th>\n",
       "      <td>99996</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161980</th>\n",
       "      <td>99997</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161981</th>\n",
       "      <td>99998</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161982</th>\n",
       "      <td>99999</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>161983 rows Ã— 45 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "TYPE   chebi_id Agricola citation BPDB accession Beilstein Registry Number  \\\n",
       "0            10               NaN            NaN                       NaN   \n",
       "1           100               NaN            NaN                   1257009   \n",
       "2         10000               NaN            NaN                       NaN   \n",
       "3        100000               NaN            NaN                       NaN   \n",
       "4        100001               NaN            NaN                       NaN   \n",
       "...         ...               ...            ...                       ...   \n",
       "161978    99995               NaN            NaN                       NaN   \n",
       "161979    99996               NaN            NaN                       NaN   \n",
       "161980    99997               NaN            NaN                       NaN   \n",
       "161981    99998               NaN            NaN                       NaN   \n",
       "161982    99999               NaN            NaN                       NaN   \n",
       "\n",
       "TYPE      CAS Registry Number COMe accession ChemIDplus accession  \\\n",
       "0                  21008-67-3            NaN                  NaN   \n",
       "1       32383-76-9;32383-76-9            NaN                  NaN   \n",
       "2                  87605-72-9            NaN                  NaN   \n",
       "3                         NaN            NaN                  NaN   \n",
       "4                         NaN            NaN                  NaN   \n",
       "...                       ...            ...                  ...   \n",
       "161978                    NaN            NaN                  NaN   \n",
       "161979                    NaN            NaN                  NaN   \n",
       "161980                    NaN            NaN                  NaN   \n",
       "161981                    NaN            NaN                  NaN   \n",
       "161982                    NaN            NaN                  NaN   \n",
       "\n",
       "TYPE   Chemspider accession Chinese Abstracts citation CiteXplore citation  \\\n",
       "0                       NaN                        NaN                 NaN   \n",
       "1                       NaN                        NaN                 NaN   \n",
       "2                       NaN                        NaN                 NaN   \n",
       "3                       NaN                        NaN                 NaN   \n",
       "4                       NaN                        NaN                 NaN   \n",
       "...                     ...                        ...                 ...   \n",
       "161978                  NaN                        NaN                 NaN   \n",
       "161979                  NaN                        NaN                 NaN   \n",
       "161980                  NaN                        NaN                 NaN   \n",
       "161981                  NaN                        NaN                 NaN   \n",
       "161982                  NaN                        NaN                 NaN   \n",
       "\n",
       "TYPE    ... PubMed citation Pubchem accession RESID accession  \\\n",
       "0       ...             NaN               NaN             NaN   \n",
       "1       ...             NaN               NaN             NaN   \n",
       "2       ...             NaN               NaN             NaN   \n",
       "3       ...             NaN               NaN             NaN   \n",
       "4       ...             NaN               NaN             NaN   \n",
       "...     ...             ...               ...             ...   \n",
       "161978  ...             NaN               NaN             NaN   \n",
       "161979  ...             NaN               NaN             NaN   \n",
       "161980  ...             NaN               NaN             NaN   \n",
       "161981  ...             NaN               NaN             NaN   \n",
       "161982  ...             NaN               NaN             NaN   \n",
       "\n",
       "TYPE   Reaxys Registry Number SMID accession UM-BBD compID VSDB accession  \\\n",
       "0                         NaN            NaN           NaN            NaN   \n",
       "1                         NaN            NaN           NaN            NaN   \n",
       "2                         NaN            NaN           NaN            NaN   \n",
       "3                         NaN            NaN           NaN            NaN   \n",
       "4                         NaN            NaN           NaN            NaN   \n",
       "...                       ...            ...           ...            ...   \n",
       "161978                    NaN            NaN           NaN            NaN   \n",
       "161979                    NaN            NaN           NaN            NaN   \n",
       "161980                    NaN            NaN           NaN            NaN   \n",
       "161981                    NaN            NaN           NaN            NaN   \n",
       "161982                    NaN            NaN           NaN            NaN   \n",
       "\n",
       "TYPE   WebElements accession Wikipedia accession YMDB accession  \n",
       "0                        NaN                 NaN            NaN  \n",
       "1                        NaN                 NaN            NaN  \n",
       "2                        NaN                 NaN            NaN  \n",
       "3                        NaN                 NaN            NaN  \n",
       "4                        NaN                 NaN            NaN  \n",
       "...                      ...                 ...            ...  \n",
       "161978                   NaN                 NaN            NaN  \n",
       "161979                   NaN                 NaN            NaN  \n",
       "161980                   NaN                 NaN            NaN  \n",
       "161981                   NaN                 NaN            NaN  \n",
       "161982                   NaN                 NaN            NaN  \n",
       "\n",
       "[161983 rows x 45 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chebi_xref = pd.read_csv('database_accession.tsv', sep='\\t')  # Load the 'chebi_xrefs.tsv' file into a DataFrame\n",
    "chebi_xref['COMPOUND_ID'] = chebi_xref['COMPOUND_ID'].apply(lambda x: str(int(x)))  # Convert the 'COMPOUND_ID' column to a string\n",
    "chebi_xref = chebi_xref[['COMPOUND_ID', 'TYPE', 'ACCESSION_NUMBER']]  # Select only the relevant columns\n",
    "chebi_xref = chebi_xref.rename(columns={'COMPOUND_ID': 'chebi_id'})  # Rename the columns\n",
    "\n",
    "chebi_xref_pivot = chebi_xref.pivot_table(index='chebi_id', columns='TYPE', values='ACCESSION_NUMBER', aggfunc=lambda x: ';'.join(map(str, x)))  # Pivot the DataFrame\n",
    "chebi_xref_pivot.reset_index(inplace=True)  # Reset the index\n",
    "chebi_xref_pivot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "chebi_id",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "chebi_name",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "CAS Registry Number",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "HMDB accession",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "9b05e8fa-c001-40f0-91bf-ec8ed06e1cbb",
       "rows": [
        [
         "0",
         "10216",
         "cedr-8-ene",
         "469-61-4",
         "HMDB0059695"
        ],
        [
         "1",
         "10224",
         "alpha-cubebene",
         "17699-14-8",
         "HMDB0036413"
        ],
        [
         "2",
         "102485",
         "5-carboxy-2'-deoxyuridine",
         "14599-46-3",
         "HMDB0060774"
        ],
        [
         "3",
         "10295",
         "alpha-L-sorbopyranose",
         "470-15-5",
         null
        ],
        [
         "4",
         "10319",
         "1-naphthol",
         "90-15-3",
         "HMDB0012138"
        ],
        [
         "5",
         "10432",
         "2-naphthol",
         "135-19-3",
         "HMDB0012322"
        ],
        [
         "6",
         "104586",
         "tetrahexadecanoyl cardiolipin",
         null,
         "HMDB0056387"
        ],
        [
         "7",
         "10577",
         "gamma-terpinene",
         "99-85-4",
         "HMDB0005806"
        ],
        [
         "8",
         "10588",
         "1-(3-chlorophenyl)piperazine",
         "6640-24-0",
         "HMDB0061008"
        ],
        [
         "9",
         "10589",
         "m-toluic acid",
         "99-04-7",
         null
        ],
        [
         "10",
         "10642",
         "scyllo-inositol",
         "488-59-5",
         null
        ],
        [
         "11",
         "109455",
         "1-hexadecanoyl-2-[(9Z)-hexadecenoyl]-3-[(9Z)-octadecenoyl]-sn-glycerol",
         null,
         "HMDB0005377"
        ],
        [
         "12",
         "11060",
         "(S)-carnitine",
         "541-14-0",
         null
        ],
        [
         "13",
         "11152",
         "1,2-didecanoylglycerol",
         "17863-69-3",
         null
        ],
        [
         "14",
         "111762",
         "nordazepam",
         "1088-11-5",
         null
        ],
        [
         "15",
         "113",
         "(S)-salsolinol",
         "27740-96-1",
         null
        ],
        [
         "16",
         "113373",
         "sodium 3-hydroxybutyrate",
         "150-83-4",
         null
        ],
        [
         "17",
         "113451",
         "sodium ascorbate",
         "134-03-2",
         null
        ],
        [
         "18",
         "113455",
         "sodium benzoate",
         "532-32-1",
         null
        ],
        [
         "19",
         "114126",
         "sodium hexanoate",
         "10051-44-2",
         null
        ],
        [
         "20",
         "1148",
         "2-hydroxybutyric acid",
         "600-15-7",
         "HMDB0000008"
        ],
        [
         "21",
         "115197",
         "sodium gallate",
         "2053-21-6",
         null
        ],
        [
         "22",
         "1156",
         "2-hydroxyestrone",
         "362-06-1",
         "HMDB0000343"
        ],
        [
         "23",
         "1157",
         "isethionic acid",
         "107-36-8",
         "HMDB0003903"
        ],
        [
         "24",
         "116314",
         "oleamide",
         "301-02-0",
         "HMDB0002117"
        ],
        [
         "25",
         "11684",
         "3,3',5'-triiodo-L-thyronine",
         "5817-39-0",
         null
        ],
        [
         "26",
         "1189",
         "2-methoxyestrone",
         "362-08-3",
         null
        ],
        [
         "27",
         "12387",
         "beta-L-fucose 1-phosphate",
         "28553-11-9",
         null
        ],
        [
         "28",
         "125678",
         "N-acetyldopamine",
         "2494-12-4",
         "HMDB0041943"
        ],
        [
         "29",
         "1294",
         "(20R,22R)-20,22-dihydroxycholesterol",
         "596-94-1",
         "HMDB0006763"
        ],
        [
         "30",
         "1296",
         "20-hydroxycholesterol",
         "516-72-3",
         "HMDB0006283"
        ],
        [
         "31",
         "12962",
         "D-glucosamine 6-phosphate",
         null,
         "HMDB0001254"
        ],
        [
         "32",
         "131190",
         "androsta-1,4,6-triene-3,17-dione",
         "633-35-2",
         null
        ],
        [
         "33",
         "131194",
         "3,3',5,5'-tetraiodothyroacetic acid",
         "67-30-1",
         null
        ],
        [
         "34",
         "131392",
         "3-hydroxy-2,2-dimethylbutyric acid",
         "29269-83-8",
         null
        ],
        [
         "35",
         "131424",
         "(2-ethoxyethoxy)acetic acid",
         "7743-94-4",
         null
        ],
        [
         "36",
         "131431",
         "(3,5-dihydroxyphenyl)acetic acid",
         "4670-09-1",
         "HMDB0094709"
        ],
        [
         "37",
         "131434",
         "5-hydroxyhexanoic acid",
         "44843-89-2",
         "HMDB0000525"
        ],
        [
         "38",
         "131529",
         "pyridoxal hydrochloride",
         "65-22-5",
         null
        ],
        [
         "39",
         "131531",
         "pyridoxamine hydrochloride",
         "5103-96-8",
         null
        ],
        [
         "40",
         "131532",
         "pyridoxamine dihydrochloride",
         "524-36-7",
         null
        ],
        [
         "41",
         "131607",
         "2-phenylpropan-2-ol",
         "617-94-7",
         null
        ],
        [
         "42",
         "131690",
         "1-icosanoyl-sn-glycero-3-phosphoethanolamine",
         null,
         "HMDB0011511"
        ],
        [
         "43",
         "131743",
         "2-hexadecanoyl-sn-glycero-3-phosphoethanolamine",
         null,
         "HMDB0011473"
        ],
        [
         "44",
         "131845",
         "2-methylpropane-1,2-diol",
         "558-43-0",
         null
        ],
        [
         "45",
         "131887",
         "O-heptadecanoylcarnitine",
         null,
         "HMDB0006210"
        ],
        [
         "46",
         "131888",
         "8-epi-prostaglandin E2",
         "27415-25-4",
         "HMDB0005844"
        ],
        [
         "47",
         "131924",
         "1-pentadecanoyl-sn-glycero-3-phosphocholine",
         null,
         "HMDB0010381"
        ],
        [
         "48",
         "131977",
         "1,2-dioleoyl-3-[(11Z)-icosenoyl]-sn-glycerol",
         null,
         "HMDB0005454"
        ],
        [
         "49",
         "132041",
         "perindoprilat",
         "95153-31-4",
         "HMDB0060574"
        ]
       ],
       "shape": {
        "columns": 4,
        "rows": 2934
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>TYPE</th>\n",
       "      <th>chebi_id</th>\n",
       "      <th>chebi_name</th>\n",
       "      <th>CAS Registry Number</th>\n",
       "      <th>HMDB accession</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10216</td>\n",
       "      <td>cedr-8-ene</td>\n",
       "      <td>469-61-4</td>\n",
       "      <td>HMDB0059695</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10224</td>\n",
       "      <td>alpha-cubebene</td>\n",
       "      <td>17699-14-8</td>\n",
       "      <td>HMDB0036413</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>102485</td>\n",
       "      <td>5-carboxy-2'-deoxyuridine</td>\n",
       "      <td>14599-46-3</td>\n",
       "      <td>HMDB0060774</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10295</td>\n",
       "      <td>alpha-L-sorbopyranose</td>\n",
       "      <td>470-15-5</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>10319</td>\n",
       "      <td>1-naphthol</td>\n",
       "      <td>90-15-3</td>\n",
       "      <td>HMDB0012138</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2929</th>\n",
       "      <td>9410</td>\n",
       "      <td>taurodeoxycholic acid</td>\n",
       "      <td>516-50-7</td>\n",
       "      <td>HMDB0000896</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2930</th>\n",
       "      <td>9440</td>\n",
       "      <td>tenuazonic acid</td>\n",
       "      <td>27778-66-1</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2931</th>\n",
       "      <td>9533</td>\n",
       "      <td>thiamine(1+) monophosphate</td>\n",
       "      <td>10023-48-0</td>\n",
       "      <td>HMDB0002666</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2932</th>\n",
       "      <td>9534</td>\n",
       "      <td>thiamine(1+) triphosphate</td>\n",
       "      <td>50851-39-3</td>\n",
       "      <td>HMDB0001512</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2933</th>\n",
       "      <td>9907</td>\n",
       "      <td>ursodeoxycholic acid</td>\n",
       "      <td>128-13-2</td>\n",
       "      <td>HMDB0000946</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2934 rows Ã— 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "TYPE chebi_id                  chebi_name CAS Registry Number HMDB accession\n",
       "0       10216                  cedr-8-ene            469-61-4    HMDB0059695\n",
       "1       10224              alpha-cubebene          17699-14-8    HMDB0036413\n",
       "2      102485   5-carboxy-2'-deoxyuridine          14599-46-3    HMDB0060774\n",
       "3       10295       alpha-L-sorbopyranose            470-15-5            NaN\n",
       "4       10319                  1-naphthol             90-15-3    HMDB0012138\n",
       "...       ...                         ...                 ...            ...\n",
       "2929     9410       taurodeoxycholic acid            516-50-7    HMDB0000896\n",
       "2930     9440             tenuazonic acid          27778-66-1            NaN\n",
       "2931     9533  thiamine(1+) monophosphate          10023-48-0    HMDB0002666\n",
       "2932     9534   thiamine(1+) triphosphate          50851-39-3    HMDB0001512\n",
       "2933     9907        ursodeoxycholic acid            128-13-2    HMDB0000946\n",
       "\n",
       "[2934 rows x 4 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chebi_final = pd.merge(chebi, chebi_xref, on='chebi_id', how='left')  # Merge the 'chebi' and 'chebi_xref' DataFrames\n",
    "chebi_filter = chebi_final[(chebi_final['TYPE'] == 'CAS Registry Number') | (chebi_final['TYPE'] == 'HMDB accession')]  # Filter the 'chebi_final' DataFrame for rows where the 'TYPE' column is 'CAS Registry Number' or 'HMDB accession'\n",
    "\n",
    "# create a pivot table from the 'chebi_filter' DataFrame\n",
    "chebi_pivot = chebi_filter.pivot_table(index=['chebi_id', 'chebi_name'], columns='TYPE', values='ACCESSION_NUMBER', aggfunc=lambda x: ';'.join(pd.Series(x).unique()))\n",
    "chebi_pivot = chebi_pivot.reset_index()  # Reset the index of the DataFrame\n",
    "chebi_pivot"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 3. Merge Data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "# check duplicates inside the dataframe\n",
    "def merge_column(df, column1, column2, new_column):\n",
    "    df[column1] = df[column1].fillna('')\n",
    "    df[column2] = df[column2].fillna('')\n",
    "    df[new_column] = df.apply(lambda row: f\"{row[column1]} {row[column2]}\".strip(), axis=1)\n",
    "\n",
    "    expanded_rows = df[new_column].str.split(expand=True).stack().reset_index(level=1, drop=True)\n",
    "    expanded_rows.name = new_column\n",
    "\n",
    "    df = df.drop(columns=[new_column]).join(expanded_rows)\n",
    "    df.drop(columns=[column1, column2], inplace=True)\n",
    "    df.drop_duplicates(inplace=True)\n",
    "    \n",
    "    return df\n",
    "\n",
    "def merge_string_columns(df, columns, merge_name, separator=';'):\n",
    "    def merge_strings(row):\n",
    "        combined = set()\n",
    "        for column in columns:\n",
    "            if pd.notnull(row[column]):\n",
    "                combined.update(row[column].split(separator))\n",
    "        return separator.join(combined)\n",
    "    \n",
    "    # Apply the function to each row and create a new column\n",
    "    combined_column_name = merge_name\n",
    "    df[combined_column_name] = df.apply(merge_strings, axis=1)\n",
    "    df.drop(columns=columns, inplace=True)\n",
    "    \n",
    "    return df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 3.1 HMDB + ChEBI"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "iupac_name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "smiles",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "inchi",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "inchikey",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chemspider_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "drugbank_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "pubchem_compound_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "pdb_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chebi_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "kegg_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chebi_name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "HMDB_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "CAS_ID",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "f4b6b2c3-c405-4d45-876f-d60dd888c811",
       "rows": [
        [
         "0",
         "Visnagin",
         "4-methoxy-7-methyl-5H-furo[3,2-g]chromen-5-one",
         "COC1=C2C=COC2=CC2=C1C(=O)C=C(C)O2",
         "InChI=1S/C13H10O4/c1-7-5-9(14)12-11(17-7)6-10-8(3-4-16-10)13(12)15-2/h3-6H,1-2H3",
         "NZVQLVGOZRELTG-UHFFFAOYSA-N",
         "6460",
         null,
         null,
         null,
         "10002",
         "C09049",
         null,
         "HMDB0259840",
         null
        ],
        [
         "1",
         "13,14-Dihydro PGE1",
         "7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl]-5-oxocyclopentyl]heptanoic acid",
         "CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O",
         "InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h15-17,19,21,23H,2-14H2,1H3,(H,24,25)/t15-,16+,17+,19+/m0/s1",
         "DPOINJQWXDTOSF-DODZYUBVSA-N",
         "141668",
         null,
         "161273",
         null,
         "1000694",
         null,
         null,
         "HMDB0002689",
         "19313-28-1"
        ],
        [
         "2",
         "Dihydrocubebin",
         "2,3-bis(2H-1,3-benzodioxol-5-ylmethyl)butane-1,4-diol",
         "OCC(CC1=CC2=C(OCO2)C=C1)C(CO)CC1=CC2=C(OCO2)C=C1",
         "InChI=1S/C20H22O6/c21-9-15(5-13-1-3-17-19(7-13)25-11-23-17)16(10-22)6-14-2-4-18-20(8-14)26-12-24-18/h1-4,7-8,15-16,21-22H,5-6,9-12H2",
         "JKCVMTYNARDGET-UHFFFAOYSA-N",
         "3683161",
         null,
         "4485343",
         null,
         "1001275",
         "C10558",
         null,
         "HMDB0030709",
         "24563-03-9"
        ],
        [
         "3",
         "Nalidixic Acid",
         "1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",
         "CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2",
         "InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)",
         "MHWLWQUZZRMNGJ-UHFFFAOYSA-N",
         "4268",
         "DB00779",
         "4421",
         null,
         "100147",
         "C05079",
         null,
         "HMDB0014917",
         "389-08-2"
        ],
        [
         "4",
         "Girinimbine",
         "3,3,5-trimethyl-3H,11H-pyrano[3,2-a]carbazole",
         "CC1=C2OC(C)(C)C=CC2=C2NC3=CC=CC=C3C2=C1",
         "InChI=1S/C18H17NO/c1-11-10-14-12-6-4-5-7-15(12)19-16(14)13-8-9-18(2,3)20-17(11)13/h4-10,19H,1-3H3",
         "GAEQWKVGMHUUKO-UHFFFAOYSA-N",
         "87534",
         null,
         "96943",
         null,
         "1001644",
         null,
         null,
         "HMDB0030241",
         "23095-44-5"
        ],
        [
         "5",
         "Voriconazole",
         "(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol",
         "C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1",
         "InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",
         "BCEHBSKCWLPMDN-MGPLVRAMSA-N",
         "64684",
         "DB00582",
         "71616",
         "VOR",
         "10023",
         "C07622",
         null,
         "HMDB0014720",
         "137234-62-9"
        ],
        [
         "6",
         "Ciprofloxacin",
         "1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid",
         "OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O",
         "InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)",
         "MYSWGUAQZAJSOK-UHFFFAOYSA-N",
         "2662",
         "DB00537",
         "2764",
         "CPF",
         "100241",
         "C05349",
         null,
         "HMDB0014677",
         "85721-33-1"
        ],
        [
         "7",
         "Procaterol",
         "8-hydroxy-5-[(1R,2S)-1-hydroxy-2-[(propan-2-yl)amino]butyl]-1,2-dihydroquinolin-2-one",
         "CC[C@H](NC(C)C)[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1",
         "InChI=1S/C16H22N2O3/c1-4-12(17-9(2)3)16(21)11-5-7-13(19)15-10(11)6-8-14(20)18-15/h5-9,12,16-17,19,21H,4H2,1-3H3,(H,18,20)/t12-,16+/m0/s1",
         "FKNXQNWAXFXVNW-BLLLJJGKSA-N",
         "599984",
         "DB01366",
         "688561",
         null,
         "1002414",
         null,
         null,
         "HMDB0015453",
         "72332-33-3"
        ],
        [
         "8",
         "Norfloxacin",
         "1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid",
         "CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1",
         "InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)",
         "OGJPXUAPXNRGGI-UHFFFAOYSA-N",
         "4380",
         "DB01059",
         "4539",
         null,
         "100246",
         "C06687",
         null,
         "HMDB0015192",
         "70458-96-7"
        ],
        [
         "9",
         "glutamine-betaxanthin",
         "(2S,4E)-4-[(2Z)-2-{[(1S)-3-carbamoyl-1-carboxypropyl]imino}ethylidene]-1,2,3,4-tetrahydropyridine-2,6-dicarboxylic acid",
         "NC(=O)CC[C@H](\\N=C/C=C1\\C[C@H](NC(=C1)C(O)=O)C(O)=O)C(O)=O",
         "InChI=1S/C14H17N3O7/c15-11(18)2-1-8(12(19)20)16-4-3-7-5-9(13(21)22)17-10(6-7)14(23)24/h3-5,8,10,17H,1-2,6H2,(H2,15,18)(H,19,20)(H,21,22)(H,23,24)/b7-3-,16-4-/t8-,10-/m0/s1",
         "PDBJJFJKNSKTSW-IRFVBRLPSA-N",
         "30791219",
         null,
         null,
         null,
         "10025",
         "C08568",
         null,
         "HMDB0304684",
         null
        ],
        [
         "10",
         "5-(5-(2,6-Dichloro-4-(4,5-Dihydro-2-Oxazoly)phenoxy)pentyl)-3-Methyl Isoxazole",
         "5-{5-[2,6-dichloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methyl-1,2-oxazole",
         "CC1=NOC(CCCCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1",
         "InChI=1S/C18H20Cl2N2O3/c1-12-9-14(25-22-12)5-3-2-4-7-23-17-15(19)10-13(11-16(17)20)18-21-6-8-24-18/h9-11H,2-8H2,1H3",
         "JJDHAOLOHQTGMG-UHFFFAOYSA-N",
         "389867",
         "DB08723",
         "441048",
         "W54",
         "10029",
         "C06493",
         null,
         "HMDB0259896",
         null
        ],
        [
         "11",
         "Wedelolactone",
         "3,13,14-trihydroxy-5-methoxy-8,17-dioxatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2,4,6,11,13,15-heptaen-9-one",
         "COC1=CC(O)=C2C3=C(C4=CC(O)=C(O)C=C4O3)C(=O)OC2=C1",
         "InChI=1S/C16H10O7/c1-21-6-2-10(19)14-12(3-6)23-16(20)13-7-4-8(17)9(18)5-11(7)22-15(13)14/h2-5,17-19H,1H3",
         "XQDCKJKKMFWXGB-UHFFFAOYSA-N",
         "4445124",
         null,
         null,
         null,
         "10037",
         "C10541",
         null,
         "HMDB0259891",
         null
        ],
        [
         "12",
         "1,2,3,4-Tetrahydro-beta-carboline",
         "1H,2H,3H,4H,9H-pyrido[3,4-b]indole",
         "C1CC2=C(CN1)NC1=C2C=CC=C1",
         "InChI=1S/C11H12N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12-13H,5-7H2",
         "CFTOTSJVQRFXOF-UHFFFAOYSA-N",
         "96979",
         null,
         "107838",
         null,
         "100417",
         null,
         null,
         "HMDB0012488",
         null
        ],
        [
         "13",
         "Xanthosine 5-triphosphate",
         "({[({[(2R,3S,4R,5R)-5-(2,6-dihydroxy-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",
         "O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=C(O)N=C2O",
         "InChI=1S/C10H15N4O15P3/c15-5-3(1-26-31(22,23)29-32(24,25)28-30(19,20)21)27-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H2,12,13,17,18)/t3-,5-,6-,9-/m1/s1",
         "CAEFEWVYEZABLA-UUOKFMHZSA-N",
         "388429",
         null,
         "439296",
         null,
         "10049",
         "C00700",
         null,
         "HMDB0000293",
         "6253-56-1"
        ],
        [
         "14",
         "XANOMELINE",
         "5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine",
         "CCCCCCOC1=NSN=C1C1=CCCN(C)C1",
         "InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3",
         "JOLJIIDDOBNFHW-UHFFFAOYSA-N",
         "54797",
         null,
         null,
         null,
         "10056",
         "C11767",
         null,
         "HMDB0259915",
         null
        ],
        [
         "15",
         "Xanthan",
         "6-({6-[(acetyloxy)methyl]-2-[(3-{[3,4-dihydroxy-6-(hydroxymethyl)-5-(phosphanyloxy)oxan-2-yl]oxy}-5-hydroxy-2-(hydroxymethyl)-6-(phosphanylmethyl)oxan-4-yl)oxy]-4,5-dihydroxyoxan-3-yl}oxy)-3-({2-carboxy-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl}oxy)-4,5-dihydroxyoxane-2-carboxylic acid",
         "CC(=O)OCC1OC(OC2C(O)C(CP)OC(CO)C2OC2OC(CO)C(OP)C(O)C2O)C(OC2OC(C(OC3OC4COC(C)(OC4C(O)C3O)C(O)=O)C(O)C2O)C(O)=O)C(O)C1O",
         "InChI=1S/C36H58O29P2/c1-8(39)53-5-11-14(40)16(42)28(34(57-11)61-26-15(41)13(7-66)55-10(4-38)25(26)59-31-21(47)18(44)24(65-67)9(3-37)56-31)62-33-22(48)19(45)27(29(63-33)30(49)50)60-32-20(46)17(43)23-12(58-32)6-54-36(2,64-23)35(51)52/h9-29,31-34,37-38,40-48H,3-7,66-67H2,1-2H3,(H,49,50)(H,51,52)",
         "KCOUXTVJDWNYJS-UHFFFAOYSA-N",
         null,
         null,
         "131750926",
         null,
         "10057",
         "C01464",
         null,
         "HMDB0029923",
         "11138-66-2"
        ],
        [
         "16",
         "Xanthurenic acid",
         "4,8-dihydroxyquinoline-2-carboxylic acid",
         "OC(=O)C1=NC2=C(O)C=CC=C2C(O)=C1",
         "InChI=1S/C10H7NO4/c12-7-3-1-2-5-8(13)4-6(10(14)15)11-9(5)7/h1-4,12H,(H,11,13)(H,14,15)",
         "FBZONXHGGPHHIY-UHFFFAOYSA-N",
         "5497",
         null,
         "5699",
         null,
         "10072",
         "C02470",
         null,
         "HMDB0000881",
         "59-00-7"
        ],
        [
         "17",
         "(-)-Wikstromol",
         "3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one",
         "COC1=C(O)C=CC(CC2COC(=O)C2(O)CC2=CC(OC)=C(O)C=C2)=C1",
         "InChI=1S/C20H22O7/c1-25-17-8-12(3-5-15(17)21)7-14-11-27-19(23)20(14,24)10-13-4-6-16(22)18(9-13)26-2/h3-6,8-9,14,21-22,24H,7,10-11H2,1-2H3",
         "ZITBJWXLODLDRH-UHFFFAOYSA-N",
         "90295",
         null,
         "99938",
         null,
         "1007254",
         "C10725",
         null,
         "HMDB0030598",
         "34444-37-6"
        ],
        [
         "18",
         "2-(4-(Benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine",
         "2-[4-(2H-1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl]-6-methylpyridine",
         "CC1=CC=CC(=N1)C1=C(N=C(N1)C(C)(C)C)C1=CC2=C(OCO2)C=C1",
         "InChI=1S/C20H21N3O2/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15/h5-10H,11H2,1-4H3,(H,22,23)",
         "WGZOTBUYUFBEPZ-UHFFFAOYSA-N",
         "8034640",
         null,
         null,
         null,
         "100922",
         null,
         null,
         "HMDB0257525",
         null
        ],
        [
         "19",
         "Yohimbine",
         "methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0Â²,Â¹â°.0â´,â¹.0Â¹âµ,Â²â°]henicosa-2(10),4,6,8-tetraene-19-carboxylate",
         "[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2",
         "InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1",
         "BLGXFZZNTVWLAY-SCYLSFHTSA-N",
         "8622",
         "DB01392",
         "8969",
         null,
         "10093",
         "C09256",
         null,
         "HMDB0015464",
         "146-48-5"
        ],
        [
         "20",
         "Zafirlukast",
         "cyclopentyl N-[3-({2-methoxy-4-[(2-methylbenzenesulfonyl)carbamoyl]phenyl}methyl)-1-methyl-1H-indol-5-yl]carbamate",
         "COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=CC=CC=C1C",
         "InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",
         "YEEZWCHGZNKEEK-UHFFFAOYSA-N",
         "5515",
         "DB00549",
         "5717",
         null,
         "10100",
         "C07206",
         null,
         "HMDB0014689",
         "107753-78-6"
        ],
        [
         "21",
         "Fencamfamine",
         "N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine",
         "CCNC1C2CCC(C2)C1C1=CC=CC=C1",
         "InChI=1S/C15H21N/c1-2-16-15-13-9-8-12(10-13)14(15)11-6-4-3-5-7-11/h3-7,12-16H,2,8-10H2,1H3",
         "IKFBPFGUINLYQI-UHFFFAOYSA-N",
         "13922",
         "DB01463",
         "14584",
         null,
         "101009",
         null,
         null,
         "HMDB0015508",
         "1209-98-9"
        ],
        [
         "22",
         "Zalcitabine",
         "4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",
         "NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1",
         "InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1",
         "WREGKURFCTUGRC-POYBYMJQSA-N",
         "22498",
         "DB00943",
         "24066",
         null,
         "10101",
         "C07207",
         null,
         "HMDB0015078",
         "7481-89-2"
        ],
        [
         "23",
         "Zaleplon",
         "N-(3-{3-cyanopyrazolo[1,5-a]pyrimidin-7-yl}phenyl)-N-ethylacetamide",
         "CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N",
         "InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3",
         "HUNXMJYCHXQEGX-UHFFFAOYSA-N",
         "5517",
         "DB00962",
         "5719",
         null,
         "10102",
         "C07484",
         null,
         "HMDB0015097",
         "151319-34-5"
        ],
        [
         "24",
         "Dichlorphenamide",
         "4,5-dichlorobenzene-1,3-disulfonamide",
         "NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O",
         "InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)",
         "GJQPMPFPNINLKP-UHFFFAOYSA-N",
         "2930",
         "DB01144",
         "3038",
         "I7A",
         "101085",
         "C07459",
         null,
         "HMDB0015275",
         "120-97-8"
        ],
        [
         "25",
         "Ethoxzolamide",
         "6-ethoxy-1,3-benzothiazole-2-sulfonamide",
         "CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O",
         "InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13)",
         "OUZWUKMCLIBBOG-UHFFFAOYSA-N",
         "3179",
         "DB00311",
         "3295",
         null,
         "101096",
         null,
         null,
         "HMDB0014456",
         "452-35-7"
        ],
        [
         "26",
         "Zidovudine",
         "1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione",
         "CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O",
         "InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",
         "HBOMLICNUCNMMY-XLPZGREQSA-N",
         "32555",
         "DB00495",
         "35370",
         null,
         "10110",
         "C07210",
         null,
         "HMDB0014638",
         "30516-87-1"
        ],
        [
         "27",
         "Zileuton",
         "1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea",
         "CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1",
         "InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",
         "MWLSOWXNZPKENC-UHFFFAOYSA-N",
         "54531",
         "DB00744",
         "60490",
         null,
         "10112",
         null,
         null,
         "HMDB0014882",
         "111406-87-2"
        ],
        [
         "28",
         "Ziprasidone",
         "5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one",
         "ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1",
         "InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)",
         "MVWVFYHBGMAFLY-UHFFFAOYSA-N",
         "54841",
         "DB00246",
         "60854",
         null,
         "10119",
         "C07568",
         null,
         "HMDB0014391",
         "146939-27-7"
        ],
        [
         "29",
         "Guanabenz",
         "2-{[(2,6-dichlorophenyl)methylidene]amino}guanidine",
         "NC(N)=NN=CC1=C(Cl)C=CC=C1Cl",
         "InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)",
         "WDZVGELJXXEGPV-UHFFFAOYSA-N",
         "4642445",
         "DB00629",
         "5702063",
         null,
         "101202",
         "C07034",
         null,
         "HMDB0014767",
         "5051-62-7"
        ],
        [
         "30",
         "5,7-Dihydroxyisoflavone",
         "5,7-dihydroxy-3-phenyl-4H-chromen-4-one",
         "OC1=CC(O)=C2C(OC=C(C2=O)C2=CC=CC=C2)=C1",
         "InChI=1S/C15H10O4/c16-10-6-12(17)14-13(7-10)19-8-11(15(14)18)9-4-2-1-3-5-9/h1-8,16-17H",
         "PJJGZPJJTHBVMX-UHFFFAOYSA-N",
         "4526438",
         null,
         "5377381",
         null,
         "1012277",
         "C02168",
         null,
         "HMDB0030699",
         "4044-00-2"
        ],
        [
         "31",
         "Zolmitriptan",
         "(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one",
         "CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12",
         "InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1",
         "ULSDMUVEXKOYBU-ZDUSSCGKSA-N",
         "54844",
         "DB00315",
         "60857",
         null,
         "10124",
         "C07218",
         null,
         "HMDB0014460",
         "139264-17-8"
        ],
        [
         "32",
         "Zolpidem",
         "N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide",
         "CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1",
         "InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",
         "ZAFYATHCZYHLPB-UHFFFAOYSA-N",
         "5530",
         "DB00425",
         "5732",
         null,
         "10125",
         "C07219",
         null,
         "HMDB0005023",
         "82626-48-0"
        ],
        [
         "33",
         "Zonisamide",
         "1,2-benzoxazol-3-ylmethanesulfonamide",
         "NS(=O)(=O)CC1=NOC2=CC=CC=C12",
         "InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",
         "UBQNRHZMVUUOMG-UHFFFAOYSA-N",
         "5532",
         "DB00909",
         "5734",
         "ZON",
         "10127",
         "C07504",
         null,
         "HMDB0015045",
         "68291-97-4"
        ],
        [
         "34",
         "Diltiazem",
         "(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate",
         "COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O",
         "InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1",
         "HSUGRBWQSSZJOP-RTWAWAEBSA-N",
         "35850",
         "DB00343",
         "39186",
         null,
         "101278",
         "C06958",
         null,
         "HMDB0014487",
         "42399-41-7"
        ],
        [
         "35",
         "Bis(2-hydroxy-1-naphthyl) disulfide",
         "1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol",
         "OC1=C(SSC2=C(O)C=CC3=CC=CC=C23)C2=CC=CC=C2C=C1",
         "InChI=1S/C20H14O2S2/c21-17-11-9-13-5-1-3-7-15(13)19(17)23-24-20-16-8-4-2-6-14(16)10-12-18(20)22/h1-12,21-22H",
         "RFAXLXKIAKIUDT-UHFFFAOYSA-N",
         "454544",
         null,
         "521106",
         null,
         "101355",
         null,
         null,
         "HMDB0253560",
         null
        ],
        [
         "36",
         "Olsalazine",
         "5-[(E)-2-(3-carboxy-4-hydroxyphenyl)diazen-1-yl]-2-hydroxybenzoic acid",
         "OC(=O)C1=CC(=CC=C1O)\\N=N\\C1=CC=C(O)C(=C1)C(O)=O",
         "InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",
         "QQBDLJCYGRGAKP-FOCLMDBBSA-N",
         "10642377",
         "DB01250",
         null,
         null,
         "101369",
         "C07323",
         null,
         "HMDB0015380",
         "15722-48-2"
        ],
        [
         "37",
         "2-Aminobenzenesulfonic acid",
         "2-aminobenzene-1-sulfonic acid",
         "NC1=CC=CC=C1S(O)(=O)=O",
         "InChI=1S/C6H7NO3S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H,8,9,10)",
         "ZMCHBSMFKQYNKA-UHFFFAOYSA-N",
         null,
         null,
         "6926",
         null,
         "1015",
         "C06333",
         null,
         "HMDB0304940",
         null
        ],
        [
         "38",
         "Cinnamtannin III",
         "(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol",
         "O[C@@H]1CC2=C(O)C=C(O)C([C@@H]3[C@@H](O)[C@H](OC4=C([C@@H]5[C@@H](O)[C@H](OC6=C([C@@H]7[C@@H](O)[C@H](OC8=C([C@@H]9[C@@H](O)[C@H](OC%10=C([C@@H]%11[C@@H](O)[C@H](OC%12=CC(O)=CC(O)=C%11%12)C%11=CC=C(O)C(O)=C%11)C(O)=CC(O)=C9%10)C9=CC=C(O)C(O)=C9)C(O)=CC(O)=C78)C7=CC=C(O)C(O)=C7)C(O)=CC(O)=C56)C5=CC=C(O)C(O)=C5)C(O)=CC(O)=C34)C3=CC=C(O)C(O)=C3)=C2O[C@@H]1C1=CC=C(O)C(O)=C1",
         "InChI=1S/C90H74O36/c91-33-19-48(105)60-59(20-33)121-81(28-2-8-36(93)43(100)14-28)75(116)70(60)62-50(107)23-52(109)64-72(77(118)83(123-87(62)64)30-4-10-38(95)45(102)16-30)66-54(111)25-56(113)68-74(79(120)85(125-89(66)68)32-6-12-40(97)47(104)18-32)69-57(114)26-55(112)67-73(78(119)84(126-90(67)69)31-5-11-39(96)46(103)17-31)65-53(110)24-51(108)63-71(76(117)82(124-88(63)65)29-3-9-37(94)44(101)15-29)61-49(106)22-41(98)34-21-58(115)80(122-86(34)61)27-1-7-35(92)42(99)13-27/h1-20,22-26,58,70-85,91-120H,21H2/t58-,70-,71+,72-,73+,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-/m1/s1",
         "UUOWTYGESRVWCF-WKWFDMPLSA-N",
         "10272881",
         null,
         "16129623",
         null,
         "10150",
         "C10222",
         null,
         "HMDB0037658",
         "88847-05-6"
        ],
        [
         "39",
         "Gemifloxacin",
         "7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",
         "CO\\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O",
         "InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+",
         "ZRCVYEYHRGVLOC-HYARGMPZSA-N",
         "7845573",
         "DB01155",
         "9571107",
         null,
         "101853",
         null,
         null,
         "HMDB0015286",
         "175463-14-6"
        ],
        [
         "40",
         "Spirapril",
         "(8S)-7-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid",
         "CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2",
         "InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1",
         "HRWCVUIFMSZDJS-SZMVWBNQSA-N",
         "4470933",
         "DB01348",
         "5311447",
         null,
         "101967",
         null,
         null,
         "HMDB0015438",
         "83647-97-6"
        ],
        [
         "41",
         "Sulfamerazine",
         "4-amino-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide",
         "CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1",
         "InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)",
         "QPPBRPIAZZHUNT-UHFFFAOYSA-N",
         "5134",
         "DB01581",
         "5325",
         null,
         "102130",
         null,
         null,
         "HMDB0015521",
         "127-79-7"
        ],
        [
         "42",
         "alpha-Cedrene",
         "(1S,2R,5S,7S)-2,6,6,8-tetramethyltricyclo[5.3.1.0^{1,5}]undec-8-ene",
         "[H][C@@]12CC[C@@H](C)[C@]11C[C@@H](C(C)=CC1)C2(C)C",
         "InChI=1S/C15H24/c1-10-7-8-15-9-12(10)14(3,4)13(15)6-5-11(15)2/h7,11-13H,5-6,8-9H2,1-4H3/t11-,12+,13+,15+/m1/s1",
         "IRAQOCYXUMOFCW-OSFYFWSMSA-N",
         "4936353",
         null,
         "6431015",
         null,
         "10216",
         "C09630",
         "cedr-8-ene",
         "HMDB0059695",
         "469-61-4"
        ],
        [
         "43",
         "Thiopental",
         "5-ethyl-5-(pentan-2-yl)-2-sulfanylidene-1,3-diazinane-4,6-dione",
         "CCCC(C)C1(CC)C(=O)NC(=S)NC1=O",
         "InChI=1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",
         "IUJDSEJGGMCXSG-UHFFFAOYSA-N",
         "2272258",
         "DB00599",
         "3000715",
         null,
         "102166",
         "C07521",
         null,
         "HMDB0014737",
         "76-75-5"
        ],
        [
         "44",
         "Talarozole",
         "N-{4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine",
         "CCC(CC)C(N1C=NC=N1)C1=CC=C(NC2=NC3=CC=CC=C3S2)C=C1",
         "InChI=1S/C21H23N5S/c1-3-15(4-2)20(26-14-22-13-23-26)16-9-11-17(12-10-16)24-21-25-18-7-5-6-8-19(18)27-21/h5-15,20H,3-4H2,1-2H3,(H,24,25)",
         "SNFYYXUGUBUECJ-UHFFFAOYSA-N",
         "7975653",
         "DB13083",
         null,
         null,
         "102167",
         null,
         null,
         "HMDB0258688",
         null
        ],
        [
         "45",
         "Cedorol",
         "(1S,2R,5S,7R,8R)-2,6,6,8-tetramethyltricyclo[5.3.1.0^{1,5}]undecan-8-ol",
         "[H][C@@]12CC[C@@H](C)[C@]11C[C@H](C2(C)C)[C@](C)(O)CC1",
         "InChI=1S/C15H26O/c1-10-5-6-11-13(2,3)12-9-15(10,11)8-7-14(12,4)16/h10-12,16H,5-9H2,1-4H3/t10-,11+,12-,14-,15+/m1/s1",
         "SVURIXNDRWRAFU-OGMFBOKVSA-N",
         null,
         null,
         "65575",
         null,
         "10217",
         "C09631",
         null,
         "HMDB0303103",
         null
        ],
        [
         "46",
         "Methohexital",
         "5-(hex-3-yn-2-yl)-1-methyl-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione",
         "CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O",
         "InChI=1S/C14H18N2O3/c1-5-7-8-10(3)14(9-6-2)11(17)15-13(19)16(4)12(14)18/h6,10H,2,5,9H2,1,3-4H3,(H,15,17,19)",
         "NZXKDOXHBHYTKP-UHFFFAOYSA-N",
         "8683",
         "DB00474",
         null,
         null,
         "102216",
         "C07844",
         null,
         "HMDB0014617",
         "151-83-7"
        ],
        [
         "47",
         "Dimethyloxalylglycine",
         "methyl [(2-methoxy-2-oxoethyl)carbamoyl]formate",
         "COC(=O)CNC(=O)C(=O)OC",
         "InChI=1S/C6H9NO5/c1-11-4(8)3-7-5(9)6(10)12-2/h3H2,1-2H3,(H,7,9)",
         "BNJOZDZCRHCODO-UHFFFAOYSA-N",
         "487098",
         null,
         null,
         null,
         "102218",
         null,
         null,
         "HMDB0251540",
         null
        ],
        [
         "48",
         "Alpha-Cryptoxanthin",
         "(1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-ol",
         "C\\C(\\C=C\\C=C(/C)\\C=C\\C1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/C1=C(C)CCCC1(C)C",
         "InChI=1S/C40H56O/c1-30(18-13-20-32(3)23-25-37-34(5)22-15-27-39(37,7)8)16-11-12-17-31(2)19-14-21-33(4)24-26-38-35(6)28-36(41)29-40(38,9)10/h11-14,16-21,23-26,28,36,38,41H,15,22,27,29H2,1-10H3/b12-11+,18-13+,19-14+,25-23+,26-24+,30-16+,31-17+,32-20+,33-21+/t36-,38?/m0/s1",
         "ORAKUVXRZWMARG-DWADUKLPSA-N",
         "30791985",
         null,
         "23724629",
         null,
         "10223",
         "C15981",
         null,
         "HMDB0002268",
         "24480-38-4"
        ],
        [
         "49",
         "alpha-Cubebene",
         "(1R,5S,6R,7S,10R)-4,10-dimethyl-7-(propan-2-yl)tricyclo[4.4.0.0^{1,5}]dec-3-ene",
         "[H][C@]12[C@@H](CC[C@@H](C)[C@]11CC=C(C)[C@]21[H])C(C)C",
         "InChI=1S/C15H24/c1-9(2)12-6-5-11(4)15-8-7-10(3)13(15)14(12)15/h7,9,11-14H,5-6,8H2,1-4H3/t11-,12+,13-,14-,15+/m1/s1",
         "XUEHVOLRMXNRKQ-KHMAMNHCSA-N",
         "390811",
         null,
         "442359",
         null,
         "10224",
         "C09647",
         "alpha-cubebene",
         "HMDB0036413",
         "17699-14-8"
        ]
       ],
       "shape": {
        "columns": 14,
        "rows": 219300
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>iupac_name</th>\n",
       "      <th>smiles</th>\n",
       "      <th>inchi</th>\n",
       "      <th>inchikey</th>\n",
       "      <th>chemspider_id</th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>pubchem_compound_id</th>\n",
       "      <th>pdb_id</th>\n",
       "      <th>chebi_id</th>\n",
       "      <th>kegg_id</th>\n",
       "      <th>chebi_name</th>\n",
       "      <th>HMDB_ID</th>\n",
       "      <th>CAS_ID</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Visnagin</td>\n",
       "      <td>4-methoxy-7-methyl-5H-furo[3,2-g]chromen-5-one</td>\n",
       "      <td>COC1=C2C=COC2=CC2=C1C(=O)C=C(C)O2</td>\n",
       "      <td>InChI=1S/C13H10O4/c1-7-5-9(14)12-11(17-7)6-10-...</td>\n",
       "      <td>NZVQLVGOZRELTG-UHFFFAOYSA-N</td>\n",
       "      <td>6460</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10002</td>\n",
       "      <td>C09049</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0259840</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>13,14-Dihydro PGE1</td>\n",
       "      <td>7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl...</td>\n",
       "      <td>CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC...</td>\n",
       "      <td>InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16...</td>\n",
       "      <td>DPOINJQWXDTOSF-DODZYUBVSA-N</td>\n",
       "      <td>141668</td>\n",
       "      <td>NaN</td>\n",
       "      <td>161273</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1000694</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0002689</td>\n",
       "      <td>19313-28-1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Dihydrocubebin</td>\n",
       "      <td>2,3-bis(2H-1,3-benzodioxol-5-ylmethyl)butane-1...</td>\n",
       "      <td>OCC(CC1=CC2=C(OCO2)C=C1)C(CO)CC1=CC2=C(OCO2)C=C1</td>\n",
       "      <td>InChI=1S/C20H22O6/c21-9-15(5-13-1-3-17-19(7-13...</td>\n",
       "      <td>JKCVMTYNARDGET-UHFFFAOYSA-N</td>\n",
       "      <td>3683161</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4485343</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1001275</td>\n",
       "      <td>C10558</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0030709</td>\n",
       "      <td>24563-03-9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Nalidixic Acid</td>\n",
       "      <td>1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthy...</td>\n",
       "      <td>CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2</td>\n",
       "      <td>InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15...</td>\n",
       "      <td>MHWLWQUZZRMNGJ-UHFFFAOYSA-N</td>\n",
       "      <td>4268</td>\n",
       "      <td>DB00779</td>\n",
       "      <td>4421</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100147</td>\n",
       "      <td>C05079</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0014917</td>\n",
       "      <td>389-08-2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Girinimbine</td>\n",
       "      <td>3,3,5-trimethyl-3H,11H-pyrano[3,2-a]carbazole</td>\n",
       "      <td>CC1=C2OC(C)(C)C=CC2=C2NC3=CC=CC=C3C2=C1</td>\n",
       "      <td>InChI=1S/C18H17NO/c1-11-10-14-12-6-4-5-7-15(12...</td>\n",
       "      <td>GAEQWKVGMHUUKO-UHFFFAOYSA-N</td>\n",
       "      <td>87534</td>\n",
       "      <td>NaN</td>\n",
       "      <td>96943</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1001644</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0030241</td>\n",
       "      <td>23095-44-5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219110</th>\n",
       "      <td>Glycohyodeoxycholic acid</td>\n",
       "      <td>2-(4-{5,8-dihydroxy-2,15-dimethyltetracyclo[8....</td>\n",
       "      <td>CC(CCC(=O)NCC(O)=O)C1CCC2C3CC(O)C4CC(O)CCC4(C)...</td>\n",
       "      <td>InChI=1S/C26H43NO5/c1-15(4-7-23(30)27-14-24(31...</td>\n",
       "      <td>SPOIYSFQOFYOFZ-UHFFFAOYSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>13955650</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0304944</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219111</th>\n",
       "      <td>Indole-3-acetic acid ethyl ester</td>\n",
       "      <td>ethyl 2-(1H-indol-3-yl)acetate</td>\n",
       "      <td>CCOC(=O)CC1=CNC2=CC=CC=C12</td>\n",
       "      <td>InChI=1S/C12H13NO2/c1-2-15-12(14)7-9-8-13-11-6...</td>\n",
       "      <td>HUDBDWIQSIGUDI-UHFFFAOYSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>13067</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0304946</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219112</th>\n",
       "      <td>Nordeoxycholic acid</td>\n",
       "      <td>3-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7....</td>\n",
       "      <td>CC(CC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C</td>\n",
       "      <td>InChI=1S/C23H38O4/c1-13(10-21(26)27)17-6-7-18-...</td>\n",
       "      <td>PLRQOCVIINWCFA-UHFFFAOYSA-N</td>\n",
       "      <td>278117</td>\n",
       "      <td>NaN</td>\n",
       "      <td>314374</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0304947</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219113</th>\n",
       "      <td>3-Oxo-5beta-cholanoic acid</td>\n",
       "      <td>4-{2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}...</td>\n",
       "      <td>CC(CCC(O)=O)C1CCC2C3CCC4CC(=O)CCC4(C)C3CCC12C</td>\n",
       "      <td>InChI=1S/C24H38O3/c1-15(4-9-22(26)27)19-7-8-20...</td>\n",
       "      <td>KIQFUORWRVZTHT-UHFFFAOYSA-N</td>\n",
       "      <td>473110</td>\n",
       "      <td>NaN</td>\n",
       "      <td>543448</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0304950</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219114</th>\n",
       "      <td>d-Fucitol</td>\n",
       "      <td>(2R,3S,4R,5S)-hexane-1,2,3,4,5-pentol</td>\n",
       "      <td>[H][C@@](C)(O)[C@@]([H])(O)[C@@]([H])(O)[C@]([...</td>\n",
       "      <td>InChI=1S/C6H14O5/c1-3(8)5(10)6(11)4(9)2-7/h3-1...</td>\n",
       "      <td>SKCKOFZKJLZSFA-KCDKBNATSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>DB03815</td>\n",
       "      <td>445724</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0304954</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>219300 rows Ã— 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                    name  \\\n",
       "0                               Visnagin   \n",
       "1                     13,14-Dihydro PGE1   \n",
       "2                         Dihydrocubebin   \n",
       "3                         Nalidixic Acid   \n",
       "4                            Girinimbine   \n",
       "...                                  ...   \n",
       "219110          Glycohyodeoxycholic acid   \n",
       "219111  Indole-3-acetic acid ethyl ester   \n",
       "219112               Nordeoxycholic acid   \n",
       "219113        3-Oxo-5beta-cholanoic acid   \n",
       "219114                         d-Fucitol   \n",
       "\n",
       "                                               iupac_name  \\\n",
       "0          4-methoxy-7-methyl-5H-furo[3,2-g]chromen-5-one   \n",
       "1       7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl...   \n",
       "2       2,3-bis(2H-1,3-benzodioxol-5-ylmethyl)butane-1...   \n",
       "3       1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthy...   \n",
       "4           3,3,5-trimethyl-3H,11H-pyrano[3,2-a]carbazole   \n",
       "...                                                   ...   \n",
       "219110  2-(4-{5,8-dihydroxy-2,15-dimethyltetracyclo[8....   \n",
       "219111                     ethyl 2-(1H-indol-3-yl)acetate   \n",
       "219112  3-{5,16-dihydroxy-2,15-dimethyltetracyclo[8.7....   \n",
       "219113  4-{2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}...   \n",
       "219114              (2R,3S,4R,5S)-hexane-1,2,3,4,5-pentol   \n",
       "\n",
       "                                                   smiles  \\\n",
       "0                       COC1=C2C=COC2=CC2=C1C(=O)C=C(C)O2   \n",
       "1       CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC...   \n",
       "2        OCC(CC1=CC2=C(OCO2)C=C1)C(CO)CC1=CC2=C(OCO2)C=C1   \n",
       "3                     CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2   \n",
       "4                 CC1=C2OC(C)(C)C=CC2=C2NC3=CC=CC=C3C2=C1   \n",
       "...                                                   ...   \n",
       "219110  CC(CCC(=O)NCC(O)=O)C1CCC2C3CC(O)C4CC(O)CCC4(C)...   \n",
       "219111                         CCOC(=O)CC1=CNC2=CC=CC=C12   \n",
       "219112     CC(CC(O)=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C   \n",
       "219113      CC(CCC(O)=O)C1CCC2C3CCC4CC(=O)CCC4(C)C3CCC12C   \n",
       "219114  [H][C@@](C)(O)[C@@]([H])(O)[C@@]([H])(O)[C@]([...   \n",
       "\n",
       "                                                    inchi  \\\n",
       "0       InChI=1S/C13H10O4/c1-7-5-9(14)12-11(17-7)6-10-...   \n",
       "1       InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16...   \n",
       "2       InChI=1S/C20H22O6/c21-9-15(5-13-1-3-17-19(7-13...   \n",
       "3       InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15...   \n",
       "4       InChI=1S/C18H17NO/c1-11-10-14-12-6-4-5-7-15(12...   \n",
       "...                                                   ...   \n",
       "219110  InChI=1S/C26H43NO5/c1-15(4-7-23(30)27-14-24(31...   \n",
       "219111  InChI=1S/C12H13NO2/c1-2-15-12(14)7-9-8-13-11-6...   \n",
       "219112  InChI=1S/C23H38O4/c1-13(10-21(26)27)17-6-7-18-...   \n",
       "219113  InChI=1S/C24H38O3/c1-15(4-9-22(26)27)19-7-8-20...   \n",
       "219114  InChI=1S/C6H14O5/c1-3(8)5(10)6(11)4(9)2-7/h3-1...   \n",
       "\n",
       "                           inchikey chemspider_id drugbank_id  \\\n",
       "0       NZVQLVGOZRELTG-UHFFFAOYSA-N          6460         NaN   \n",
       "1       DPOINJQWXDTOSF-DODZYUBVSA-N        141668         NaN   \n",
       "2       JKCVMTYNARDGET-UHFFFAOYSA-N       3683161         NaN   \n",
       "3       MHWLWQUZZRMNGJ-UHFFFAOYSA-N          4268     DB00779   \n",
       "4       GAEQWKVGMHUUKO-UHFFFAOYSA-N         87534         NaN   \n",
       "...                             ...           ...         ...   \n",
       "219110  SPOIYSFQOFYOFZ-UHFFFAOYSA-N          <NA>         NaN   \n",
       "219111  HUDBDWIQSIGUDI-UHFFFAOYSA-N          <NA>         NaN   \n",
       "219112  PLRQOCVIINWCFA-UHFFFAOYSA-N        278117         NaN   \n",
       "219113  KIQFUORWRVZTHT-UHFFFAOYSA-N        473110         NaN   \n",
       "219114  SKCKOFZKJLZSFA-KCDKBNATSA-N          <NA>     DB03815   \n",
       "\n",
       "       pubchem_compound_id pdb_id chebi_id kegg_id chebi_name      HMDB_ID  \\\n",
       "0                     <NA>    NaN    10002  C09049        NaN  HMDB0259840   \n",
       "1                   161273    NaN  1000694     NaN        NaN  HMDB0002689   \n",
       "2                  4485343    NaN  1001275  C10558        NaN  HMDB0030709   \n",
       "3                     4421    NaN   100147  C05079        NaN  HMDB0014917   \n",
       "4                    96943    NaN  1001644     NaN        NaN  HMDB0030241   \n",
       "...                    ...    ...      ...     ...        ...          ...   \n",
       "219110            13955650    NaN     <NA>     NaN        NaN  HMDB0304944   \n",
       "219111               13067    NaN     <NA>     NaN        NaN  HMDB0304946   \n",
       "219112              314374    NaN     <NA>     NaN        NaN  HMDB0304947   \n",
       "219113              543448    NaN     <NA>     NaN        NaN  HMDB0304950   \n",
       "219114              445724    NaN     <NA>     NaN        NaN  HMDB0304954   \n",
       "\n",
       "            CAS_ID  \n",
       "0              NaN  \n",
       "1       19313-28-1  \n",
       "2       24563-03-9  \n",
       "3         389-08-2  \n",
       "4       23095-44-5  \n",
       "...            ...  \n",
       "219110         NaN  \n",
       "219111         NaN  \n",
       "219112         NaN  \n",
       "219113         NaN  \n",
       "219114         NaN  \n",
       "\n",
       "[219300 rows x 14 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hmdb_chebi = pd.merge(hmdb, chebi_pivot, on='chebi_id', how='outer')  # Merge the 'hmdb' and 'chebi' DataFrames\n",
    "hmdb_chebi_v1 = merge_column(hmdb_chebi, 'accession', 'HMDB accession', 'HMDB_ID')\n",
    "hmdb_chebi_v1 = merge_column(hmdb_chebi_v1, 'cas_registry_number', 'CAS Registry Number', 'CAS_ID')\n",
    "hmdb_chebi_v1 = hmdb_chebi_v1.replace('', pd.NA)\n",
    "hmdb_chebi_v1"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 3.2 Make HMDB Unique"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "iupac_name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "smiles",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "inchi",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "inchikey",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chemspider_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "drugbank_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "pubchem_compound_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "pdb_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chebi_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "kegg_id",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "chebi_name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "HMDB_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "CAS_ID",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "e1c44341-b20f-410b-af6b-eec49c2b83d8",
       "rows": [
        [
         "0",
         "Visnagin",
         "4-methoxy-7-methyl-5H-furo[3,2-g]chromen-5-one",
         "COC1=C2C=COC2=CC2=C1C(=O)C=C(C)O2",
         "InChI=1S/C13H10O4/c1-7-5-9(14)12-11(17-7)6-10-8(3-4-16-10)13(12)15-2/h3-6H,1-2H3",
         "NZVQLVGOZRELTG-UHFFFAOYSA-N",
         "6460",
         null,
         null,
         null,
         "10002",
         "C09049",
         null,
         "HMDB0259840",
         null
        ],
        [
         "1",
         "13,14-Dihydro PGE1",
         "7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl]-5-oxocyclopentyl]heptanoic acid",
         "CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O",
         "InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h15-17,19,21,23H,2-14H2,1H3,(H,24,25)/t15-,16+,17+,19+/m0/s1",
         "DPOINJQWXDTOSF-DODZYUBVSA-N",
         "141668",
         null,
         "161273",
         null,
         "1000694",
         null,
         null,
         "HMDB0002689",
         "19313-28-1"
        ],
        [
         "2",
         "Dihydrocubebin",
         "2,3-bis(2H-1,3-benzodioxol-5-ylmethyl)butane-1,4-diol",
         "OCC(CC1=CC2=C(OCO2)C=C1)C(CO)CC1=CC2=C(OCO2)C=C1",
         "InChI=1S/C20H22O6/c21-9-15(5-13-1-3-17-19(7-13)25-11-23-17)16(10-22)6-14-2-4-18-20(8-14)26-12-24-18/h1-4,7-8,15-16,21-22H,5-6,9-12H2",
         "JKCVMTYNARDGET-UHFFFAOYSA-N",
         "3683161",
         null,
         "4485343",
         null,
         "1001275",
         "C10558",
         null,
         "HMDB0030709",
         "24563-03-9"
        ],
        [
         "3",
         "Nalidixic Acid",
         "1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",
         "CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2",
         "InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)",
         "MHWLWQUZZRMNGJ-UHFFFAOYSA-N",
         "4268",
         "DB00779",
         "4421",
         null,
         "100147",
         "C05079",
         null,
         "HMDB0014917",
         "389-08-2"
        ],
        [
         "4",
         "Girinimbine",
         "3,3,5-trimethyl-3H,11H-pyrano[3,2-a]carbazole",
         "CC1=C2OC(C)(C)C=CC2=C2NC3=CC=CC=C3C2=C1",
         "InChI=1S/C18H17NO/c1-11-10-14-12-6-4-5-7-15(12)19-16(14)13-8-9-18(2,3)20-17(11)13/h4-10,19H,1-3H3",
         "GAEQWKVGMHUUKO-UHFFFAOYSA-N",
         "87534",
         null,
         "96943",
         null,
         "1001644",
         null,
         null,
         "HMDB0030241",
         "23095-44-5"
        ],
        [
         "5",
         "Voriconazole",
         "(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol",
         "C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1",
         "InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",
         "BCEHBSKCWLPMDN-MGPLVRAMSA-N",
         "64684",
         "DB00582",
         "71616",
         "VOR",
         "10023",
         "C07622",
         null,
         "HMDB0014720",
         "137234-62-9"
        ],
        [
         "6",
         "Ciprofloxacin",
         "1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid",
         "OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O",
         "InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)",
         "MYSWGUAQZAJSOK-UHFFFAOYSA-N",
         "2662",
         "DB00537",
         "2764",
         "CPF",
         "100241",
         "C05349",
         null,
         "HMDB0014677",
         "85721-33-1"
        ],
        [
         "7",
         "Procaterol",
         "8-hydroxy-5-[(1R,2S)-1-hydroxy-2-[(propan-2-yl)amino]butyl]-1,2-dihydroquinolin-2-one",
         "CC[C@H](NC(C)C)[C@H](O)C1=C2C=CC(=O)NC2=C(O)C=C1",
         "InChI=1S/C16H22N2O3/c1-4-12(17-9(2)3)16(21)11-5-7-13(19)15-10(11)6-8-14(20)18-15/h5-9,12,16-17,19,21H,4H2,1-3H3,(H,18,20)/t12-,16+/m0/s1",
         "FKNXQNWAXFXVNW-BLLLJJGKSA-N",
         "599984",
         "DB01366",
         "688561",
         null,
         "1002414",
         null,
         null,
         "HMDB0015453",
         "72332-33-3"
        ],
        [
         "8",
         "Norfloxacin",
         "1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid",
         "CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1",
         "InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)",
         "OGJPXUAPXNRGGI-UHFFFAOYSA-N",
         "4380",
         "DB01059",
         "4539",
         null,
         "100246",
         "C06687",
         null,
         "HMDB0015192",
         "70458-96-7"
        ],
        [
         "9",
         "glutamine-betaxanthin",
         "(2S,4E)-4-[(2Z)-2-{[(1S)-3-carbamoyl-1-carboxypropyl]imino}ethylidene]-1,2,3,4-tetrahydropyridine-2,6-dicarboxylic acid",
         "NC(=O)CC[C@H](\\N=C/C=C1\\C[C@H](NC(=C1)C(O)=O)C(O)=O)C(O)=O",
         "InChI=1S/C14H17N3O7/c15-11(18)2-1-8(12(19)20)16-4-3-7-5-9(13(21)22)17-10(6-7)14(23)24/h3-5,8,10,17H,1-2,6H2,(H2,15,18)(H,19,20)(H,21,22)(H,23,24)/b7-3-,16-4-/t8-,10-/m0/s1",
         "PDBJJFJKNSKTSW-IRFVBRLPSA-N",
         "30791219",
         null,
         null,
         null,
         "10025",
         "C08568",
         null,
         "HMDB0304684",
         null
        ],
        [
         "10",
         "5-(5-(2,6-Dichloro-4-(4,5-Dihydro-2-Oxazoly)phenoxy)pentyl)-3-Methyl Isoxazole",
         "5-{5-[2,6-dichloro-4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]pentyl}-3-methyl-1,2-oxazole",
         "CC1=NOC(CCCCCOC2=C(Cl)C=C(C=C2Cl)C2=NCCO2)=C1",
         "InChI=1S/C18H20Cl2N2O3/c1-12-9-14(25-22-12)5-3-2-4-7-23-17-15(19)10-13(11-16(17)20)18-21-6-8-24-18/h9-11H,2-8H2,1H3",
         "JJDHAOLOHQTGMG-UHFFFAOYSA-N",
         "389867",
         "DB08723",
         "441048",
         "W54",
         "10029",
         "C06493",
         null,
         "HMDB0259896",
         null
        ],
        [
         "11",
         "Wedelolactone",
         "3,13,14-trihydroxy-5-methoxy-8,17-dioxatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2,4,6,11,13,15-heptaen-9-one",
         "COC1=CC(O)=C2C3=C(C4=CC(O)=C(O)C=C4O3)C(=O)OC2=C1",
         "InChI=1S/C16H10O7/c1-21-6-2-10(19)14-12(3-6)23-16(20)13-7-4-8(17)9(18)5-11(7)22-15(13)14/h2-5,17-19H,1H3",
         "XQDCKJKKMFWXGB-UHFFFAOYSA-N",
         "4445124",
         null,
         null,
         null,
         "10037",
         "C10541",
         null,
         "HMDB0259891",
         null
        ],
        [
         "12",
         "1,2,3,4-Tetrahydro-beta-carboline",
         "1H,2H,3H,4H,9H-pyrido[3,4-b]indole",
         "C1CC2=C(CN1)NC1=C2C=CC=C1",
         "InChI=1S/C11H12N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12-13H,5-7H2",
         "CFTOTSJVQRFXOF-UHFFFAOYSA-N",
         "96979",
         null,
         "107838",
         null,
         "100417",
         null,
         null,
         "HMDB0012488",
         null
        ],
        [
         "13",
         "Xanthosine 5-triphosphate",
         "({[({[(2R,3S,4R,5R)-5-(2,6-dihydroxy-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",
         "O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]([C@@H]1O)N1C=NC2=C1N=C(O)N=C2O",
         "InChI=1S/C10H15N4O15P3/c15-5-3(1-26-31(22,23)29-32(24,25)28-30(19,20)21)27-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H2,12,13,17,18)/t3-,5-,6-,9-/m1/s1",
         "CAEFEWVYEZABLA-UUOKFMHZSA-N",
         "388429",
         null,
         "439296",
         null,
         "10049",
         "C00700",
         null,
         "HMDB0000293",
         "6253-56-1"
        ],
        [
         "14",
         "XANOMELINE",
         "5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine",
         "CCCCCCOC1=NSN=C1C1=CCCN(C)C1",
         "InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3",
         "JOLJIIDDOBNFHW-UHFFFAOYSA-N",
         "54797",
         null,
         null,
         null,
         "10056",
         "C11767",
         null,
         "HMDB0259915",
         null
        ],
        [
         "15",
         "Xanthan",
         "6-({6-[(acetyloxy)methyl]-2-[(3-{[3,4-dihydroxy-6-(hydroxymethyl)-5-(phosphanyloxy)oxan-2-yl]oxy}-5-hydroxy-2-(hydroxymethyl)-6-(phosphanylmethyl)oxan-4-yl)oxy]-4,5-dihydroxyoxan-3-yl}oxy)-3-({2-carboxy-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl}oxy)-4,5-dihydroxyoxane-2-carboxylic acid",
         "CC(=O)OCC1OC(OC2C(O)C(CP)OC(CO)C2OC2OC(CO)C(OP)C(O)C2O)C(OC2OC(C(OC3OC4COC(C)(OC4C(O)C3O)C(O)=O)C(O)C2O)C(O)=O)C(O)C1O",
         "InChI=1S/C36H58O29P2/c1-8(39)53-5-11-14(40)16(42)28(34(57-11)61-26-15(41)13(7-66)55-10(4-38)25(26)59-31-21(47)18(44)24(65-67)9(3-37)56-31)62-33-22(48)19(45)27(29(63-33)30(49)50)60-32-20(46)17(43)23-12(58-32)6-54-36(2,64-23)35(51)52/h9-29,31-34,37-38,40-48H,3-7,66-67H2,1-2H3,(H,49,50)(H,51,52)",
         "KCOUXTVJDWNYJS-UHFFFAOYSA-N",
         null,
         null,
         "131750926",
         null,
         "10057",
         "C01464",
         null,
         "HMDB0029923",
         "11138-66-2"
        ],
        [
         "16",
         "Xanthurenic acid",
         "4,8-dihydroxyquinoline-2-carboxylic acid",
         "OC(=O)C1=NC2=C(O)C=CC=C2C(O)=C1",
         "InChI=1S/C10H7NO4/c12-7-3-1-2-5-8(13)4-6(10(14)15)11-9(5)7/h1-4,12H,(H,11,13)(H,14,15)",
         "FBZONXHGGPHHIY-UHFFFAOYSA-N",
         "5497",
         null,
         "5699",
         null,
         "10072",
         "C02470",
         null,
         "HMDB0000881",
         "59-00-7"
        ],
        [
         "17",
         "(-)-Wikstromol",
         "3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one",
         "COC1=C(O)C=CC(CC2COC(=O)C2(O)CC2=CC(OC)=C(O)C=C2)=C1",
         "InChI=1S/C20H22O7/c1-25-17-8-12(3-5-15(17)21)7-14-11-27-19(23)20(14,24)10-13-4-6-16(22)18(9-13)26-2/h3-6,8-9,14,21-22,24H,7,10-11H2,1-2H3",
         "ZITBJWXLODLDRH-UHFFFAOYSA-N",
         "90295",
         null,
         "99938",
         null,
         "1007254",
         "C10725",
         null,
         "HMDB0030598",
         "34444-37-6"
        ],
        [
         "18",
         "2-(4-(Benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine",
         "2-[4-(2H-1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl]-6-methylpyridine",
         "CC1=CC=CC(=N1)C1=C(N=C(N1)C(C)(C)C)C1=CC2=C(OCO2)C=C1",
         "InChI=1S/C20H21N3O2/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15/h5-10H,11H2,1-4H3,(H,22,23)",
         "WGZOTBUYUFBEPZ-UHFFFAOYSA-N",
         "8034640",
         null,
         null,
         null,
         "100922",
         null,
         null,
         "HMDB0257525",
         null
        ],
        [
         "19",
         "Yohimbine",
         "methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0Â²,Â¹â°.0â´,â¹.0Â¹âµ,Â²â°]henicosa-2(10),4,6,8-tetraene-19-carboxylate",
         "[H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2",
         "InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1",
         "BLGXFZZNTVWLAY-SCYLSFHTSA-N",
         "8622",
         "DB01392",
         "8969",
         null,
         "10093",
         "C09256",
         null,
         "HMDB0015464",
         "146-48-5"
        ],
        [
         "20",
         "Zafirlukast",
         "cyclopentyl N-[3-({2-methoxy-4-[(2-methylbenzenesulfonyl)carbamoyl]phenyl}methyl)-1-methyl-1H-indol-5-yl]carbamate",
         "COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=CC=CC=C1C",
         "InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",
         "YEEZWCHGZNKEEK-UHFFFAOYSA-N",
         "5515",
         "DB00549",
         "5717",
         null,
         "10100",
         "C07206",
         null,
         "HMDB0014689",
         "107753-78-6"
        ],
        [
         "21",
         "Fencamfamine",
         "N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine",
         "CCNC1C2CCC(C2)C1C1=CC=CC=C1",
         "InChI=1S/C15H21N/c1-2-16-15-13-9-8-12(10-13)14(15)11-6-4-3-5-7-11/h3-7,12-16H,2,8-10H2,1H3",
         "IKFBPFGUINLYQI-UHFFFAOYSA-N",
         "13922",
         "DB01463",
         "14584",
         null,
         "101009",
         null,
         null,
         "HMDB0015508",
         "1209-98-9"
        ],
        [
         "22",
         "Zalcitabine",
         "4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",
         "NC1=NC(=O)N(C=C1)[C@H]1CC[C@@H](CO)O1",
         "InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1",
         "WREGKURFCTUGRC-POYBYMJQSA-N",
         "22498",
         "DB00943",
         "24066",
         null,
         "10101",
         "C07207",
         null,
         "HMDB0015078",
         "7481-89-2"
        ],
        [
         "23",
         "Zaleplon",
         "N-(3-{3-cyanopyrazolo[1,5-a]pyrimidin-7-yl}phenyl)-N-ethylacetamide",
         "CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N",
         "InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3",
         "HUNXMJYCHXQEGX-UHFFFAOYSA-N",
         "5517",
         "DB00962",
         "5719",
         null,
         "10102",
         "C07484",
         null,
         "HMDB0015097",
         "151319-34-5"
        ],
        [
         "24",
         "Dichlorphenamide",
         "4,5-dichlorobenzene-1,3-disulfonamide",
         "NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O",
         "InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)",
         "GJQPMPFPNINLKP-UHFFFAOYSA-N",
         "2930",
         "DB01144",
         "3038",
         "I7A",
         "101085",
         "C07459",
         null,
         "HMDB0015275",
         "120-97-8"
        ],
        [
         "25",
         "Ethoxzolamide",
         "6-ethoxy-1,3-benzothiazole-2-sulfonamide",
         "CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O",
         "InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13)",
         "OUZWUKMCLIBBOG-UHFFFAOYSA-N",
         "3179",
         "DB00311",
         "3295",
         null,
         "101096",
         null,
         null,
         "HMDB0014456",
         "452-35-7"
        ],
        [
         "26",
         "Zidovudine",
         "1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione",
         "CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O",
         "InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",
         "HBOMLICNUCNMMY-XLPZGREQSA-N",
         "32555",
         "DB00495",
         "35370",
         null,
         "10110",
         "C07210",
         null,
         "HMDB0014638",
         "30516-87-1"
        ],
        [
         "27",
         "Zileuton",
         "1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea",
         "CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1",
         "InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",
         "MWLSOWXNZPKENC-UHFFFAOYSA-N",
         "54531",
         "DB00744",
         "60490",
         null,
         "10112",
         null,
         null,
         "HMDB0014882",
         "111406-87-2"
        ],
        [
         "28",
         "Ziprasidone",
         "5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one",
         "ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1",
         "InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)",
         "MVWVFYHBGMAFLY-UHFFFAOYSA-N",
         "54841",
         "DB00246",
         "60854",
         null,
         "10119",
         "C07568",
         null,
         "HMDB0014391",
         "146939-27-7"
        ],
        [
         "29",
         "Guanabenz",
         "2-{[(2,6-dichlorophenyl)methylidene]amino}guanidine",
         "NC(N)=NN=CC1=C(Cl)C=CC=C1Cl",
         "InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)",
         "WDZVGELJXXEGPV-UHFFFAOYSA-N",
         "4642445",
         "DB00629",
         "5702063",
         null,
         "101202",
         "C07034",
         null,
         "HMDB0014767",
         "5051-62-7"
        ],
        [
         "30",
         "5,7-Dihydroxyisoflavone",
         "5,7-dihydroxy-3-phenyl-4H-chromen-4-one",
         "OC1=CC(O)=C2C(OC=C(C2=O)C2=CC=CC=C2)=C1",
         "InChI=1S/C15H10O4/c16-10-6-12(17)14-13(7-10)19-8-11(15(14)18)9-4-2-1-3-5-9/h1-8,16-17H",
         "PJJGZPJJTHBVMX-UHFFFAOYSA-N",
         "4526438",
         null,
         "5377381",
         null,
         "1012277",
         "C02168",
         null,
         "HMDB0030699",
         "4044-00-2"
        ],
        [
         "31",
         "Zolmitriptan",
         "(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one",
         "CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12",
         "InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1",
         "ULSDMUVEXKOYBU-ZDUSSCGKSA-N",
         "54844",
         "DB00315",
         "60857",
         null,
         "10124",
         "C07218",
         null,
         "HMDB0014460",
         "139264-17-8"
        ],
        [
         "32",
         "Zolpidem",
         "N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide",
         "CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1",
         "InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",
         "ZAFYATHCZYHLPB-UHFFFAOYSA-N",
         "5530",
         "DB00425",
         "5732",
         null,
         "10125",
         "C07219",
         null,
         "HMDB0005023",
         "82626-48-0"
        ],
        [
         "33",
         "Zonisamide",
         "1,2-benzoxazol-3-ylmethanesulfonamide",
         "NS(=O)(=O)CC1=NOC2=CC=CC=C12",
         "InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",
         "UBQNRHZMVUUOMG-UHFFFAOYSA-N",
         "5532",
         "DB00909",
         "5734",
         "ZON",
         "10127",
         "C07504",
         null,
         "HMDB0015045",
         "68291-97-4"
        ],
        [
         "34",
         "Diltiazem",
         "(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate",
         "COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O",
         "InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1",
         "HSUGRBWQSSZJOP-RTWAWAEBSA-N",
         "35850",
         "DB00343",
         "39186",
         null,
         "101278",
         "C06958",
         null,
         "HMDB0014487",
         "42399-41-7"
        ],
        [
         "35",
         "Bis(2-hydroxy-1-naphthyl) disulfide",
         "1-[(2-hydroxynaphthalen-1-yl)disulfanyl]naphthalen-2-ol",
         "OC1=C(SSC2=C(O)C=CC3=CC=CC=C23)C2=CC=CC=C2C=C1",
         "InChI=1S/C20H14O2S2/c21-17-11-9-13-5-1-3-7-15(13)19(17)23-24-20-16-8-4-2-6-14(16)10-12-18(20)22/h1-12,21-22H",
         "RFAXLXKIAKIUDT-UHFFFAOYSA-N",
         "454544",
         null,
         "521106",
         null,
         "101355",
         null,
         null,
         "HMDB0253560",
         null
        ],
        [
         "36",
         "Olsalazine",
         "5-[(E)-2-(3-carboxy-4-hydroxyphenyl)diazen-1-yl]-2-hydroxybenzoic acid",
         "OC(=O)C1=CC(=CC=C1O)\\N=N\\C1=CC=C(O)C(=C1)C(O)=O",
         "InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",
         "QQBDLJCYGRGAKP-FOCLMDBBSA-N",
         "10642377",
         "DB01250",
         null,
         null,
         "101369",
         "C07323",
         null,
         "HMDB0015380",
         "15722-48-2"
        ],
        [
         "37",
         "2-Aminobenzenesulfonic acid",
         "2-aminobenzene-1-sulfonic acid",
         "NC1=CC=CC=C1S(O)(=O)=O",
         "InChI=1S/C6H7NO3S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H,8,9,10)",
         "ZMCHBSMFKQYNKA-UHFFFAOYSA-N",
         null,
         null,
         "6926",
         null,
         "1015",
         "C06333",
         null,
         "HMDB0304940",
         null
        ],
        [
         "38",
         "Cinnamtannin III",
         "(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-yl]-3,4-dihydro-2H-1-benzopyran-3,5,7-triol",
         "O[C@@H]1CC2=C(O)C=C(O)C([C@@H]3[C@@H](O)[C@H](OC4=C([C@@H]5[C@@H](O)[C@H](OC6=C([C@@H]7[C@@H](O)[C@H](OC8=C([C@@H]9[C@@H](O)[C@H](OC%10=C([C@@H]%11[C@@H](O)[C@H](OC%12=CC(O)=CC(O)=C%11%12)C%11=CC=C(O)C(O)=C%11)C(O)=CC(O)=C9%10)C9=CC=C(O)C(O)=C9)C(O)=CC(O)=C78)C7=CC=C(O)C(O)=C7)C(O)=CC(O)=C56)C5=CC=C(O)C(O)=C5)C(O)=CC(O)=C34)C3=CC=C(O)C(O)=C3)=C2O[C@@H]1C1=CC=C(O)C(O)=C1",
         "InChI=1S/C90H74O36/c91-33-19-48(105)60-59(20-33)121-81(28-2-8-36(93)43(100)14-28)75(116)70(60)62-50(107)23-52(109)64-72(77(118)83(123-87(62)64)30-4-10-38(95)45(102)16-30)66-54(111)25-56(113)68-74(79(120)85(125-89(66)68)32-6-12-40(97)47(104)18-32)69-57(114)26-55(112)67-73(78(119)84(126-90(67)69)31-5-11-39(96)46(103)17-31)65-53(110)24-51(108)63-71(76(117)82(124-88(63)65)29-3-9-37(94)44(101)15-29)61-49(106)22-41(98)34-21-58(115)80(122-86(34)61)27-1-7-35(92)42(99)13-27/h1-20,22-26,58,70-85,91-120H,21H2/t58-,70-,71+,72-,73+,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-/m1/s1",
         "UUOWTYGESRVWCF-WKWFDMPLSA-N",
         "10272881",
         null,
         "16129623",
         null,
         "10150",
         "C10222",
         null,
         "HMDB0037658",
         "88847-05-6"
        ],
        [
         "39",
         "Gemifloxacin",
         "7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid",
         "CO\\N=C1/CN(CC1CN)C1=NC2=C(C=C1F)C(=O)C(=CN2C1CC1)C(O)=O",
         "InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+",
         "ZRCVYEYHRGVLOC-HYARGMPZSA-N",
         "7845573",
         "DB01155",
         "9571107",
         null,
         "101853",
         null,
         null,
         "HMDB0015286",
         "175463-14-6"
        ],
        [
         "40",
         "Spirapril",
         "(8S)-7-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid",
         "CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2",
         "InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1",
         "HRWCVUIFMSZDJS-SZMVWBNQSA-N",
         "4470933",
         "DB01348",
         "5311447",
         null,
         "101967",
         null,
         null,
         "HMDB0015438",
         "83647-97-6"
        ],
        [
         "41",
         "Sulfamerazine",
         "4-amino-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide",
         "CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1",
         "InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)",
         "QPPBRPIAZZHUNT-UHFFFAOYSA-N",
         "5134",
         "DB01581",
         "5325",
         null,
         "102130",
         null,
         null,
         "HMDB0015521",
         "127-79-7"
        ],
        [
         "42",
         "alpha-Cedrene",
         "(1S,2R,5S,7S)-2,6,6,8-tetramethyltricyclo[5.3.1.0^{1,5}]undec-8-ene",
         "[H][C@@]12CC[C@@H](C)[C@]11C[C@@H](C(C)=CC1)C2(C)C",
         "InChI=1S/C15H24/c1-10-7-8-15-9-12(10)14(3,4)13(15)6-5-11(15)2/h7,11-13H,5-6,8-9H2,1-4H3/t11-,12+,13+,15+/m1/s1",
         "IRAQOCYXUMOFCW-OSFYFWSMSA-N",
         "4936353",
         null,
         "6431015",
         null,
         "10216",
         "C09630",
         "cedr-8-ene",
         "HMDB0059695",
         "469-61-4"
        ],
        [
         "43",
         "Thiopental",
         "5-ethyl-5-(pentan-2-yl)-2-sulfanylidene-1,3-diazinane-4,6-dione",
         "CCCC(C)C1(CC)C(=O)NC(=S)NC1=O",
         "InChI=1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",
         "IUJDSEJGGMCXSG-UHFFFAOYSA-N",
         "2272258",
         "DB00599",
         "3000715",
         null,
         "102166",
         "C07521",
         null,
         "HMDB0014737",
         "76-75-5"
        ],
        [
         "44",
         "Talarozole",
         "N-{4-[2-ethyl-1-(1H-1,2,4-triazol-1-yl)butyl]phenyl}-1,3-benzothiazol-2-amine",
         "CCC(CC)C(N1C=NC=N1)C1=CC=C(NC2=NC3=CC=CC=C3S2)C=C1",
         "InChI=1S/C21H23N5S/c1-3-15(4-2)20(26-14-22-13-23-26)16-9-11-17(12-10-16)24-21-25-18-7-5-6-8-19(18)27-21/h5-15,20H,3-4H2,1-2H3,(H,24,25)",
         "SNFYYXUGUBUECJ-UHFFFAOYSA-N",
         "7975653",
         "DB13083",
         null,
         null,
         "102167",
         null,
         null,
         "HMDB0258688",
         null
        ],
        [
         "45",
         "Cedorol",
         "(1S,2R,5S,7R,8R)-2,6,6,8-tetramethyltricyclo[5.3.1.0^{1,5}]undecan-8-ol",
         "[H][C@@]12CC[C@@H](C)[C@]11C[C@H](C2(C)C)[C@](C)(O)CC1",
         "InChI=1S/C15H26O/c1-10-5-6-11-13(2,3)12-9-15(10,11)8-7-14(12,4)16/h10-12,16H,5-9H2,1-4H3/t10-,11+,12-,14-,15+/m1/s1",
         "SVURIXNDRWRAFU-OGMFBOKVSA-N",
         null,
         null,
         "65575",
         null,
         "10217",
         "C09631",
         null,
         "HMDB0303103",
         null
        ],
        [
         "46",
         "Methohexital",
         "5-(hex-3-yn-2-yl)-1-methyl-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione",
         "CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O",
         "InChI=1S/C14H18N2O3/c1-5-7-8-10(3)14(9-6-2)11(17)15-13(19)16(4)12(14)18/h6,10H,2,5,9H2,1,3-4H3,(H,15,17,19)",
         "NZXKDOXHBHYTKP-UHFFFAOYSA-N",
         "8683",
         "DB00474",
         null,
         null,
         "102216",
         "C07844",
         null,
         "HMDB0014617",
         "151-83-7"
        ],
        [
         "47",
         "Dimethyloxalylglycine",
         "methyl [(2-methoxy-2-oxoethyl)carbamoyl]formate",
         "COC(=O)CNC(=O)C(=O)OC",
         "InChI=1S/C6H9NO5/c1-11-4(8)3-7-5(9)6(10)12-2/h3H2,1-2H3,(H,7,9)",
         "BNJOZDZCRHCODO-UHFFFAOYSA-N",
         "487098",
         null,
         null,
         null,
         "102218",
         null,
         null,
         "HMDB0251540",
         null
        ],
        [
         "48",
         "Alpha-Cryptoxanthin",
         "(1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohex-1-en-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]cyclohex-2-en-1-ol",
         "C\\C(\\C=C\\C=C(/C)\\C=C\\C1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\\C)/C=C/C=C(\\C)/C=C/C1=C(C)CCCC1(C)C",
         "InChI=1S/C40H56O/c1-30(18-13-20-32(3)23-25-37-34(5)22-15-27-39(37,7)8)16-11-12-17-31(2)19-14-21-33(4)24-26-38-35(6)28-36(41)29-40(38,9)10/h11-14,16-21,23-26,28,36,38,41H,15,22,27,29H2,1-10H3/b12-11+,18-13+,19-14+,25-23+,26-24+,30-16+,31-17+,32-20+,33-21+/t36-,38?/m0/s1",
         "ORAKUVXRZWMARG-DWADUKLPSA-N",
         "30791985",
         null,
         "23724629",
         null,
         "10223",
         "C15981",
         null,
         "HMDB0002268",
         "24480-38-4"
        ],
        [
         "49",
         "alpha-Cubebene",
         "(1R,5S,6R,7S,10R)-4,10-dimethyl-7-(propan-2-yl)tricyclo[4.4.0.0^{1,5}]dec-3-ene",
         "[H][C@]12[C@@H](CC[C@@H](C)[C@]11CC=C(C)[C@]21[H])C(C)C",
         "InChI=1S/C15H24/c1-9(2)12-6-5-11(4)15-8-7-10(3)13(15)14(12)15/h7,9,11-14H,5-6,8H2,1-4H3/t11-,12+,13-,14-,15+/m1/s1",
         "XUEHVOLRMXNRKQ-KHMAMNHCSA-N",
         "390811",
         null,
         "442359",
         null,
         "10224",
         "C09647",
         "alpha-cubebene",
         "HMDB0036413",
         "17699-14-8"
        ]
       ],
       "shape": {
        "columns": 14,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>name</th>\n",
       "      <th>iupac_name</th>\n",
       "      <th>smiles</th>\n",
       "      <th>inchi</th>\n",
       "      <th>inchikey</th>\n",
       "      <th>chemspider_id</th>\n",
       "      <th>drugbank_id</th>\n",
       "      <th>pubchem_compound_id</th>\n",
       "      <th>pdb_id</th>\n",
       "      <th>chebi_id</th>\n",
       "      <th>kegg_id</th>\n",
       "      <th>chebi_name</th>\n",
       "      <th>HMDB_ID</th>\n",
       "      <th>CAS_ID</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Visnagin</td>\n",
       "      <td>4-methoxy-7-methyl-5H-furo[3,2-g]chromen-5-one</td>\n",
       "      <td>COC1=C2C=COC2=CC2=C1C(=O)C=C(C)O2</td>\n",
       "      <td>InChI=1S/C13H10O4/c1-7-5-9(14)12-11(17-7)6-10-...</td>\n",
       "      <td>NZVQLVGOZRELTG-UHFFFAOYSA-N</td>\n",
       "      <td>6460</td>\n",
       "      <td>NaN</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10002</td>\n",
       "      <td>C09049</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0259840</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>13,14-Dihydro PGE1</td>\n",
       "      <td>7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl...</td>\n",
       "      <td>CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC...</td>\n",
       "      <td>InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16...</td>\n",
       "      <td>DPOINJQWXDTOSF-DODZYUBVSA-N</td>\n",
       "      <td>141668</td>\n",
       "      <td>NaN</td>\n",
       "      <td>161273</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1000694</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0002689</td>\n",
       "      <td>19313-28-1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Dihydrocubebin</td>\n",
       "      <td>2,3-bis(2H-1,3-benzodioxol-5-ylmethyl)butane-1...</td>\n",
       "      <td>OCC(CC1=CC2=C(OCO2)C=C1)C(CO)CC1=CC2=C(OCO2)C=C1</td>\n",
       "      <td>InChI=1S/C20H22O6/c21-9-15(5-13-1-3-17-19(7-13...</td>\n",
       "      <td>JKCVMTYNARDGET-UHFFFAOYSA-N</td>\n",
       "      <td>3683161</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4485343</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1001275</td>\n",
       "      <td>C10558</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0030709</td>\n",
       "      <td>24563-03-9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Nalidixic Acid</td>\n",
       "      <td>1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthy...</td>\n",
       "      <td>CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2</td>\n",
       "      <td>InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15...</td>\n",
       "      <td>MHWLWQUZZRMNGJ-UHFFFAOYSA-N</td>\n",
       "      <td>4268</td>\n",
       "      <td>DB00779</td>\n",
       "      <td>4421</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100147</td>\n",
       "      <td>C05079</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0014917</td>\n",
       "      <td>389-08-2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Girinimbine</td>\n",
       "      <td>3,3,5-trimethyl-3H,11H-pyrano[3,2-a]carbazole</td>\n",
       "      <td>CC1=C2OC(C)(C)C=CC2=C2NC3=CC=CC=C3C2=C1</td>\n",
       "      <td>InChI=1S/C18H17NO/c1-11-10-14-12-6-4-5-7-15(12...</td>\n",
       "      <td>GAEQWKVGMHUUKO-UHFFFAOYSA-N</td>\n",
       "      <td>87534</td>\n",
       "      <td>NaN</td>\n",
       "      <td>96943</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1001644</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HMDB0030241</td>\n",
       "      <td>23095-44-5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>PS(22:2(13Z,16Z)/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))</td>\n",
       "      <td>(2S)-2-amino-3-({[(2R)-2-{[(5R,6Z,8E,10E,12S,1...</td>\n",
       "      <td>[H][C@@](COC(=O)CCCCCCCCCCC\\C=C/C\\C=C/CCCCC)(C...</td>\n",
       "      <td>InChI=1S/C48H82NO12P/c1-3-5-7-9-11-12-13-14-15...</td>\n",
       "      <td>KCLZSFVFYNHPLH-YKPLNWMYSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>230137</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>PS(22:2(13Z,16Z)/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))</td>\n",
       "      <td>HMDB0283120</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>DG(12:0/18:1(12Z)-O(9S,10R)/0:0)</td>\n",
       "      <td>(2S)-3-hydroxy-2-[(8-{3-[(2Z)-oct-2-en-1-yl]ox...</td>\n",
       "      <td>CCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCC1OC1C...</td>\n",
       "      <td>InChI=1S/C33H60O6/c1-3-5-7-9-11-12-13-17-21-25...</td>\n",
       "      <td>LITIJTZLGLUHRG-FVGXFSABSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>231192</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>DG(12:0/18:1(12Z)-O(9S,10R)/0:0)</td>\n",
       "      <td>HMDB0294725</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))</td>\n",
       "      <td>(2R)-2-hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxi...</td>\n",
       "      <td>CCCCCCCCCCCCCCC(=O)OC[C@@H](O)COC(=O)CCC\\C=C/C...</td>\n",
       "      <td>InChI=1S/C38H66O6/c1-3-5-7-8-9-10-11-12-16-19-...</td>\n",
       "      <td>QZRFNZSUPCFJCE-PSMWKCNTSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>230153</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))</td>\n",
       "      <td>HMDB0295185</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>DG(8:0/18:1(12Z)-2OH(9,10)/0:0)</td>\n",
       "      <td>(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (9S,...</td>\n",
       "      <td>CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC[C@H](O)[C...</td>\n",
       "      <td>InChI=1S/C29H54O7/c1-3-5-7-9-12-15-19-26(31)27...</td>\n",
       "      <td>VVIFSARANRPVQE-PTUZYTQWSA-N</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>231035</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>DG(8:0/18:1(12Z)-2OH(9,10)/0:0)</td>\n",
       "      <td>HMDB0297171</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>ent-Gallocatechin 3-gallate</td>\n",
       "      <td>(2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxypheny...</td>\n",
       "      <td>OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3...</td>\n",
       "      <td>InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-2...</td>\n",
       "      <td>WMBWREPUVVBILR-NQIIRXRSSA-N</td>\n",
       "      <td>172662</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>199472</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>156271</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>(-)-gallocatechin gallate</td>\n",
       "      <td>HMDB0301673</td>\n",
       "      <td>68-22-4;4233-96-9</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                     name  \\\n",
       "0                                                Visnagin   \n",
       "1                                      13,14-Dihydro PGE1   \n",
       "2                                          Dihydrocubebin   \n",
       "3                                          Nalidixic Acid   \n",
       "4                                             Girinimbine   \n",
       "...                                                   ...   \n",
       "218330  PS(22:2(13Z,16Z)/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))   \n",
       "218331                   DG(12:0/18:1(12Z)-O(9S,10R)/0:0)   \n",
       "218332            DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))   \n",
       "218333                    DG(8:0/18:1(12Z)-2OH(9,10)/0:0)   \n",
       "218334                        ent-Gallocatechin 3-gallate   \n",
       "\n",
       "                                               iupac_name  \\\n",
       "0          4-methoxy-7-methyl-5H-furo[3,2-g]chromen-5-one   \n",
       "1       7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl...   \n",
       "2       2,3-bis(2H-1,3-benzodioxol-5-ylmethyl)butane-1...   \n",
       "3       1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthy...   \n",
       "4           3,3,5-trimethyl-3H,11H-pyrano[3,2-a]carbazole   \n",
       "...                                                   ...   \n",
       "218330  (2S)-2-amino-3-({[(2R)-2-{[(5R,6Z,8E,10E,12S,1...   \n",
       "218331  (2S)-3-hydroxy-2-[(8-{3-[(2Z)-oct-2-en-1-yl]ox...   \n",
       "218332  (2R)-2-hydroxy-3-{[(5Z,8Z,11Z)-13-(3-pentyloxi...   \n",
       "218333  (2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (9S,...   \n",
       "218334  (2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxypheny...   \n",
       "\n",
       "                                                   smiles  \\\n",
       "0                       COC1=C2C=COC2=CC2=C1C(=O)C=C(C)O2   \n",
       "1       CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC...   \n",
       "2        OCC(CC1=CC2=C(OCO2)C=C1)C(CO)CC1=CC2=C(OCO2)C=C1   \n",
       "3                     CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2   \n",
       "4                 CC1=C2OC(C)(C)C=CC2=C2NC3=CC=CC=C3C2=C1   \n",
       "...                                                   ...   \n",
       "218330  [H][C@@](COC(=O)CCCCCCCCCCC\\C=C/C\\C=C/CCCCC)(C...   \n",
       "218331  CCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCC1OC1C...   \n",
       "218332  CCCCCCCCCCCCCCC(=O)OC[C@@H](O)COC(=O)CCC\\C=C/C...   \n",
       "218333  CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC[C@H](O)[C...   \n",
       "218334  OC1=CC(O)=C2C[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3...   \n",
       "\n",
       "                                                    inchi  \\\n",
       "0       InChI=1S/C13H10O4/c1-7-5-9(14)12-11(17-7)6-10-...   \n",
       "1       InChI=1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16...   \n",
       "2       InChI=1S/C20H22O6/c21-9-15(5-13-1-3-17-19(7-13...   \n",
       "3       InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15...   \n",
       "4       InChI=1S/C18H17NO/c1-11-10-14-12-6-4-5-7-15(12...   \n",
       "...                                                   ...   \n",
       "218330  InChI=1S/C48H82NO12P/c1-3-5-7-9-11-12-13-14-15...   \n",
       "218331  InChI=1S/C33H60O6/c1-3-5-7-9-11-12-13-17-21-25...   \n",
       "218332  InChI=1S/C38H66O6/c1-3-5-7-8-9-10-11-12-16-19-...   \n",
       "218333  InChI=1S/C29H54O7/c1-3-5-7-9-12-15-19-26(31)27...   \n",
       "218334  InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-2...   \n",
       "\n",
       "                           inchikey chemspider_id drugbank_id  \\\n",
       "0       NZVQLVGOZRELTG-UHFFFAOYSA-N          6460         NaN   \n",
       "1       DPOINJQWXDTOSF-DODZYUBVSA-N        141668         NaN   \n",
       "2       JKCVMTYNARDGET-UHFFFAOYSA-N       3683161         NaN   \n",
       "3       MHWLWQUZZRMNGJ-UHFFFAOYSA-N          4268     DB00779   \n",
       "4       GAEQWKVGMHUUKO-UHFFFAOYSA-N         87534         NaN   \n",
       "...                             ...           ...         ...   \n",
       "218330  KCLZSFVFYNHPLH-YKPLNWMYSA-N          <NA>        <NA>   \n",
       "218331  LITIJTZLGLUHRG-FVGXFSABSA-N          <NA>        <NA>   \n",
       "218332  QZRFNZSUPCFJCE-PSMWKCNTSA-N          <NA>        <NA>   \n",
       "218333  VVIFSARANRPVQE-PTUZYTQWSA-N          <NA>        <NA>   \n",
       "218334  WMBWREPUVVBILR-NQIIRXRSSA-N        172662        <NA>   \n",
       "\n",
       "       pubchem_compound_id pdb_id chebi_id kegg_id  \\\n",
       "0                     <NA>    NaN    10002  C09049   \n",
       "1                   161273    NaN  1000694     NaN   \n",
       "2                  4485343    NaN  1001275  C10558   \n",
       "3                     4421    NaN   100147  C05079   \n",
       "4                    96943    NaN  1001644     NaN   \n",
       "...                    ...    ...      ...     ...   \n",
       "218330                <NA>   <NA>   230137    <NA>   \n",
       "218331                <NA>   <NA>   231192    <NA>   \n",
       "218332                <NA>   <NA>   230153    <NA>   \n",
       "218333                <NA>   <NA>   231035    <NA>   \n",
       "218334              199472   <NA>   156271    <NA>   \n",
       "\n",
       "                                               chebi_name      HMDB_ID  \\\n",
       "0                                                     NaN  HMDB0259840   \n",
       "1                                                     NaN  HMDB0002689   \n",
       "2                                                     NaN  HMDB0030709   \n",
       "3                                                     NaN  HMDB0014917   \n",
       "4                                                     NaN  HMDB0030241   \n",
       "...                                                   ...          ...   \n",
       "218330  PS(22:2(13Z,16Z)/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))  HMDB0283120   \n",
       "218331                   DG(12:0/18:1(12Z)-O(9S,10R)/0:0)  HMDB0294725   \n",
       "218332            DG(15:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))  HMDB0295185   \n",
       "218333                    DG(8:0/18:1(12Z)-2OH(9,10)/0:0)  HMDB0297171   \n",
       "218334                          (-)-gallocatechin gallate  HMDB0301673   \n",
       "\n",
       "                   CAS_ID  \n",
       "0                     NaN  \n",
       "1              19313-28-1  \n",
       "2              24563-03-9  \n",
       "3                389-08-2  \n",
       "4              23095-44-5  \n",
       "...                   ...  \n",
       "218330               <NA>  \n",
       "218331               <NA>  \n",
       "218332               <NA>  \n",
       "218333               <NA>  \n",
       "218334  68-22-4;4233-96-9  \n",
       "\n",
       "[218335 rows x 14 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def data_cleaning(df, column):\n",
    "    # Step 1: Separate the DataFrame into unique and duplicated entries based on the column\n",
    "    df_no_duplicates = df[~(df[column].duplicated(keep=False) & df[column].notna()) | df[column].isna()]\n",
    "    df_duplicates = df[df[column].notna() & df.duplicated(column, keep=False)].sort_values(column)\n",
    "    \n",
    "    # Step 2: Define the merge_entries function to handle merging of duplicated entries\n",
    "    def merge_entries(series):\n",
    "        filtered = series.dropna().astype(str)\n",
    "        unique_filtered = ';'.join(filtered.unique())\n",
    "        return unique_filtered\n",
    "    \n",
    "    # Step 3: Group the duplicated entries and merge them using the merge_entries function\n",
    "    df_duplicates_merged = df_duplicates.groupby(column).agg(merge_entries).reset_index()\n",
    "    \n",
    "    return df_no_duplicates, df_duplicates_merged\n",
    "\n",
    "no_duplicated_hmdb, duplicated_hmdb = data_cleaning(hmdb_chebi_v1, 'HMDB_ID')\n",
    "hmdb_chebi_v2 = pd.concat([no_duplicated_hmdb, duplicated_hmdb], ignore_index=True)\n",
    "hmdb_chebi_v2.replace('', pd.NA, inplace=True)\n",
    "hmdb_chebi_v2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 218335 entries, 0 to 218334\n",
      "Data columns (total 14 columns):\n",
      " #   Column               Non-Null Count   Dtype \n",
      "---  ------               --------------   ----- \n",
      " 0   name                 217934 non-null  object\n",
      " 1   iupac_name           216866 non-null  object\n",
      " 2   smiles               217910 non-null  object\n",
      " 3   inchi                217909 non-null  object\n",
      " 4   inchikey             217913 non-null  object\n",
      " 5   chemspider_id        31291 non-null   object\n",
      " 6   drugbank_id          3269 non-null    object\n",
      " 7   pubchem_compound_id  104246 non-null  object\n",
      " 8   pdb_id               524 non-null     object\n",
      " 9   chebi_id             14822 non-null   object\n",
      " 10  kegg_id              6826 non-null    object\n",
      " 11  chebi_name           2959 non-null    object\n",
      " 12  HMDB_ID              217942 non-null  object\n",
      " 13  CAS_ID               16312 non-null   object\n",
      "dtypes: object(14)\n",
      "memory usage: 23.3+ MB\n"
     ]
    }
   ],
   "source": [
    "hmdb_chebi_v2.info()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 4. BioMedGraphica ID"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "HMDB_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PubChem_CID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "CAS_RN",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ChemSpider_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PDB_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ChEBI_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "KEGG_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "HMDB_Name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ChEBI_Name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "IUPAC_Name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "SMILES",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "InChI",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "InChIKey",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "4290acf5-612a-4446-a569-cfc5fe73109f",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "HMDB0000001",
         "92105",
         "332-80-9",
         "83153",
         null,
         "50599",
         "C01152",
         "1-Methylhistidine",
         "N(tele)-methyl-L-histidine",
         "(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid",
         "CN1C=NC(C[C@H](N)C(O)=O)=C1",
         "InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1",
         "BRMWTNUJHUMWMS-LURJTMIESA-N"
        ],
        [
         "1",
         "BMG_MT000002",
         "HMDB0000002",
         "428",
         "109-76-2",
         "415",
         null,
         "15725",
         "C00986",
         "1,3-Diaminopropane",
         "trimethylenediamine",
         "propane-1,3-diamine",
         "NCCCN",
         "InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2",
         "XFNJVJPLKCPIBV-UHFFFAOYSA-N"
        ],
        [
         "2",
         "BMG_MT000003",
         "HMDB0000005",
         "58",
         "600-18-0",
         "57",
         null,
         "30831;16763",
         "C00109",
         "2-Ketobutyric acid",
         "2-oxobutanoate",
         "2-oxobutanoic acid",
         "CCC(=O)C(O)=O",
         "InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)",
         "TYEYBOSBBBHJIV-UHFFFAOYSA-N"
        ],
        [
         "3",
         "BMG_MT000004",
         "HMDB0000008",
         "440864",
         "600-15-7;3347-90-8",
         "389701",
         null,
         "1148;50613",
         "C05984",
         "2-Hydroxybutyric acid",
         "2-hydroxybutyric acid",
         "(2S)-2-hydroxybutanoic acid",
         "CC[C@H](O)C(O)=O",
         "InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1",
         "AFENDNXGAFYKQO-VKHMYHEASA-N"
        ],
        [
         "4",
         "BMG_MT000005",
         "HMDB0000010",
         "440624",
         "362-08-3",
         "389515",
         null,
         "1189",
         "C05299",
         "2-Methoxyestrone",
         "2-methoxyestrone",
         "(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3",
         "InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1",
         "WHEUWNKSCXYKBU-QPWUGHHJSA-N"
        ],
        [
         "5",
         "BMG_MT000006",
         "HMDB0000011",
         "92135",
         "625-72-9",
         "83181",
         null,
         "17066",
         "C01089",
         "3-Hydroxybutyric acid",
         "(R)-3-hydroxybutyric acid",
         "(3R)-3-hydroxybutanoic acid",
         "C[C@@H](O)CC(O)=O",
         "InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1",
         "WHBMMWSBFZVSSR-GSVOUGTGSA-N"
        ],
        [
         "6",
         "BMG_MT000007",
         "HMDB0000012",
         "13712",
         "951-78-0",
         "13118",
         null,
         "16450",
         "C00526",
         "Deoxyuridine",
         "2'-deoxyuridine",
         "1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione",
         "OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O",
         "InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1",
         "MXHRCPNRJAMMIM-SHYZEUOFSA-N"
        ],
        [
         "7",
         "BMG_MT000008",
         "HMDB0000014",
         "13711",
         "951-77-9",
         "13117",
         null,
         "15698",
         "C00881",
         "Deoxycytidine",
         "2'-deoxycytidine",
         "4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",
         "NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1",
         "InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",
         "CKTSBUTUHBMZGZ-SHYZEUOFSA-N"
        ],
        [
         "8",
         "BMG_MT000009",
         "HMDB0000015",
         "440707",
         "152-58-9",
         "389582",
         null,
         "28324",
         "C05488",
         "Cortexolone",
         "11-deoxycortisol",
         "(1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1",
         "WHBHBVVOGNECLV-OBQKJFGGSA-N"
        ],
        [
         "9",
         "BMG_MT000010",
         "HMDB0000016",
         "6166",
         "64-85-7",
         "5932",
         null,
         "16973",
         "C03205",
         "Deoxycorticosterone",
         "11-deoxycorticosterone",
         "(1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1",
         "ZESRJSPZRDMNHY-YFWFAHHUSA-N"
        ],
        [
         "10",
         "BMG_MT000011",
         "HMDB0000017",
         "6723",
         "82-82-6",
         "6467",
         null,
         "17405",
         "C00847",
         "4-Pyridoxic acid",
         "4-pyridoxic acid",
         "3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid",
         "CC1=NC=C(CO)C(C(O)=O)=C1O",
         "InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)",
         "HXACOUQIXZGNBF-UHFFFAOYSA-N"
        ],
        [
         "11",
         "BMG_MT000012",
         "HMDB0000019",
         "49",
         "759-05-7",
         "48",
         null,
         "16530",
         "C00141",
         "alpha-Ketoisovaleric acid",
         "3-methyl-2-oxobutanoic acid",
         "3-methyl-2-oxobutanoic acid",
         "CC(C)C(=O)C(O)=O",
         "InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)",
         "QHKABHOOEWYVLI-UHFFFAOYSA-N"
        ],
        [
         "12",
         "BMG_MT000013",
         "HMDB0000020",
         "127",
         "156-38-7",
         "124",
         null,
         "18101",
         "C00642",
         "p-Hydroxyphenylacetic acid",
         "4-hydroxyphenylacetic acid",
         "2-(4-hydroxyphenyl)acetic acid",
         "OC(=O)CC1=CC=C(O)C=C1",
         "InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)",
         "XQXPVVBIMDBYFF-UHFFFAOYSA-N"
        ],
        [
         "13",
         "BMG_MT000014",
         "HMDB0000021",
         "439744",
         "70-78-0",
         "388804",
         null,
         "27847",
         "C02515",
         "Iodotyrosine",
         "3-iodo-L-tyrosine",
         "(2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid",
         "N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O",
         "InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1",
         "UQTZMGFTRHFAAM-ZETCQYMHSA-N"
        ],
        [
         "14",
         "BMG_MT000015",
         "HMDB0000022",
         "1669",
         "554-52-9",
         "1606",
         null,
         "1582;742324",
         "C05587",
         "3-Methoxytyramine",
         "3-methoxytyramine",
         "4-(2-aminoethyl)-2-methoxyphenol",
         "COC1=C(O)C=CC(CCN)=C1",
         "InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3",
         "DIVQKHQLANKJQO-UHFFFAOYSA-N"
        ],
        [
         "15",
         "BMG_MT000016",
         "HMDB0000023",
         "440873",
         "26543-05-5",
         "389707",
         null,
         "37373",
         "C06001",
         "(S)-3-Hydroxyisobutyric acid",
         null,
         "(2S)-3-hydroxy-2-methylpropanoic acid",
         "C[C@@H](CO)C(O)=O",
         "InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1",
         "DBXBTMSZEOQQDU-VKHMYHEASA-N"
        ],
        [
         "16",
         "BMG_MT000017",
         "HMDB0000024",
         "24779585",
         "151122-71-3",
         "24823255",
         null,
         null,
         null,
         "3-O-Sulfogalactosylceramide (d18:1/24:0)",
         null,
         "[(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid",
         "[H][C@@](CO[C@@H]1O[C@H](CO)[C@H](O)C(OS(O)(=O)=O)C1O)(NC(=O)CCCCCCCCCCCCCCCCCCCCCCC)[C@]([H])(O)\\C=C\\CCCCCCCCCCCCC",
         "InChI=1S/C48H93NO11S/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2)40-58-48-46(54)47(60-61(55,56)57)45(53)43(39-50)59-48/h35,37,41-43,45-48,50-51,53-54H,3-34,36,38-40H2,1-2H3,(H,49,52)(H,55,56,57)/b37-35+/t41-,42+,43+,45-,46?,47?,48+/m0/s1",
         "MEAZTWJVOWHKJM-YQTIZROBSA-N"
        ],
        [
         "17",
         "BMG_MT000018",
         "HMDB0000026",
         null,
         "462-88-4",
         "109",
         null,
         "18261",
         "C02642",
         "Ureidopropionic acid",
         null,
         "3-(carbamoylamino)propanoic acid",
         "NC(=O)NCCC(O)=O",
         "InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9)",
         "JSJWCHRYRHKBBW-UHFFFAOYSA-N"
        ],
        [
         "18",
         "BMG_MT000019",
         "HMDB0000027",
         "44257",
         "27070-47-9;17528-72-2;62989-33-7",
         "40270",
         null,
         "59560",
         "C00272",
         "Tetrahydrobiopterin",
         "sapropterin",
         "(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,5,6,7,8-hexahydropteridin-4-one",
         "[H][C@@]1(CNC2=C(N1)C(=O)N=C(N)N2)[C@@H](O)[C@H](C)O",
         "InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1",
         "FNKQXYHWGSIFBK-RPDRRWSUSA-N"
        ],
        [
         "19",
         "BMG_MT000020",
         "HMDB0000030",
         "171548",
         "58-85-5",
         "149962",
         null,
         "15956",
         "C00120",
         "Biotin",
         "biotin",
         "5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid",
         "[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2",
         "InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",
         "YBJHBAHKTGYVGT-ZKWXMUAHSA-N"
        ],
        [
         "20",
         "BMG_MT000021",
         "HMDB0000031",
         "5879",
         "53-41-8",
         "5668",
         null,
         "16032",
         "C00523",
         "Androsterone",
         "androsterone",
         "(1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)CC[C@]12C",
         "InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,18-,19-/m0/s1",
         "QGXBDMJGAMFCBF-HLUDHZFRSA-N"
        ],
        [
         "21",
         "BMG_MT000022",
         "HMDB0000032",
         "439423",
         "434-16-2",
         null,
         null,
         "17759",
         "C01164",
         "7-Dehydrocholesterol",
         "cholesta-5,7-dien-3beta-ol",
         "(1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,9-dien-5-ol",
         "[H][C@@]1(CC[C@@]2([H])C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C",
         "InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1",
         "UCTLRSWJYQTBFZ-DDPQNLDTSA-N"
        ],
        [
         "22",
         "BMG_MT000023",
         "HMDB0000033",
         "439224",
         "305-84-0",
         "388363",
         null,
         "15727",
         "C00386",
         "Carnosine",
         "carnosine",
         "(2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid",
         "NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O",
         "InChI=1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1",
         "CQOVPNPJLQNMDC-ZETCQYMHSA-N"
        ],
        [
         "23",
         "BMG_MT000024",
         "HMDB0000034",
         "190",
         "73-24-5",
         "185",
         null,
         "16708",
         "C00147",
         "Adenine",
         "adenine",
         "7H-purin-6-amine",
         "NC1=C2NC=NC2=NC=N1",
         "InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)",
         "GFFGJBXGBJISGV-UHFFFAOYSA-N"
        ],
        [
         "24",
         "BMG_MT000025",
         "HMDB0000036",
         "6675",
         "81-24-3",
         "6423",
         null,
         "28865",
         "C05122",
         "Taurocholic acid",
         "taurocholic acid",
         "2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid",
         "[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O",
         "InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1",
         "WBWWGRHZICKQGZ-HZAMXZRMSA-N"
        ],
        [
         "25",
         "BMG_MT000026",
         "HMDB0000037",
         "5839",
         "52-39-1",
         "5633",
         null,
         "27584",
         "C01780",
         "Aldosterone",
         "aldosterone",
         "(1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde",
         "[H][C@@]12CC[C@H](C(=O)CO)[C@]1(C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C)C=O",
         "InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",
         "PQSUYGKTWSAVDQ-ZVIOFETBSA-N"
        ],
        [
         "26",
         "BMG_MT000027",
         "HMDB0000038",
         "119055",
         "6779-87-9",
         "106382",
         null,
         "43029",
         "C02953",
         "Dihydrobiopterin",
         null,
         "2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,7,8-tetrahydropteridin-4-one",
         "C[C@H](O)[C@H](O)C1=NC2=C(NC1)NC(N)=NC2=O",
         "InChI=1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3,6,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,6-/m0/s1",
         "FEMXZDUTFRTWPE-DZSWIPIPSA-N"
        ],
        [
         "27",
         "BMG_MT000028",
         "HMDB0000039",
         "264",
         "107-92-6",
         "259",
         null,
         "30772",
         "C00246",
         "Butyric acid",
         "butyric acid",
         "butanoic acid",
         "CCCC(O)=O",
         "InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)",
         "FERIUCNNQQJTOY-UHFFFAOYSA-N"
        ],
        [
         "28",
         "BMG_MT000029",
         "HMDB0000042",
         "176",
         "64-19-7",
         "171",
         null,
         "15366",
         "C00033",
         "Acetic acid",
         null,
         "acetic acid",
         "CC(O)=O",
         "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)",
         "QTBSBXVTEAMEQO-UHFFFAOYSA-N"
        ],
        [
         "29",
         "BMG_MT000030",
         "HMDB0000043",
         "248",
         "6915-17-9",
         "243",
         null,
         "41139",
         null,
         "Betaine",
         null,
         "(carboxymethyl)trimethylazanium",
         "C[N+](C)(C)CC(O)=O",
         "InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3/p+1",
         "KWIUHFFTVRNATP-UHFFFAOYSA-O"
        ],
        [
         "30",
         "BMG_MT000031",
         "HMDB0000044",
         null,
         "50-81-7",
         "10189562",
         null,
         "29073",
         "C01041",
         "Ascorbic acid",
         null,
         "(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one",
         "[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO",
         "InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1",
         "CIWBSHSKHKDKBQ-JLAZNSOCSA-N"
        ],
        [
         "31",
         "BMG_MT000032",
         "HMDB0000045",
         "6083",
         "61-19-8",
         "5858",
         null,
         "16027;456215",
         "C00020",
         "Adenosine monophosphate",
         "adenosine 5'-monophosphate(2-)",
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid",
         "NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
         "UDMBCSSLTHHNCD-KQYNXXCUSA-N"
        ],
        [
         "32",
         "BMG_MT000033",
         "HMDB0000048",
         "6602503",
         "13299-20-2",
         null,
         null,
         null,
         null,
         "Melibiose",
         null,
         "(2S,3R,4S,5S,6R)-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol",
         "OC[C@H]1O[C@H](OC[C@H]2O[C@H](O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O",
         "InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2/t3-,4-,5+,6-,7+,8+,9-,10-,11+,12+/m1/s1",
         "DLRVVLDZNNYCBX-CQHUIXDMSA-N"
        ],
        [
         "33",
         "BMG_MT000034",
         "HMDB0000050",
         "60961",
         "58-61-7",
         "54923",
         null,
         "16335",
         "C00212",
         "Adenosine",
         "adenosine",
         "(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",
         "NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
         "OIRDTQYFTABQOQ-KQYNXXCUSA-N"
        ],
        [
         "34",
         "BMG_MT000035",
         "HMDB0000051",
         "222",
         "7664-41-7",
         "217",
         null,
         "16134",
         "C00014",
         "Ammonia",
         null,
         "ammonia",
         "N",
         "InChI=1S/H3N/h1H3",
         "QGZKDVFQNNGYKY-UHFFFAOYSA-N"
        ],
        [
         "35",
         "BMG_MT000036",
         "HMDB0000052",
         "16950",
         "2387-71-5",
         "16059",
         null,
         "15682",
         "C03406",
         "Argininosuccinic acid",
         null,
         "(2S)-2-{N'-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid",
         "N[C@@H](CCCNC(=N)N[C@@H](CC(O)=O)C(O)=O)C(O)=O",
         "InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/t5-,6-/m0/s1",
         "KDZOASGQNOPSCU-WDSKDSINSA-N"
        ],
        [
         "36",
         "BMG_MT000037",
         "HMDB0000053",
         "6128",
         "63-05-8",
         "5898",
         null,
         "16422",
         "C00280",
         "Androstenedione",
         "androst-4-ene-3,17-dione",
         "(1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,14-dione",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",
         "AEMFNILZOJDQLW-QAGGRKNESA-N"
        ],
        [
         "37",
         "BMG_MT000038",
         "HMDB0000054",
         "5280352",
         "635-65-4",
         "4444055",
         null,
         "16990",
         "C00486",
         "Bilirubin",
         "bilirubin IXalpha",
         "3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",
         "CC1=C(C=C)\\C(NC1=O)=C\\C1=C(C)C(CCC(O)=O)=C(CC2=C(CCC(O)=O)C(C)=C(N2)\\C=C2/NC(=O)C(C=C)=C2C)N1",
         "InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-",
         "BPYKTIZUTYGOLE-IFADSCNNSA-N"
        ],
        [
         "38",
         "BMG_MT000039",
         "HMDB0000055",
         "10712",
         "528-50-7",
         "10261",
         null,
         "36217",
         "C06422",
         "Cellobiose",
         null,
         "(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol",
         "OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O",
         "InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11-,12+/m1/s1",
         "GUBGYTABKSRVRQ-QRZGKKJRSA-N"
        ],
        [
         "39",
         "BMG_MT000040",
         "HMDB0000056",
         "239",
         "107-95-9",
         "234",
         null,
         "16958",
         "C00099",
         "beta-Alanine",
         "beta-alanine",
         "3-aminopropanoic acid",
         "NCCC(O)=O",
         "InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)",
         "UCMIRNVEIXFBKS-UHFFFAOYSA-N"
        ],
        [
         "40",
         "BMG_MT000041",
         "HMDB0000058",
         "6076",
         "60-92-4",
         "5851",
         null,
         "17489",
         "C00575",
         "Cyclic AMP",
         "3',5'-cyclic AMP",
         "(4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one",
         "[H][C@@]12COP(O)(=O)O[C@@]1([H])[C@@H](O)[C@@H](O2)N1C=NC2=C1N=CN=C2N",
         "InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
         "IVOMOUWHDPKRLL-KQYNXXCUSA-N"
        ],
        [
         "41",
         "BMG_MT000042",
         "HMDB0000060",
         "96",
         "541-50-4",
         "94",
         null,
         "15344",
         "C00164",
         "Acetoacetic acid",
         null,
         "3-oxobutanoic acid",
         "CC(=O)CC(O)=O",
         "InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7)",
         "WDJHALXBUFZDSR-UHFFFAOYSA-N"
        ],
        [
         "42",
         "BMG_MT000043",
         "HMDB0000061",
         "159296",
         "1053-73-2",
         "140102",
         null,
         "17985",
         "C00054",
         "Adenosine 3',5'-diphosphate",
         null,
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}phosphonic acid",
         "NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1",
         "WHTCPDAXWFLDIH-KQYNXXCUSA-N"
        ],
        [
         "43",
         "BMG_MT000044",
         "HMDB0000062",
         "10917",
         "541-15-1",
         "2006614",
         null,
         "16347",
         "C00318",
         "L-Carnitine",
         "(R)-carnitine",
         "(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate",
         "C[N+](C)(C)C[C@H](O)CC(O)=O",
         "InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/p+1/t6-/m1/s1",
         "PHIQHXFUZVPYII-ZCFIWIBFSA-O"
        ],
        [
         "44",
         "BMG_MT000045",
         "HMDB0000063",
         "5754",
         "50-23-7",
         null,
         null,
         "17650",
         "C00735",
         "Cortisol",
         "cortisol",
         "(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",
         "JYGXADMDTFJGBT-VWUMJDOOSA-N"
        ],
        [
         "45",
         "BMG_MT000046",
         "HMDB0000064",
         "586",
         "57-00-1",
         "566",
         null,
         "16919",
         "C00300",
         "Creatine",
         "creatine",
         "2-(N-methylcarbamimidamido)acetic acid",
         "CN(CC(O)=O)C(N)=N",
         "InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)",
         "CVSVTCORWBXHQV-UHFFFAOYSA-N"
        ],
        [
         "46",
         "BMG_MT000047",
         "HMDB0000067",
         "5997",
         "57-88-5",
         null,
         null,
         "16113",
         "C00187",
         "Cholesterol",
         "cholesterol",
         "(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",
         "[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C",
         "InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1",
         "HVYWMOMLDIMFJA-DPAQBDIFSA-N"
        ],
        [
         "47",
         "BMG_MT000048",
         "HMDB0000068",
         "5816",
         "51-43-4",
         "5611",
         null,
         "28918",
         "C00788",
         "Epinephrine",
         null,
         "4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol",
         "CNC[C@H](O)C1=CC(O)=C(O)C=C1",
         "InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",
         "UCTWMZQNUQWSLP-VIFPVBQESA-N"
        ],
        [
         "48",
         "BMG_MT000049",
         "HMDB0000070",
         "849",
         "535-75-1",
         "826",
         null,
         "17964",
         "C00408",
         "Pipecolic acid",
         null,
         "piperidine-2-carboxylic acid",
         "OC(=O)C1CCCCN1",
         "InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)",
         "HXEACLLIILLPRG-UHFFFAOYSA-N"
        ],
        [
         "49",
         "BMG_MT000050",
         "HMDB0000071",
         "65058",
         "890-38-0",
         "58569",
         null,
         "28997",
         "C05512",
         "Deoxyinosine",
         "2'-deoxyinosine",
         "9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-ol",
         "OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC2=O",
         "InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1",
         "VGONTNSXDCQUGY-RRKCRQDMSA-N"
        ]
       ],
       "shape": {
        "columns": 14,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>HMDB_ID</th>\n",
       "      <th>PubChem_CID</th>\n",
       "      <th>CAS_RN</th>\n",
       "      <th>ChemSpider_ID</th>\n",
       "      <th>PDB_ID</th>\n",
       "      <th>ChEBI_ID</th>\n",
       "      <th>KEGG_ID</th>\n",
       "      <th>HMDB_Name</th>\n",
       "      <th>ChEBI_Name</th>\n",
       "      <th>IUPAC_Name</th>\n",
       "      <th>SMILES</th>\n",
       "      <th>InChI</th>\n",
       "      <th>InChIKey</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>HMDB0000001</td>\n",
       "      <td>92105</td>\n",
       "      <td>332-80-9</td>\n",
       "      <td>83153</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50599</td>\n",
       "      <td>C01152</td>\n",
       "      <td>1-Methylhistidine</td>\n",
       "      <td>N(tele)-methyl-L-histidine</td>\n",
       "      <td>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...</td>\n",
       "      <td>CN1C=NC(C[C@H](N)C(O)=O)=C1</td>\n",
       "      <td>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11...</td>\n",
       "      <td>BRMWTNUJHUMWMS-LURJTMIESA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>HMDB0000002</td>\n",
       "      <td>428</td>\n",
       "      <td>109-76-2</td>\n",
       "      <td>415</td>\n",
       "      <td>NaN</td>\n",
       "      <td>15725</td>\n",
       "      <td>C00986</td>\n",
       "      <td>1,3-Diaminopropane</td>\n",
       "      <td>trimethylenediamine</td>\n",
       "      <td>propane-1,3-diamine</td>\n",
       "      <td>NCCCN</td>\n",
       "      <td>InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2</td>\n",
       "      <td>XFNJVJPLKCPIBV-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>HMDB0000005</td>\n",
       "      <td>58</td>\n",
       "      <td>600-18-0</td>\n",
       "      <td>57</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>30831;16763</td>\n",
       "      <td>C00109</td>\n",
       "      <td>2-Ketobutyric acid</td>\n",
       "      <td>2-oxobutanoate</td>\n",
       "      <td>2-oxobutanoic acid</td>\n",
       "      <td>CCC(=O)C(O)=O</td>\n",
       "      <td>InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)</td>\n",
       "      <td>TYEYBOSBBBHJIV-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>HMDB0000008</td>\n",
       "      <td>440864</td>\n",
       "      <td>600-15-7;3347-90-8</td>\n",
       "      <td>389701</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>1148;50613</td>\n",
       "      <td>C05984</td>\n",
       "      <td>2-Hydroxybutyric acid</td>\n",
       "      <td>2-hydroxybutyric acid</td>\n",
       "      <td>(2S)-2-hydroxybutanoic acid</td>\n",
       "      <td>CC[C@H](O)C(O)=O</td>\n",
       "      <td>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(...</td>\n",
       "      <td>AFENDNXGAFYKQO-VKHMYHEASA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>HMDB0000010</td>\n",
       "      <td>440624</td>\n",
       "      <td>362-08-3</td>\n",
       "      <td>389515</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1189</td>\n",
       "      <td>C05299</td>\n",
       "      <td>2-Methoxyestrone</td>\n",
       "      <td>2-methoxyestrone</td>\n",
       "      <td>(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyl...</td>\n",
       "      <td>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[...</td>\n",
       "      <td>InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18...</td>\n",
       "      <td>WHEUWNKSCXYKBU-QPWUGHHJSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>52-89-1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>91247</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>L-cysteine hydrochloride</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7048-04-6</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>91248</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>L-cysteine hydrochloride hydrate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2706-75-4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>91251</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>sodium glyoxylate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>23017-93-8</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>91272</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>13-HPODE</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>27778-66-1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>9440</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>tenuazonic acid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 14 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID      HMDB_ID PubChem_CID              CAS_RN  \\\n",
       "0           BMG_MT000001  HMDB0000001       92105            332-80-9   \n",
       "1           BMG_MT000002  HMDB0000002         428            109-76-2   \n",
       "2           BMG_MT000003  HMDB0000005          58            600-18-0   \n",
       "3           BMG_MT000004  HMDB0000008      440864  600-15-7;3347-90-8   \n",
       "4           BMG_MT000005  HMDB0000010      440624            362-08-3   \n",
       "...                  ...          ...         ...                 ...   \n",
       "218330      BMG_MT218331          NaN         NaN             52-89-1   \n",
       "218331      BMG_MT218332          NaN         NaN           7048-04-6   \n",
       "218332      BMG_MT218333          NaN         NaN           2706-75-4   \n",
       "218333      BMG_MT218334          NaN         NaN          23017-93-8   \n",
       "218334      BMG_MT218335          NaN         NaN          27778-66-1   \n",
       "\n",
       "       ChemSpider_ID PDB_ID     ChEBI_ID KEGG_ID              HMDB_Name  \\\n",
       "0              83153    NaN        50599  C01152      1-Methylhistidine   \n",
       "1                415    NaN        15725  C00986     1,3-Diaminopropane   \n",
       "2                 57   <NA>  30831;16763  C00109     2-Ketobutyric acid   \n",
       "3             389701   <NA>   1148;50613  C05984  2-Hydroxybutyric acid   \n",
       "4             389515    NaN         1189  C05299       2-Methoxyestrone   \n",
       "...              ...    ...          ...     ...                    ...   \n",
       "218330           NaN    NaN        91247     NaN                    NaN   \n",
       "218331           NaN    NaN        91248     NaN                    NaN   \n",
       "218332           NaN    NaN        91251     NaN                    NaN   \n",
       "218333           NaN    NaN        91272     NaN                    NaN   \n",
       "218334           NaN    NaN         9440     NaN                    NaN   \n",
       "\n",
       "                              ChEBI_Name  \\\n",
       "0             N(tele)-methyl-L-histidine   \n",
       "1                    trimethylenediamine   \n",
       "2                         2-oxobutanoate   \n",
       "3                  2-hydroxybutyric acid   \n",
       "4                       2-methoxyestrone   \n",
       "...                                  ...   \n",
       "218330          L-cysteine hydrochloride   \n",
       "218331  L-cysteine hydrochloride hydrate   \n",
       "218332                 sodium glyoxylate   \n",
       "218333                          13-HPODE   \n",
       "218334                   tenuazonic acid   \n",
       "\n",
       "                                               IUPAC_Name  \\\n",
       "0       (2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...   \n",
       "1                                     propane-1,3-diamine   \n",
       "2                                      2-oxobutanoic acid   \n",
       "3                             (2S)-2-hydroxybutanoic acid   \n",
       "4       (1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyl...   \n",
       "...                                                   ...   \n",
       "218330                                                NaN   \n",
       "218331                                                NaN   \n",
       "218332                                                NaN   \n",
       "218333                                                NaN   \n",
       "218334                                                NaN   \n",
       "\n",
       "                                                   SMILES  \\\n",
       "0                             CN1C=NC(C[C@H](N)C(O)=O)=C1   \n",
       "1                                                   NCCCN   \n",
       "2                                           CCC(=O)C(O)=O   \n",
       "3                                        CC[C@H](O)C(O)=O   \n",
       "4       [H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[...   \n",
       "...                                                   ...   \n",
       "218330                                                NaN   \n",
       "218331                                                NaN   \n",
       "218332                                                NaN   \n",
       "218333                                                NaN   \n",
       "218334                                                NaN   \n",
       "\n",
       "                                                    InChI  \\\n",
       "0       InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11...   \n",
       "1                      InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2   \n",
       "2         InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)   \n",
       "3       InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(...   \n",
       "4       InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18...   \n",
       "...                                                   ...   \n",
       "218330                                                NaN   \n",
       "218331                                                NaN   \n",
       "218332                                                NaN   \n",
       "218333                                                NaN   \n",
       "218334                                                NaN   \n",
       "\n",
       "                           InChIKey  \n",
       "0       BRMWTNUJHUMWMS-LURJTMIESA-N  \n",
       "1       XFNJVJPLKCPIBV-UHFFFAOYSA-N  \n",
       "2       TYEYBOSBBBHJIV-UHFFFAOYSA-N  \n",
       "3       AFENDNXGAFYKQO-VKHMYHEASA-N  \n",
       "4       WHEUWNKSCXYKBU-QPWUGHHJSA-N  \n",
       "...                             ...  \n",
       "218330                          NaN  \n",
       "218331                          NaN  \n",
       "218332                          NaN  \n",
       "218333                          NaN  \n",
       "218334                          NaN  \n",
       "\n",
       "[218335 rows x 14 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "biomedgraphica_metabolite = hmdb_chebi_v2.sort_values(by=['HMDB_ID'], na_position='last')\n",
    "biomedgraphica_metabolite.reset_index(drop=True, inplace=True)\n",
    "\n",
    "max_length = len(str(len(biomedgraphica_metabolite)))\n",
    "biomedgraphica_metabolite['BioMedGraphica_ID'] = ['BMG_MT' + str(i).zfill(max_length) for i in range(1, len(biomedgraphica_metabolite) + 1)]\n",
    "biomedgraphica_metabolite.rename(columns={'iupac_name': 'IUPAC_Name', 'smiles': 'SMILES', 'inchi': 'InChI', 'inchikey': 'InChIKey', 'chemspider_id': 'ChemSpider_ID', 'drugbank_id': 'DrugBank_ID', 'pubchem_compound_id': 'PubChem_CID', 'pdb_id': 'PDB_ID', 'chebi_id': 'ChEBI_ID', 'kegg_id': 'KEGG_ID', 'name': 'HMDB_Name', 'chebi_name':'ChEBI_Name', 'CAS_ID':'CAS_RN'}, inplace=True)\n",
    "column_order = ['BioMedGraphica_ID', 'HMDB_ID', 'PubChem_CID', 'CAS_RN', 'ChemSpider_ID', 'PDB_ID', 'ChEBI_ID', 'KEGG_ID', 'HMDB_Name', 'ChEBI_Name', 'IUPAC_Name', 'SMILES', 'InChI', 'InChIKey']\n",
    "biomedgraphica_metabolite = biomedgraphica_metabolite[column_order]\n",
    "biomedgraphica_metabolite"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data has been saved to D:\\RA\\BMG\\BioMedGraphica\\Entity\\Metabolite\\BioMedGraphica_Metabolite.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "# get the current working directory\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "\n",
    "# get the output directory\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "\n",
    "target_folder = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite'\n",
    "if not target_folder.exists():\n",
    "    target_folder.mkdir(parents=True)\n",
    "    print(f\"Folder {target_folder} has been created.\")\n",
    "\n",
    "output_file_path = target_folder / 'BioMedGraphica_Metabolite.csv'\n",
    "biomedgraphica_metabolite.to_csv(output_file_path, index=False)\n",
    "print(f\"Data has been saved to {output_file_path}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 5. Description"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "target_dir = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite' / 'BioMedGraphica_Metabolite.csv'\n",
    "biomedgraphica_metabolite = pd.read_csv(target_dir, dtype=str)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 5.1 From HMDB"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import xml.etree.ElementTree as ET\n",
    "import csv\n",
    "\n",
    "tree = ET.parse('hmdb_metabolites.xml')\n",
    "root = tree.getroot()\n",
    "\n",
    "# Extract the relevant fields\n",
    "namespace = {'hmdb': 'http://www.hmdb.ca'}\n",
    "metabolites = []\n",
    "for metabolite in root.findall('hmdb:metabolite', namespace):\n",
    "    data = {\n",
    "        'accession': metabolite.find('hmdb:accession', namespace).text,\n",
    "        'hmdb_description': metabolite.find('hmdb:description', namespace).text,\n",
    "    }\n",
    "    metabolites.append(data)\n",
    "\n",
    "import pandas as pd\n",
    "# Convert the data to a DataFrame\n",
    "hmdb = pd.DataFrame(metabolites)  # Correctly create DataFrame from metabolites\n",
    "hmdb.to_csv('hmdb_description.csv', index=False)  # Save DataFrame to CSV file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "accession",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "hmdb_description",
         "rawType": "object",
         "type": "string"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "bdea1275-5815-4966-b341-139b25e976e9",
       "rows": [
        [
         "0",
         "HMDB0000001",
         "1-Methylhistidine, also known as 1-MHis or 1MH, belongs to the class of organic compounds known as histidine and derivatives. 1MH is also classified as a methylamino acid. Methylamino acids are primarily proteogenic amino acids (found in proteins) which have been methylated (in situ) on their side chains by various methyltransferase enzymes. Histidine can be methylated at either the N1 or N3 position of its imidazole ring, yielding the isomers 1-methylhistidine (1MH; also referred to as pi-methylhistidine) or 3-methylhistidine (3MH; tau-methylhistidine), respectively. There is considerable confusion with regard to the nomenclature of the methylated nitrogen atoms on the imidazole ring of histidine and other histidine-containing peptides such as anserine. In particular, older literature (mostly prior to the year 2000) designated anserine (Npi methylated) as beta-alanyl-N1-methyl-histidine, whereas according to standard IUPAC nomenclature, anserine is correctly named as beta-alanyl-N3-methyl-histidine. As a result, many papers published prior to the year 2000 incorrectly identified 1MH as a specific marker for dietary consumption or various pathophysiological effects when they really were referring to 3MH (PMID: 24137022).  Recent discoveries have shown that 1MH is produced in essentially all mammals (and other vertebrates) via the enzyme known as METTL9 (PMID: 33563959). METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mammalian proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where \"x\" is a small amino acid. This HxH motif is found in a number of abundant mammalian proteins such as ARMC6, S100A9, and NDUFB3 (PMID: 33563959). Because of its abundance in many muscle-related proteins, 1MH has been found to be a good biomarker for the consumption of meat (PMID: 21527577). Dietary studies have shown that poultry consumption (p-trend = 0.0006) and chicken consumption (p-trend = 0.0003) are associated with increased levels of 1MH in human plasma (PMID: 30018457). The consumption of fish, especially salmon and cod, has also been shown to increase the levels of 1MH in serum and urine (PMID: 31401679). As a general rule, urinary 1MH is associated with white meat intake (p< 0.001), whereas urinary 3MH is associated with red meat intake (p< 0.001) (PMID: 34091671)."
        ],
        [
         "1",
         "HMDB0000002",
         "1,3-Diaminopropane, also known as DAP or trimethylenediamine, belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing a primary aliphatic amine group. 1,3-Diaminopropane is a stable, flammable, and highly hygroscopic fluid. It is a polyamine that is normally quite toxic if swallowed, inhaled, or absorbed through the skin. It is a catabolic byproduct of spermidine. It is also a precursor in the enzymatic synthesis of beta-alanine. 1,3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway. 1,3-Diaminopropane has been detected, but not quantified in, several different foods, such as cassava, shiitakes, oyster mushrooms, muscadine grapes, and cinnamons. This could make 1,3-diaminopropane a potential biomarker for the consumption of these foods."
        ],
        [
         "2",
         "HMDB0000005",
         "2-Ketobutyric acid, also known as alpha-ketobutyrate or 2-oxobutyrate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. It is also one of the degradation products of threonine. It can be converted into propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted into succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle. More specifically, 2-ketobutyric acid is a product of the lysis of cystathionine."
        ],
        [
         "3",
         "HMDB0000008",
         "2-Hydroxybutyric acid (CAS: 600-15-7), also known as alpha-hydroxybutyrate, is an organic acid derived from alpha-ketobutyrate. alpha-Ketobutyrate is produced by amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) and is metabolized into propionyl-CoA and carbon dioxide (PMID: 20526369). 2-Hydroxybutyric acid is formed as a byproduct from the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH). alpha-Hydroxybutyric acid is primarily produced in mammalian hepatic tissues that catabolize L-threonine or synthesize glutathione. Oxidative stress or detoxification of xenobiotics in the liver can dramatically increase the rate of hepatic glutathione synthesis. Under such metabolic stress conditions, supplies of L-cysteine for glutathione synthesis become limiting, so homocysteine is diverted from the transmethylation pathway (which forms methionine) into the transsulfuration pathway (which forms cystathionine). alpha-Ketobutyrate is released as a byproduct when cystathionine is cleaved into cysteine that is incorporated into glutathione. Chronic shifts in the rate of glutathione synthesis may be reflected by urinary excretion of 2-hydroxybutyrate. 2-Hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation that appears to arise due to increased lipid oxidation and oxidative stress (PMID: 20526369). 2-Hydroxybutyric acid is often found in the urine of patients suffering from lactic acidosis and ketoacidosis. 2-Hydroxybutyric acid generally appears at high concentrations in situations related to deficient energy metabolism (e.g. birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as \"cerebral\" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. More recently it has been noted that elevated levels of alpha-hydroxybutyrate in the plasma is a good marker for early-stage type II diabetes (PMID: 19166731). It was concluded from studies done in the mid-1970s that an increased NADH2/NAD ratio was the most important factor for the production of 2-hydroxybutyric acid (PMID: 168632)."
        ],
        [
         "4",
         "HMDB0000010",
         "2-Methoxyestrone (or 2-ME1) belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, 2-methoxyestrone is considered to be a steroid or steroid derivative. It is a by-product of estrone and 2-hydroxyestrone metabolism and has been detected in all mammals. More specifically, 2-methoxyestrone is an endogenous, naturally occurring methoxylated catechol estrogen and a metabolite of estrone that is formed by catechol O-methyltransferase via the intermediate 2-hydroxyestrone. 2-Methoxyestrone is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone has been determined to be 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17). Unlike estrone but similarly to 2-hydroxyestrone and 2-methoxyestradiol, 2-methoxyestrone has very low affinity for the estrogen receptor and lacks significant estrogenic activity (PMID: 10865186)."
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 5
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>accession</th>\n",
       "      <th>hmdb_description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>HMDB0000001</td>\n",
       "      <td>1-Methylhistidine, also known as 1-MHis or 1MH...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>HMDB0000002</td>\n",
       "      <td>1,3-Diaminopropane, also known as DAP or trime...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>HMDB0000005</td>\n",
       "      <td>2-Ketobutyric acid, also known as alpha-ketobu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>HMDB0000008</td>\n",
       "      <td>2-Hydroxybutyric acid (CAS: 600-15-7), also kn...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>HMDB0000010</td>\n",
       "      <td>2-Methoxyestrone (or 2-ME1) belongs to the cla...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     accession                                   hmdb_description\n",
       "0  HMDB0000001  1-Methylhistidine, also known as 1-MHis or 1MH...\n",
       "1  HMDB0000002  1,3-Diaminopropane, also known as DAP or trime...\n",
       "2  HMDB0000005  2-Ketobutyric acid, also known as alpha-ketobu...\n",
       "3  HMDB0000008  2-Hydroxybutyric acid (CAS: 600-15-7), also kn...\n",
       "4  HMDB0000010  2-Methoxyestrone (or 2-ME1) belongs to the cla..."
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hmdb_description = pd.read_csv('hmdb_description.csv')  # Load the CSV file into a DataFrame\n",
    "hmdb_description.head()  # Display the first few rows of the DataFrame"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\shunn\\AppData\\Local\\Temp\\ipykernel_27608\\3737318054.py:2: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  bmg_hmdb['HMDB_ID'] = bmg_hmdb['HMDB_ID'].str.split(';')\n"
     ]
    },
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "HMDB",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "ef1070d3-1d32-4f92-88b1-675c7712fd49",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "1-Methylhistidine, also known as 1-MHis or 1MH, belongs to the class of organic compounds known as histidine and derivatives. 1MH is also classified as a methylamino acid. Methylamino acids are primarily proteogenic amino acids (found in proteins) which have been methylated (in situ) on their side chains by various methyltransferase enzymes. Histidine can be methylated at either the N1 or N3 position of its imidazole ring, yielding the isomers 1-methylhistidine (1MH; also referred to as pi-methylhistidine) or 3-methylhistidine (3MH; tau-methylhistidine), respectively. There is considerable confusion with regard to the nomenclature of the methylated nitrogen atoms on the imidazole ring of histidine and other histidine-containing peptides such as anserine. In particular, older literature (mostly prior to the year 2000) designated anserine (Npi methylated) as beta-alanyl-N1-methyl-histidine, whereas according to standard IUPAC nomenclature, anserine is correctly named as beta-alanyl-N3-methyl-histidine. As a result, many papers published prior to the year 2000 incorrectly identified 1MH as a specific marker for dietary consumption or various pathophysiological effects when they really were referring to 3MH (PMID: 24137022).  Recent discoveries have shown that 1MH is produced in essentially all mammals (and other vertebrates) via the enzyme known as METTL9 (PMID: 33563959). METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mammalian proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where \"x\" is a small amino acid. This HxH motif is found in a number of abundant mammalian proteins such as ARMC6, S100A9, and NDUFB3 (PMID: 33563959). Because of its abundance in many muscle-related proteins, 1MH has been found to be a good biomarker for the consumption of meat (PMID: 21527577). Dietary studies have shown that poultry consumption (p-trend = 0.0006) and chicken consumption (p-trend = 0.0003) are associated with increased levels of 1MH in human plasma (PMID: 30018457). The consumption of fish, especially salmon and cod, has also been shown to increase the levels of 1MH in serum and urine (PMID: 31401679). As a general rule, urinary 1MH is associated with white meat intake (p< 0.001), whereas urinary 3MH is associated with red meat intake (p< 0.001) (PMID: 34091671)."
        ],
        [
         "1",
         "BMG_MT000002",
         "1,3-Diaminopropane, also known as DAP or trimethylenediamine, belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing a primary aliphatic amine group. 1,3-Diaminopropane is a stable, flammable, and highly hygroscopic fluid. It is a polyamine that is normally quite toxic if swallowed, inhaled, or absorbed through the skin. It is a catabolic byproduct of spermidine. It is also a precursor in the enzymatic synthesis of beta-alanine. 1,3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway. 1,3-Diaminopropane has been detected, but not quantified in, several different foods, such as cassava, shiitakes, oyster mushrooms, muscadine grapes, and cinnamons. This could make 1,3-diaminopropane a potential biomarker for the consumption of these foods."
        ],
        [
         "2",
         "BMG_MT000003",
         "2-Ketobutyric acid, also known as alpha-ketobutyrate or 2-oxobutyrate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. It is also one of the degradation products of threonine. It can be converted into propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted into succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle. More specifically, 2-ketobutyric acid is a product of the lysis of cystathionine."
        ],
        [
         "3",
         "BMG_MT000004",
         "2-Hydroxybutyric acid (CAS: 600-15-7), also known as alpha-hydroxybutyrate, is an organic acid derived from alpha-ketobutyrate. alpha-Ketobutyrate is produced by amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) and is metabolized into propionyl-CoA and carbon dioxide (PMID: 20526369). 2-Hydroxybutyric acid is formed as a byproduct from the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH). alpha-Hydroxybutyric acid is primarily produced in mammalian hepatic tissues that catabolize L-threonine or synthesize glutathione. Oxidative stress or detoxification of xenobiotics in the liver can dramatically increase the rate of hepatic glutathione synthesis. Under such metabolic stress conditions, supplies of L-cysteine for glutathione synthesis become limiting, so homocysteine is diverted from the transmethylation pathway (which forms methionine) into the transsulfuration pathway (which forms cystathionine). alpha-Ketobutyrate is released as a byproduct when cystathionine is cleaved into cysteine that is incorporated into glutathione. Chronic shifts in the rate of glutathione synthesis may be reflected by urinary excretion of 2-hydroxybutyrate. 2-Hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation that appears to arise due to increased lipid oxidation and oxidative stress (PMID: 20526369). 2-Hydroxybutyric acid is often found in the urine of patients suffering from lactic acidosis and ketoacidosis. 2-Hydroxybutyric acid generally appears at high concentrations in situations related to deficient energy metabolism (e.g. birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as \"cerebral\" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. More recently it has been noted that elevated levels of alpha-hydroxybutyrate in the plasma is a good marker for early-stage type II diabetes (PMID: 19166731). It was concluded from studies done in the mid-1970s that an increased NADH2/NAD ratio was the most important factor for the production of 2-hydroxybutyric acid (PMID: 168632)."
        ],
        [
         "4",
         "BMG_MT000005",
         "2-Methoxyestrone (or 2-ME1) belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, 2-methoxyestrone is considered to be a steroid or steroid derivative. It is a by-product of estrone and 2-hydroxyestrone metabolism and has been detected in all mammals. More specifically, 2-methoxyestrone is an endogenous, naturally occurring methoxylated catechol estrogen and a metabolite of estrone that is formed by catechol O-methyltransferase via the intermediate 2-hydroxyestrone. 2-Methoxyestrone is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone has been determined to be 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17). Unlike estrone but similarly to 2-hydroxyestrone and 2-methoxyestradiol, 2-methoxyestrone has very low affinity for the estrogen receptor and lacks significant estrogenic activity (PMID: 10865186)."
        ],
        [
         "5",
         "BMG_MT000006",
         "3-Hydroxybutyric acid (CAS: 300-85-6), also known as beta-hydroxybutanoic acid, is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis. This acid is metabolized by 3-hydroxybutyrate dehydrogenase (catalyzes the oxidation of 3-hydroxybutyrate to form acetoacetate, using NAD+ as an electron acceptor). The enzyme functions in nervous tissues and muscles, enabling the use of circulating hydroxybutyrate as a fuel. In the liver mitochondrial matrix, the enzyme can also catalyze the reverse reaction, a step in ketogenesis. 3-Hydroxybutyric acid is a chiral compound having two enantiomers, D-3-hydroxybutyric acid and L-3-hydroxybutyric acid, and is a ketone body. Like the other ketone bodies (acetoacetate and acetone), levels of 3-hydroxybutyrate in blood and urine are raised in ketosis. In humans, 3-hydroxybutyrate is synthesized in the liver from acetyl-CoA and can be used as an energy source by the brain when blood glucose is low. Blood levels of 3-hydroxybutyric acid levels may be monitored in diabetic patients to look for diabetic ketoacidosis. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing mammals. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for the synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for the synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first two weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmitoylphosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391). 3-Hydroxybutyric acid is found to be associated with fumarase deficiency and medium-chain acyl-CoA dehydrogenase deficiency, which are inborn errors of metabolism. 3-Hydroxybutyric acid is a metabolite of Alcaligenes and can be produced from plastic metabolization or incorporated into polymers, depending on the species (PMID: 7646009, 18615882)."
        ],
        [
         "6",
         "BMG_MT000007",
         "Deoxyuridine, also known as dU, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group. Deoxyuridine exists in all living organisms, ranging from bacteria to humans. Within humans, deoxyuridine participates in a number of enzymatic reactions. In particular, deoxyuridine can be biosynthesized from deoxycytidine through its interaction with the enzyme cytidine deaminase. In addition, deoxyuridine can be converted into uracil and deoxyribose 1-phosphate through its interaction with the enzyme thymidine phosphorylase. Deoxyuridine is considered to be an antimetabolite that is converted into deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies. In humans, deoxyuridine is involved in the metabolic disorder called UMP synthase deficiency (orotic aciduria). Outside of the human body, deoxyuridine has been detected, but not quantified in, several different foods, such as lichee, highbush blueberries, agaves, macadamia nut (M. tetraphylla), and red bell peppers. This could make deoxyuridine a potential biomarker for the consumption of these foods."
        ],
        [
         "7",
         "BMG_MT000008",
         "Deoxycytidine, also known as dC, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. Deoxycytidine is also classified as a deoxyribonucleoside, a component of deoxyribonucleic acid (DNA). Deoxycytidine is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the 2' position. Deoxycytidine exists in all living species, ranging from bacteria to plants to humans. Degradation of DNA through apoptosis or cell death produces deoxycytidine. Within humans, deoxycytidine participates in a number of enzymatic reactions. In particular, deoxycytidine can be biosynthesized from dCMP through the action of the enzyme cytosolic purine 5'-nucleotidase. In addition, deoxycytidine can be converted into dCMP; which is mediated by the enzyme uridine-cytidine kinase-like 1. Deoxycytidine can be phosphorylated at the C-5 position by the enzyme deoxycytidine kinase to produce deoxycytidine monophosphate (dCMP), and to a lesser extent, deoxycytidine diphosphate (dCDP), and deoxycytidine triphosphate (dCTP). Deoxycytidine can also be phosphorylated by thymidine kinase 2 (TK2). Deoxycytidine can potentially be used for the treatment of the metabolic disorder known as thymidine kinase 2 deficiency (TK2 deficiency). TK2 deficiency has three disease subtypes: i) infantile-onset myopathy with rapid progression to early death ii) childhood-onset myopathy, which resembles spinal muscular atrophy (SMA) type III, begins between ages 1 and 12 years with progression to loss of ambulation within few years and iii) late-onset myopathy starting at age 12 year or later with moderate to severe myopathy manifesting as either isolated chronic progressive external ophthalmoplegia (CPEO) or a generalized myopathy with CPEO plus facial and limb weakness, gradual progression, and, in some cases, respiratory failure and loss of ability to walk in adulthood (PMID: 28318037). In mouse models of TK2, dC was shown to delay disease onset, prolong life span and restore mtDNA copy number as well as respiratory chain enzyme activities (PMID: 28318037)."
        ],
        [
         "8",
         "BMG_MT000009",
         "Cortexolone, also known as cortodoxone or 11-deoxycortisol, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, cortexolone is considered to be a steroid molecule. Cortexolone is an endogenous glucocorticoid steroid hormone, and a metabolic intermediate in the synthesis of cortisol. It was first described by Tadeusz Reichstein in 1938 and named as Substance S. It has also been referred to as Reichstein's Substance S or Compound S. Cortexolone acts as a glucocorticoid, though it is less potent than cortisol. Cortexolone is synthesized from 17Å’Â±-hydroxyprogesterone by 21-hydroxylase and is converted to cortisol by 11Å’â‰¤-hydroxylase. As a result, the level of cortexolone is often measured in patients to diagnose impaired cortisol synthesis, to identify any enzyme deficiency that may be causing impairment along the pathway to cortisol, and to differentiate adrenal disorders. Cortexolone in mammals has limited biological activity and mainly acts as metabolic intermediate within the glucocorticoid pathway, leading to cortisol. On the other hand, in sea lampreys, cortexolone is the major glucocorticoid, with mineralocorticoid activity. Cortexolone in sea lampreys binds to specific corticosteroid receptors and is involved in intestinal osmoregulation and in sea lamprey at metamorphosis, a process in which they develop seawater tolerance before downstream migration."
        ],
        [
         "9",
         "BMG_MT000010",
         "11-Deoxycorticosterone (also called desoxycortone, 21-hydroxyprogesterone, DOC, or simply deoxycorticosterone) is a steroid hormone produced by the adrenal gland that possesses mineralocorticoid activity and acts as a precursor to aldosterone. It is classified as a member of the 21-hydroxysteroids. 21-hydroxysteroids are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Deoxycorticosterone is very hydrophobic, practically insoluble (in water), and relatively neutral. Deoxycorticosterone can be synthesized from progesterone by 21-beta-hydroxylase and is then converted to corticosterone by 11-beta-hydroxylase. Corticosterone is then converted to aldosterone by aldosterone synthase. Deoxycorticosterone stimulates the collecting tubules in the kidney to continue to excrete potassium in much the same way that aldosterone does. Deoxycorticosterone has about 1/20 of the sodium retaining power of aldosterone and about 1/5 the potassium excreting power of aldosterone (Wikipedia). Deoxycorticosterone can be found throughout all human tissues and has been detected in amniotic fluid and blood. When present in sufficiently high levels, deoxycorticosterone can act as a hypertensive agent and a metabotoxin. A hypertensive agent increases blood pressure and causes the production of more urine. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels.  Chronically high levels of deoxycorticosterone are associated with congenital adrenal hyperplasia (CAH) and with adrenal tumors producing deoxycorticosterone (PMID: 20671982). High levels of this mineralocorticoid are associated with resistant hypertension, which can result in polyuria, polydipsia, increased blood volume, edema, and cardiac enlargement. Deoxycorticosterone can be used to treat adrenal insufficiency. In particular, desoxycorticosterone acetate (DOCA) is used as replacement therapy in Addison's disease."
        ],
        [
         "10",
         "BMG_MT000011",
         "4-Pyridoxic acid is a member of the class of compounds known as methylpyridines. More specifically it is a 2-methylpyridine derivative substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. 4-Pyridoxic acid is the catabolic product of vitamin B6 (also known as pyridoxine, pyridoxal and pyradoxamine) and is excreted in the urine. Urinary levels of 4-pyridoxic acid are lower in females than in males and will be reduced even further in persons with a riboflavin deficiency. 4-Pyridoxic acid is formed by the action of aldehyde oxidase I (an endogenous enzyme) and by microbial enzymes (pyridoxal 4-dehydrogenase), an NAD-dependent aldehyde dehydrogenase. 4-pyridoxic acid can be further broken down by the gut microflora via the enzyme known as 4-pyridoxic acid dehydrogenase. This enzyme catalyzes the four-electron oxidation of 4-pyridoxic acid to 3-hydroxy-2-methylpyridine-4,5-dicarboxylate, using nicotinamide adenine dinucleotide (NAD) as a cofactor."
        ],
        [
         "11",
         "BMG_MT000012",
         "alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of alpha-ketoisovaleric acid are associated with maple syrup urine disease. MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma.  In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465). alpha-Ketoisovaleric acid is a keto-acid, which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated MSUD. Many affected children with organic acidemias experience intellectual disability or delayed development."
        ],
        [
         "12",
         "BMG_MT000013",
         "p-Hydroxyphenylacetic acid, also known as 4-hydroxybenzeneacetate, is classified as a member of the 1-hydroxy-2-unsubstituted benzenoids. 1-Hydroxy-2-unsubstituted benzenoids are phenols that are unsubstituted at the 2-position. p-Hydroxyphenylacetic acid is considered to be slightly soluble (in water) and acidic.Â  p-Hydroxyphenylacetic acid can be synthesized from acetic acid. It is also a parent compound for other transformation products, including but not limited to, methyl 2-(4-hydroxyphenyl)acetate, ixerochinolide, and lactucopicrin 15-oxalate.Â  p-Hydroxyphenylacetic acid can be found in numerous foods such as olives, cocoa beans, oats, and mushrooms. p-Hydroxyphenylacetic acid can be found throughout all human tissues and in all biofluids. Within a cell, p-hydroxyphenylacetic acid is primarily located in the cytoplasm and in the extracellular space. p-Hydroxyphenylacetic acid is also a microbial metabolite produced by Acinetobacter, Clostridium, Klebsiella, Pseudomonas, and Proteus. Higher levels of this metabolite are associated with an overgrowth of small intestinal bacteria from Clostridia species including C. difficile, C. stricklandii, C. lituseburense, C. subterminale, C. putrefaciens, and C. propionicum (PMID: 476929, 12173102). p-Hydroxyphenylacetic acid is detected after the consumption of whole grain."
        ],
        [
         "13",
         "BMG_MT000014",
         "Iodotyrosine is an iodated derivative of L-tyrosine. This is an early precursor to L-thyroxine, one of the primary thyroid hormones. In the thyroid gland, iodide is trapped, transported, and concentrated in the follicular lumen for thyroid hormone synthesis. Before trapped iodide can react with tyrosine residues, it must be oxidized by thyroid peroxidase. Iodotyrosine is made from tyrosine via thyroid peroxidase and then further iodinated by this enzyme to make the di-iodo and tri-iodo variants. Two molecules of di-iodotyrosine combine to form T4, and one molecule of mono-iodotyrosine combines with one molecule of di-iodotyrosine to form T3."
        ],
        [
         "14",
         "BMG_MT000015",
         "3-methoxytyramine, also known as 4-(2-amino-Ethyl)-2-methoxy-phenol or 3-O-Methyldopamine, is classified as a member of the Methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. 3-methoxytyramine is considered to be slightly soluble (in water) and acidic.  3-methoxytyramine can be found primarily in human brain and most tissues tissues; and in blood, cerebrospinal fluid (csf) or urine. Within a cell, 3-methoxytyramine is primarily located in the cytoplasm"
        ],
        [
         "15",
         "BMG_MT000016",
         "(S)-3-Hydroxyisobutyric acid (3-HIBA) (CAS: 2068-83-9) is an organic acid. 3-HIBA is an intermediate in L-valine metabolism. 3-HIBA plays an important role in the diagnosis of the very rare inherited metabolic diseases 3-hydroxyisobutyric aciduria (OMIM: 236795) and methylmalonic semialdehyde dehydrogenase deficiency (OMIM: 603178). Patients with 3-hydroxyisobutyric aciduria excrete a significant amount of 3-HIBA not only during the acute stage but also when stable. 3-Hydroxyisobutyric aciduria is caused by a 3-hydroxyisobutyryl-CoA dehydrogenase deficiency (PMID: 18329219). The severity of this disease varies from case to case. Most patients exhibit dysmorphic features, such as a small triangular face, a long philtrum, low set ears, and micrognathia (PMID: 10686279). Lactic acidemia is also found in the affected patients, indicating that mitochondrial dysfunction is involved. 3-HIBA appears to specifically inhibit the function of the respiratory chain complex I-III and mitochondrial creatine kinase (PMID: 18329219). BioTransformer predicts that 3-HIBA is a product of 2-methylpropanoic acid metabolism via a hydroxylation-of-terminal-methyl reaction catalyzed by CYP2B6 and CYP2E1 enzymes (PMID: 30612223)."
        ],
        [
         "16",
         "BMG_MT000017",
         "3-O-Sulfogalactosylceramide is an acidic, sulfated glycosphingolipid, often known as sulfatide. This lipid occurs in membranes of various cell types, but is found in particularly high concentrations in myelin where it constitutes 3-4% of total membrane lipids. This lipid is synthesized primarily in the oligodendrocytes in the central nervous system. Accumulation of this lipid in the lysosomes is a characteristic of metachromatic leukodystrophy, a lysosomal storage disease caused by the deficiency of arylsulfatase A. Alterations in sulfatide metabolism, trafficking, and homeostasis are present in the earliest clinically recognizable stages of Alzheimer's disease. Cerebrosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Cerebrosides have a single sugar group linked to ceramide. The most common are galactocerebrosides (containing galactose), the least common are glucocerebrosides (containing glucose). Galactocerebrosides are found predominantly in neuronal cell membranes. In contrast glucocerebrosides are not normally found in membranes. Instead, they are typically intermediates in the synthesis or degradation of more complex glycosphingolipids. Galactocerebrosides are synthesized from ceramide and UDP-galactose. Excess lysosomal accumulation of glucocerebrosides is found in Gaucher disease. Sulfatides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Sulfatides are the sulfuric acid esters of galactocerebrosides. They are synthesized from galactocerebrosides and activated sulfate, 3'-phosphoadenosine 5'-phosphosulfate (PAPS)."
        ],
        [
         "17",
         "BMG_MT000018",
         "Ureidopropionic acid, also known as 3-ureidopropanoate or N-carbamoyl-beta-alanine, belongs to the class of organic compounds known as ureas. Ureas are compounds containing two amine groups joined by a carbonyl (C=O) functional group. Ureidopropionic acid is an intermediate in the metabolism of uracil. More specifically, it is a breakdown product of dihydrouracil and is produced by the enzyme dihydropyrimidase. It is further decomposed into beta-alanine via the enzyme beta-ureidopropionase. Ureidopropionic acid is essentially a urea derivative of beta-alanine. High levels of ureidopropionic acid are found in individuals with beta-ureidopropionase (UP) deficiency (PMID: 11675655). Enzyme deficiencies in pyrimidine metabolism are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil. Ureidopropionic acid has been detected, but not quantified in, several different foods, such as gram beans, broccoli, climbing beans, oriental wheat, and mandarin orange (clementine, tangerine). This could make ureidopropionic acid a potential biomarker for the consumption of these foods."
        ],
        [
         "18",
         "BMG_MT000019",
         "Tetrahydrobiopterin (CAS: 17528-72-2), also known as BH4, is an essential cofactor in the synthesis of neurotransmitters and nitric oxide (PMID: 16946131). In fact, it is used by all three human nitric-oxide synthases (NOS) eNOS, nNOS, and iNOS as well as the enzyme glyceryl-ether monooxygenase. It is also essential in the conversion of phenylalanine into tyrosine by the enzyme phenylalanine-4-hydroxylase; the conversion of tyrosine into L-dopa by the enzyme tyrosine hydroxylase; and the conversion of tryptophan into 5-hydroxytryptophan via tryptophan hydroxylase. Specifically, tetrahydrobiopterin is a cofactor for tryptophan 5-hydroxylase 1, tyrosine 3-monooxygenase, and phenylalanine hydroxylase, all of which are essential for the formation of the neurotransmitters dopamine, noradrenaline, and adrenaline. Tetrahydrobiopterin has been proposed to be involved in the promotion of neurotransmitter release in the brain and the regulation of human melanogenesis. A defect in BH4 production and/or a defect in the enzyme dihydropteridine reductase (DHPR) causes phenylketonuria type IV, as well as dopa-responsive dystonias. BH4 is also implicated in Parkinson's disease, Alzheimer's disease, and depression. Tetrahydrobiopterin is present in probably every cell or tissue of higher animals. On the other hand, most bacteria, fungi and plants do not synthesize tetrahydrobiopterin (Wikipedia)."
        ],
        [
         "19",
         "BMG_MT000020",
         "Biotin is an enzyme co-factor present in minute amounts in every living cell. Biotin is also known as coenzyme R and vitamin H or B7. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Biotin has been recognized as an essential nutrient. Humans fulfill their biotin requirement through their diet through endogenous reutilization of biotin and perhaps through the capture of biotin generated in the intestinal flora. The utilization of biotin for covalent attachment to carboxylases and its reutilization through the release of carboxylase biotin after proteolytic degradation constitutes the 'biotin cycle'. Biotin deficiency is associated with neurological manifestations, skin rash, hair loss, and metabolic disturbances that are thought to relate to the various carboxylase deficiencies (metabolic ketoacidosis with lactic acidosis). It has also been suggested that biotin deficiency is associated with protein malnutrition, and that marginal biotin deficiency in pregnant women may be teratogenic. Biotin acts as a carboxyl carrier in carboxylation reactions. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC), and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a lysine residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. Evidence is emerging that biotin participates in processes other than classical carboxylation reactions. Specifically, novel roles for biotin in cell signalling, gene expression, and chromatin structure have been identified in recent years. Human cells accumulate biotin by using both the sodium-dependent multivitamin transporter and monocarboxylate transporter 1. These transporters and other biotin-binding proteins partition biotin to compartments involved in biotin signalling: cytoplasm, mitochondria, and nuclei. The activity of cell signals such as biotinyl-AMP, Sp1 and Sp3, nuclear factor (NF)-kappaB, and receptor tyrosine kinases depends on biotin supply. Consistent with a role for biotin and its catabolites in modulating these cell signals, greater than 2000 biotin-dependent genes have been identified in various human tissues. Many biotin-dependent gene products play roles in signal transduction and localize to the cell nucleus, consistent with a role for biotin in cell signalling. Posttranscriptional events related to ribosomal activity and protein folding may further contribute to the effects of biotin on gene expression. Finally, research has shown that biotinidase and holocarboxylase synthetase mediate covalent binding of biotin to histones (DNA-binding proteins), affecting chromatin structure; at least seven biotinylation sites have been identified in human histones. Biotinylation of histones appears to play a role in cell proliferation, gene silencing, and the cellular response to DNA repair. Roles for biotin in cell signalling and chromatin structure are consistent with the notion that biotin has a unique significance in cell biology (PMID: 15992684, 16011464)."
        ],
        [
         "20",
         "BMG_MT000021",
         "Androsterone is an inactive breakdown metabolite of testosterone, the product of a reaction mediated by the enzyme oxidative 17beta-hydroxysteroid dehydrogenase (EC 1.1.1.51, 17beta-HSD). Androsterone can also be metabolized from other adrenal androgens such as dehydroepiandrosterone, dihydrotestosterone, or androstenedione, and is considered an inactive end product. However, it can be a physiological effector in its own right. Androsterone might be converted back to dihydrotestosterone. Humans (and other primates) are unique among mammals in having high levels of circulating androsterone glucuronide, a process that is the major role of uridine-diphospho-glucuronosyltransferase enzymes (EC 2.4.1.17, UGT) for glucuronidation of steroid metabolism in humans. Conjugation of androsterone is a pathway found in all vertebrates and it is widely recognized that the liver is a major site of glucuronidation. However, it is now clear that extrahepatic tissues are also involved in the conjugation of compounds to which these tissues are exposed. High levels of androsterone glucuronide found in the human prostate, breast cyst fluid, and ovary follicular fluid suggest that glucuronidation of 5alpha-reduced C19 steroids occurs in these tissues as well. In doping control, the ratio of androsterone/etiocholanolone provides valuable information that allows the assignment of a urine specimen to a particular person or the identification of urine samples with identical steroid profiles; this is particularly important to detect attempts of urine manipulation including urine alteration and substitution (PMID: 9188497, 17017935, 14643063, 12943709, 9699884, 17260133)."
        ],
        [
         "21",
         "BMG_MT000022",
         "7-Dehydrocholesterol (7-DHC), also known as provitamin D3 or 5,7-cholestadien-3-b-ol, belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. Thus, 7-dehydrocholesterol is also classified as a sterol. 7-Dehydrocholesterol is known as a zoosterol, meaning that it is a sterol isolated from animals (to distinguish those sterols isolated from plants which are called phytosterols). 7-DHC functions in the serum as a cholesterol precursor and is photochemically converted to vitamin D3 in the skin. Therefore 7-DHC functions as provitamin-D3. The presence of 7-DHC in human skin enables humans and other mammals to manufacture vitamin D3 (cholecalciferol) from ultraviolet rays in the sun light, via an intermediate isomer pre-vitamin D3. 7-DHC absorbs UV light most effectively at wavelengths between 290 and 320 nm and, thus, the production of vitamin D3 will occur primarily at those wavelengths (PMID: 9625080).  The two most important factors that govern the generation of pre-vitamin D3 are the quantity (intensity) and quality (appropriate wavelength) of the UVB irradiation reaching the 7-dehydrocholesterol deep in the stratum basale and stratum spinosum (PMID: 9625080). 7-DHC is also found in the milk of several mammalian species, including cows (PMID: 10999630; PMID: 225459). It was discovered by Nobel-laureate organic chemist Adolf Windaus. 7-DHC can be produced by animals and plants via different pathways (PMID: 23717318). It is not produced by fungi in significant amounts. 7-DHC is made by some algae and can also be produced by some bacteria."
        ],
        [
         "22",
         "BMG_MT000023",
         "Carnosine, which is also known as beta-alanyl-L-histidine) is a dipeptide consisting of the amino acids beta-alanine and histidine. It is found exclusively in animal tissues and is naturally produced in the body by the liver. Carnosine has a pKa value of 6.83, making it a good buffer for the pH range of animal muscles.  Since beta-alanine is a non-proteogenic amino acid and is not incorporated into proteins, carnosine can be stored at relatively high concentrations (millimolar) in muscles, with concentrations as high as 17â€šÃ„Ã¬25 mmol/kg (dry muscle). Carnosine is also highly concentrated in brain tissues. Carnosine has been shown to scavenge reactive oxygen species (ROS) as well as alpha-beta unsaturated aldehydes formed from peroxidation of fatty acids during oxidative stress. The antioxidant mechanism of carnosine is attributed to its chelating effect against divalent metal ions, superoxide dismutase (SOD)-like activity, as well as its ROS and free radicals scavenging ability (PMID: 16406688). Carnosine also buffers muscle cells, and acts as a neurotransmitter in the brain. Carnosine has the potential to suppress many of the biochemical changes that accompany ageing (e.g. protein oxidation, glycation, AGE formation, and cross-linking) and associated pathologies (PMID: 16804013). Some autistic patients take carnosine as a dietary supplement and attribute an improvement in their condition to it. Supplemental carnosine may increase corticosterone levels. This may explain the \"hyperactivity\" seen in autistic subjects at higher doses. A positive association between muscle tissue carnosine concentration and exercise performance has been found. Å’â‰¤-Alanine supplementation is thought increase exercise performance by promoting carnosine production in muscle. Exercise has conversely been found to increase muscle carnosine concentrations, and muscle carnosine content is higher in athletes engaging in anaerobic exercise. Carnosine is also a biomarker for the consumption of meat. Elevated levels of urinary and plasma carnosine are associated with carnosinuria (also known as carnosinemia), which is an inborn error of metabolism. caused by a deficiency of the enzyme carnosinase. Carnosinas cleaves carnosine into its constituent amino acids: Å’â‰¤-Alanine and histidine. Carnonsinemia results in an excess of carnosine in the urine, cerebrospinal fluid, blood, and nervous tissue. A variety of neurological symptoms have been associated with carnosinemia. They include: hypotonia, developmental delay, mental retardation, degeneration of axons, sensory neuropathy, tremors, demyelinization, gray matter anomalies, myoclonic seizures, and loss of purkinje fibers."
        ],
        [
         "23",
         "BMG_MT000024",
         "Adenine is a purine base. Adenine is found in both DNA and RNA. Adenine is a fundamental component of adenine nucleotides. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300). (PMID: 17052198, 17520339)."
        ],
        [
         "24",
         "BMG_MT000025",
         "Taurocholic acid is a bile acid and is the product of the conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Taurocholic acid, as with all bile acids, acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic (a bile purging agent). Hydrolysis of taurocholic acid yields taurine, a nonessential amino acid. Taurocholic acid is one of the main components of urinary nonsulfated bile acids in biliary atresia. Raised levels of taurocholate in fetal serum in obstetric cholestasis may result in the development of a fetal dysrhythmia and sudden intra-uterine death (PMID: 3944741, 11256973)."
        ],
        [
         "25",
         "BMG_MT000026",
         "Aldosterone is a steroid hormone produced by the adrenal cortex in the adrenal gland to regulate sodium and potassium balance in the blood. Specifically, it regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. It is synthesized from cholesterol by aldosterone synthase, which is absent in other sections of the adrenal gland. It is the sole endogenous member of the class of mineralocorticoids. Aldosterone increases the permeability of the apical (luminal) membrane of the kidney's collecting ducts to potassium and sodium and activates their basolateral Na+/K+ pumps, stimulating ATP hydrolysis, reabsorbing sodium (Na+) ions and water into the blood, and excreting potassium (K+) ions into the urine."
        ],
        [
         "26",
         "BMG_MT000027",
         "Dihydrobiopterin, also known as BH2, 7,8-dihydrobiopterin, L-erythro-7,8-dihydrobiopterin, quinonoid dihydrobiopterin or q-BH2, belongs to the class of organic compounds known as biopterins and derivatives. These are coenzymes containing a 2-amino-pteridine-4-one derivative. Dihydrobiopterin is also classified as a pteridine. Pteridines are aromatic compounds composed of fused pyrimidine and pyrazine rings. Dihydrobiopterin is produced during the synthesis of neurotransmitters L-DOPA, dopamine, norepinephrine and epinephrine. It is restored to the required cofactor tetrahydrobiopterin via the NADPH-dependant reduction of dihydrobiopterin reductase. Dihydrobiopterin can also be converted to tetrahydrobiopterin by nitric oxide synthase (NOS) which is catalyzed by the flavoprotein \"diaphorase\" activity of NOS. This activity is located on the reductase (C-terminal) domain of NOS, whereas the high affinity tetrahydrobiopterin site involved in NOS activation is located on the oxygenase (N-terminal) domain (PMID: 8626754). Sepiapterin reductase (SPR) is another enzyme that plays a role in the production of dihydrobiopterin. SPR catalyzes the reduction of sepiapterin to dihydrobiopterin (BH2), the precursor for tetrahydrobiopterin (BH4). BH4 is a cofactor critical for nitric oxide biosynthesis and alkylglycerol and aromatic amino acid metabolism (PMID: 25550200). Dihydrobiopterin is known to be synthesized in several parts of the body, including the pineal gland. Dihydrobiopterin exists in all eukaryotes, ranging from yeast to humans. In humans, dihydrobiopterin is involved in several metabolic disorders including dihydropteridine reductase (DHPR) deficiency. DHPR deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4) leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties. Dihydrobiopterin is also associated with another metabolic disorder known as sepiapterin reductase deficiency (SRD). Sepiapterin reductase catalyzes the (NADP-dependent) reduction of carbonyl derivatives, including pteridines, and plays an important role in tetrahydrobiopterin biosynthesis. Low dihydrofolate reductase activity in the brain leads to the accumulation of dihydrobiopterin, which in turn, inhibits tyrosine and tryptophan hydroxylases. This uncouples neuronal nitric oxide synthase, leading to neurotransmitter deficiencies and neuronal cell death. SRD is characterized by low cerebrospinal fluid neurotransmitter levels and the presence of elevated cerebrospinal fluid dihydrobiopterin. SRD is characterized by motor delay, axial hypotonia, language delay, diurnal fluctuation of symptoms, dystonia, weakness, oculogyric crises, dysarthria, parkinsonian signs and hyperreflexia."
        ],
        [
         "27",
         "BMG_MT000028",
         "Butyric acid is a short-chain fatty acid (SCFA) formed in the mammalian colon by bacterial fermentation of carbohydrates (including dietary fibre). It is a straight-chain alkyl carboxylic acid that appears as an oily, colorless liquid with an unpleasant (rancid butter) odor. The name butyric acid comes from the Greek word for \"butter\", the substance in which it was first found. Triglycerides of butyric acid constitute 3â€šÃ„Ã¬4% of butter. When butter goes rancid, butyric acid is liberated from the short-chain triglycerides via hydrolysis. Butyric acid is a widely distributed SCFA and is found in all organisms ranging from bacteria to plants to animals. It is present in animal fat and plant oils, bovine milk, breast milk, butter, parmesan cheese, body odor and vomit. While butyric acid has an unpleasant odor, it does have a pleasant buttery taste. As a result, butyric acid is used as a flavoring agent in food manufacturing. Low-molecular-weight esters of butyric acid, such as methyl butyrate, also have very pleasant aromas or tastes. As a result, several butyrate esters are used as food and perfume additives. Butyrate is naturally produced by fermentation processes performed by obligate anaerobic bacteria found in the mammalian gut. It is a metabolite of several bacterial genera including Anaerostipes, Coprococcus, Eubacterium, Faecalibacterium and Roseburia (PMID: 12324374; PMID: 27446020). Highly-fermentable fiber residues, such as those from resistant starch, oat bran, pectin, and guar can be transformed by colonic bacteria into butyrate. One study found that resistant starch consistently produces more butyrate than other types of dietary fibre (PMID: 14747692). The production of butyrate from fibres in ruminant animals such as cattle is responsible for the butyrate content of milk and butter. Butyrate has a number of important biological functions and binds to several specific receptors. In humans, butyric acid is one of two primary endogenous agonists of human hydroxycarboxylic acid receptor 2 (HCA2), a G protein-coupled receptor. Like other SCFAs, butyrate is also an agonist at the free fatty acid receptors FFAR2 and FFAR3, which function as nutrient sensors that facilitate the homeostatic control of energy balance. Butyrate is essential to host immune homeostasis (PMID: 25875123). Butyrate's effects on the immune system are mediated through the inhibition of class I histone deacetylases (specifically, HDAC1, HDAC2, HDAC3, and HDAC8) and activation of its G-protein coupled receptor targets including HCA2, FFAR2 and FFAR3. Among the short-chain fatty acids, butyrate is the most potent promoter of intestinal regulatory T cells in vitro and the only SCFA that is an HCA2 ligand (PMID: 25741338). Butyrate has been shown to be a critical mediator of the colonic inflammatory response. It possesses both preventive and therapeutic potential to counteract inflammation-mediated ulcerative colitis and colorectal cancer. As a short-chain fatty acid, butyrate is metabolized by mitochondria as an energy source through fatty acid metabolism. In particular, it is an important energy source for cells lining the mammalian colon (colonocytes). Without butyrate, colon cells undergo autophagy (i.e., self-digestion) and die."
        ],
        [
         "28",
         "BMG_MT000029",
         "Acetic acid is a two-carbon, straight-chain fatty acid. It is the smallest short-chain fatty acid (SCFA) and one of the simplest carboxylic acids. is an acidic, colourless liquid and is the main component in vinegar. Acetic acid has a sour taste and pungent smell. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. Acetic acid is found in all organisms, from bacteria to plants to humans. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A (to form acetylCoA) it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted in large amounts by certain acetic acid bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil. Due to their widespread presence on fruit, acetic acid is produced naturally as fruits and many other sugar-rich foods spoil. Several species of anaerobic bacteria, including members of the genus Clostridium and Acetobacterium can convert sugars to acetic acid directly. However, Clostridium bacteria are less acid-tolerant than Acetobacter. Even the most acid-tolerant Clostridium strains can produce acetic acid in concentrations of only a few per cent, compared to Acetobacter strains that can produce acetic acid in concentrations up to 20%. Acetic acid is also a component of the vaginal lubrication of humans and other primates, where it appears to serve as a mild antibacterial agent. Acetic acid can be found in other biofluids such as urine at low concentrations. Urinary acetic acid is produced by bacteria such as Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Enterobacter, Acinetobacter, Proteus mirabilis, Citrobacter frundii, Enterococcus faecalis, Streptococcus group B, Staphylococcus saprophyticus (PMID: 22292465). Acetic acid concentrations greater than 30 uM/mM creatinine in the urine can indicate a urinary tract infection, which typically suggests the presence of E. coli or Klebshiella pneumonia in the urinary tract. (PMID: 24909875) Acetic acid is also produced by other bacteria such as Akkermansia, Bacteroidetes, Bifidobacterium, Prevotella and Ruminococcus (PMID: 20444704; PMID: 22292465)."
        ],
        [
         "29",
         "BMG_MT000030",
         "Betaine (CAS: 107-43-7), also known as N,N,N-trimethylglycine, was named after its discovery in sugar beet (Beta vulgaris) in the 19th century. It is a small N-trimethylated amino acid, existing in zwitterionic form at neutral pH. It is now often called glycine betaine to distinguish it from other betaines that are widely distributed in microorganisms, plants, and animals. Many naturally occurring betaines serve as organic osmolytes, substances synthesized or taken up from the environment by cells for protection against osmotic stress, drought, high salinity, or high temperature. Intracellular accumulation of betaines permits water retention in cells, thus protecting from the effects of dehydration (Wikipedia). Betaine functions as a methyl donor in that it carries and donates methyl functional groups to facilitate necessary chemical processes. In particular, it methylates homocysteine to methionine, also producing N,N-dimethylglycine. The donation of methyl groups is important to proper liver function, cellular replication, and detoxification reactions. Betaine also plays a role in the manufacture of carnitine and serves to protect the kidneys from damage. Betaine comes from either the diet or by the oxidation of choline. Betaine insufficiency is associated with metabolic syndrome, lipid disorders, and diabetes, and may have a role in vascular and other diseases (PMID: 20346934). Betaine is important in development, from the pre-implantation embryo to infancy. Betaine is also widely regarded as an anti-oxidant. Betaine has been shown to have an inhibitory effect on NO release in activated microglial cells and may be an effective therapeutic component to control neurological disorders (PMID: 22801281). As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances (Martindale, The Extra Pharmacopoeia, 30th Ed, p1341)."
        ],
        [
         "30",
         "BMG_MT000031",
         "Ascorbic acid is found naturally in citrus fruits and many vegetables and is an essential nutrient in human diets. It is necessary to maintain connective tissue and bone. The biologically active form of ascorbic acid is vitamin C. Vitamin C is a water soluble vitamin. Primates (including humans) and a few other species in all divisions of the animal kingdom, notably the guinea pig, have lost the ability to synthesize ascorbic acid and must obtain it in their food. Vitamin C functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant (PubChem). Ascorbic acid is an electron donor for enzymes involved in collagen hydroxylation, biosynthesis of carnitine and norepinephrine, tyrosine metabolism, and amidation of peptide hormones. Ascrobic acid (vitamin C) deficiency causes scurvy. The amount of vitamin C necessary to prevent scurvy may not be adequate to maintain optimal health. The ability of vitamin C to donate electrons also makes it a potent water-soluble antioxidant that readily scavenges free radicals such as molecular oxygen, superoxide, hydroxyl radical, and hypochlorous acid. In this setting, several mechanisms could account for a link between vitamin C and heart disease. One is the relation between LDL oxidation and vitamins C and E. Vitamin C in vitro can recycle vitamin E, which can donate electrons to prevent LDL oxidation in vitro. As the lipid-phase vitamin E is oxidized, it can be regenerated by aqueous vitamin C. Other possibilities are that vitamin C could decrease cholesterol by mechanisms not well characterized, or could improve vasodilatation and vascular reactivity, perhaps by decreasing the interactions of nitric oxide with oxidants (PMID: 10799361). Moreover, ascorbic acid is found to be associated with hyperoxalemia, which is an inborn error of metabolism. Ascorbic acid is also a microbial metabolite produced by Ketogulonicigenium (PMID: 15785002)."
        ],
        [
         "31",
         "BMG_MT000032",
         "Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a 'Bitter Blocker' additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem 'sweeter'. This potentially makes lower calorie food products more palatable."
        ],
        [
         "32",
         "BMG_MT000033",
         "Melibiose (CAS: 585-99-9) is a disaccharide consisting of one galactose and one glucose moiety in an alpha (1-6) glycosidic linkage. This sugar is produced and metabolized only by enteric and lactic acid bacteria and other microbes, such as Dickeya dadantii, Escherichia, Leuconostoc, and Saccharomyces (PMID: 19734309, 28453942). It is not an endogenous metabolite but may be obtained from the consumption of partially fermented molasses, brown sugar, or honey. Antibodies to melibiose will appear in individuals affected by Chagas' disease (Trypanosoma cruzi infection). Melibiose is not metabolized by humans but can be broken down by gut microflora, such as E. coli. In fact, E. coli is able to utilize melibiose as a sole source of carbon. Melibiose is first imported by the melibiose permease, MelB and then converted into Î²-D-glucose and Î²-D-galactose by the Î±-galactosidase encoded by melA. Because of its poor digestibility, melibiose (along with rhamnose) can be used together for noninvasive intestinal mucosa barrier testing. This test can be used to assess malabsorption or impairment of intestinal permeability. Recent studies with dietary melibiose have shown that it can strongly affect the Th cell responses to an ingested antigen. It has been suggested that melibiose could be used to enhance the induction of oral tolerance (PMID: 17986780)."
        ],
        [
         "33",
         "BMG_MT000034",
         "Adenosine is a nucleoside that is composed of adenine and D-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. For instance, adenosine plays an important role in energy transfer as adenosine triphosphate (ATP) and adenosine diphosphate (ADP). It also plays a role in signal transduction as cyclic adenosine monophosphate (cAMP). Adenosine itself is both a neurotransmitter and potent vasodilator. When administered intravenously adenosine causes transient heart block in the AV node. Due to the effects of adenosine on AV node-dependent supraventricular tachycardia, adenosine is considered a class V antiarrhythmic agent. Overdoses of adenosine intake (as a drug) can lead to several side effects including chest pain, feeling faint, shortness of breath, and tingling of the senses. Serious side effects include a worsening dysrhythmia and low blood pressure. When present in sufficiently high levels, adenosine can act as an immunotoxin and a metabotoxin. An immunotoxin disrupts, limits the function, or destroys immune cells. A metabotoxin is an endogenous metabolite that causes adverse health effects at chronically high levels. Chronically high levels of adenosine are associated with adenosine deaminase deficiency. Adenosine is a precursor to deoxyadenosine, which is a precursor to dATP. A buildup of dATP in cells inhibits ribonucleotide reductase and prevents DNA synthesis, so cells are unable to divide. Since developing T cells and B cells are some of the most mitotically active cells, they are unable to divide and propagate to respond to immune challenges. High levels of deoxyadenosine also lead to an increase in S-adenosylhomocysteine, which is toxic to immature lymphocytes."
        ],
        [
         "34",
         "BMG_MT000035",
         "Ammonia is a colourless alkaline gas and is one of the most abundant nitrogen-containing compounds in the atmosphere. It is an irritant with a characteristic pungent odor that is widely used in industry. Inasmuch as ammonia is highly soluble in water and, upon inhalation, is deposited in the upper airways, occupational exposures to ammonia have commonly been associated with sinusitis, upper airway irritation, and eye irritation. Acute exposures to high levels of ammonia have also been associated with diseases of the lower airways and interstitial lung. Small amounts of ammonia are naturally formed in nearly all tissues and organs of the vertebrate organism. Ammonia is both a neurotoxin and a metabotoxin. In fact, it is the most common endogenous neurotoxin. A neurotoxin is a compound that causes damage to neural tissue and neural cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Ammonia is recognized to be central in the pathogenesis of a brain condition known as hepatic encephalopathy, which arises from various liver diseases and leads to a build up ammonia in the blood (hyperammonemia). More than 40% of people with cirrhosis develop hepatic encephalopathy. Part of the neurotoxicity of ammonia arises from the fact that it easily crosses the blood-brain barrier and is absorbed and metabolized by the astrocytes, a population of cells in the brain that constitutes 30% of the cerebral cortex. Astrocytes use ammonia when synthesizing glutamine from glutamate. The increased levels of glutamine lead to an increase in osmotic pressure in the astrocytes, which become swollen. There is increased activity of the inhibitory gamma-aminobutyric acid (GABA) system, and the energy supply to other brain cells is decreased. This can be thought of as an example of brain edema. The source of the ammonia leading to hepatic encaphlopahy is not entirely clear. The gut produces ammonia, which is metabolized in the liver, and almost all organ systems are involved in ammonia metabolism. Colonic bacteria produce ammonia by splitting urea and other amino acids, however this does not fully explain hyperammonemia and hepatic encephalopathy. The alternative explanation is that hyperammonemia is the result of intestinal breakdown of amino acids, especially glutamine. The intestines have significant glutaminase activity, predominantly located in the enterocytes. On the other hand, intestinal tissues only have a little glutamine synthetase activity, making it a major glutamine-consuming organ. In addition to the intestine, the kidney is an important source of blood ammonia in patients with liver disease. Ammonia is also taken up by the muscle and brain in hepatic coma, and there is confirmation that ammonia is metabolized in muscle. Excessive formation of ammonia in the brains of Alzheimer's disease patients has also been demonstrated, and it has been shown that some Alzheimer's disease patients exhibit elevated blood ammonia concentrations. Ammonia is the most important natural modulator of lysosomal protein processing. Indeed, there is strong evidence for the involvement of aberrant lysosomal processing of beta-amyloid precursor protein (beta-APP) in the formation of amyloid deposits. Inflammatory processes and activation of microglia are widely believed to be implicated in the pathology of Alzheimer's disease. Ammonia is able to affect the characteristic functions of microglia, such as endocytosis, and cytokine production. Based on these facts, an ammonia-based hypothesis for Alzheimer's disease has been suggested (PMID: 17006913, 16167195, 15377862, 15369278). Chronically high levels of ammonia in the blood are associated with nearly twenty different inborn errors of metabolism including: 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, 3-methyl-crotonylglycinuria, argininemia, argininosuccinic aciduria, beta-ketothiolase deficiency, biotinidase deficiency, carbamoyl phosphate synthetase deficiency, carnitine-acylcarnitine translocase deficiency, citrullinemia type I, hyperinsulinism-hyperammonemia syndrome, hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, isovaleric aciduria, lysinuric protein intolerance, malonic aciduria, methylmalonic aciduria, methylmalonic aciduria due to cobalamin-related disorders, propionic acidemia, pyruvate carboxylase deficiency, and short chain acyl CoA dehydrogenase deficiency (SCAD deficiency). Many of these inborn errors of metabolism are associated with urea cycle disorders or impairment to amino acid metabolism. High levels of ammonia in the blood (hyperammonemia) lead to the activation of NMDA receptors in the brain. This results in the depletion of brain ATP, which in turn leads to release of glutamate. Ammonia also leads to the impairment of mitochondrial function and calcium homeostasis, thereby decreasing ATP synthesis. Excess ammonia also increases the formation of nitric oxide (NO), which in turn reduces the activity of glutamine synthetase, and thereby decreases the elimination of ammonia in the brain (PMID: 12020609). As a neurotoxin, ammonia predominantly affects astrocytes. Disturbed mitochondrial function and oxidative stress, factors implicated in the induction of the mitochondrial permeability transition, appear to be involved in the mechanism of ammonia neurotoxicity. Ammonia can also affect the glutamatergic and GABAergic neuronal systems, the two prevailing neuronal systems of the cortical structures. All of these effects can lead to irreversible brain damage, coma, and/or death. Infants with urea cycle disorders and hyperammonia initially exhibit vomiting and increasing lethargy. If untreated, seizures, hypotonia (poor muscle tone, floppiness), respiratory distress (respiratory alkalosis), and coma can occur. Adults with urea cycle disorders and hyperammonia will exhibit episodes of disorientation, confusion, slurred speech, unusual and extreme combativeness or agitation, stroke-like symptoms, lethargy, and delirium. Ammonia also has toxic effects when an individual is exposed to ammonia solutions. Acute exposure to high levels of ammonia in air may be irritating to skin, eyes, throat, and lungs and cause coughing and burns. Lung damage and death may occur after exposure to very high concentrations of ammonia. Swallowing concentrated solutions of ammonia can cause burns in the mouth, throat, and stomach. Splashing ammonia into eyes can cause burns and even blindness."
        ],
        [
         "35",
         "BMG_MT000036",
         "Arginosuccinic acid is a basic amino acid. Some cells synthesize it from citrulline, aspartic acid and use it as a precursor for arginine in the urea cycle or Citrulline-NO cycle. The enzyme that catalyzes the reaction is argininosuccinate synthetase. Argininosuccinic acid is a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. Defects in the argininosuccinate lyase enzyme can lead to argininosuccinate lyase deficiency, which is an inborn error of metabolism. Argininosuccinate (ASA) lyase deficiency results in defective cleavage of ASA. This leads to an accumulation of ASA in cells and an excessive excretion of ASA in urine (argininosuccinic aciduria). In virtually all respects, this disorder shares the characteristics of other urea cycle defects. The most important characteristic of ASA lyase deficiency is its propensity to cause hyperammonemia in affected individuals. ASA in affected individuals is excreted by the kidney at a rate practically equivalent to the glomerular filtration rate (GFR). Whether ASA itself causes a degree of toxicity due to hepatocellular accumulation is unknown; such an effect could help explain hyperammonemia development in affected individuals. Regardless, the name of the disease is derived from the rapid clearance of ASA in urine, although elevated levels of ASA can be found in plasma. ASA lyase deficiency is associated with high mortality and morbidity rates. Symptoms of ASA lyase deficiency include anorexia, irritability rapid breathing, lethargy and vomiting. Extreme symptoms include coma and cerebral edema."
        ],
        [
         "36",
         "BMG_MT000037",
         "Androstenedione is a delta-4 19-carbon steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol. It is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione originates either from the conversion of dehydroepiandrosterone or from 17-hydroxyprogesterone. It is further converted to either testosterone or estrone. The production of adrenal androstenedione is governed by ACTH, while the production of gonadal androstenedione is under control by gonadotropins."
        ],
        [
         "37",
         "BMG_MT000038",
         "Bilirubin is a yellow bile pigment that is a degradation product of heme. It occurs in the normal catabolic pathway that breaks down heme in vertebrates. This catabolism is a necessary process in the body's clearance of waste products that arise from the destruction of aged or abnormal red blood cells. Bilirubin has been found in all vertebrates and in certain plants including Strelitzia nicolai (PMID: 28573242). Bilirubin levels in humans are elevated in certain diseases such as jaundice and liver disease and it is responsible for the yellow color of bruises and the yellow discoloration in jaundice. Bilirubin breakdown products, such as stercobilin, cause the brown color of feces. A different breakdown product, urobilin, is the main component of the straw-yellow color in urine. Bilirubin consists of an open chain of four pyrroles (tetrapyrrole). It is formed by oxidative cleavage of a porphyrin in heme, which leads to biliverdin, a green tetrapyrrolic bile pigment that is also a product of heme catabolism. Biliverdin is then reduced to bilirubin via biliverdin reductase. After conjugation with glucuronic acid, bilirubin can be excreted in the urine. Bilirubin is structurally similar to the pigment phycobilin used by certain algae to capture light energy, and to the pigment phytochrome used by plants to sense light. Elevated bilirubin levels in humans are associated with Crigler-Najjar syndrome type I, which is an inborn error of metabolism. Crigler-Najjar syndrome is a rare genetic disorder characterized by an inability to properly convert and clear bilirubin from the body. Affected individuals cannot convert unconjugated bilirubin to the conjugated form because they lack a specific liver enzyme required to break down (metabolize) bilirubin. Since they cannot convert bilirubin, they develop abnormally high levels of unconjugated bilirubin in the blood (hyperbilirubinemia). Crigler-Najjar syndrome is caused by mutations in the UGT1A1 gene. The hallmark finding of Crigler-Najjar syndrome is a persistent yellowing of the skin, mucous membranes and whites of the eyes (jaundice). Elevation of both alanine aminotransferase and bilirubin levels in serum or plasma can be indicative of serious liver injury. High levels of bilirubin are indicative of jaundice, which is easily recognizable due to a yellowing of the skin and eyes.  Bilirubin is also an antioxidant. Bilirubin's antioxidant activity may be particularly important in the brain, where it prevents excitotoxicity and neuronal death by scavenging superoxide during N-methyl-D-aspartic acid neurotransmission (PMID: 31353321)."
        ],
        [
         "38",
         "BMG_MT000039",
         "Cellobiose, also known as GLCB1-4GLCB or cellose, is a disaccharide. It is also classified as a reducing sugar. In terms of its chemical structure, it is derived from the condensation of a pair beta-glucose molecules creating a beta (1â€šÃœÃ­4) bond. It belongs to the class of organic compounds known as O-glycosyl compounds. These are glycosides in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Cellobiose can be obtained by enzymatic hydrolysis of cellulose and cellulose-rich materials such as cotton, jute, or paper. Cellobiose is a plant metabolite found in flowering plants, conifers and other gymnosperms. Cellobiose can also be found in vertebrates that have consumed plant foods. It has been detected, but not quantified in, several different foods, such as okra, common chokecherries, cherry tomatoes, and welsh onions. Cellobiose can be used as an indicator carbohydrate for Crohn's disease and malabsorption syndrome. Intestinal permeability to detect Crohn's disease and malabsorption syndrome can be measured by the sugar absorption test. This test is based on determining the ratio of the urinary excretion of a large (a disaccharide such as cellobiose) and a small carbohydrate (a monosaccharide such as lactulose or rhamnose) after oral administration. Patients with Crohn's disease or with ulcerative colitis have increased permeability indices in comparison to healthy controls (PMID: 15546811)."
        ],
        [
         "39",
         "BMG_MT000040",
         "beta-Alanine is the only naturally occurring beta-amino acid - an amino acid in which the amino group is at the beta-position from the carboxylate group. It is formed in vivo by the degradation of dihydrouracil and carnosine. It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (vitamin B-5), which itself is a component of coenzyme A. Under normal conditions, beta-alanine is metabolized into acetic acid. beta-Alanine can undergo a transanimation reaction with pyruvate to form malonate-semialdehyde and L-alanine. The malonate semialdehyde can then be converted into malonate via malonate-semialdehyde dehydrogenase. Malonate is then converted into malonyl-CoA and enter fatty acid biosynthesis. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, beta-alanine may act as a false transmitter replacing gamma-aminobutyric acid. When present in sufficiently high levels, beta-alanine can act as a neurotoxin, a mitochondrial toxin, and a metabotoxin. A neurotoxin is a compound that damages the brain or nerve tissue. A mitochondrial toxin is a compound that damages mitochondria and reduces cellular respiration as well as oxidative phosphorylation. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of beta-alanine are associated with at least three inborn errors of metabolism, including GABA-transaminase deficiency, hyper-beta-alaninemia, and methylmalonate semialdehyde dehydrogenase deficiency. beta-Alanine is a central nervous system (CNS) depressant and is an inhibitor of GABA transaminase. The associated inhibition of GABA transaminase and displacement of GABA from CNS binding sites can also lead to GABAuria (high levels of GABA in the urine) and convulsions. In addition to its neurotoxicity, beta-alanine reduces cellular levels of taurine, which are required for normal respiratory chain function. Cellular taurine depletion is known to reduce respiratory function and elevate mitochondrial superoxide generation, which damages mitochondria and increases oxidative stress (PMID: 27023909). Individuals suffering from mitochondrial defects or mitochondrial toxicity typically develop neurotoxicity, hypotonia, respiratory distress, and cardiac failure. beta-Alanine is a biomarker for the consumption of meat, especially red meat."
        ],
        [
         "40",
         "BMG_MT000041",
         "Cyclic AMP (cAMP) or cyclic adenosine monophosphate is an adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. cAMP is found in all organisms ranging from bacteria to plants to animals. In humans and other mammals it is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon and ACTH. cAMP is synthesized from ATP by adenylate cyclase. Adenylate cyclase is located at the inner side of cell membranes. Adenylate cyclase is activated by the hormones glucagon and adrenaline and by G protein. Liver adenylate cyclase responds more strongly to glucagon, and muscle adenylate cyclase responds more strongly to adrenaline. cAMP decomposition into AMP is catalyzed by the enzyme phosphodiesterase. cAMP is primarily used for intracellular signal transduction, such as transferring into cells the effects of hormones like glucagon and adrenaline, which cannot pass through the plasma membrane. cAMP is also involved in the activation of protein kinases. In addition, cAMP binds to and regulates the function of ion channels such as the HCN channels. Hyperpolarization-activated cyclic nucleotideâ€šÃ„Ã¬gated (HCN) channels are integral membrane proteins that serve as nonselective voltage-gated cation channels in the plasma membranes of heart and brain cells. HCN channels are sometimes referred to as pacemaker channels because they help to generate rhythmic activity within groups of heart and brain cells."
        ],
        [
         "41",
         "BMG_MT000042",
         "Acetoacetic acid (AcAc) is a weak organic acid that can be produced in the human liver under certain conditions of poor metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis). It is then partially converted into acetone by decarboxylation and excreted either in urine or through respiration. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing rats. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first two weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies are utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391). The acid is also present in the metabolism of those undergoing starvation or prolonged physical exertion as part of gluconeogenesis. When ketone bodies are measured by way of urine concentration, acetoacetic acid, along with beta-hydroxybutyric acid or acetone, is what is detected."
        ],
        [
         "42",
         "BMG_MT000043",
         "Adenosine 3', 5'-diphosphate or PAP is a nucleotide that is closely related to ADP. It has two phosphate groups attached to the 5' and 3' positions of the pentose sugar ribose (instead of pyrophosphoric acid at the 5' position, as found in ADP), and the nucleobase adenine. PAP is converted to PAPS by Sulfotransferase and then back to PAP after the sulfotransferase reaction. Sulfotransferase (STs) catalyze the transfer reaction of the sulfate group from the ubiquitous donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to an acceptor group of numerous substrates. This reaction, often referred to as sulfuryl transfer, sulfation, or sulfonation, is widely observed from bacteria to humans and plays a key role in various biological processes such as cell communication, growth and development, and defense. PAP also appears to a role in bipolar depression. Phosphatases converting 3'-phosphoadenosine 5'-phosphate (PAP) into adenosine 5'-phosphate are of fundamental importance in living cells as the accumulation of PAP is toxic to several cellular systems. These enzymes are lithium-sensitive and we have characterized a human PAP phosphatase as a potential target of lithium therapy."
        ],
        [
         "43",
         "BMG_MT000044",
         "Carnitine is a non-essential amino acid and a quaternary ammonium compound. Carnitine is also classified as an alcohol (specifically, a trimethylated carboxy-alcohol). Carnitine exists as one of two stereoisomers (the two enantiomers D-carnitine and L-carnitine. Both are biologically active, but only L-carnitine naturally occurs in animals, and D-carnitine is toxic as it inhibits the activity of the L-form. Carnitine is involved in the metabolism in most mammals, plants, and some bacteria.  Carnitine plays a key role in lipid metabolism and beta-oxidation. It is used to transport long-chain fatty acids into the mitochondria to be oxidized for energy production. This is done by forming a long chain acetylcarnitine esters which are then transported by carnitine palmitoyltransferase I and carnitine palmitoyltransferase II. Carnitine also participates in removing products of metabolism from cells. Given its key metabolic roles, carnitine is concentrated in skeletal and cardiac muscle as well as other tissues that metabolize fatty acids as an energy source. A normal 70 kilogram person typically produces 11â€šÃ„Ã¬34 mg of carnitine per day. Adults eating mixed diets of red meat and other animal products ingest 60â€šÃ„Ã¬180 mg of carnitine per day, while vegans consume about 10â€šÃ„Ã¬12 mg per day. Most carnitine obtained from the diet is absorbed in the small intestine before entering the blood.[3] The total body content of carnitine is about 20 grams in a person weighing 70 kilograms, with nearly all of it contained within skeletal muscle cells. Carnitine is so important in providing energy to muscles (including the heart) that some researchers are now recommending carnitine supplements in the diet, particularly for people who do not consume much red meat (the main food source for carnitine). Carnitine has been described as a vitamin, an amino acid, or a metabimin (i.e. an essential metabolite). Like the B vitamins, carnitine contains nitrogen and is very soluble in water. However, most animals, including humans, make their own carnitine; thus, carnitine cannot be considered to be a vitamin. In certain circumstances, such as methionine deficiency, lysine deficiency, vitamin C deficiency or kidney dialysis, carnitine shortages can develop. Under these conditions, carnitine must be absorbed from food, and for this reason, it is sometimes referred to as a \"metabimin\" or a conditionally essential metabolite. In humans, about 25% of carnitine is synthesized in the liver, kidney, and brain from lysine and methionine. Most of the carnitine in the body comes from dietary sources such as red meat and dairy products. Inborn errors of carnitine metabolism such as Reyeâ€šÃ„Ã´s syndrome can lead to brain deterioration gradually worsening muscle weakness, Duchenne-like muscular dystrophy, and extreme muscle weakness with fat accumulation in muscles. Carnitine is an essential nutrient for pre-term babies and individuals who are unable to eat a normal diet (e.g. non-ketotic hypoglycemics, kidney dialysis patients) (PMID: 115309). In conditions such as kwashiorkor, cirrhosis, and heart muscle disease (cardiomyopathy) as well as in inborn errors of metabolism such as type IV hyperlipidemia and propionic aciduria, carnitine is essential to life and carnitine supplements are critically important. Carnitine therapy may also be useful in a wide variety of clinical conditions. Carnitine supplementation has improved some patients who have angina secondary to coronary artery disease. Carnitine supplements may also be useful in many forms of metabolic liver diseases and heart muscle disease. Hearts undergoing severe arrhythmia quickly deplete their stores of carnitine. Athletes, particularly in Europe, have used carnitine supplements for improved endurance. Carnitine may improve muscle building by improving fat utilization and may even be useful in treating obesity. Carnitine may be of value in treating pregnant women, hypothyroid individuals, and male infertility due to the low motility of sperm. Carnitine deficiency is noted in abnormal liver function, renal dialysis patients, and severe to moderate muscular weakness with associated anorexia. Carnitine is a biomarker for the consumption of meat. In fact, carnitine was first extracted from meat extracts in 1905, leading to its name from Latin, \"caro/carnis\" or flesh."
        ],
        [
         "44",
         "BMG_MT000045",
         "Cortisol is the main glucocorticoid secreted by the adrenal cortex and it is involved in the stress response. Its synthetic counterpart hydrocortisone is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Hydrocortisone is synthesized from pregnenolone and is used as an immunosuppressive drug given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis. Cortisol increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning and lower levels in the evening, several hours after the onset of sleep. Cortisol is found to be associated with ACTH deficiency and glucocorticoid deficiency, which are inborn errors of metabolism. Cortisol binds to the cytosolic glucocorticoid receptor. After binding the receptor, the newly formed receptor-ligand complex translocates itself into the cell nucleus where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA-bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically, glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes and prevents phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In other words, the two main products of inflammation, prostaglandins and leukotrienes, are inhibited by the action of glucocorticoids. Glucocorticoids also stimulate the escape of lipocortin-1 into the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst, and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines, etc.) from neutrophils, macrophages, and mastocytes. Additionally, the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding."
        ],
        [
         "45",
         "BMG_MT000046",
         "Creatine, is a naturally occurring non-protein compound. It belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Creatine is found in all vertebrates where it facilitates recycling of adenosine triphosphate (ATP). Its primary metabolic role is to combine with a phosphoryl group, via the enzyme creatine kinase, to generate phosphocreatine, which is used to regenerate ATP. Most of the human body's total creatine and phosphocreatine stores are found in skeletal muscle (95%), while the remainder is distributed in the blood, brain, testes, and other tissues. Creatine is not an essential nutrient as it is naturally produced in the human body from the amino acids glycine and arginine, with an additional requirement for methionine to catalyze the transformation of guanidinoacetate to creatine. In the first step of its biosynthesis glycine and arginine are combined by the enzyme arginine:glycine amidinotransferase (AGAT) to form guanidinoacetate, which is then methylated by guanidinoacetate N-methyltransferase (GAMT), using S-adenosyl methionine as the methyl donor. Creatine can also be obtained through the diet at a rate of about 1 gram per day from an omnivorous diet. A cyclic form of creatine, called creatinine, exists in equilibrium with its tautomer and with creatine. Clinically, there are three distinct disorders of creatine metabolism. Deficiencies in the two synthesis enzymes (AGAT and GAMT) can cause L-arginine:glycine amidinotransferase deficiency (caused by variants in AGAT) and guanidinoacetate methyltransferase deficiency (caused by variants in GAMT). Both disorders are inherited in an autosomal recessive manner. A third defect, creatine transporter defect, is caused by mutations in SLC6A8 and inherited in a X-linked manner. Creatine is widely used as a supplement by athletes. Its use can increase maximum power and performance in high-intensity anaerobic repetitive work (periods of work and rest) by 5 to 15% (PMID: 24688272). Creatine has no significant effect on aerobic endurance, although it will increase power during short sessions of high-intensity aerobic exercise (PMID: 9662683)."
        ],
        [
         "46",
         "BMG_MT000047",
         "Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol. This is because researchers first identified cholesterol in solid form in gallstones in 1784. In the body, cholesterol can exist in either the free form or as an ester with a single fatty acid (of 10-20 carbons in length) covalently attached to the hydroxyl group at position 3 of the cholesterol ring. Due to the mechanism of synthesis, plasma cholesterol esters tend to contain relatively high proportions of polyunsaturated fatty acids. Most of the cholesterol consumed as a dietary lipid exists as cholesterol esters. Cholesterol esters have a lower solubility in water than cholesterol and are more hydrophobic. They are hydrolyzed by the pancreatic enzyme cholesterol esterase to produce cholesterol and free fatty acids. Cholesterol has vital structural roles in membranes and in lipid metabolism in general. It is a biosynthetic precursor of bile acids, vitamin D, and steroid hormones (glucocorticoids, estrogens, progesterones, androgens and aldosterone). In addition, it contributes to the development and functioning of the central nervous system, and it has major functions in signal transduction and sperm development. Cholesterol is a ubiquitous component of all animal tissues where much of it is located in the membranes, although it is not evenly distributed. The highest proportion of unesterified cholesterol is in the plasma membrane (roughly 30-50% of the lipid in the membrane or 60-80% of the cholesterol in the cell), while mitochondria and the endoplasmic reticulum have very low cholesterol contents. Cholesterol is also enriched in early and recycling endosomes, but not in late endosomes. The brain contains more cholesterol than any other organ where it comprises roughly a quarter of the total free cholesterol in the human body. Of all the organic constituents of blood, only glucose is present in a higher molar concentration than cholesterol. Cholesterol esters appear to be the preferred form for transport in plasma and as a biologically inert storage (de-toxified) form. They do not contribute to membranes but are packed into intracellular lipid particles. Cholesterol molecules (i.e. cholesterol esters) are transported throughout the body via lipoprotein particles. The largest lipoproteins, which primarily transport fats from the intestinal mucosa to the liver, are called chylomicrons. They carry mostly triglyceride fats and cholesterol that are from food, especially internal cholesterol secreted by the liver into the bile. In the liver, chylomicron particles give up triglycerides and some cholesterol. They are then converted into low-density lipoprotein (LDL) particles, which carry triglycerides and cholesterol on to other body cells. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. (Lack of information on LDL particle number and size is one of the major problems of conventional lipid tests.). In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. There is a worldwide trend to believe that lower total cholesterol levels tend to correlate with lower atherosclerosis event rates (though some studies refute this idea). As a result, cholesterol has become a very large focus for the scientific community trying to determine the proper amount of cholesterol needed in a healthy diet. However, the primary association of atherosclerosis with cholesterol has always been specifically with cholesterol transport patterns, not total cholesterol per se. For example, total cholesterol can be low, yet made up primarily of small LDL and small HDL particles and atheroma growth rates are high. In contrast, however, if LDL particle number is low (mostly large particles) and a large percentage of the HDL particles are large (HDL is actively reverse transporting cholesterol), then atheroma growth rates are usually low, even negative, for any given total cholesterol concentration. These effects are further complicated by the relative concentration of asymmetric dimethylarginine (ADMA) in the endothelium since ADMA down-regulates production of nitric oxide, a relaxant of the endothelium. Thus, high levels of ADMA, associated with highly oxidized levels of LDL, pose a heightened risk factor for vascular disease. Chronically high levels of cholesterol are associated with at least five inborn errors of metabolism, including cerebrotendinous xanthomatosis, cholesteryl ester storage disease, congenital lipoid adrenal hyperplasia, hypercholesterolemia, and Zellweger syndrome. In chronically high levels, cholesterol can function as an atherogen (causes atherosclerosis and cardiovascular disease). Specifically, chronically high levels (from diet or from genetic predisposition or from diseases such as hyperlipidemia) of cholesterol and cholesterol esters lead to an excess of low-density lipoprotein (LDL) particles. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. Resistin, a protein secreted by fat tissue, has been shown to increase the production of LDL in human liver cells and also degrades LDL receptors in the liver. As a result, the liver is less able to clear cholesterol from the bloodstream. Resistin accelerates the accumulation of LDL in arteries, increasing the risk of heart disease. Cholesterol is considered to be practically insoluble (in water) and basic."
        ],
        [
         "47",
         "BMG_MT000048",
         "Epinephrine is a catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine and tyrosine. It is the active sympathomimetic hormone secreted from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. Epinephrine also constricts arterioles in the skin and gut while dilating arterioles in leg muscles. It elevates the blood sugar level by increasing hydrolysis of glycogen to glucose in the liver, and at the same time begins the breakdown of lipids in adipocytes. Epinephrine has a suppressive effect on the immune system."
        ],
        [
         "48",
         "BMG_MT000049",
         "Pipecolic acid is a metabolite of lysine found in human physiological fluids such as urine, plasma and CSF. However, it is uncertain if pipecolic acid originates directly from food intake or from mammalian or intestinal bacterial enzyme metabolism. Recent studies suggest that plasma pipecolic acid, particularly the D-isomer, originates mainly from the catabolism of dietary lysine by intestinal bacteria rather than by direct food intake. In classic Zellweger syndrome (a cerebro-hepato-renal genetic disorder, OMIM 214100) pipecolic acid accumulate in the plasma of the patients. It is known that plasma pipecolic acid levels are also elevated in patients with chronic liver diseases. Pipecolic acid is moderately elevated in patients with pyridoxine-dependent seizures and might therefore be a possible biochemical marker for selecting candidates for pyridoxine therapy (Plecko et al 2000). Pipecolic acid was also elevated in CSF in these vitamin B6-responsive patients (PMID 12705501). Pipecolic acid is found to be associated with adrenoleukodystrophy, infantile Refsum disease, and peroxisomal biogenesis defect, which are also inborn errors of metabolism. Pipecolic acid is a biomarker for the consumption of dried and cooked beans."
        ],
        [
         "49",
         "BMG_MT000050",
         "Deoxyinosine is a nucleoside that is formed when hypoxanthine is attached to a deoxyribose ring (also known as a ribofuranose) via a beta-N9-glycosidic bond. Deoxyinosine is found in DNA while inosine is found in RNA. Inosine is a nucleic acid important for RNA editing. Adenosine deaminase (ADA) catalyzes the conversion of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. ADA-deficient individuals suffer from severe combined immunodeficiency (SCID) and are unable to produce significant numbers of mature T or B lymphocytes. This occurs as a consequence of the accumulation of ADA substrates or their metabolites. Inosine is also an intermediate in a chain of purine nucleotides reactions required for muscle movements. Moreover, deoxyinosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism."
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>HMDB</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>1-Methylhistidine, also known as 1-MHis or 1MH...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>1,3-Diaminopropane, also known as DAP or trime...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>2-Ketobutyric acid, also known as alpha-ketobu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>2-Hydroxybutyric acid (CAS: 600-15-7), also kn...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>2-Methoxyestrone (or 2-ME1) belongs to the cla...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID                                               HMDB\n",
       "0           BMG_MT000001  1-Methylhistidine, also known as 1-MHis or 1MH...\n",
       "1           BMG_MT000002  1,3-Diaminopropane, also known as DAP or trime...\n",
       "2           BMG_MT000003  2-Ketobutyric acid, also known as alpha-ketobu...\n",
       "3           BMG_MT000004  2-Hydroxybutyric acid (CAS: 600-15-7), also kn...\n",
       "4           BMG_MT000005  2-Methoxyestrone (or 2-ME1) belongs to the cla...\n",
       "...                  ...                                                ...\n",
       "218330      BMG_MT218331                                               <NA>\n",
       "218331      BMG_MT218332                                               <NA>\n",
       "218332      BMG_MT218333                                               <NA>\n",
       "218333      BMG_MT218334                                               <NA>\n",
       "218334      BMG_MT218335                                               <NA>\n",
       "\n",
       "[218335 rows x 2 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bmg_hmdb = biomedgraphica_metabolite[['BioMedGraphica_ID', 'HMDB_ID']]\n",
    "bmg_hmdb['HMDB_ID'] = bmg_hmdb['HMDB_ID'].str.split(';')\n",
    "bmg_hmdb = bmg_hmdb.explode('HMDB_ID')\n",
    "\n",
    "metabolite_description_hmdb = pd.merge(bmg_hmdb, hmdb_description, left_on='HMDB_ID', right_on='accession', how='left')\n",
    "metabolite_description_hmdb.drop(columns=['accession', 'HMDB_ID'], inplace=True)\n",
    "metabolite_description_hmdb.rename(columns={'hmdb_description':'HMDB'}, inplace=True)\n",
    "metabolite_description_hmdb = metabolite_description_hmdb.groupby('BioMedGraphica_ID').agg({\n",
    "    'HMDB': lambda x: ';'.join(x.dropna().unique())\n",
    "}).reset_index()\n",
    "metabolite_description_hmdb.replace('', pd.NA, inplace=True)\n",
    "metabolite_description_hmdb"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 5.2 From ChEBI"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Finished: chebi_def.csv\n"
     ]
    }
   ],
   "source": [
    "import csv\n",
    "\n",
    "def parse_obo_to_csv(obo_file_path, csv_file_path):\n",
    "    with open(obo_file_path, 'r') as obo_file:\n",
    "        lines = obo_file.readlines()\n",
    "\n",
    "    terms = []\n",
    "    current_term = {}\n",
    "    is_in_term_block = False\n",
    "\n",
    "    for line in lines:\n",
    "        line = line.strip()\n",
    "\n",
    "        if line == \"[Term]\":\n",
    "            # Save the previous term if it exists\n",
    "            if current_term:\n",
    "                terms.append(current_term)\n",
    "            # Start a new term\n",
    "            current_term = {}\n",
    "            is_in_term_block = True\n",
    "        elif is_in_term_block and line == \"\":\n",
    "            # End of the current term block\n",
    "            if current_term:\n",
    "                terms.append(current_term)\n",
    "            current_term = {}\n",
    "            is_in_term_block = False\n",
    "        elif is_in_term_block:\n",
    "            # Parse lines within a term block\n",
    "            if line.startswith(\"id: \"):\n",
    "                current_term['id'] = line.split(\"id: \")[1]\n",
    "            elif line.startswith(\"def: \"):\n",
    "                current_term['def'] = line.split(\"def: \")[1]\n",
    "\n",
    "    # Add the last term if it exists\n",
    "    if current_term:\n",
    "        terms.append(current_term)\n",
    "\n",
    "    # Write to CSV\n",
    "    with open(csv_file_path, 'w', newline='', encoding='utf-8') as csv_file:\n",
    "        writer = csv.DictWriter(csv_file, fieldnames=[\"id\", \"def\"])\n",
    "        writer.writeheader()\n",
    "        for term in terms:\n",
    "            writer.writerow(term)\n",
    "\n",
    "obo_file = \"chebi_lite.obo\"\n",
    "csv_file = \"chebi_def.csv\"\n",
    "\n",
    "parse_obo_to_csv(obo_file, csv_file)\n",
    "\n",
    "print(f\"Finished: {csv_file}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "id",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "def",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "127b1907-760f-4c53-85f6-180cf7385e5e",
       "rows": [
        [
         "0",
         "24431",
         "A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances."
        ],
        [
         "1",
         "23367",
         "Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity."
        ],
        [
         "2",
         "24870",
         "A molecular entity having a net electric charge."
        ],
        [
         "3",
         "24867",
         null
        ],
        [
         "4",
         "23905",
         null
        ],
        [
         "5",
         "33429",
         null
        ],
        [
         "6",
         "30151",
         "A monoatomic aluminium that has formula Al."
        ],
        [
         "7",
         "16042",
         "A monoatomic monoanion resulting from the addition of an electron to any halogen atom."
        ],
        [
         "8",
         "17051",
         "A monoatomic fluorine that has formula F."
        ],
        [
         "9",
         "24060",
         null
        ],
        [
         "10",
         "28741",
         "A metal fluoride salt with a Na(+) counterion."
        ],
        [
         "11",
         "32129",
         "A fluoride salt that has formula Ag.F.2H3N."
        ],
        [
         "12",
         "30340",
         "A silver salt that has formula AgF."
        ],
        [
         "13",
         "51990",
         "A tetrabutylammonium salt that has formula C16H36FN."
        ],
        [
         "14",
         "49499",
         "The fluoride salt of beryllium (+2 oxidation state). In the solid state it exists as a glass, with four-coordinate Be(2+) tetrahedral centres and two-coordinate fluoride centres. As a gas it adopts a linear triatomic structure and in the liquid state a fluctuating tetrahedral structure. In protein crystallography it is used as a mimic of phosphate."
        ],
        [
         "15",
         "66871",
         "A fluoride salt having ammonium (NH4+) as the counterion."
        ],
        [
         "16",
         "66872",
         "A fluoride salt having K+ as the counterion."
        ],
        [
         "17",
         "190416",
         "A fluoride salt that lacks C-H bonds"
        ],
        [
         "18",
         "135933",
         "An inorganic fluoride salt that has formula F2Sn."
        ],
        [
         "19",
         "193146",
         "An inorganic fluoride salt that has formula F5Sb."
        ],
        [
         "20",
         "190417",
         "A fluoride salt with C-H bonds"
        ],
        [
         "21",
         "17996",
         "A halide anion formed when chlorine picks up an electron to form an an anion."
        ],
        [
         "22",
         "23114",
         null
        ],
        [
         "23",
         "36093",
         null
        ],
        [
         "24",
         "6636",
         "A magnesium salt comprising of two chlorine atoms bound to a magnesium atom."
        ],
        [
         "25",
         "86345",
         "A hydrate that is the hexahydrate form of magnesium dichloride."
        ],
        [
         "26",
         "86355",
         "A hydrate that is the monohydrate form of magnesium dichloride."
        ],
        [
         "27",
         "131394",
         "A hydrate that is the dihydrate form of magnesium dichloride."
        ],
        [
         "28",
         "31206",
         "An inorganic chloride having ammonium as the counterion."
        ],
        [
         "29",
         "3312",
         "An inorganic calcium salt that has formula CaCl2."
        ],
        [
         "30",
         "86158",
         "A hydrate that is the dihydrate form of calcium chloride."
        ],
        [
         "31",
         "91243",
         "A hydrate that is the hexahydrate form of calcium chloride."
        ],
        [
         "32",
         "26710",
         "An inorganic chloride salt having sodium(1+) as the counterion."
        ],
        [
         "33",
         "46715",
         null
        ],
        [
         "34",
         "30341",
         "A silver salt that has formula AgCl."
        ],
        [
         "35",
         "32588",
         "A metal chloride salt with a K(+) counterion."
        ],
        [
         "36",
         "35696",
         "A cobalt salt in which the cobalt metal is in the +2 oxidation state and the counter-anion is chloride. It is used as an indicator for water in desiccants."
        ],
        [
         "37",
         "53503",
         "A hydrate of cobalt chloride containing cobalt (in +2 oxidation state), chloride and water moieties in the ratio 1:2:6."
        ],
        [
         "38",
         "36383",
         "A strontium salt that has formula Cl2Sr."
        ],
        [
         "39",
         "36385",
         "A strontium salt that has formula Cl2H12O6Sr."
        ],
        [
         "40",
         "37117",
         "A thallium molecular entity that has formula ClTl."
        ],
        [
         "41",
         "32213",
         "A thallium monochloride that has formula Cl."
        ],
        [
         "42",
         "48607",
         "A metal chloride salt with a Li(+) counterion."
        ],
        [
         "43",
         "49976",
         "A compound of zinc and chloride ions in the ratio 1:2. It exists in four crystalline forms, in each of which the Zn(2+) ions are trigonal planar coordinated to four chloride ions."
        ],
        [
         "44",
         "87627",
         "An organic chloride salt composed of 3,3'-dimethoxy-4,4'-bis(diazonium), zinc and chloride ions in a ratio of 1:1:4. Used for detection of marijuana metabolites in urine."
        ],
        [
         "45",
         "49553",
         "An inorganic chloride of copper in which the metal is in the +2 oxidation state."
        ],
        [
         "46",
         "86318",
         "A hydrate that is the dihydrate form of copper(II) chloride. It occurs naturally as the mineral eriochalcite."
        ],
        [
         "47",
         "91245",
         "A hydrate that is the pentahydrate form of copper(II) chloride."
        ],
        [
         "48",
         "53472",
         "An inorganic chloride of copper in which the metal is in the +1 oxidation state."
        ],
        [
         "49",
         "62843",
         "A compound of beryllium (+2 oxidation state) and chloride in the ratio 1:2."
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 202209
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>def</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>24431</td>\n",
       "      <td>A chemical entity is a physical entity of inte...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>23367</td>\n",
       "      <td>Any constitutionally or isotopically distinct ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>24870</td>\n",
       "      <td>A molecular entity having a net electric charge.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>24867</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>23905</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202204</th>\n",
       "      <td>196964</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202205</th>\n",
       "      <td>191404</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202206</th>\n",
       "      <td>189822</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202207</th>\n",
       "      <td>187876</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202208</th>\n",
       "      <td>231551</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>202209 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            id                                                def\n",
       "0        24431  A chemical entity is a physical entity of inte...\n",
       "1        23367  Any constitutionally or isotopically distinct ...\n",
       "2        24870   A molecular entity having a net electric charge.\n",
       "3        24867                                                NaN\n",
       "4        23905                                                NaN\n",
       "...        ...                                                ...\n",
       "202204  196964                                                NaN\n",
       "202205  191404                                                NaN\n",
       "202206  189822                                                NaN\n",
       "202207  187876                                                NaN\n",
       "202208  231551                                                NaN\n",
       "\n",
       "[202209 rows x 2 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chebi_def = pd.read_csv('chebi_def.csv', dtype=str)  # Load the CSV file into a DataFrame\n",
    "chebi_def[\"def\"] = chebi_def[\"def\"].str.replace('\"', '', regex=False).str.replace(r'\\[.*?\\]', '', regex=True).str.strip()\n",
    "chebi_def['id'] = chebi_def['id'].str.replace('CHEBI:', '')\n",
    "chebi_def"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\shunn\\AppData\\Local\\Temp\\ipykernel_27608\\1335047898.py:2: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  bmg_chebi['ChEBI_ID'] = bmg_chebi['ChEBI_ID'].str.split(';')\n"
     ]
    },
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "ChEBI_ID",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "13f3a744-9007-49cb-a2fb-540ed0c304f3",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "50599"
        ],
        [
         "1",
         "BMG_MT000002",
         "15725"
        ],
        [
         "2",
         "BMG_MT000003",
         "30831"
        ],
        [
         "2",
         "BMG_MT000003",
         "16763"
        ],
        [
         "3",
         "BMG_MT000004",
         "1148"
        ],
        [
         "3",
         "BMG_MT000004",
         "50613"
        ],
        [
         "4",
         "BMG_MT000005",
         "1189"
        ],
        [
         "5",
         "BMG_MT000006",
         "17066"
        ],
        [
         "6",
         "BMG_MT000007",
         "16450"
        ],
        [
         "7",
         "BMG_MT000008",
         "15698"
        ],
        [
         "8",
         "BMG_MT000009",
         "28324"
        ],
        [
         "9",
         "BMG_MT000010",
         "16973"
        ],
        [
         "10",
         "BMG_MT000011",
         "17405"
        ],
        [
         "11",
         "BMG_MT000012",
         "16530"
        ],
        [
         "12",
         "BMG_MT000013",
         "18101"
        ],
        [
         "13",
         "BMG_MT000014",
         "27847"
        ],
        [
         "14",
         "BMG_MT000015",
         "1582"
        ],
        [
         "14",
         "BMG_MT000015",
         "742324"
        ],
        [
         "15",
         "BMG_MT000016",
         "37373"
        ],
        [
         "16",
         "BMG_MT000017",
         null
        ],
        [
         "17",
         "BMG_MT000018",
         "18261"
        ],
        [
         "18",
         "BMG_MT000019",
         "59560"
        ],
        [
         "19",
         "BMG_MT000020",
         "15956"
        ],
        [
         "20",
         "BMG_MT000021",
         "16032"
        ],
        [
         "21",
         "BMG_MT000022",
         "17759"
        ],
        [
         "22",
         "BMG_MT000023",
         "15727"
        ],
        [
         "23",
         "BMG_MT000024",
         "16708"
        ],
        [
         "24",
         "BMG_MT000025",
         "28865"
        ],
        [
         "25",
         "BMG_MT000026",
         "27584"
        ],
        [
         "26",
         "BMG_MT000027",
         "43029"
        ],
        [
         "27",
         "BMG_MT000028",
         "30772"
        ],
        [
         "28",
         "BMG_MT000029",
         "15366"
        ],
        [
         "29",
         "BMG_MT000030",
         "41139"
        ],
        [
         "30",
         "BMG_MT000031",
         "29073"
        ],
        [
         "31",
         "BMG_MT000032",
         "16027"
        ],
        [
         "31",
         "BMG_MT000032",
         "456215"
        ],
        [
         "32",
         "BMG_MT000033",
         null
        ],
        [
         "33",
         "BMG_MT000034",
         "16335"
        ],
        [
         "34",
         "BMG_MT000035",
         "16134"
        ],
        [
         "35",
         "BMG_MT000036",
         "15682"
        ],
        [
         "36",
         "BMG_MT000037",
         "16422"
        ],
        [
         "37",
         "BMG_MT000038",
         "16990"
        ],
        [
         "38",
         "BMG_MT000039",
         "36217"
        ],
        [
         "39",
         "BMG_MT000040",
         "16958"
        ],
        [
         "40",
         "BMG_MT000041",
         "17489"
        ],
        [
         "41",
         "BMG_MT000042",
         "15344"
        ],
        [
         "42",
         "BMG_MT000043",
         "17985"
        ],
        [
         "43",
         "BMG_MT000044",
         "16347"
        ],
        [
         "44",
         "BMG_MT000045",
         "17650"
        ],
        [
         "45",
         "BMG_MT000046",
         "16919"
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 218465
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>ChEBI_ID</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>50599</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>15725</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>30831</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>16763</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>1148</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>91247</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>91248</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>91251</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>91272</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>9440</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218465 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID ChEBI_ID\n",
       "0           BMG_MT000001    50599\n",
       "1           BMG_MT000002    15725\n",
       "2           BMG_MT000003    30831\n",
       "2           BMG_MT000003    16763\n",
       "3           BMG_MT000004     1148\n",
       "...                  ...      ...\n",
       "218330      BMG_MT218331    91247\n",
       "218331      BMG_MT218332    91248\n",
       "218332      BMG_MT218333    91251\n",
       "218333      BMG_MT218334    91272\n",
       "218334      BMG_MT218335     9440\n",
       "\n",
       "[218465 rows x 2 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bmg_chebi = biomedgraphica_metabolite[['BioMedGraphica_ID', 'ChEBI_ID']]\n",
    "bmg_chebi['ChEBI_ID'] = bmg_chebi['ChEBI_ID'].str.split(';')\n",
    "bmg_chebi = bmg_chebi.explode('ChEBI_ID')\n",
    "bmg_chebi"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "ChEBI",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "ccd68b1c-240d-45bc-a8e3-549020b3e93e",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "A L-histidine derivative in which the methyl group is at N(tele)-position."
        ],
        [
         "1",
         "BMG_MT000002",
         "An alkane-alpha,omega-diamine comprising a propane skeleton with amino substituents at positions 1 and 3."
        ],
        [
         "2",
         "BMG_MT000003",
         "A 2-oxo monocarboxylic acid that is the 2-oxo derivative of butanoic acid. | A 2-oxo monocarboxylic acid anion that is the conjugate base of 2-oxobutanoic acid, obtained by deprotonation of the carboxy group."
        ],
        [
         "3",
         "BMG_MT000004",
         "A hydroxybutyric acid having a single hydroxyl group located at position 2; urinary secretion of 2-hydroxybutyric acid is increased with alcohol ingestion or vigorous physical exercise and is associated with lactic acidosis and ketoacidosis in humans and diabetes in animals. | An optically active form of 2-hydroxybutyric acid having (S)-configuration."
        ],
        [
         "4",
         "BMG_MT000005",
         "A 17-oxo steroid that is estrone in which the hydrogen at position 2 has been replaced by a methoxy group."
        ],
        [
         "5",
         "BMG_MT000006",
         "The R-enantiomer of 3-hydroxybutyric acid. Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics. It is a sex pheremone in the European spider Linyphia triangularis."
        ],
        [
         "6",
         "BMG_MT000007",
         "A pyrimidine 2'-deoxyribonucleoside having uracil as the nucleobase."
        ],
        [
         "7",
         "BMG_MT000008",
         "A pyrimidine 2'-deoxyribonucleoside having cytosine as the nucleobase."
        ],
        [
         "8",
         "BMG_MT000009",
         "A deoxycortisol that is cortisol in which the hydroxy group at position 11 has been replaced by a hydrogen."
        ],
        [
         "9",
         "BMG_MT000010",
         "A mineralocorticoid that is progesterone substituted at position 21 by a hydroxy group."
        ],
        [
         "10",
         "BMG_MT000011",
         "A methylpyridine that is 2-methylpyridine substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. It is the catabolic product of vitamin B6 and is excreted in the urine."
        ],
        [
         "11",
         "BMG_MT000012",
         "A 2-oxo monocarboxylic acid that is the 2-oxo derivative of isovaleric acid."
        ],
        [
         "12",
         "BMG_MT000013",
         "A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group."
        ],
        [
         "13",
         "BMG_MT000014",
         "The monoiodotyrosine that is L-tyrosine carrying an iodo-substituent at position C-3 of the benzyl group."
        ],
        [
         "14",
         "BMG_MT000015",
         "A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas."
        ],
        [
         "15",
         "BMG_MT000016",
         "A 3-hydroxyisobutyric acid that has formula C4H8O3."
        ],
        [
         "16",
         "BMG_MT000017",
         null
        ],
        [
         "17",
         "BMG_MT000018",
         "A beta-alanine derivative that is propionic acid bearing a ureido group at position 3."
        ],
        [
         "18",
         "BMG_MT000019",
         "A tetrahydropterin that is 2-amino-5,6,7,8-tetrahydropteridin-4(3H)-one in which a hydrogen at position 6 is substituted by a 1,2-dihydroxypropyl group (6R,1'R,2'S-enantiomer)."
        ],
        [
         "19",
         "BMG_MT000020",
         "An organic heterobicyclic compound that consists of 2-oxohexahydro-1H-thienoimidazole having a valeric acid substituent attached to the tetrahydrothiophene ring. The parent of the class of biotins."
        ],
        [
         "20",
         "BMG_MT000021",
         "An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone ."
        ],
        [
         "21",
         "BMG_MT000022",
         "A Delta(5),Delta(7)-sterol that has formula C27H44O."
        ],
        [
         "22",
         "BMG_MT000023",
         "A dipeptide that is the N-(beta-alanyl) derivative of L-histidine."
        ],
        [
         "23",
         "BMG_MT000024",
         "The parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6."
        ],
        [
         "24",
         "BMG_MT000025",
         "A bile acid taurine conjugate of  cholic acid that usually occurs as the sodium salt of bile in mammals."
        ],
        [
         "25",
         "BMG_MT000026",
         "A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney."
        ],
        [
         "26",
         "BMG_MT000027",
         "A 7,8-dihydrobiopterin in which the 1,2-dihydroxypropyl group has (1R,2S)-configuration; naturally occurring form."
        ],
        [
         "27",
         "BMG_MT000028",
         "A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group."
        ],
        [
         "28",
         "BMG_MT000029",
         "A simple monocarboxylic acid containing two carbons."
        ],
        [
         "29",
         "BMG_MT000030",
         "A quaternary ammonium ion in which the substituents on nitrogen are methyl (three) and carboxymethyl."
        ],
        [
         "30",
         "BMG_MT000031",
         "The L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate."
        ],
        [
         "31",
         "BMG_MT000032",
         "A purine ribonucleoside 5'-monophosphate having adenine as the nucleobase. | A nucleoside 5'-monophosphate(2-) that results from the removal of two protons from the phosphate group of adenosine 5'-monophosphate (AMP)."
        ],
        [
         "32",
         "BMG_MT000033",
         null
        ],
        [
         "33",
         "BMG_MT000034",
         "A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond."
        ],
        [
         "34",
         "BMG_MT000035",
         "An azane that consists of a single nitrogen atom covelently bonded to three hydrogen atoms."
        ],
        [
         "35",
         "BMG_MT000036",
         "A L-arginine derivative that has formula C10H18N4O6."
        ],
        [
         "36",
         "BMG_MT000037",
         "A 3-oxo Delta(4)-steroid that is androst-4-ene substituted by oxo groups at positions 3 and 17. It is a steroid hormone synthesized in the adrenal glands and gonads."
        ],
        [
         "37",
         "BMG_MT000038",
         "A member of the class of  biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin."
        ],
        [
         "38",
         "BMG_MT000039",
         "A cellobiose with beta configuration at the reducing-end glucose residue."
        ],
        [
         "39",
         "BMG_MT000040",
         "A naturally-occurring beta-amino acid comprising propionic acid with the amino group in the 3-position."
        ],
        [
         "40",
         "BMG_MT000041",
         "A 3',5'-cyclic purine nucleotide having having adenine as the nucleobase."
        ],
        [
         "41",
         "BMG_MT000042",
         "A 3-oxo monocarboxylic acid that is butyric acid bearing a 3-oxo substituent."
        ],
        [
         "42",
         "BMG_MT000043",
         "An adenosine bisphosphate having two monophosphate groups at the 3'- and 5'-positions."
        ],
        [
         "43",
         "BMG_MT000044",
         "The (R)-enantiomer of carnitine."
        ],
        [
         "44",
         "BMG_MT000045",
         "A 17alpha-hydroxy-C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the \\stress hormone\\ as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses."
        ],
        [
         "45",
         "BMG_MT000046",
         "A glycine derivative having methyl and amidino groups attached to the nitrogen."
        ],
        [
         "46",
         "BMG_MT000047",
         "A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group."
        ],
        [
         "47",
         "BMG_MT000048",
         "The R-enantiomer of adrenaline. It is a hormone secreted by the adrenal glands resulting in the 'fight-or-flight' response."
        ],
        [
         "48",
         "BMG_MT000049",
         "A piperidinemonocarboxylic acid in which the carboxy group is located at position C-2."
        ],
        [
         "49",
         "BMG_MT000050",
         "A purine 2'-deoxyribonucleoside that is inosine in which the hydroxy group at position 2' is replaced by a hydrogen."
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>ChEBI</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>A L-histidine derivative in which the methyl g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>An alkane-alpha,omega-diamine comprising a pro...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>A 2-oxo monocarboxylic acid that is the 2-oxo ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>A hydroxybutyric acid having a single hydroxyl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>A 17-oxo steroid that is estrone in which the ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>A hydrochloride obtained by combining L-cystei...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>A hydrate that is the monohydrate form of L-cy...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>An organic sodium salt that is the monosodium ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>An HPODE (hydroperoxyoctadecadienoic acid) in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>A member of the class of pyrrolidin-2-ones tha...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID                                              ChEBI\n",
       "0           BMG_MT000001  A L-histidine derivative in which the methyl g...\n",
       "1           BMG_MT000002  An alkane-alpha,omega-diamine comprising a pro...\n",
       "2           BMG_MT000003  A 2-oxo monocarboxylic acid that is the 2-oxo ...\n",
       "3           BMG_MT000004  A hydroxybutyric acid having a single hydroxyl...\n",
       "4           BMG_MT000005  A 17-oxo steroid that is estrone in which the ...\n",
       "...                  ...                                                ...\n",
       "218330      BMG_MT218331  A hydrochloride obtained by combining L-cystei...\n",
       "218331      BMG_MT218332  A hydrate that is the monohydrate form of L-cy...\n",
       "218332      BMG_MT218333  An organic sodium salt that is the monosodium ...\n",
       "218333      BMG_MT218334  An HPODE (hydroperoxyoctadecadienoic acid) in ...\n",
       "218334      BMG_MT218335  A member of the class of pyrrolidin-2-ones tha...\n",
       "\n",
       "[218335 rows x 2 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metabolite_description_chebi = pd.merge(bmg_chebi, chebi_def, left_on='ChEBI_ID', right_on='id', how='left')\n",
    "metabolite_description_chebi.drop(columns=['id', 'ChEBI_ID'], inplace=True)\n",
    "metabolite_description_chebi.rename(columns={'def':'ChEBI'}, inplace=True)\n",
    "metabolite_description_chebi = metabolite_description_chebi.groupby('BioMedGraphica_ID').agg({\n",
    "    'ChEBI': lambda x: ' | '.join(x.dropna().unique())\n",
    "}).reset_index()\n",
    "metabolite_description_chebi.replace('', pd.NA, inplace=True)\n",
    "metabolite_description_chebi"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 5.3 Final Description"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "HMDB",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ChEBI",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "eccf29fb-828e-4769-9dda-9d4b814987e6",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "1-Methylhistidine, also known as 1-MHis or 1MH, belongs to the class of organic compounds known as histidine and derivatives. 1MH is also classified as a methylamino acid. Methylamino acids are primarily proteogenic amino acids (found in proteins) which have been methylated (in situ) on their side chains by various methyltransferase enzymes. Histidine can be methylated at either the N1 or N3 position of its imidazole ring, yielding the isomers 1-methylhistidine (1MH; also referred to as pi-methylhistidine) or 3-methylhistidine (3MH; tau-methylhistidine), respectively. There is considerable confusion with regard to the nomenclature of the methylated nitrogen atoms on the imidazole ring of histidine and other histidine-containing peptides such as anserine. In particular, older literature (mostly prior to the year 2000) designated anserine (Npi methylated) as beta-alanyl-N1-methyl-histidine, whereas according to standard IUPAC nomenclature, anserine is correctly named as beta-alanyl-N3-methyl-histidine. As a result, many papers published prior to the year 2000 incorrectly identified 1MH as a specific marker for dietary consumption or various pathophysiological effects when they really were referring to 3MH (PMID: 24137022).  Recent discoveries have shown that 1MH is produced in essentially all mammals (and other vertebrates) via the enzyme known as METTL9 (PMID: 33563959). METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mammalian proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where \"x\" is a small amino acid. This HxH motif is found in a number of abundant mammalian proteins such as ARMC6, S100A9, and NDUFB3 (PMID: 33563959). Because of its abundance in many muscle-related proteins, 1MH has been found to be a good biomarker for the consumption of meat (PMID: 21527577). Dietary studies have shown that poultry consumption (p-trend = 0.0006) and chicken consumption (p-trend = 0.0003) are associated with increased levels of 1MH in human plasma (PMID: 30018457). The consumption of fish, especially salmon and cod, has also been shown to increase the levels of 1MH in serum and urine (PMID: 31401679). As a general rule, urinary 1MH is associated with white meat intake (p< 0.001), whereas urinary 3MH is associated with red meat intake (p< 0.001) (PMID: 34091671).",
         "A L-histidine derivative in which the methyl group is at N(tele)-position."
        ],
        [
         "1",
         "BMG_MT000002",
         "1,3-Diaminopropane, also known as DAP or trimethylenediamine, belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing a primary aliphatic amine group. 1,3-Diaminopropane is a stable, flammable, and highly hygroscopic fluid. It is a polyamine that is normally quite toxic if swallowed, inhaled, or absorbed through the skin. It is a catabolic byproduct of spermidine. It is also a precursor in the enzymatic synthesis of beta-alanine. 1,3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway. 1,3-Diaminopropane has been detected, but not quantified in, several different foods, such as cassava, shiitakes, oyster mushrooms, muscadine grapes, and cinnamons. This could make 1,3-diaminopropane a potential biomarker for the consumption of these foods.",
         "An alkane-alpha,omega-diamine comprising a propane skeleton with amino substituents at positions 1 and 3."
        ],
        [
         "2",
         "BMG_MT000003",
         "2-Ketobutyric acid, also known as alpha-ketobutyrate or 2-oxobutyrate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. It is also one of the degradation products of threonine. It can be converted into propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted into succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle. More specifically, 2-ketobutyric acid is a product of the lysis of cystathionine.",
         "A 2-oxo monocarboxylic acid that is the 2-oxo derivative of butanoic acid. | A 2-oxo monocarboxylic acid anion that is the conjugate base of 2-oxobutanoic acid, obtained by deprotonation of the carboxy group."
        ],
        [
         "3",
         "BMG_MT000004",
         "2-Hydroxybutyric acid (CAS: 600-15-7), also known as alpha-hydroxybutyrate, is an organic acid derived from alpha-ketobutyrate. alpha-Ketobutyrate is produced by amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) and is metabolized into propionyl-CoA and carbon dioxide (PMID: 20526369). 2-Hydroxybutyric acid is formed as a byproduct from the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH). alpha-Hydroxybutyric acid is primarily produced in mammalian hepatic tissues that catabolize L-threonine or synthesize glutathione. Oxidative stress or detoxification of xenobiotics in the liver can dramatically increase the rate of hepatic glutathione synthesis. Under such metabolic stress conditions, supplies of L-cysteine for glutathione synthesis become limiting, so homocysteine is diverted from the transmethylation pathway (which forms methionine) into the transsulfuration pathway (which forms cystathionine). alpha-Ketobutyrate is released as a byproduct when cystathionine is cleaved into cysteine that is incorporated into glutathione. Chronic shifts in the rate of glutathione synthesis may be reflected by urinary excretion of 2-hydroxybutyrate. 2-Hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation that appears to arise due to increased lipid oxidation and oxidative stress (PMID: 20526369). 2-Hydroxybutyric acid is often found in the urine of patients suffering from lactic acidosis and ketoacidosis. 2-Hydroxybutyric acid generally appears at high concentrations in situations related to deficient energy metabolism (e.g. birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as \"cerebral\" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. More recently it has been noted that elevated levels of alpha-hydroxybutyrate in the plasma is a good marker for early-stage type II diabetes (PMID: 19166731). It was concluded from studies done in the mid-1970s that an increased NADH2/NAD ratio was the most important factor for the production of 2-hydroxybutyric acid (PMID: 168632).",
         "A hydroxybutyric acid having a single hydroxyl group located at position 2; urinary secretion of 2-hydroxybutyric acid is increased with alcohol ingestion or vigorous physical exercise and is associated with lactic acidosis and ketoacidosis in humans and diabetes in animals. | An optically active form of 2-hydroxybutyric acid having (S)-configuration."
        ],
        [
         "4",
         "BMG_MT000005",
         "2-Methoxyestrone (or 2-ME1) belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, 2-methoxyestrone is considered to be a steroid or steroid derivative. It is a by-product of estrone and 2-hydroxyestrone metabolism and has been detected in all mammals. More specifically, 2-methoxyestrone is an endogenous, naturally occurring methoxylated catechol estrogen and a metabolite of estrone that is formed by catechol O-methyltransferase via the intermediate 2-hydroxyestrone. 2-Methoxyestrone is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone has been determined to be 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17). Unlike estrone but similarly to 2-hydroxyestrone and 2-methoxyestradiol, 2-methoxyestrone has very low affinity for the estrogen receptor and lacks significant estrogenic activity (PMID: 10865186).",
         "A 17-oxo steroid that is estrone in which the hydrogen at position 2 has been replaced by a methoxy group."
        ],
        [
         "5",
         "BMG_MT000006",
         "3-Hydroxybutyric acid (CAS: 300-85-6), also known as beta-hydroxybutanoic acid, is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis. This acid is metabolized by 3-hydroxybutyrate dehydrogenase (catalyzes the oxidation of 3-hydroxybutyrate to form acetoacetate, using NAD+ as an electron acceptor). The enzyme functions in nervous tissues and muscles, enabling the use of circulating hydroxybutyrate as a fuel. In the liver mitochondrial matrix, the enzyme can also catalyze the reverse reaction, a step in ketogenesis. 3-Hydroxybutyric acid is a chiral compound having two enantiomers, D-3-hydroxybutyric acid and L-3-hydroxybutyric acid, and is a ketone body. Like the other ketone bodies (acetoacetate and acetone), levels of 3-hydroxybutyrate in blood and urine are raised in ketosis. In humans, 3-hydroxybutyrate is synthesized in the liver from acetyl-CoA and can be used as an energy source by the brain when blood glucose is low. Blood levels of 3-hydroxybutyric acid levels may be monitored in diabetic patients to look for diabetic ketoacidosis. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing mammals. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for the synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for the synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first two weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmitoylphosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391). 3-Hydroxybutyric acid is found to be associated with fumarase deficiency and medium-chain acyl-CoA dehydrogenase deficiency, which are inborn errors of metabolism. 3-Hydroxybutyric acid is a metabolite of Alcaligenes and can be produced from plastic metabolization or incorporated into polymers, depending on the species (PMID: 7646009, 18615882).",
         "The R-enantiomer of 3-hydroxybutyric acid. Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics. It is a sex pheremone in the European spider Linyphia triangularis."
        ],
        [
         "6",
         "BMG_MT000007",
         "Deoxyuridine, also known as dU, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group. Deoxyuridine exists in all living organisms, ranging from bacteria to humans. Within humans, deoxyuridine participates in a number of enzymatic reactions. In particular, deoxyuridine can be biosynthesized from deoxycytidine through its interaction with the enzyme cytidine deaminase. In addition, deoxyuridine can be converted into uracil and deoxyribose 1-phosphate through its interaction with the enzyme thymidine phosphorylase. Deoxyuridine is considered to be an antimetabolite that is converted into deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies. In humans, deoxyuridine is involved in the metabolic disorder called UMP synthase deficiency (orotic aciduria). Outside of the human body, deoxyuridine has been detected, but not quantified in, several different foods, such as lichee, highbush blueberries, agaves, macadamia nut (M. tetraphylla), and red bell peppers. This could make deoxyuridine a potential biomarker for the consumption of these foods.",
         "A pyrimidine 2'-deoxyribonucleoside having uracil as the nucleobase."
        ],
        [
         "7",
         "BMG_MT000008",
         "Deoxycytidine, also known as dC, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. Deoxycytidine is also classified as a deoxyribonucleoside, a component of deoxyribonucleic acid (DNA). Deoxycytidine is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the 2' position. Deoxycytidine exists in all living species, ranging from bacteria to plants to humans. Degradation of DNA through apoptosis or cell death produces deoxycytidine. Within humans, deoxycytidine participates in a number of enzymatic reactions. In particular, deoxycytidine can be biosynthesized from dCMP through the action of the enzyme cytosolic purine 5'-nucleotidase. In addition, deoxycytidine can be converted into dCMP; which is mediated by the enzyme uridine-cytidine kinase-like 1. Deoxycytidine can be phosphorylated at the C-5 position by the enzyme deoxycytidine kinase to produce deoxycytidine monophosphate (dCMP), and to a lesser extent, deoxycytidine diphosphate (dCDP), and deoxycytidine triphosphate (dCTP). Deoxycytidine can also be phosphorylated by thymidine kinase 2 (TK2). Deoxycytidine can potentially be used for the treatment of the metabolic disorder known as thymidine kinase 2 deficiency (TK2 deficiency). TK2 deficiency has three disease subtypes: i) infantile-onset myopathy with rapid progression to early death ii) childhood-onset myopathy, which resembles spinal muscular atrophy (SMA) type III, begins between ages 1 and 12 years with progression to loss of ambulation within few years and iii) late-onset myopathy starting at age 12 year or later with moderate to severe myopathy manifesting as either isolated chronic progressive external ophthalmoplegia (CPEO) or a generalized myopathy with CPEO plus facial and limb weakness, gradual progression, and, in some cases, respiratory failure and loss of ability to walk in adulthood (PMID: 28318037). In mouse models of TK2, dC was shown to delay disease onset, prolong life span and restore mtDNA copy number as well as respiratory chain enzyme activities (PMID: 28318037).",
         "A pyrimidine 2'-deoxyribonucleoside having cytosine as the nucleobase."
        ],
        [
         "8",
         "BMG_MT000009",
         "Cortexolone, also known as cortodoxone or 11-deoxycortisol, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, cortexolone is considered to be a steroid molecule. Cortexolone is an endogenous glucocorticoid steroid hormone, and a metabolic intermediate in the synthesis of cortisol. It was first described by Tadeusz Reichstein in 1938 and named as Substance S. It has also been referred to as Reichstein's Substance S or Compound S. Cortexolone acts as a glucocorticoid, though it is less potent than cortisol. Cortexolone is synthesized from 17Å’Â±-hydroxyprogesterone by 21-hydroxylase and is converted to cortisol by 11Å’â‰¤-hydroxylase. As a result, the level of cortexolone is often measured in patients to diagnose impaired cortisol synthesis, to identify any enzyme deficiency that may be causing impairment along the pathway to cortisol, and to differentiate adrenal disorders. Cortexolone in mammals has limited biological activity and mainly acts as metabolic intermediate within the glucocorticoid pathway, leading to cortisol. On the other hand, in sea lampreys, cortexolone is the major glucocorticoid, with mineralocorticoid activity. Cortexolone in sea lampreys binds to specific corticosteroid receptors and is involved in intestinal osmoregulation and in sea lamprey at metamorphosis, a process in which they develop seawater tolerance before downstream migration.",
         "A deoxycortisol that is cortisol in which the hydroxy group at position 11 has been replaced by a hydrogen."
        ],
        [
         "9",
         "BMG_MT000010",
         "11-Deoxycorticosterone (also called desoxycortone, 21-hydroxyprogesterone, DOC, or simply deoxycorticosterone) is a steroid hormone produced by the adrenal gland that possesses mineralocorticoid activity and acts as a precursor to aldosterone. It is classified as a member of the 21-hydroxysteroids. 21-hydroxysteroids are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Deoxycorticosterone is very hydrophobic, practically insoluble (in water), and relatively neutral. Deoxycorticosterone can be synthesized from progesterone by 21-beta-hydroxylase and is then converted to corticosterone by 11-beta-hydroxylase. Corticosterone is then converted to aldosterone by aldosterone synthase. Deoxycorticosterone stimulates the collecting tubules in the kidney to continue to excrete potassium in much the same way that aldosterone does. Deoxycorticosterone has about 1/20 of the sodium retaining power of aldosterone and about 1/5 the potassium excreting power of aldosterone (Wikipedia). Deoxycorticosterone can be found throughout all human tissues and has been detected in amniotic fluid and blood. When present in sufficiently high levels, deoxycorticosterone can act as a hypertensive agent and a metabotoxin. A hypertensive agent increases blood pressure and causes the production of more urine. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels.  Chronically high levels of deoxycorticosterone are associated with congenital adrenal hyperplasia (CAH) and with adrenal tumors producing deoxycorticosterone (PMID: 20671982). High levels of this mineralocorticoid are associated with resistant hypertension, which can result in polyuria, polydipsia, increased blood volume, edema, and cardiac enlargement. Deoxycorticosterone can be used to treat adrenal insufficiency. In particular, desoxycorticosterone acetate (DOCA) is used as replacement therapy in Addison's disease.",
         "A mineralocorticoid that is progesterone substituted at position 21 by a hydroxy group."
        ],
        [
         "10",
         "BMG_MT000011",
         "4-Pyridoxic acid is a member of the class of compounds known as methylpyridines. More specifically it is a 2-methylpyridine derivative substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. 4-Pyridoxic acid is the catabolic product of vitamin B6 (also known as pyridoxine, pyridoxal and pyradoxamine) and is excreted in the urine. Urinary levels of 4-pyridoxic acid are lower in females than in males and will be reduced even further in persons with a riboflavin deficiency. 4-Pyridoxic acid is formed by the action of aldehyde oxidase I (an endogenous enzyme) and by microbial enzymes (pyridoxal 4-dehydrogenase), an NAD-dependent aldehyde dehydrogenase. 4-pyridoxic acid can be further broken down by the gut microflora via the enzyme known as 4-pyridoxic acid dehydrogenase. This enzyme catalyzes the four-electron oxidation of 4-pyridoxic acid to 3-hydroxy-2-methylpyridine-4,5-dicarboxylate, using nicotinamide adenine dinucleotide (NAD) as a cofactor.",
         "A methylpyridine that is 2-methylpyridine substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. It is the catabolic product of vitamin B6 and is excreted in the urine."
        ],
        [
         "11",
         "BMG_MT000012",
         "alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of alpha-ketoisovaleric acid are associated with maple syrup urine disease. MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma.  In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465). alpha-Ketoisovaleric acid is a keto-acid, which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated MSUD. Many affected children with organic acidemias experience intellectual disability or delayed development.",
         "A 2-oxo monocarboxylic acid that is the 2-oxo derivative of isovaleric acid."
        ],
        [
         "12",
         "BMG_MT000013",
         "p-Hydroxyphenylacetic acid, also known as 4-hydroxybenzeneacetate, is classified as a member of the 1-hydroxy-2-unsubstituted benzenoids. 1-Hydroxy-2-unsubstituted benzenoids are phenols that are unsubstituted at the 2-position. p-Hydroxyphenylacetic acid is considered to be slightly soluble (in water) and acidic.Â  p-Hydroxyphenylacetic acid can be synthesized from acetic acid. It is also a parent compound for other transformation products, including but not limited to, methyl 2-(4-hydroxyphenyl)acetate, ixerochinolide, and lactucopicrin 15-oxalate.Â  p-Hydroxyphenylacetic acid can be found in numerous foods such as olives, cocoa beans, oats, and mushrooms. p-Hydroxyphenylacetic acid can be found throughout all human tissues and in all biofluids. Within a cell, p-hydroxyphenylacetic acid is primarily located in the cytoplasm and in the extracellular space. p-Hydroxyphenylacetic acid is also a microbial metabolite produced by Acinetobacter, Clostridium, Klebsiella, Pseudomonas, and Proteus. Higher levels of this metabolite are associated with an overgrowth of small intestinal bacteria from Clostridia species including C. difficile, C. stricklandii, C. lituseburense, C. subterminale, C. putrefaciens, and C. propionicum (PMID: 476929, 12173102). p-Hydroxyphenylacetic acid is detected after the consumption of whole grain.",
         "A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group."
        ],
        [
         "13",
         "BMG_MT000014",
         "Iodotyrosine is an iodated derivative of L-tyrosine. This is an early precursor to L-thyroxine, one of the primary thyroid hormones. In the thyroid gland, iodide is trapped, transported, and concentrated in the follicular lumen for thyroid hormone synthesis. Before trapped iodide can react with tyrosine residues, it must be oxidized by thyroid peroxidase. Iodotyrosine is made from tyrosine via thyroid peroxidase and then further iodinated by this enzyme to make the di-iodo and tri-iodo variants. Two molecules of di-iodotyrosine combine to form T4, and one molecule of mono-iodotyrosine combines with one molecule of di-iodotyrosine to form T3.",
         "The monoiodotyrosine that is L-tyrosine carrying an iodo-substituent at position C-3 of the benzyl group."
        ],
        [
         "14",
         "BMG_MT000015",
         "3-methoxytyramine, also known as 4-(2-amino-Ethyl)-2-methoxy-phenol or 3-O-Methyldopamine, is classified as a member of the Methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. 3-methoxytyramine is considered to be slightly soluble (in water) and acidic.  3-methoxytyramine can be found primarily in human brain and most tissues tissues; and in blood, cerebrospinal fluid (csf) or urine. Within a cell, 3-methoxytyramine is primarily located in the cytoplasm",
         "A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas."
        ],
        [
         "15",
         "BMG_MT000016",
         "(S)-3-Hydroxyisobutyric acid (3-HIBA) (CAS: 2068-83-9) is an organic acid. 3-HIBA is an intermediate in L-valine metabolism. 3-HIBA plays an important role in the diagnosis of the very rare inherited metabolic diseases 3-hydroxyisobutyric aciduria (OMIM: 236795) and methylmalonic semialdehyde dehydrogenase deficiency (OMIM: 603178). Patients with 3-hydroxyisobutyric aciduria excrete a significant amount of 3-HIBA not only during the acute stage but also when stable. 3-Hydroxyisobutyric aciduria is caused by a 3-hydroxyisobutyryl-CoA dehydrogenase deficiency (PMID: 18329219). The severity of this disease varies from case to case. Most patients exhibit dysmorphic features, such as a small triangular face, a long philtrum, low set ears, and micrognathia (PMID: 10686279). Lactic acidemia is also found in the affected patients, indicating that mitochondrial dysfunction is involved. 3-HIBA appears to specifically inhibit the function of the respiratory chain complex I-III and mitochondrial creatine kinase (PMID: 18329219). BioTransformer predicts that 3-HIBA is a product of 2-methylpropanoic acid metabolism via a hydroxylation-of-terminal-methyl reaction catalyzed by CYP2B6 and CYP2E1 enzymes (PMID: 30612223).",
         "A 3-hydroxyisobutyric acid that has formula C4H8O3."
        ],
        [
         "16",
         "BMG_MT000017",
         "3-O-Sulfogalactosylceramide is an acidic, sulfated glycosphingolipid, often known as sulfatide. This lipid occurs in membranes of various cell types, but is found in particularly high concentrations in myelin where it constitutes 3-4% of total membrane lipids. This lipid is synthesized primarily in the oligodendrocytes in the central nervous system. Accumulation of this lipid in the lysosomes is a characteristic of metachromatic leukodystrophy, a lysosomal storage disease caused by the deficiency of arylsulfatase A. Alterations in sulfatide metabolism, trafficking, and homeostasis are present in the earliest clinically recognizable stages of Alzheimer's disease. Cerebrosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Cerebrosides have a single sugar group linked to ceramide. The most common are galactocerebrosides (containing galactose), the least common are glucocerebrosides (containing glucose). Galactocerebrosides are found predominantly in neuronal cell membranes. In contrast glucocerebrosides are not normally found in membranes. Instead, they are typically intermediates in the synthesis or degradation of more complex glycosphingolipids. Galactocerebrosides are synthesized from ceramide and UDP-galactose. Excess lysosomal accumulation of glucocerebrosides is found in Gaucher disease. Sulfatides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Sulfatides are the sulfuric acid esters of galactocerebrosides. They are synthesized from galactocerebrosides and activated sulfate, 3'-phosphoadenosine 5'-phosphosulfate (PAPS).",
         null
        ],
        [
         "17",
         "BMG_MT000018",
         "Ureidopropionic acid, also known as 3-ureidopropanoate or N-carbamoyl-beta-alanine, belongs to the class of organic compounds known as ureas. Ureas are compounds containing two amine groups joined by a carbonyl (C=O) functional group. Ureidopropionic acid is an intermediate in the metabolism of uracil. More specifically, it is a breakdown product of dihydrouracil and is produced by the enzyme dihydropyrimidase. It is further decomposed into beta-alanine via the enzyme beta-ureidopropionase. Ureidopropionic acid is essentially a urea derivative of beta-alanine. High levels of ureidopropionic acid are found in individuals with beta-ureidopropionase (UP) deficiency (PMID: 11675655). Enzyme deficiencies in pyrimidine metabolism are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil. Ureidopropionic acid has been detected, but not quantified in, several different foods, such as gram beans, broccoli, climbing beans, oriental wheat, and mandarin orange (clementine, tangerine). This could make ureidopropionic acid a potential biomarker for the consumption of these foods.",
         "A beta-alanine derivative that is propionic acid bearing a ureido group at position 3."
        ],
        [
         "18",
         "BMG_MT000019",
         "Tetrahydrobiopterin (CAS: 17528-72-2), also known as BH4, is an essential cofactor in the synthesis of neurotransmitters and nitric oxide (PMID: 16946131). In fact, it is used by all three human nitric-oxide synthases (NOS) eNOS, nNOS, and iNOS as well as the enzyme glyceryl-ether monooxygenase. It is also essential in the conversion of phenylalanine into tyrosine by the enzyme phenylalanine-4-hydroxylase; the conversion of tyrosine into L-dopa by the enzyme tyrosine hydroxylase; and the conversion of tryptophan into 5-hydroxytryptophan via tryptophan hydroxylase. Specifically, tetrahydrobiopterin is a cofactor for tryptophan 5-hydroxylase 1, tyrosine 3-monooxygenase, and phenylalanine hydroxylase, all of which are essential for the formation of the neurotransmitters dopamine, noradrenaline, and adrenaline. Tetrahydrobiopterin has been proposed to be involved in the promotion of neurotransmitter release in the brain and the regulation of human melanogenesis. A defect in BH4 production and/or a defect in the enzyme dihydropteridine reductase (DHPR) causes phenylketonuria type IV, as well as dopa-responsive dystonias. BH4 is also implicated in Parkinson's disease, Alzheimer's disease, and depression. Tetrahydrobiopterin is present in probably every cell or tissue of higher animals. On the other hand, most bacteria, fungi and plants do not synthesize tetrahydrobiopterin (Wikipedia).",
         "A tetrahydropterin that is 2-amino-5,6,7,8-tetrahydropteridin-4(3H)-one in which a hydrogen at position 6 is substituted by a 1,2-dihydroxypropyl group (6R,1'R,2'S-enantiomer)."
        ],
        [
         "19",
         "BMG_MT000020",
         "Biotin is an enzyme co-factor present in minute amounts in every living cell. Biotin is also known as coenzyme R and vitamin H or B7. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Biotin has been recognized as an essential nutrient. Humans fulfill their biotin requirement through their diet through endogenous reutilization of biotin and perhaps through the capture of biotin generated in the intestinal flora. The utilization of biotin for covalent attachment to carboxylases and its reutilization through the release of carboxylase biotin after proteolytic degradation constitutes the 'biotin cycle'. Biotin deficiency is associated with neurological manifestations, skin rash, hair loss, and metabolic disturbances that are thought to relate to the various carboxylase deficiencies (metabolic ketoacidosis with lactic acidosis). It has also been suggested that biotin deficiency is associated with protein malnutrition, and that marginal biotin deficiency in pregnant women may be teratogenic. Biotin acts as a carboxyl carrier in carboxylation reactions. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC), and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a lysine residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. Evidence is emerging that biotin participates in processes other than classical carboxylation reactions. Specifically, novel roles for biotin in cell signalling, gene expression, and chromatin structure have been identified in recent years. Human cells accumulate biotin by using both the sodium-dependent multivitamin transporter and monocarboxylate transporter 1. These transporters and other biotin-binding proteins partition biotin to compartments involved in biotin signalling: cytoplasm, mitochondria, and nuclei. The activity of cell signals such as biotinyl-AMP, Sp1 and Sp3, nuclear factor (NF)-kappaB, and receptor tyrosine kinases depends on biotin supply. Consistent with a role for biotin and its catabolites in modulating these cell signals, greater than 2000 biotin-dependent genes have been identified in various human tissues. Many biotin-dependent gene products play roles in signal transduction and localize to the cell nucleus, consistent with a role for biotin in cell signalling. Posttranscriptional events related to ribosomal activity and protein folding may further contribute to the effects of biotin on gene expression. Finally, research has shown that biotinidase and holocarboxylase synthetase mediate covalent binding of biotin to histones (DNA-binding proteins), affecting chromatin structure; at least seven biotinylation sites have been identified in human histones. Biotinylation of histones appears to play a role in cell proliferation, gene silencing, and the cellular response to DNA repair. Roles for biotin in cell signalling and chromatin structure are consistent with the notion that biotin has a unique significance in cell biology (PMID: 15992684, 16011464).",
         "An organic heterobicyclic compound that consists of 2-oxohexahydro-1H-thienoimidazole having a valeric acid substituent attached to the tetrahydrothiophene ring. The parent of the class of biotins."
        ],
        [
         "20",
         "BMG_MT000021",
         "Androsterone is an inactive breakdown metabolite of testosterone, the product of a reaction mediated by the enzyme oxidative 17beta-hydroxysteroid dehydrogenase (EC 1.1.1.51, 17beta-HSD). Androsterone can also be metabolized from other adrenal androgens such as dehydroepiandrosterone, dihydrotestosterone, or androstenedione, and is considered an inactive end product. However, it can be a physiological effector in its own right. Androsterone might be converted back to dihydrotestosterone. Humans (and other primates) are unique among mammals in having high levels of circulating androsterone glucuronide, a process that is the major role of uridine-diphospho-glucuronosyltransferase enzymes (EC 2.4.1.17, UGT) for glucuronidation of steroid metabolism in humans. Conjugation of androsterone is a pathway found in all vertebrates and it is widely recognized that the liver is a major site of glucuronidation. However, it is now clear that extrahepatic tissues are also involved in the conjugation of compounds to which these tissues are exposed. High levels of androsterone glucuronide found in the human prostate, breast cyst fluid, and ovary follicular fluid suggest that glucuronidation of 5alpha-reduced C19 steroids occurs in these tissues as well. In doping control, the ratio of androsterone/etiocholanolone provides valuable information that allows the assignment of a urine specimen to a particular person or the identification of urine samples with identical steroid profiles; this is particularly important to detect attempts of urine manipulation including urine alteration and substitution (PMID: 9188497, 17017935, 14643063, 12943709, 9699884, 17260133).",
         "An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone ."
        ],
        [
         "21",
         "BMG_MT000022",
         "7-Dehydrocholesterol (7-DHC), also known as provitamin D3 or 5,7-cholestadien-3-b-ol, belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. Thus, 7-dehydrocholesterol is also classified as a sterol. 7-Dehydrocholesterol is known as a zoosterol, meaning that it is a sterol isolated from animals (to distinguish those sterols isolated from plants which are called phytosterols). 7-DHC functions in the serum as a cholesterol precursor and is photochemically converted to vitamin D3 in the skin. Therefore 7-DHC functions as provitamin-D3. The presence of 7-DHC in human skin enables humans and other mammals to manufacture vitamin D3 (cholecalciferol) from ultraviolet rays in the sun light, via an intermediate isomer pre-vitamin D3. 7-DHC absorbs UV light most effectively at wavelengths between 290 and 320 nm and, thus, the production of vitamin D3 will occur primarily at those wavelengths (PMID: 9625080).  The two most important factors that govern the generation of pre-vitamin D3 are the quantity (intensity) and quality (appropriate wavelength) of the UVB irradiation reaching the 7-dehydrocholesterol deep in the stratum basale and stratum spinosum (PMID: 9625080). 7-DHC is also found in the milk of several mammalian species, including cows (PMID: 10999630; PMID: 225459). It was discovered by Nobel-laureate organic chemist Adolf Windaus. 7-DHC can be produced by animals and plants via different pathways (PMID: 23717318). It is not produced by fungi in significant amounts. 7-DHC is made by some algae and can also be produced by some bacteria.",
         "A Delta(5),Delta(7)-sterol that has formula C27H44O."
        ],
        [
         "22",
         "BMG_MT000023",
         "Carnosine, which is also known as beta-alanyl-L-histidine) is a dipeptide consisting of the amino acids beta-alanine and histidine. It is found exclusively in animal tissues and is naturally produced in the body by the liver. Carnosine has a pKa value of 6.83, making it a good buffer for the pH range of animal muscles.  Since beta-alanine is a non-proteogenic amino acid and is not incorporated into proteins, carnosine can be stored at relatively high concentrations (millimolar) in muscles, with concentrations as high as 17â€šÃ„Ã¬25 mmol/kg (dry muscle). Carnosine is also highly concentrated in brain tissues. Carnosine has been shown to scavenge reactive oxygen species (ROS) as well as alpha-beta unsaturated aldehydes formed from peroxidation of fatty acids during oxidative stress. The antioxidant mechanism of carnosine is attributed to its chelating effect against divalent metal ions, superoxide dismutase (SOD)-like activity, as well as its ROS and free radicals scavenging ability (PMID: 16406688). Carnosine also buffers muscle cells, and acts as a neurotransmitter in the brain. Carnosine has the potential to suppress many of the biochemical changes that accompany ageing (e.g. protein oxidation, glycation, AGE formation, and cross-linking) and associated pathologies (PMID: 16804013). Some autistic patients take carnosine as a dietary supplement and attribute an improvement in their condition to it. Supplemental carnosine may increase corticosterone levels. This may explain the \"hyperactivity\" seen in autistic subjects at higher doses. A positive association between muscle tissue carnosine concentration and exercise performance has been found. Å’â‰¤-Alanine supplementation is thought increase exercise performance by promoting carnosine production in muscle. Exercise has conversely been found to increase muscle carnosine concentrations, and muscle carnosine content is higher in athletes engaging in anaerobic exercise. Carnosine is also a biomarker for the consumption of meat. Elevated levels of urinary and plasma carnosine are associated with carnosinuria (also known as carnosinemia), which is an inborn error of metabolism. caused by a deficiency of the enzyme carnosinase. Carnosinas cleaves carnosine into its constituent amino acids: Å’â‰¤-Alanine and histidine. Carnonsinemia results in an excess of carnosine in the urine, cerebrospinal fluid, blood, and nervous tissue. A variety of neurological symptoms have been associated with carnosinemia. They include: hypotonia, developmental delay, mental retardation, degeneration of axons, sensory neuropathy, tremors, demyelinization, gray matter anomalies, myoclonic seizures, and loss of purkinje fibers.",
         "A dipeptide that is the N-(beta-alanyl) derivative of L-histidine."
        ],
        [
         "23",
         "BMG_MT000024",
         "Adenine is a purine base. Adenine is found in both DNA and RNA. Adenine is a fundamental component of adenine nucleotides. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300). (PMID: 17052198, 17520339).",
         "The parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6."
        ],
        [
         "24",
         "BMG_MT000025",
         "Taurocholic acid is a bile acid and is the product of the conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Taurocholic acid, as with all bile acids, acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic (a bile purging agent). Hydrolysis of taurocholic acid yields taurine, a nonessential amino acid. Taurocholic acid is one of the main components of urinary nonsulfated bile acids in biliary atresia. Raised levels of taurocholate in fetal serum in obstetric cholestasis may result in the development of a fetal dysrhythmia and sudden intra-uterine death (PMID: 3944741, 11256973).",
         "A bile acid taurine conjugate of  cholic acid that usually occurs as the sodium salt of bile in mammals."
        ],
        [
         "25",
         "BMG_MT000026",
         "Aldosterone is a steroid hormone produced by the adrenal cortex in the adrenal gland to regulate sodium and potassium balance in the blood. Specifically, it regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. It is synthesized from cholesterol by aldosterone synthase, which is absent in other sections of the adrenal gland. It is the sole endogenous member of the class of mineralocorticoids. Aldosterone increases the permeability of the apical (luminal) membrane of the kidney's collecting ducts to potassium and sodium and activates their basolateral Na+/K+ pumps, stimulating ATP hydrolysis, reabsorbing sodium (Na+) ions and water into the blood, and excreting potassium (K+) ions into the urine.",
         "A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney."
        ],
        [
         "26",
         "BMG_MT000027",
         "Dihydrobiopterin, also known as BH2, 7,8-dihydrobiopterin, L-erythro-7,8-dihydrobiopterin, quinonoid dihydrobiopterin or q-BH2, belongs to the class of organic compounds known as biopterins and derivatives. These are coenzymes containing a 2-amino-pteridine-4-one derivative. Dihydrobiopterin is also classified as a pteridine. Pteridines are aromatic compounds composed of fused pyrimidine and pyrazine rings. Dihydrobiopterin is produced during the synthesis of neurotransmitters L-DOPA, dopamine, norepinephrine and epinephrine. It is restored to the required cofactor tetrahydrobiopterin via the NADPH-dependant reduction of dihydrobiopterin reductase. Dihydrobiopterin can also be converted to tetrahydrobiopterin by nitric oxide synthase (NOS) which is catalyzed by the flavoprotein \"diaphorase\" activity of NOS. This activity is located on the reductase (C-terminal) domain of NOS, whereas the high affinity tetrahydrobiopterin site involved in NOS activation is located on the oxygenase (N-terminal) domain (PMID: 8626754). Sepiapterin reductase (SPR) is another enzyme that plays a role in the production of dihydrobiopterin. SPR catalyzes the reduction of sepiapterin to dihydrobiopterin (BH2), the precursor for tetrahydrobiopterin (BH4). BH4 is a cofactor critical for nitric oxide biosynthesis and alkylglycerol and aromatic amino acid metabolism (PMID: 25550200). Dihydrobiopterin is known to be synthesized in several parts of the body, including the pineal gland. Dihydrobiopterin exists in all eukaryotes, ranging from yeast to humans. In humans, dihydrobiopterin is involved in several metabolic disorders including dihydropteridine reductase (DHPR) deficiency. DHPR deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4) leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties. Dihydrobiopterin is also associated with another metabolic disorder known as sepiapterin reductase deficiency (SRD). Sepiapterin reductase catalyzes the (NADP-dependent) reduction of carbonyl derivatives, including pteridines, and plays an important role in tetrahydrobiopterin biosynthesis. Low dihydrofolate reductase activity in the brain leads to the accumulation of dihydrobiopterin, which in turn, inhibits tyrosine and tryptophan hydroxylases. This uncouples neuronal nitric oxide synthase, leading to neurotransmitter deficiencies and neuronal cell death. SRD is characterized by low cerebrospinal fluid neurotransmitter levels and the presence of elevated cerebrospinal fluid dihydrobiopterin. SRD is characterized by motor delay, axial hypotonia, language delay, diurnal fluctuation of symptoms, dystonia, weakness, oculogyric crises, dysarthria, parkinsonian signs and hyperreflexia.",
         "A 7,8-dihydrobiopterin in which the 1,2-dihydroxypropyl group has (1R,2S)-configuration; naturally occurring form."
        ],
        [
         "27",
         "BMG_MT000028",
         "Butyric acid is a short-chain fatty acid (SCFA) formed in the mammalian colon by bacterial fermentation of carbohydrates (including dietary fibre). It is a straight-chain alkyl carboxylic acid that appears as an oily, colorless liquid with an unpleasant (rancid butter) odor. The name butyric acid comes from the Greek word for \"butter\", the substance in which it was first found. Triglycerides of butyric acid constitute 3â€šÃ„Ã¬4% of butter. When butter goes rancid, butyric acid is liberated from the short-chain triglycerides via hydrolysis. Butyric acid is a widely distributed SCFA and is found in all organisms ranging from bacteria to plants to animals. It is present in animal fat and plant oils, bovine milk, breast milk, butter, parmesan cheese, body odor and vomit. While butyric acid has an unpleasant odor, it does have a pleasant buttery taste. As a result, butyric acid is used as a flavoring agent in food manufacturing. Low-molecular-weight esters of butyric acid, such as methyl butyrate, also have very pleasant aromas or tastes. As a result, several butyrate esters are used as food and perfume additives. Butyrate is naturally produced by fermentation processes performed by obligate anaerobic bacteria found in the mammalian gut. It is a metabolite of several bacterial genera including Anaerostipes, Coprococcus, Eubacterium, Faecalibacterium and Roseburia (PMID: 12324374; PMID: 27446020). Highly-fermentable fiber residues, such as those from resistant starch, oat bran, pectin, and guar can be transformed by colonic bacteria into butyrate. One study found that resistant starch consistently produces more butyrate than other types of dietary fibre (PMID: 14747692). The production of butyrate from fibres in ruminant animals such as cattle is responsible for the butyrate content of milk and butter. Butyrate has a number of important biological functions and binds to several specific receptors. In humans, butyric acid is one of two primary endogenous agonists of human hydroxycarboxylic acid receptor 2 (HCA2), a G protein-coupled receptor. Like other SCFAs, butyrate is also an agonist at the free fatty acid receptors FFAR2 and FFAR3, which function as nutrient sensors that facilitate the homeostatic control of energy balance. Butyrate is essential to host immune homeostasis (PMID: 25875123). Butyrate's effects on the immune system are mediated through the inhibition of class I histone deacetylases (specifically, HDAC1, HDAC2, HDAC3, and HDAC8) and activation of its G-protein coupled receptor targets including HCA2, FFAR2 and FFAR3. Among the short-chain fatty acids, butyrate is the most potent promoter of intestinal regulatory T cells in vitro and the only SCFA that is an HCA2 ligand (PMID: 25741338). Butyrate has been shown to be a critical mediator of the colonic inflammatory response. It possesses both preventive and therapeutic potential to counteract inflammation-mediated ulcerative colitis and colorectal cancer. As a short-chain fatty acid, butyrate is metabolized by mitochondria as an energy source through fatty acid metabolism. In particular, it is an important energy source for cells lining the mammalian colon (colonocytes). Without butyrate, colon cells undergo autophagy (i.e., self-digestion) and die.",
         "A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group."
        ],
        [
         "28",
         "BMG_MT000029",
         "Acetic acid is a two-carbon, straight-chain fatty acid. It is the smallest short-chain fatty acid (SCFA) and one of the simplest carboxylic acids. is an acidic, colourless liquid and is the main component in vinegar. Acetic acid has a sour taste and pungent smell. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. Acetic acid is found in all organisms, from bacteria to plants to humans. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A (to form acetylCoA) it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted in large amounts by certain acetic acid bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil. Due to their widespread presence on fruit, acetic acid is produced naturally as fruits and many other sugar-rich foods spoil. Several species of anaerobic bacteria, including members of the genus Clostridium and Acetobacterium can convert sugars to acetic acid directly. However, Clostridium bacteria are less acid-tolerant than Acetobacter. Even the most acid-tolerant Clostridium strains can produce acetic acid in concentrations of only a few per cent, compared to Acetobacter strains that can produce acetic acid in concentrations up to 20%. Acetic acid is also a component of the vaginal lubrication of humans and other primates, where it appears to serve as a mild antibacterial agent. Acetic acid can be found in other biofluids such as urine at low concentrations. Urinary acetic acid is produced by bacteria such as Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Enterobacter, Acinetobacter, Proteus mirabilis, Citrobacter frundii, Enterococcus faecalis, Streptococcus group B, Staphylococcus saprophyticus (PMID: 22292465). Acetic acid concentrations greater than 30 uM/mM creatinine in the urine can indicate a urinary tract infection, which typically suggests the presence of E. coli or Klebshiella pneumonia in the urinary tract. (PMID: 24909875) Acetic acid is also produced by other bacteria such as Akkermansia, Bacteroidetes, Bifidobacterium, Prevotella and Ruminococcus (PMID: 20444704; PMID: 22292465).",
         "A simple monocarboxylic acid containing two carbons."
        ],
        [
         "29",
         "BMG_MT000030",
         "Betaine (CAS: 107-43-7), also known as N,N,N-trimethylglycine, was named after its discovery in sugar beet (Beta vulgaris) in the 19th century. It is a small N-trimethylated amino acid, existing in zwitterionic form at neutral pH. It is now often called glycine betaine to distinguish it from other betaines that are widely distributed in microorganisms, plants, and animals. Many naturally occurring betaines serve as organic osmolytes, substances synthesized or taken up from the environment by cells for protection against osmotic stress, drought, high salinity, or high temperature. Intracellular accumulation of betaines permits water retention in cells, thus protecting from the effects of dehydration (Wikipedia). Betaine functions as a methyl donor in that it carries and donates methyl functional groups to facilitate necessary chemical processes. In particular, it methylates homocysteine to methionine, also producing N,N-dimethylglycine. The donation of methyl groups is important to proper liver function, cellular replication, and detoxification reactions. Betaine also plays a role in the manufacture of carnitine and serves to protect the kidneys from damage. Betaine comes from either the diet or by the oxidation of choline. Betaine insufficiency is associated with metabolic syndrome, lipid disorders, and diabetes, and may have a role in vascular and other diseases (PMID: 20346934). Betaine is important in development, from the pre-implantation embryo to infancy. Betaine is also widely regarded as an anti-oxidant. Betaine has been shown to have an inhibitory effect on NO release in activated microglial cells and may be an effective therapeutic component to control neurological disorders (PMID: 22801281). As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances (Martindale, The Extra Pharmacopoeia, 30th Ed, p1341).",
         "A quaternary ammonium ion in which the substituents on nitrogen are methyl (three) and carboxymethyl."
        ],
        [
         "30",
         "BMG_MT000031",
         "Ascorbic acid is found naturally in citrus fruits and many vegetables and is an essential nutrient in human diets. It is necessary to maintain connective tissue and bone. The biologically active form of ascorbic acid is vitamin C. Vitamin C is a water soluble vitamin. Primates (including humans) and a few other species in all divisions of the animal kingdom, notably the guinea pig, have lost the ability to synthesize ascorbic acid and must obtain it in their food. Vitamin C functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant (PubChem). Ascorbic acid is an electron donor for enzymes involved in collagen hydroxylation, biosynthesis of carnitine and norepinephrine, tyrosine metabolism, and amidation of peptide hormones. Ascrobic acid (vitamin C) deficiency causes scurvy. The amount of vitamin C necessary to prevent scurvy may not be adequate to maintain optimal health. The ability of vitamin C to donate electrons also makes it a potent water-soluble antioxidant that readily scavenges free radicals such as molecular oxygen, superoxide, hydroxyl radical, and hypochlorous acid. In this setting, several mechanisms could account for a link between vitamin C and heart disease. One is the relation between LDL oxidation and vitamins C and E. Vitamin C in vitro can recycle vitamin E, which can donate electrons to prevent LDL oxidation in vitro. As the lipid-phase vitamin E is oxidized, it can be regenerated by aqueous vitamin C. Other possibilities are that vitamin C could decrease cholesterol by mechanisms not well characterized, or could improve vasodilatation and vascular reactivity, perhaps by decreasing the interactions of nitric oxide with oxidants (PMID: 10799361). Moreover, ascorbic acid is found to be associated with hyperoxalemia, which is an inborn error of metabolism. Ascorbic acid is also a microbial metabolite produced by Ketogulonicigenium (PMID: 15785002).",
         "The L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate."
        ],
        [
         "31",
         "BMG_MT000032",
         "Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a 'Bitter Blocker' additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem 'sweeter'. This potentially makes lower calorie food products more palatable.",
         "A purine ribonucleoside 5'-monophosphate having adenine as the nucleobase. | A nucleoside 5'-monophosphate(2-) that results from the removal of two protons from the phosphate group of adenosine 5'-monophosphate (AMP)."
        ],
        [
         "32",
         "BMG_MT000033",
         "Melibiose (CAS: 585-99-9) is a disaccharide consisting of one galactose and one glucose moiety in an alpha (1-6) glycosidic linkage. This sugar is produced and metabolized only by enteric and lactic acid bacteria and other microbes, such as Dickeya dadantii, Escherichia, Leuconostoc, and Saccharomyces (PMID: 19734309, 28453942). It is not an endogenous metabolite but may be obtained from the consumption of partially fermented molasses, brown sugar, or honey. Antibodies to melibiose will appear in individuals affected by Chagas' disease (Trypanosoma cruzi infection). Melibiose is not metabolized by humans but can be broken down by gut microflora, such as E. coli. In fact, E. coli is able to utilize melibiose as a sole source of carbon. Melibiose is first imported by the melibiose permease, MelB and then converted into Î²-D-glucose and Î²-D-galactose by the Î±-galactosidase encoded by melA. Because of its poor digestibility, melibiose (along with rhamnose) can be used together for noninvasive intestinal mucosa barrier testing. This test can be used to assess malabsorption or impairment of intestinal permeability. Recent studies with dietary melibiose have shown that it can strongly affect the Th cell responses to an ingested antigen. It has been suggested that melibiose could be used to enhance the induction of oral tolerance (PMID: 17986780).",
         null
        ],
        [
         "33",
         "BMG_MT000034",
         "Adenosine is a nucleoside that is composed of adenine and D-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. For instance, adenosine plays an important role in energy transfer as adenosine triphosphate (ATP) and adenosine diphosphate (ADP). It also plays a role in signal transduction as cyclic adenosine monophosphate (cAMP). Adenosine itself is both a neurotransmitter and potent vasodilator. When administered intravenously adenosine causes transient heart block in the AV node. Due to the effects of adenosine on AV node-dependent supraventricular tachycardia, adenosine is considered a class V antiarrhythmic agent. Overdoses of adenosine intake (as a drug) can lead to several side effects including chest pain, feeling faint, shortness of breath, and tingling of the senses. Serious side effects include a worsening dysrhythmia and low blood pressure. When present in sufficiently high levels, adenosine can act as an immunotoxin and a metabotoxin. An immunotoxin disrupts, limits the function, or destroys immune cells. A metabotoxin is an endogenous metabolite that causes adverse health effects at chronically high levels. Chronically high levels of adenosine are associated with adenosine deaminase deficiency. Adenosine is a precursor to deoxyadenosine, which is a precursor to dATP. A buildup of dATP in cells inhibits ribonucleotide reductase and prevents DNA synthesis, so cells are unable to divide. Since developing T cells and B cells are some of the most mitotically active cells, they are unable to divide and propagate to respond to immune challenges. High levels of deoxyadenosine also lead to an increase in S-adenosylhomocysteine, which is toxic to immature lymphocytes.",
         "A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond."
        ],
        [
         "34",
         "BMG_MT000035",
         "Ammonia is a colourless alkaline gas and is one of the most abundant nitrogen-containing compounds in the atmosphere. It is an irritant with a characteristic pungent odor that is widely used in industry. Inasmuch as ammonia is highly soluble in water and, upon inhalation, is deposited in the upper airways, occupational exposures to ammonia have commonly been associated with sinusitis, upper airway irritation, and eye irritation. Acute exposures to high levels of ammonia have also been associated with diseases of the lower airways and interstitial lung. Small amounts of ammonia are naturally formed in nearly all tissues and organs of the vertebrate organism. Ammonia is both a neurotoxin and a metabotoxin. In fact, it is the most common endogenous neurotoxin. A neurotoxin is a compound that causes damage to neural tissue and neural cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Ammonia is recognized to be central in the pathogenesis of a brain condition known as hepatic encephalopathy, which arises from various liver diseases and leads to a build up ammonia in the blood (hyperammonemia). More than 40% of people with cirrhosis develop hepatic encephalopathy. Part of the neurotoxicity of ammonia arises from the fact that it easily crosses the blood-brain barrier and is absorbed and metabolized by the astrocytes, a population of cells in the brain that constitutes 30% of the cerebral cortex. Astrocytes use ammonia when synthesizing glutamine from glutamate. The increased levels of glutamine lead to an increase in osmotic pressure in the astrocytes, which become swollen. There is increased activity of the inhibitory gamma-aminobutyric acid (GABA) system, and the energy supply to other brain cells is decreased. This can be thought of as an example of brain edema. The source of the ammonia leading to hepatic encaphlopahy is not entirely clear. The gut produces ammonia, which is metabolized in the liver, and almost all organ systems are involved in ammonia metabolism. Colonic bacteria produce ammonia by splitting urea and other amino acids, however this does not fully explain hyperammonemia and hepatic encephalopathy. The alternative explanation is that hyperammonemia is the result of intestinal breakdown of amino acids, especially glutamine. The intestines have significant glutaminase activity, predominantly located in the enterocytes. On the other hand, intestinal tissues only have a little glutamine synthetase activity, making it a major glutamine-consuming organ. In addition to the intestine, the kidney is an important source of blood ammonia in patients with liver disease. Ammonia is also taken up by the muscle and brain in hepatic coma, and there is confirmation that ammonia is metabolized in muscle. Excessive formation of ammonia in the brains of Alzheimer's disease patients has also been demonstrated, and it has been shown that some Alzheimer's disease patients exhibit elevated blood ammonia concentrations. Ammonia is the most important natural modulator of lysosomal protein processing. Indeed, there is strong evidence for the involvement of aberrant lysosomal processing of beta-amyloid precursor protein (beta-APP) in the formation of amyloid deposits. Inflammatory processes and activation of microglia are widely believed to be implicated in the pathology of Alzheimer's disease. Ammonia is able to affect the characteristic functions of microglia, such as endocytosis, and cytokine production. Based on these facts, an ammonia-based hypothesis for Alzheimer's disease has been suggested (PMID: 17006913, 16167195, 15377862, 15369278). Chronically high levels of ammonia in the blood are associated with nearly twenty different inborn errors of metabolism including: 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, 3-methyl-crotonylglycinuria, argininemia, argininosuccinic aciduria, beta-ketothiolase deficiency, biotinidase deficiency, carbamoyl phosphate synthetase deficiency, carnitine-acylcarnitine translocase deficiency, citrullinemia type I, hyperinsulinism-hyperammonemia syndrome, hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, isovaleric aciduria, lysinuric protein intolerance, malonic aciduria, methylmalonic aciduria, methylmalonic aciduria due to cobalamin-related disorders, propionic acidemia, pyruvate carboxylase deficiency, and short chain acyl CoA dehydrogenase deficiency (SCAD deficiency). Many of these inborn errors of metabolism are associated with urea cycle disorders or impairment to amino acid metabolism. High levels of ammonia in the blood (hyperammonemia) lead to the activation of NMDA receptors in the brain. This results in the depletion of brain ATP, which in turn leads to release of glutamate. Ammonia also leads to the impairment of mitochondrial function and calcium homeostasis, thereby decreasing ATP synthesis. Excess ammonia also increases the formation of nitric oxide (NO), which in turn reduces the activity of glutamine synthetase, and thereby decreases the elimination of ammonia in the brain (PMID: 12020609). As a neurotoxin, ammonia predominantly affects astrocytes. Disturbed mitochondrial function and oxidative stress, factors implicated in the induction of the mitochondrial permeability transition, appear to be involved in the mechanism of ammonia neurotoxicity. Ammonia can also affect the glutamatergic and GABAergic neuronal systems, the two prevailing neuronal systems of the cortical structures. All of these effects can lead to irreversible brain damage, coma, and/or death. Infants with urea cycle disorders and hyperammonia initially exhibit vomiting and increasing lethargy. If untreated, seizures, hypotonia (poor muscle tone, floppiness), respiratory distress (respiratory alkalosis), and coma can occur. Adults with urea cycle disorders and hyperammonia will exhibit episodes of disorientation, confusion, slurred speech, unusual and extreme combativeness or agitation, stroke-like symptoms, lethargy, and delirium. Ammonia also has toxic effects when an individual is exposed to ammonia solutions. Acute exposure to high levels of ammonia in air may be irritating to skin, eyes, throat, and lungs and cause coughing and burns. Lung damage and death may occur after exposure to very high concentrations of ammonia. Swallowing concentrated solutions of ammonia can cause burns in the mouth, throat, and stomach. Splashing ammonia into eyes can cause burns and even blindness.",
         "An azane that consists of a single nitrogen atom covelently bonded to three hydrogen atoms."
        ],
        [
         "35",
         "BMG_MT000036",
         "Arginosuccinic acid is a basic amino acid. Some cells synthesize it from citrulline, aspartic acid and use it as a precursor for arginine in the urea cycle or Citrulline-NO cycle. The enzyme that catalyzes the reaction is argininosuccinate synthetase. Argininosuccinic acid is a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. Defects in the argininosuccinate lyase enzyme can lead to argininosuccinate lyase deficiency, which is an inborn error of metabolism. Argininosuccinate (ASA) lyase deficiency results in defective cleavage of ASA. This leads to an accumulation of ASA in cells and an excessive excretion of ASA in urine (argininosuccinic aciduria). In virtually all respects, this disorder shares the characteristics of other urea cycle defects. The most important characteristic of ASA lyase deficiency is its propensity to cause hyperammonemia in affected individuals. ASA in affected individuals is excreted by the kidney at a rate practically equivalent to the glomerular filtration rate (GFR). Whether ASA itself causes a degree of toxicity due to hepatocellular accumulation is unknown; such an effect could help explain hyperammonemia development in affected individuals. Regardless, the name of the disease is derived from the rapid clearance of ASA in urine, although elevated levels of ASA can be found in plasma. ASA lyase deficiency is associated with high mortality and morbidity rates. Symptoms of ASA lyase deficiency include anorexia, irritability rapid breathing, lethargy and vomiting. Extreme symptoms include coma and cerebral edema.",
         "A L-arginine derivative that has formula C10H18N4O6."
        ],
        [
         "36",
         "BMG_MT000037",
         "Androstenedione is a delta-4 19-carbon steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol. It is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione originates either from the conversion of dehydroepiandrosterone or from 17-hydroxyprogesterone. It is further converted to either testosterone or estrone. The production of adrenal androstenedione is governed by ACTH, while the production of gonadal androstenedione is under control by gonadotropins.",
         "A 3-oxo Delta(4)-steroid that is androst-4-ene substituted by oxo groups at positions 3 and 17. It is a steroid hormone synthesized in the adrenal glands and gonads."
        ],
        [
         "37",
         "BMG_MT000038",
         "Bilirubin is a yellow bile pigment that is a degradation product of heme. It occurs in the normal catabolic pathway that breaks down heme in vertebrates. This catabolism is a necessary process in the body's clearance of waste products that arise from the destruction of aged or abnormal red blood cells. Bilirubin has been found in all vertebrates and in certain plants including Strelitzia nicolai (PMID: 28573242). Bilirubin levels in humans are elevated in certain diseases such as jaundice and liver disease and it is responsible for the yellow color of bruises and the yellow discoloration in jaundice. Bilirubin breakdown products, such as stercobilin, cause the brown color of feces. A different breakdown product, urobilin, is the main component of the straw-yellow color in urine. Bilirubin consists of an open chain of four pyrroles (tetrapyrrole). It is formed by oxidative cleavage of a porphyrin in heme, which leads to biliverdin, a green tetrapyrrolic bile pigment that is also a product of heme catabolism. Biliverdin is then reduced to bilirubin via biliverdin reductase. After conjugation with glucuronic acid, bilirubin can be excreted in the urine. Bilirubin is structurally similar to the pigment phycobilin used by certain algae to capture light energy, and to the pigment phytochrome used by plants to sense light. Elevated bilirubin levels in humans are associated with Crigler-Najjar syndrome type I, which is an inborn error of metabolism. Crigler-Najjar syndrome is a rare genetic disorder characterized by an inability to properly convert and clear bilirubin from the body. Affected individuals cannot convert unconjugated bilirubin to the conjugated form because they lack a specific liver enzyme required to break down (metabolize) bilirubin. Since they cannot convert bilirubin, they develop abnormally high levels of unconjugated bilirubin in the blood (hyperbilirubinemia). Crigler-Najjar syndrome is caused by mutations in the UGT1A1 gene. The hallmark finding of Crigler-Najjar syndrome is a persistent yellowing of the skin, mucous membranes and whites of the eyes (jaundice). Elevation of both alanine aminotransferase and bilirubin levels in serum or plasma can be indicative of serious liver injury. High levels of bilirubin are indicative of jaundice, which is easily recognizable due to a yellowing of the skin and eyes.  Bilirubin is also an antioxidant. Bilirubin's antioxidant activity may be particularly important in the brain, where it prevents excitotoxicity and neuronal death by scavenging superoxide during N-methyl-D-aspartic acid neurotransmission (PMID: 31353321).",
         "A member of the class of  biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin."
        ],
        [
         "38",
         "BMG_MT000039",
         "Cellobiose, also known as GLCB1-4GLCB or cellose, is a disaccharide. It is also classified as a reducing sugar. In terms of its chemical structure, it is derived from the condensation of a pair beta-glucose molecules creating a beta (1â€šÃœÃ­4) bond. It belongs to the class of organic compounds known as O-glycosyl compounds. These are glycosides in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Cellobiose can be obtained by enzymatic hydrolysis of cellulose and cellulose-rich materials such as cotton, jute, or paper. Cellobiose is a plant metabolite found in flowering plants, conifers and other gymnosperms. Cellobiose can also be found in vertebrates that have consumed plant foods. It has been detected, but not quantified in, several different foods, such as okra, common chokecherries, cherry tomatoes, and welsh onions. Cellobiose can be used as an indicator carbohydrate for Crohn's disease and malabsorption syndrome. Intestinal permeability to detect Crohn's disease and malabsorption syndrome can be measured by the sugar absorption test. This test is based on determining the ratio of the urinary excretion of a large (a disaccharide such as cellobiose) and a small carbohydrate (a monosaccharide such as lactulose or rhamnose) after oral administration. Patients with Crohn's disease or with ulcerative colitis have increased permeability indices in comparison to healthy controls (PMID: 15546811).",
         "A cellobiose with beta configuration at the reducing-end glucose residue."
        ],
        [
         "39",
         "BMG_MT000040",
         "beta-Alanine is the only naturally occurring beta-amino acid - an amino acid in which the amino group is at the beta-position from the carboxylate group. It is formed in vivo by the degradation of dihydrouracil and carnosine. It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (vitamin B-5), which itself is a component of coenzyme A. Under normal conditions, beta-alanine is metabolized into acetic acid. beta-Alanine can undergo a transanimation reaction with pyruvate to form malonate-semialdehyde and L-alanine. The malonate semialdehyde can then be converted into malonate via malonate-semialdehyde dehydrogenase. Malonate is then converted into malonyl-CoA and enter fatty acid biosynthesis. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, beta-alanine may act as a false transmitter replacing gamma-aminobutyric acid. When present in sufficiently high levels, beta-alanine can act as a neurotoxin, a mitochondrial toxin, and a metabotoxin. A neurotoxin is a compound that damages the brain or nerve tissue. A mitochondrial toxin is a compound that damages mitochondria and reduces cellular respiration as well as oxidative phosphorylation. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of beta-alanine are associated with at least three inborn errors of metabolism, including GABA-transaminase deficiency, hyper-beta-alaninemia, and methylmalonate semialdehyde dehydrogenase deficiency. beta-Alanine is a central nervous system (CNS) depressant and is an inhibitor of GABA transaminase. The associated inhibition of GABA transaminase and displacement of GABA from CNS binding sites can also lead to GABAuria (high levels of GABA in the urine) and convulsions. In addition to its neurotoxicity, beta-alanine reduces cellular levels of taurine, which are required for normal respiratory chain function. Cellular taurine depletion is known to reduce respiratory function and elevate mitochondrial superoxide generation, which damages mitochondria and increases oxidative stress (PMID: 27023909). Individuals suffering from mitochondrial defects or mitochondrial toxicity typically develop neurotoxicity, hypotonia, respiratory distress, and cardiac failure. beta-Alanine is a biomarker for the consumption of meat, especially red meat.",
         "A naturally-occurring beta-amino acid comprising propionic acid with the amino group in the 3-position."
        ],
        [
         "40",
         "BMG_MT000041",
         "Cyclic AMP (cAMP) or cyclic adenosine monophosphate is an adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. cAMP is found in all organisms ranging from bacteria to plants to animals. In humans and other mammals it is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon and ACTH. cAMP is synthesized from ATP by adenylate cyclase. Adenylate cyclase is located at the inner side of cell membranes. Adenylate cyclase is activated by the hormones glucagon and adrenaline and by G protein. Liver adenylate cyclase responds more strongly to glucagon, and muscle adenylate cyclase responds more strongly to adrenaline. cAMP decomposition into AMP is catalyzed by the enzyme phosphodiesterase. cAMP is primarily used for intracellular signal transduction, such as transferring into cells the effects of hormones like glucagon and adrenaline, which cannot pass through the plasma membrane. cAMP is also involved in the activation of protein kinases. In addition, cAMP binds to and regulates the function of ion channels such as the HCN channels. Hyperpolarization-activated cyclic nucleotideâ€šÃ„Ã¬gated (HCN) channels are integral membrane proteins that serve as nonselective voltage-gated cation channels in the plasma membranes of heart and brain cells. HCN channels are sometimes referred to as pacemaker channels because they help to generate rhythmic activity within groups of heart and brain cells.",
         "A 3',5'-cyclic purine nucleotide having having adenine as the nucleobase."
        ],
        [
         "41",
         "BMG_MT000042",
         "Acetoacetic acid (AcAc) is a weak organic acid that can be produced in the human liver under certain conditions of poor metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis). It is then partially converted into acetone by decarboxylation and excreted either in urine or through respiration. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing rats. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first two weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies are utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391). The acid is also present in the metabolism of those undergoing starvation or prolonged physical exertion as part of gluconeogenesis. When ketone bodies are measured by way of urine concentration, acetoacetic acid, along with beta-hydroxybutyric acid or acetone, is what is detected.",
         "A 3-oxo monocarboxylic acid that is butyric acid bearing a 3-oxo substituent."
        ],
        [
         "42",
         "BMG_MT000043",
         "Adenosine 3', 5'-diphosphate or PAP is a nucleotide that is closely related to ADP. It has two phosphate groups attached to the 5' and 3' positions of the pentose sugar ribose (instead of pyrophosphoric acid at the 5' position, as found in ADP), and the nucleobase adenine. PAP is converted to PAPS by Sulfotransferase and then back to PAP after the sulfotransferase reaction. Sulfotransferase (STs) catalyze the transfer reaction of the sulfate group from the ubiquitous donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to an acceptor group of numerous substrates. This reaction, often referred to as sulfuryl transfer, sulfation, or sulfonation, is widely observed from bacteria to humans and plays a key role in various biological processes such as cell communication, growth and development, and defense. PAP also appears to a role in bipolar depression. Phosphatases converting 3'-phosphoadenosine 5'-phosphate (PAP) into adenosine 5'-phosphate are of fundamental importance in living cells as the accumulation of PAP is toxic to several cellular systems. These enzymes are lithium-sensitive and we have characterized a human PAP phosphatase as a potential target of lithium therapy.",
         "An adenosine bisphosphate having two monophosphate groups at the 3'- and 5'-positions."
        ],
        [
         "43",
         "BMG_MT000044",
         "Carnitine is a non-essential amino acid and a quaternary ammonium compound. Carnitine is also classified as an alcohol (specifically, a trimethylated carboxy-alcohol). Carnitine exists as one of two stereoisomers (the two enantiomers D-carnitine and L-carnitine. Both are biologically active, but only L-carnitine naturally occurs in animals, and D-carnitine is toxic as it inhibits the activity of the L-form. Carnitine is involved in the metabolism in most mammals, plants, and some bacteria.  Carnitine plays a key role in lipid metabolism and beta-oxidation. It is used to transport long-chain fatty acids into the mitochondria to be oxidized for energy production. This is done by forming a long chain acetylcarnitine esters which are then transported by carnitine palmitoyltransferase I and carnitine palmitoyltransferase II. Carnitine also participates in removing products of metabolism from cells. Given its key metabolic roles, carnitine is concentrated in skeletal and cardiac muscle as well as other tissues that metabolize fatty acids as an energy source. A normal 70 kilogram person typically produces 11â€šÃ„Ã¬34 mg of carnitine per day. Adults eating mixed diets of red meat and other animal products ingest 60â€šÃ„Ã¬180 mg of carnitine per day, while vegans consume about 10â€šÃ„Ã¬12 mg per day. Most carnitine obtained from the diet is absorbed in the small intestine before entering the blood.[3] The total body content of carnitine is about 20 grams in a person weighing 70 kilograms, with nearly all of it contained within skeletal muscle cells. Carnitine is so important in providing energy to muscles (including the heart) that some researchers are now recommending carnitine supplements in the diet, particularly for people who do not consume much red meat (the main food source for carnitine). Carnitine has been described as a vitamin, an amino acid, or a metabimin (i.e. an essential metabolite). Like the B vitamins, carnitine contains nitrogen and is very soluble in water. However, most animals, including humans, make their own carnitine; thus, carnitine cannot be considered to be a vitamin. In certain circumstances, such as methionine deficiency, lysine deficiency, vitamin C deficiency or kidney dialysis, carnitine shortages can develop. Under these conditions, carnitine must be absorbed from food, and for this reason, it is sometimes referred to as a \"metabimin\" or a conditionally essential metabolite. In humans, about 25% of carnitine is synthesized in the liver, kidney, and brain from lysine and methionine. Most of the carnitine in the body comes from dietary sources such as red meat and dairy products. Inborn errors of carnitine metabolism such as Reyeâ€šÃ„Ã´s syndrome can lead to brain deterioration gradually worsening muscle weakness, Duchenne-like muscular dystrophy, and extreme muscle weakness with fat accumulation in muscles. Carnitine is an essential nutrient for pre-term babies and individuals who are unable to eat a normal diet (e.g. non-ketotic hypoglycemics, kidney dialysis patients) (PMID: 115309). In conditions such as kwashiorkor, cirrhosis, and heart muscle disease (cardiomyopathy) as well as in inborn errors of metabolism such as type IV hyperlipidemia and propionic aciduria, carnitine is essential to life and carnitine supplements are critically important. Carnitine therapy may also be useful in a wide variety of clinical conditions. Carnitine supplementation has improved some patients who have angina secondary to coronary artery disease. Carnitine supplements may also be useful in many forms of metabolic liver diseases and heart muscle disease. Hearts undergoing severe arrhythmia quickly deplete their stores of carnitine. Athletes, particularly in Europe, have used carnitine supplements for improved endurance. Carnitine may improve muscle building by improving fat utilization and may even be useful in treating obesity. Carnitine may be of value in treating pregnant women, hypothyroid individuals, and male infertility due to the low motility of sperm. Carnitine deficiency is noted in abnormal liver function, renal dialysis patients, and severe to moderate muscular weakness with associated anorexia. Carnitine is a biomarker for the consumption of meat. In fact, carnitine was first extracted from meat extracts in 1905, leading to its name from Latin, \"caro/carnis\" or flesh.",
         "The (R)-enantiomer of carnitine."
        ],
        [
         "44",
         "BMG_MT000045",
         "Cortisol is the main glucocorticoid secreted by the adrenal cortex and it is involved in the stress response. Its synthetic counterpart hydrocortisone is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Hydrocortisone is synthesized from pregnenolone and is used as an immunosuppressive drug given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis. Cortisol increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning and lower levels in the evening, several hours after the onset of sleep. Cortisol is found to be associated with ACTH deficiency and glucocorticoid deficiency, which are inborn errors of metabolism. Cortisol binds to the cytosolic glucocorticoid receptor. After binding the receptor, the newly formed receptor-ligand complex translocates itself into the cell nucleus where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA-bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically, glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes and prevents phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In other words, the two main products of inflammation, prostaglandins and leukotrienes, are inhibited by the action of glucocorticoids. Glucocorticoids also stimulate the escape of lipocortin-1 into the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst, and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines, etc.) from neutrophils, macrophages, and mastocytes. Additionally, the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.",
         "A 17alpha-hydroxy-C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the \\stress hormone\\ as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses."
        ],
        [
         "45",
         "BMG_MT000046",
         "Creatine, is a naturally occurring non-protein compound. It belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Creatine is found in all vertebrates where it facilitates recycling of adenosine triphosphate (ATP). Its primary metabolic role is to combine with a phosphoryl group, via the enzyme creatine kinase, to generate phosphocreatine, which is used to regenerate ATP. Most of the human body's total creatine and phosphocreatine stores are found in skeletal muscle (95%), while the remainder is distributed in the blood, brain, testes, and other tissues. Creatine is not an essential nutrient as it is naturally produced in the human body from the amino acids glycine and arginine, with an additional requirement for methionine to catalyze the transformation of guanidinoacetate to creatine. In the first step of its biosynthesis glycine and arginine are combined by the enzyme arginine:glycine amidinotransferase (AGAT) to form guanidinoacetate, which is then methylated by guanidinoacetate N-methyltransferase (GAMT), using S-adenosyl methionine as the methyl donor. Creatine can also be obtained through the diet at a rate of about 1 gram per day from an omnivorous diet. A cyclic form of creatine, called creatinine, exists in equilibrium with its tautomer and with creatine. Clinically, there are three distinct disorders of creatine metabolism. Deficiencies in the two synthesis enzymes (AGAT and GAMT) can cause L-arginine:glycine amidinotransferase deficiency (caused by variants in AGAT) and guanidinoacetate methyltransferase deficiency (caused by variants in GAMT). Both disorders are inherited in an autosomal recessive manner. A third defect, creatine transporter defect, is caused by mutations in SLC6A8 and inherited in a X-linked manner. Creatine is widely used as a supplement by athletes. Its use can increase maximum power and performance in high-intensity anaerobic repetitive work (periods of work and rest) by 5 to 15% (PMID: 24688272). Creatine has no significant effect on aerobic endurance, although it will increase power during short sessions of high-intensity aerobic exercise (PMID: 9662683).",
         "A glycine derivative having methyl and amidino groups attached to the nitrogen."
        ],
        [
         "46",
         "BMG_MT000047",
         "Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol. This is because researchers first identified cholesterol in solid form in gallstones in 1784. In the body, cholesterol can exist in either the free form or as an ester with a single fatty acid (of 10-20 carbons in length) covalently attached to the hydroxyl group at position 3 of the cholesterol ring. Due to the mechanism of synthesis, plasma cholesterol esters tend to contain relatively high proportions of polyunsaturated fatty acids. Most of the cholesterol consumed as a dietary lipid exists as cholesterol esters. Cholesterol esters have a lower solubility in water than cholesterol and are more hydrophobic. They are hydrolyzed by the pancreatic enzyme cholesterol esterase to produce cholesterol and free fatty acids. Cholesterol has vital structural roles in membranes and in lipid metabolism in general. It is a biosynthetic precursor of bile acids, vitamin D, and steroid hormones (glucocorticoids, estrogens, progesterones, androgens and aldosterone). In addition, it contributes to the development and functioning of the central nervous system, and it has major functions in signal transduction and sperm development. Cholesterol is a ubiquitous component of all animal tissues where much of it is located in the membranes, although it is not evenly distributed. The highest proportion of unesterified cholesterol is in the plasma membrane (roughly 30-50% of the lipid in the membrane or 60-80% of the cholesterol in the cell), while mitochondria and the endoplasmic reticulum have very low cholesterol contents. Cholesterol is also enriched in early and recycling endosomes, but not in late endosomes. The brain contains more cholesterol than any other organ where it comprises roughly a quarter of the total free cholesterol in the human body. Of all the organic constituents of blood, only glucose is present in a higher molar concentration than cholesterol. Cholesterol esters appear to be the preferred form for transport in plasma and as a biologically inert storage (de-toxified) form. They do not contribute to membranes but are packed into intracellular lipid particles. Cholesterol molecules (i.e. cholesterol esters) are transported throughout the body via lipoprotein particles. The largest lipoproteins, which primarily transport fats from the intestinal mucosa to the liver, are called chylomicrons. They carry mostly triglyceride fats and cholesterol that are from food, especially internal cholesterol secreted by the liver into the bile. In the liver, chylomicron particles give up triglycerides and some cholesterol. They are then converted into low-density lipoprotein (LDL) particles, which carry triglycerides and cholesterol on to other body cells. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. (Lack of information on LDL particle number and size is one of the major problems of conventional lipid tests.). In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. There is a worldwide trend to believe that lower total cholesterol levels tend to correlate with lower atherosclerosis event rates (though some studies refute this idea). As a result, cholesterol has become a very large focus for the scientific community trying to determine the proper amount of cholesterol needed in a healthy diet. However, the primary association of atherosclerosis with cholesterol has always been specifically with cholesterol transport patterns, not total cholesterol per se. For example, total cholesterol can be low, yet made up primarily of small LDL and small HDL particles and atheroma growth rates are high. In contrast, however, if LDL particle number is low (mostly large particles) and a large percentage of the HDL particles are large (HDL is actively reverse transporting cholesterol), then atheroma growth rates are usually low, even negative, for any given total cholesterol concentration. These effects are further complicated by the relative concentration of asymmetric dimethylarginine (ADMA) in the endothelium since ADMA down-regulates production of nitric oxide, a relaxant of the endothelium. Thus, high levels of ADMA, associated with highly oxidized levels of LDL, pose a heightened risk factor for vascular disease. Chronically high levels of cholesterol are associated with at least five inborn errors of metabolism, including cerebrotendinous xanthomatosis, cholesteryl ester storage disease, congenital lipoid adrenal hyperplasia, hypercholesterolemia, and Zellweger syndrome. In chronically high levels, cholesterol can function as an atherogen (causes atherosclerosis and cardiovascular disease). Specifically, chronically high levels (from diet or from genetic predisposition or from diseases such as hyperlipidemia) of cholesterol and cholesterol esters lead to an excess of low-density lipoprotein (LDL) particles. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. Resistin, a protein secreted by fat tissue, has been shown to increase the production of LDL in human liver cells and also degrades LDL receptors in the liver. As a result, the liver is less able to clear cholesterol from the bloodstream. Resistin accelerates the accumulation of LDL in arteries, increasing the risk of heart disease. Cholesterol is considered to be practically insoluble (in water) and basic.",
         "A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group."
        ],
        [
         "47",
         "BMG_MT000048",
         "Epinephrine is a catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine and tyrosine. It is the active sympathomimetic hormone secreted from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. Epinephrine also constricts arterioles in the skin and gut while dilating arterioles in leg muscles. It elevates the blood sugar level by increasing hydrolysis of glycogen to glucose in the liver, and at the same time begins the breakdown of lipids in adipocytes. Epinephrine has a suppressive effect on the immune system.",
         "The R-enantiomer of adrenaline. It is a hormone secreted by the adrenal glands resulting in the 'fight-or-flight' response."
        ],
        [
         "48",
         "BMG_MT000049",
         "Pipecolic acid is a metabolite of lysine found in human physiological fluids such as urine, plasma and CSF. However, it is uncertain if pipecolic acid originates directly from food intake or from mammalian or intestinal bacterial enzyme metabolism. Recent studies suggest that plasma pipecolic acid, particularly the D-isomer, originates mainly from the catabolism of dietary lysine by intestinal bacteria rather than by direct food intake. In classic Zellweger syndrome (a cerebro-hepato-renal genetic disorder, OMIM 214100) pipecolic acid accumulate in the plasma of the patients. It is known that plasma pipecolic acid levels are also elevated in patients with chronic liver diseases. Pipecolic acid is moderately elevated in patients with pyridoxine-dependent seizures and might therefore be a possible biochemical marker for selecting candidates for pyridoxine therapy (Plecko et al 2000). Pipecolic acid was also elevated in CSF in these vitamin B6-responsive patients (PMID 12705501). Pipecolic acid is found to be associated with adrenoleukodystrophy, infantile Refsum disease, and peroxisomal biogenesis defect, which are also inborn errors of metabolism. Pipecolic acid is a biomarker for the consumption of dried and cooked beans.",
         "A piperidinemonocarboxylic acid in which the carboxy group is located at position C-2."
        ],
        [
         "49",
         "BMG_MT000050",
         "Deoxyinosine is a nucleoside that is formed when hypoxanthine is attached to a deoxyribose ring (also known as a ribofuranose) via a beta-N9-glycosidic bond. Deoxyinosine is found in DNA while inosine is found in RNA. Inosine is a nucleic acid important for RNA editing. Adenosine deaminase (ADA) catalyzes the conversion of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. ADA-deficient individuals suffer from severe combined immunodeficiency (SCID) and are unable to produce significant numbers of mature T or B lymphocytes. This occurs as a consequence of the accumulation of ADA substrates or their metabolites. Inosine is also an intermediate in a chain of purine nucleotides reactions required for muscle movements. Moreover, deoxyinosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism.",
         "A purine 2'-deoxyribonucleoside that is inosine in which the hydroxy group at position 2' is replaced by a hydrogen."
        ]
       ],
       "shape": {
        "columns": 3,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>HMDB</th>\n",
       "      <th>ChEBI</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>1-Methylhistidine, also known as 1-MHis or 1MH...</td>\n",
       "      <td>A L-histidine derivative in which the methyl g...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>1,3-Diaminopropane, also known as DAP or trime...</td>\n",
       "      <td>An alkane-alpha,omega-diamine comprising a pro...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>2-Ketobutyric acid, also known as alpha-ketobu...</td>\n",
       "      <td>A 2-oxo monocarboxylic acid that is the 2-oxo ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>2-Hydroxybutyric acid (CAS: 600-15-7), also kn...</td>\n",
       "      <td>A hydroxybutyric acid having a single hydroxyl...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>2-Methoxyestrone (or 2-ME1) belongs to the cla...</td>\n",
       "      <td>A 17-oxo steroid that is estrone in which the ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>A hydrochloride obtained by combining L-cystei...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>A hydrate that is the monohydrate form of L-cy...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>An organic sodium salt that is the monosodium ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>An HPODE (hydroperoxyoctadecadienoic acid) in ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>&lt;NA&gt;</td>\n",
       "      <td>A member of the class of pyrrolidin-2-ones tha...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 3 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID                                               HMDB  \\\n",
       "0           BMG_MT000001  1-Methylhistidine, also known as 1-MHis or 1MH...   \n",
       "1           BMG_MT000002  1,3-Diaminopropane, also known as DAP or trime...   \n",
       "2           BMG_MT000003  2-Ketobutyric acid, also known as alpha-ketobu...   \n",
       "3           BMG_MT000004  2-Hydroxybutyric acid (CAS: 600-15-7), also kn...   \n",
       "4           BMG_MT000005  2-Methoxyestrone (or 2-ME1) belongs to the cla...   \n",
       "...                  ...                                                ...   \n",
       "218330      BMG_MT218331                                               <NA>   \n",
       "218331      BMG_MT218332                                               <NA>   \n",
       "218332      BMG_MT218333                                               <NA>   \n",
       "218333      BMG_MT218334                                               <NA>   \n",
       "218334      BMG_MT218335                                               <NA>   \n",
       "\n",
       "                                                    ChEBI  \n",
       "0       A L-histidine derivative in which the methyl g...  \n",
       "1       An alkane-alpha,omega-diamine comprising a pro...  \n",
       "2       A 2-oxo monocarboxylic acid that is the 2-oxo ...  \n",
       "3       A hydroxybutyric acid having a single hydroxyl...  \n",
       "4       A 17-oxo steroid that is estrone in which the ...  \n",
       "...                                                   ...  \n",
       "218330  A hydrochloride obtained by combining L-cystei...  \n",
       "218331  A hydrate that is the monohydrate form of L-cy...  \n",
       "218332  An organic sodium salt that is the monosodium ...  \n",
       "218333  An HPODE (hydroperoxyoctadecadienoic acid) in ...  \n",
       "218334  A member of the class of pyrrolidin-2-ones tha...  \n",
       "\n",
       "[218335 rows x 3 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metabolite_description = pd.merge(metabolite_description_hmdb, metabolite_description_chebi, on='BioMedGraphica_ID', how='outer')\n",
    "metabolite_description"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data has been saved to D:\\RA\\BMG\\BioMedGraphica\\Entity\\Metabolite\\BioMedGraphica_Metabolite_Description.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "# get the current working directory\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "\n",
    "# get the output directory\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "\n",
    "target_folder = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite'\n",
    "if not target_folder.exists():\n",
    "    target_folder.mkdir(parents=True)\n",
    "    print(f\"Folder {target_folder} has been created.\")\n",
    "\n",
    "output_file_path = target_folder / 'BioMedGraphica_Metabolite_Description.csv'\n",
    "metabolite_description.to_csv(output_file_path, index=False)\n",
    "print(f\"Data has been saved to {output_file_path}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 5.4 Combined Description"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Description",
         "rawType": "object",
         "type": "string"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "5a5513da-9f7e-46ff-9267-ccf9f2d9e02c",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "HMDB: 1-Methylhistidine, also known as 1-MHis or 1MH, belongs to the class of organic compounds known as histidine and derivatives. 1MH is also classified as a methylamino acid. Methylamino acids are primarily proteogenic amino acids (found in proteins) which have been methylated (in situ) on their side chains by various methyltransferase enzymes. Histidine can be methylated at either the N1 or N3 position of its imidazole ring, yielding the isomers 1-methylhistidine (1MH; also referred to as pi-methylhistidine) or 3-methylhistidine (3MH; tau-methylhistidine), respectively. There is considerable confusion with regard to the nomenclature of the methylated nitrogen atoms on the imidazole ring of histidine and other histidine-containing peptides such as anserine. In particular, older literature (mostly prior to the year 2000) designated anserine (Npi methylated) as beta-alanyl-N1-methyl-histidine, whereas according to standard IUPAC nomenclature, anserine is correctly named as beta-alanyl-N3-methyl-histidine. As a result, many papers published prior to the year 2000 incorrectly identified 1MH as a specific marker for dietary consumption or various pathophysiological effects when they really were referring to 3MH (PMID: 24137022).  Recent discoveries have shown that 1MH is produced in essentially all mammals (and other vertebrates) via the enzyme known as METTL9 (PMID: 33563959). METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mammalian proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where \"x\" is a small amino acid. This HxH motif is found in a number of abundant mammalian proteins such as ARMC6, S100A9, and NDUFB3 (PMID: 33563959). Because of its abundance in many muscle-related proteins, 1MH has been found to be a good biomarker for the consumption of meat (PMID: 21527577). Dietary studies have shown that poultry consumption (p-trend = 0.0006) and chicken consumption (p-trend = 0.0003) are associated with increased levels of 1MH in human plasma (PMID: 30018457). The consumption of fish, especially salmon and cod, has also been shown to increase the levels of 1MH in serum and urine (PMID: 31401679). As a general rule, urinary 1MH is associated with white meat intake (p< 0.001), whereas urinary 3MH is associated with red meat intake (p< 0.001) (PMID: 34091671). | ChEBI: A L-histidine derivative in which the methyl group is at N(tele)-position."
        ],
        [
         "1",
         "BMG_MT000002",
         "HMDB: 1,3-Diaminopropane, also known as DAP or trimethylenediamine, belongs to the class of organic compounds known as monoalkylamines. These are organic compounds containing a primary aliphatic amine group. 1,3-Diaminopropane is a stable, flammable, and highly hygroscopic fluid. It is a polyamine that is normally quite toxic if swallowed, inhaled, or absorbed through the skin. It is a catabolic byproduct of spermidine. It is also a precursor in the enzymatic synthesis of beta-alanine. 1,3-Diaminopropane is involved in the arginine/proline metabolic pathways and the beta-alanine metabolic pathway. 1,3-Diaminopropane has been detected, but not quantified in, several different foods, such as cassava, shiitakes, oyster mushrooms, muscadine grapes, and cinnamons. This could make 1,3-diaminopropane a potential biomarker for the consumption of these foods. | ChEBI: An alkane-alpha,omega-diamine comprising a propane skeleton with amino substituents at positions 1 and 3."
        ],
        [
         "2",
         "BMG_MT000003",
         "HMDB: 2-Ketobutyric acid, also known as alpha-ketobutyrate or 2-oxobutyrate, belongs to the class of organic compounds known as short-chain keto acids and derivatives. These are keto acids with an alkyl chain the contains less than 6 carbon atoms. 2-Ketobutyric acid is a substance that is involved in the metabolism of many amino acids (glycine, methionine, valine, leucine, serine, threonine, isoleucine) as well as propanoate metabolism and C-5 branched dibasic acid metabolism. It is also one of the degradation products of threonine. It can be converted into propionyl-CoA (and subsequently methylmalonyl CoA, which can be converted into succinyl CoA, a citric acid cycle intermediate), and thus enter the citric acid cycle. More specifically, 2-ketobutyric acid is a product of the lysis of cystathionine. | ChEBI: A 2-oxo monocarboxylic acid that is the 2-oxo derivative of butanoic acid. | ChEBI: A 2-oxo monocarboxylic acid anion that is the conjugate base of 2-oxobutanoic acid, obtained by deprotonation of the carboxy group."
        ],
        [
         "3",
         "BMG_MT000004",
         "HMDB: 2-Hydroxybutyric acid (CAS: 600-15-7), also known as alpha-hydroxybutyrate, is an organic acid derived from alpha-ketobutyrate. alpha-Ketobutyrate is produced by amino acid catabolism (threonine and methionine) and glutathione anabolism (cysteine formation pathway) and is metabolized into propionyl-CoA and carbon dioxide (PMID: 20526369). 2-Hydroxybutyric acid is formed as a byproduct from the formation of alpha-ketobutyrate via a reaction catalyzed by lactate dehydrogenase (LDH) or alpha-hydroxybutyrate dehydrogenase (alphaHBDH). alpha-Hydroxybutyric acid is primarily produced in mammalian hepatic tissues that catabolize L-threonine or synthesize glutathione. Oxidative stress or detoxification of xenobiotics in the liver can dramatically increase the rate of hepatic glutathione synthesis. Under such metabolic stress conditions, supplies of L-cysteine for glutathione synthesis become limiting, so homocysteine is diverted from the transmethylation pathway (which forms methionine) into the transsulfuration pathway (which forms cystathionine). alpha-Ketobutyrate is released as a byproduct when cystathionine is cleaved into cysteine that is incorporated into glutathione. Chronic shifts in the rate of glutathione synthesis may be reflected by urinary excretion of 2-hydroxybutyrate. 2-Hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation that appears to arise due to increased lipid oxidation and oxidative stress (PMID: 20526369). 2-Hydroxybutyric acid is often found in the urine of patients suffering from lactic acidosis and ketoacidosis. 2-Hydroxybutyric acid generally appears at high concentrations in situations related to deficient energy metabolism (e.g. birth asphyxia) and also in inherited metabolic diseases affecting the central nervous system during neonatal development, such as \"cerebral\" lactic acidosis, glutaric aciduria type II, dihydrolipoyl dehydrogenase (E3) deficiency, and propionic acidemia. More recently it has been noted that elevated levels of alpha-hydroxybutyrate in the plasma is a good marker for early-stage type II diabetes (PMID: 19166731). It was concluded from studies done in the mid-1970s that an increased NADH2/NAD ratio was the most important factor for the production of 2-hydroxybutyric acid (PMID: 168632). | ChEBI: A hydroxybutyric acid having a single hydroxyl group located at position 2; urinary secretion of 2-hydroxybutyric acid is increased with alcohol ingestion or vigorous physical exercise and is associated with lactic acidosis and ketoacidosis in humans and diabetes in animals. | ChEBI: An optically active form of 2-hydroxybutyric acid having (S)-configuration."
        ],
        [
         "4",
         "BMG_MT000005",
         "HMDB: 2-Methoxyestrone (or 2-ME1) belongs to the class of organic compounds known as estrogens and derivatives. These are steroids with a structure containing a 3-hydroxylated estrane. Thus, 2-methoxyestrone is considered to be a steroid or steroid derivative. It is a by-product of estrone and 2-hydroxyestrone metabolism and has been detected in all mammals. More specifically, 2-methoxyestrone is an endogenous, naturally occurring methoxylated catechol estrogen and a metabolite of estrone that is formed by catechol O-methyltransferase via the intermediate 2-hydroxyestrone. 2-Methoxyestrone is part of the androgen and estrogen metabolic pathway. The acid ionization constant (pKa) of 2-methoxyestrone has been determined to be 10.81 (PMID: 516114). 2-Methoxyestrone can be metabolized to a sulfated derivative (2-methoxyestrone 3-sulfate) via steroid sulfotransferase (EC 2.8.2.15). It can also be glucuronidated to 2-methoxyestrone 3-glucuronide by UDP glucuronosyltransferase (EC 2.4.1.17). Unlike estrone but similarly to 2-hydroxyestrone and 2-methoxyestradiol, 2-methoxyestrone has very low affinity for the estrogen receptor and lacks significant estrogenic activity (PMID: 10865186). | ChEBI: A 17-oxo steroid that is estrone in which the hydrogen at position 2 has been replaced by a methoxy group."
        ],
        [
         "5",
         "BMG_MT000006",
         "HMDB: 3-Hydroxybutyric acid (CAS: 300-85-6), also known as beta-hydroxybutanoic acid, is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis. This acid is metabolized by 3-hydroxybutyrate dehydrogenase (catalyzes the oxidation of 3-hydroxybutyrate to form acetoacetate, using NAD+ as an electron acceptor). The enzyme functions in nervous tissues and muscles, enabling the use of circulating hydroxybutyrate as a fuel. In the liver mitochondrial matrix, the enzyme can also catalyze the reverse reaction, a step in ketogenesis. 3-Hydroxybutyric acid is a chiral compound having two enantiomers, D-3-hydroxybutyric acid and L-3-hydroxybutyric acid, and is a ketone body. Like the other ketone bodies (acetoacetate and acetone), levels of 3-hydroxybutyrate in blood and urine are raised in ketosis. In humans, 3-hydroxybutyrate is synthesized in the liver from acetyl-CoA and can be used as an energy source by the brain when blood glucose is low. Blood levels of 3-hydroxybutyric acid levels may be monitored in diabetic patients to look for diabetic ketoacidosis. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing mammals. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for the synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate (AcAc) and beta-hydroxybutyrate are preferred over glucose as substrates for the synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first two weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies is utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmitoylphosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391). 3-Hydroxybutyric acid is found to be associated with fumarase deficiency and medium-chain acyl-CoA dehydrogenase deficiency, which are inborn errors of metabolism. 3-Hydroxybutyric acid is a metabolite of Alcaligenes and can be produced from plastic metabolization or incorporated into polymers, depending on the species (PMID: 7646009, 18615882). | ChEBI: The R-enantiomer of 3-hydroxybutyric acid. Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics. It is a sex pheremone in the European spider Linyphia triangularis."
        ],
        [
         "6",
         "BMG_MT000007",
         "HMDB: Deoxyuridine, also known as dU, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. It is similar in chemical structure to uridine, but without the 2'-hydroxyl group. Deoxyuridine exists in all living organisms, ranging from bacteria to humans. Within humans, deoxyuridine participates in a number of enzymatic reactions. In particular, deoxyuridine can be biosynthesized from deoxycytidine through its interaction with the enzyme cytidine deaminase. In addition, deoxyuridine can be converted into uracil and deoxyribose 1-phosphate through its interaction with the enzyme thymidine phosphorylase. Deoxyuridine is considered to be an antimetabolite that is converted into deoxyuridine triphosphate during DNA synthesis. Laboratory suppression of deoxyuridine is used to diagnose megaloblastic anemia due to vitamin B12 and folate deficiencies. In humans, deoxyuridine is involved in the metabolic disorder called UMP synthase deficiency (orotic aciduria). Outside of the human body, deoxyuridine has been detected, but not quantified in, several different foods, such as lichee, highbush blueberries, agaves, macadamia nut (M. tetraphylla), and red bell peppers. This could make deoxyuridine a potential biomarker for the consumption of these foods. | ChEBI: A pyrimidine 2'-deoxyribonucleoside having uracil as the nucleobase."
        ],
        [
         "7",
         "BMG_MT000008",
         "HMDB: Deoxycytidine, also known as dC, belongs to the class of organic compounds known as pyrimidine 2'-deoxyribonucleosides. Pyrimidine 2'-deoxyribonucleosides are compounds consisting of a pyrimidine linked to a ribose which lacks a hydroxyl group at position 2. Deoxycytidine is also classified as a deoxyribonucleoside, a component of deoxyribonucleic acid (DNA). Deoxycytidine is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the 2' position. Deoxycytidine exists in all living species, ranging from bacteria to plants to humans. Degradation of DNA through apoptosis or cell death produces deoxycytidine. Within humans, deoxycytidine participates in a number of enzymatic reactions. In particular, deoxycytidine can be biosynthesized from dCMP through the action of the enzyme cytosolic purine 5'-nucleotidase. In addition, deoxycytidine can be converted into dCMP; which is mediated by the enzyme uridine-cytidine kinase-like 1. Deoxycytidine can be phosphorylated at the C-5 position by the enzyme deoxycytidine kinase to produce deoxycytidine monophosphate (dCMP), and to a lesser extent, deoxycytidine diphosphate (dCDP), and deoxycytidine triphosphate (dCTP). Deoxycytidine can also be phosphorylated by thymidine kinase 2 (TK2). Deoxycytidine can potentially be used for the treatment of the metabolic disorder known as thymidine kinase 2 deficiency (TK2 deficiency). TK2 deficiency has three disease subtypes: i) infantile-onset myopathy with rapid progression to early death ii) childhood-onset myopathy, which resembles spinal muscular atrophy (SMA) type III, begins between ages 1 and 12 years with progression to loss of ambulation within few years and iii) late-onset myopathy starting at age 12 year or later with moderate to severe myopathy manifesting as either isolated chronic progressive external ophthalmoplegia (CPEO) or a generalized myopathy with CPEO plus facial and limb weakness, gradual progression, and, in some cases, respiratory failure and loss of ability to walk in adulthood (PMID: 28318037). In mouse models of TK2, dC was shown to delay disease onset, prolong life span and restore mtDNA copy number as well as respiratory chain enzyme activities (PMID: 28318037). | ChEBI: A pyrimidine 2'-deoxyribonucleoside having cytosine as the nucleobase."
        ],
        [
         "8",
         "BMG_MT000009",
         "HMDB: Cortexolone, also known as cortodoxone or 11-deoxycortisol, belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Thus, cortexolone is considered to be a steroid molecule. Cortexolone is an endogenous glucocorticoid steroid hormone, and a metabolic intermediate in the synthesis of cortisol. It was first described by Tadeusz Reichstein in 1938 and named as Substance S. It has also been referred to as Reichstein's Substance S or Compound S. Cortexolone acts as a glucocorticoid, though it is less potent than cortisol. Cortexolone is synthesized from 17Å’Â±-hydroxyprogesterone by 21-hydroxylase and is converted to cortisol by 11Å’â‰¤-hydroxylase. As a result, the level of cortexolone is often measured in patients to diagnose impaired cortisol synthesis, to identify any enzyme deficiency that may be causing impairment along the pathway to cortisol, and to differentiate adrenal disorders. Cortexolone in mammals has limited biological activity and mainly acts as metabolic intermediate within the glucocorticoid pathway, leading to cortisol. On the other hand, in sea lampreys, cortexolone is the major glucocorticoid, with mineralocorticoid activity. Cortexolone in sea lampreys binds to specific corticosteroid receptors and is involved in intestinal osmoregulation and in sea lamprey at metamorphosis, a process in which they develop seawater tolerance before downstream migration. | ChEBI: A deoxycortisol that is cortisol in which the hydroxy group at position 11 has been replaced by a hydrogen."
        ],
        [
         "9",
         "BMG_MT000010",
         "HMDB: 11-Deoxycorticosterone (also called desoxycortone, 21-hydroxyprogesterone, DOC, or simply deoxycorticosterone) is a steroid hormone produced by the adrenal gland that possesses mineralocorticoid activity and acts as a precursor to aldosterone. It is classified as a member of the 21-hydroxysteroids. 21-hydroxysteroids are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. Deoxycorticosterone is very hydrophobic, practically insoluble (in water), and relatively neutral. Deoxycorticosterone can be synthesized from progesterone by 21-beta-hydroxylase and is then converted to corticosterone by 11-beta-hydroxylase. Corticosterone is then converted to aldosterone by aldosterone synthase. Deoxycorticosterone stimulates the collecting tubules in the kidney to continue to excrete potassium in much the same way that aldosterone does. Deoxycorticosterone has about 1/20 of the sodium retaining power of aldosterone and about 1/5 the potassium excreting power of aldosterone (Wikipedia). Deoxycorticosterone can be found throughout all human tissues and has been detected in amniotic fluid and blood. When present in sufficiently high levels, deoxycorticosterone can act as a hypertensive agent and a metabotoxin. A hypertensive agent increases blood pressure and causes the production of more urine. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels.  Chronically high levels of deoxycorticosterone are associated with congenital adrenal hyperplasia (CAH) and with adrenal tumors producing deoxycorticosterone (PMID: 20671982). High levels of this mineralocorticoid are associated with resistant hypertension, which can result in polyuria, polydipsia, increased blood volume, edema, and cardiac enlargement. Deoxycorticosterone can be used to treat adrenal insufficiency. In particular, desoxycorticosterone acetate (DOCA) is used as replacement therapy in Addison's disease. | ChEBI: A mineralocorticoid that is progesterone substituted at position 21 by a hydroxy group."
        ],
        [
         "10",
         "BMG_MT000011",
         "HMDB: 4-Pyridoxic acid is a member of the class of compounds known as methylpyridines. More specifically it is a 2-methylpyridine derivative substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. 4-Pyridoxic acid is the catabolic product of vitamin B6 (also known as pyridoxine, pyridoxal and pyradoxamine) and is excreted in the urine. Urinary levels of 4-pyridoxic acid are lower in females than in males and will be reduced even further in persons with a riboflavin deficiency. 4-Pyridoxic acid is formed by the action of aldehyde oxidase I (an endogenous enzyme) and by microbial enzymes (pyridoxal 4-dehydrogenase), an NAD-dependent aldehyde dehydrogenase. 4-pyridoxic acid can be further broken down by the gut microflora via the enzyme known as 4-pyridoxic acid dehydrogenase. This enzyme catalyzes the four-electron oxidation of 4-pyridoxic acid to 3-hydroxy-2-methylpyridine-4,5-dicarboxylate, using nicotinamide adenine dinucleotide (NAD) as a cofactor. | ChEBI: A methylpyridine that is 2-methylpyridine substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5. It is the catabolic product of vitamin B6 and is excreted in the urine."
        ],
        [
         "11",
         "BMG_MT000012",
         "HMDB: alpha-Ketoisovaleric acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. alpha-Ketoisovaleric acid is a neurotoxin, an acidogen, and a metabotoxin. A neurotoxin causes damage to nerve cells and nerve tissues. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of alpha-ketoisovaleric acid are associated with maple syrup urine disease. MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma.  In maple syrup urine disease, the brain concentration of branched-chain ketoacids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis (PMID: 15930465). alpha-Ketoisovaleric acid is a keto-acid, which is a subclass of organic acids. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). These can progress to heart, liver, and kidney abnormalities, seizures, coma, and possibly death. These are also the characteristic symptoms of untreated MSUD. Many affected children with organic acidemias experience intellectual disability or delayed development. | ChEBI: A 2-oxo monocarboxylic acid that is the 2-oxo derivative of isovaleric acid."
        ],
        [
         "12",
         "BMG_MT000013",
         "HMDB: p-Hydroxyphenylacetic acid, also known as 4-hydroxybenzeneacetate, is classified as a member of the 1-hydroxy-2-unsubstituted benzenoids. 1-Hydroxy-2-unsubstituted benzenoids are phenols that are unsubstituted at the 2-position. p-Hydroxyphenylacetic acid is considered to be slightly soluble (in water) and acidic.Â  p-Hydroxyphenylacetic acid can be synthesized from acetic acid. It is also a parent compound for other transformation products, including but not limited to, methyl 2-(4-hydroxyphenyl)acetate, ixerochinolide, and lactucopicrin 15-oxalate.Â  p-Hydroxyphenylacetic acid can be found in numerous foods such as olives, cocoa beans, oats, and mushrooms. p-Hydroxyphenylacetic acid can be found throughout all human tissues and in all biofluids. Within a cell, p-hydroxyphenylacetic acid is primarily located in the cytoplasm and in the extracellular space. p-Hydroxyphenylacetic acid is also a microbial metabolite produced by Acinetobacter, Clostridium, Klebsiella, Pseudomonas, and Proteus. Higher levels of this metabolite are associated with an overgrowth of small intestinal bacteria from Clostridia species including C. difficile, C. stricklandii, C. lituseburense, C. subterminale, C. putrefaciens, and C. propionicum (PMID: 476929, 12173102). p-Hydroxyphenylacetic acid is detected after the consumption of whole grain. | ChEBI: A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group."
        ],
        [
         "13",
         "BMG_MT000014",
         "HMDB: Iodotyrosine is an iodated derivative of L-tyrosine. This is an early precursor to L-thyroxine, one of the primary thyroid hormones. In the thyroid gland, iodide is trapped, transported, and concentrated in the follicular lumen for thyroid hormone synthesis. Before trapped iodide can react with tyrosine residues, it must be oxidized by thyroid peroxidase. Iodotyrosine is made from tyrosine via thyroid peroxidase and then further iodinated by this enzyme to make the di-iodo and tri-iodo variants. Two molecules of di-iodotyrosine combine to form T4, and one molecule of mono-iodotyrosine combines with one molecule of di-iodotyrosine to form T3. | ChEBI: The monoiodotyrosine that is L-tyrosine carrying an iodo-substituent at position C-3 of the benzyl group."
        ],
        [
         "14",
         "BMG_MT000015",
         "HMDB: 3-methoxytyramine, also known as 4-(2-amino-Ethyl)-2-methoxy-phenol or 3-O-Methyldopamine, is classified as a member of the Methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. 3-methoxytyramine is considered to be slightly soluble (in water) and acidic.  3-methoxytyramine can be found primarily in human brain and most tissues tissues; and in blood, cerebrospinal fluid (csf) or urine. Within a cell, 3-methoxytyramine is primarily located in the cytoplasm | ChEBI: A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas."
        ],
        [
         "15",
         "BMG_MT000016",
         "HMDB: (S)-3-Hydroxyisobutyric acid (3-HIBA) (CAS: 2068-83-9) is an organic acid. 3-HIBA is an intermediate in L-valine metabolism. 3-HIBA plays an important role in the diagnosis of the very rare inherited metabolic diseases 3-hydroxyisobutyric aciduria (OMIM: 236795) and methylmalonic semialdehyde dehydrogenase deficiency (OMIM: 603178). Patients with 3-hydroxyisobutyric aciduria excrete a significant amount of 3-HIBA not only during the acute stage but also when stable. 3-Hydroxyisobutyric aciduria is caused by a 3-hydroxyisobutyryl-CoA dehydrogenase deficiency (PMID: 18329219). The severity of this disease varies from case to case. Most patients exhibit dysmorphic features, such as a small triangular face, a long philtrum, low set ears, and micrognathia (PMID: 10686279). Lactic acidemia is also found in the affected patients, indicating that mitochondrial dysfunction is involved. 3-HIBA appears to specifically inhibit the function of the respiratory chain complex I-III and mitochondrial creatine kinase (PMID: 18329219). BioTransformer predicts that 3-HIBA is a product of 2-methylpropanoic acid metabolism via a hydroxylation-of-terminal-methyl reaction catalyzed by CYP2B6 and CYP2E1 enzymes (PMID: 30612223). | ChEBI: A 3-hydroxyisobutyric acid that has formula C4H8O3."
        ],
        [
         "16",
         "BMG_MT000017",
         "HMDB: 3-O-Sulfogalactosylceramide is an acidic, sulfated glycosphingolipid, often known as sulfatide. This lipid occurs in membranes of various cell types, but is found in particularly high concentrations in myelin where it constitutes 3-4% of total membrane lipids. This lipid is synthesized primarily in the oligodendrocytes in the central nervous system. Accumulation of this lipid in the lysosomes is a characteristic of metachromatic leukodystrophy, a lysosomal storage disease caused by the deficiency of arylsulfatase A. Alterations in sulfatide metabolism, trafficking, and homeostasis are present in the earliest clinically recognizable stages of Alzheimer's disease. Cerebrosides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Cerebrosides have a single sugar group linked to ceramide. The most common are galactocerebrosides (containing galactose), the least common are glucocerebrosides (containing glucose). Galactocerebrosides are found predominantly in neuronal cell membranes. In contrast glucocerebrosides are not normally found in membranes. Instead, they are typically intermediates in the synthesis or degradation of more complex glycosphingolipids. Galactocerebrosides are synthesized from ceramide and UDP-galactose. Excess lysosomal accumulation of glucocerebrosides is found in Gaucher disease. Sulfatides are glycosphingolipids. There are four types of glycosphingolipids, the cerebrosides, sulfatides, globosides and gangliosides. Sulfatides are the sulfuric acid esters of galactocerebrosides. They are synthesized from galactocerebrosides and activated sulfate, 3'-phosphoadenosine 5'-phosphosulfate (PAPS)."
        ],
        [
         "17",
         "BMG_MT000018",
         "HMDB: Ureidopropionic acid, also known as 3-ureidopropanoate or N-carbamoyl-beta-alanine, belongs to the class of organic compounds known as ureas. Ureas are compounds containing two amine groups joined by a carbonyl (C=O) functional group. Ureidopropionic acid is an intermediate in the metabolism of uracil. More specifically, it is a breakdown product of dihydrouracil and is produced by the enzyme dihydropyrimidase. It is further decomposed into beta-alanine via the enzyme beta-ureidopropionase. Ureidopropionic acid is essentially a urea derivative of beta-alanine. High levels of ureidopropionic acid are found in individuals with beta-ureidopropionase (UP) deficiency (PMID: 11675655). Enzyme deficiencies in pyrimidine metabolism are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil. Ureidopropionic acid has been detected, but not quantified in, several different foods, such as gram beans, broccoli, climbing beans, oriental wheat, and mandarin orange (clementine, tangerine). This could make ureidopropionic acid a potential biomarker for the consumption of these foods. | ChEBI: A beta-alanine derivative that is propionic acid bearing a ureido group at position 3."
        ],
        [
         "18",
         "BMG_MT000019",
         "HMDB: Tetrahydrobiopterin (CAS: 17528-72-2), also known as BH4, is an essential cofactor in the synthesis of neurotransmitters and nitric oxide (PMID: 16946131). In fact, it is used by all three human nitric-oxide synthases (NOS) eNOS, nNOS, and iNOS as well as the enzyme glyceryl-ether monooxygenase. It is also essential in the conversion of phenylalanine into tyrosine by the enzyme phenylalanine-4-hydroxylase; the conversion of tyrosine into L-dopa by the enzyme tyrosine hydroxylase; and the conversion of tryptophan into 5-hydroxytryptophan via tryptophan hydroxylase. Specifically, tetrahydrobiopterin is a cofactor for tryptophan 5-hydroxylase 1, tyrosine 3-monooxygenase, and phenylalanine hydroxylase, all of which are essential for the formation of the neurotransmitters dopamine, noradrenaline, and adrenaline. Tetrahydrobiopterin has been proposed to be involved in the promotion of neurotransmitter release in the brain and the regulation of human melanogenesis. A defect in BH4 production and/or a defect in the enzyme dihydropteridine reductase (DHPR) causes phenylketonuria type IV, as well as dopa-responsive dystonias. BH4 is also implicated in Parkinson's disease, Alzheimer's disease, and depression. Tetrahydrobiopterin is present in probably every cell or tissue of higher animals. On the other hand, most bacteria, fungi and plants do not synthesize tetrahydrobiopterin (Wikipedia). | ChEBI: A tetrahydropterin that is 2-amino-5,6,7,8-tetrahydropteridin-4(3H)-one in which a hydrogen at position 6 is substituted by a 1,2-dihydroxypropyl group (6R,1'R,2'S-enantiomer)."
        ],
        [
         "19",
         "BMG_MT000020",
         "HMDB: Biotin is an enzyme co-factor present in minute amounts in every living cell. Biotin is also known as coenzyme R and vitamin H or B7. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Biotin has been recognized as an essential nutrient. Humans fulfill their biotin requirement through their diet through endogenous reutilization of biotin and perhaps through the capture of biotin generated in the intestinal flora. The utilization of biotin for covalent attachment to carboxylases and its reutilization through the release of carboxylase biotin after proteolytic degradation constitutes the 'biotin cycle'. Biotin deficiency is associated with neurological manifestations, skin rash, hair loss, and metabolic disturbances that are thought to relate to the various carboxylase deficiencies (metabolic ketoacidosis with lactic acidosis). It has also been suggested that biotin deficiency is associated with protein malnutrition, and that marginal biotin deficiency in pregnant women may be teratogenic. Biotin acts as a carboxyl carrier in carboxylation reactions. There are four biotin-dependent carboxylases in mammals: those of propionyl-CoA (PCC), 3-methylcrotonyl-CoA (MCC), pyruvate (PC), and acetyl-CoA carboxylases (isoforms ACC-1 and ACC-2). All but ACC-2 are mitochondrial enzymes. The biotin moiety is covalently bound to the epsilon amino group of a lysine residue in each of these carboxylases in a domain 60-80 amino acids long. The domain is structurally similar among carboxylases from bacteria to mammals. Evidence is emerging that biotin participates in processes other than classical carboxylation reactions. Specifically, novel roles for biotin in cell signalling, gene expression, and chromatin structure have been identified in recent years. Human cells accumulate biotin by using both the sodium-dependent multivitamin transporter and monocarboxylate transporter 1. These transporters and other biotin-binding proteins partition biotin to compartments involved in biotin signalling: cytoplasm, mitochondria, and nuclei. The activity of cell signals such as biotinyl-AMP, Sp1 and Sp3, nuclear factor (NF)-kappaB, and receptor tyrosine kinases depends on biotin supply. Consistent with a role for biotin and its catabolites in modulating these cell signals, greater than 2000 biotin-dependent genes have been identified in various human tissues. Many biotin-dependent gene products play roles in signal transduction and localize to the cell nucleus, consistent with a role for biotin in cell signalling. Posttranscriptional events related to ribosomal activity and protein folding may further contribute to the effects of biotin on gene expression. Finally, research has shown that biotinidase and holocarboxylase synthetase mediate covalent binding of biotin to histones (DNA-binding proteins), affecting chromatin structure; at least seven biotinylation sites have been identified in human histones. Biotinylation of histones appears to play a role in cell proliferation, gene silencing, and the cellular response to DNA repair. Roles for biotin in cell signalling and chromatin structure are consistent with the notion that biotin has a unique significance in cell biology (PMID: 15992684, 16011464). | ChEBI: An organic heterobicyclic compound that consists of 2-oxohexahydro-1H-thienoimidazole having a valeric acid substituent attached to the tetrahydrothiophene ring. The parent of the class of biotins."
        ],
        [
         "20",
         "BMG_MT000021",
         "HMDB: Androsterone is an inactive breakdown metabolite of testosterone, the product of a reaction mediated by the enzyme oxidative 17beta-hydroxysteroid dehydrogenase (EC 1.1.1.51, 17beta-HSD). Androsterone can also be metabolized from other adrenal androgens such as dehydroepiandrosterone, dihydrotestosterone, or androstenedione, and is considered an inactive end product. However, it can be a physiological effector in its own right. Androsterone might be converted back to dihydrotestosterone. Humans (and other primates) are unique among mammals in having high levels of circulating androsterone glucuronide, a process that is the major role of uridine-diphospho-glucuronosyltransferase enzymes (EC 2.4.1.17, UGT) for glucuronidation of steroid metabolism in humans. Conjugation of androsterone is a pathway found in all vertebrates and it is widely recognized that the liver is a major site of glucuronidation. However, it is now clear that extrahepatic tissues are also involved in the conjugation of compounds to which these tissues are exposed. High levels of androsterone glucuronide found in the human prostate, breast cyst fluid, and ovary follicular fluid suggest that glucuronidation of 5alpha-reduced C19 steroids occurs in these tissues as well. In doping control, the ratio of androsterone/etiocholanolone provides valuable information that allows the assignment of a urine specimen to a particular person or the identification of urine samples with identical steroid profiles; this is particularly important to detect attempts of urine manipulation including urine alteration and substitution (PMID: 9188497, 17017935, 14643063, 12943709, 9699884, 17260133). | ChEBI: An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone ."
        ],
        [
         "21",
         "BMG_MT000022",
         "HMDB: 7-Dehydrocholesterol (7-DHC), also known as provitamin D3 or 5,7-cholestadien-3-b-ol, belongs to the class of organic compounds known as cholesterols and derivatives. Cholesterols and derivatives are compounds containing a 3-hydroxylated cholestane core. Thus, 7-dehydrocholesterol is also classified as a sterol. 7-Dehydrocholesterol is known as a zoosterol, meaning that it is a sterol isolated from animals (to distinguish those sterols isolated from plants which are called phytosterols). 7-DHC functions in the serum as a cholesterol precursor and is photochemically converted to vitamin D3 in the skin. Therefore 7-DHC functions as provitamin-D3. The presence of 7-DHC in human skin enables humans and other mammals to manufacture vitamin D3 (cholecalciferol) from ultraviolet rays in the sun light, via an intermediate isomer pre-vitamin D3. 7-DHC absorbs UV light most effectively at wavelengths between 290 and 320 nm and, thus, the production of vitamin D3 will occur primarily at those wavelengths (PMID: 9625080).  The two most important factors that govern the generation of pre-vitamin D3 are the quantity (intensity) and quality (appropriate wavelength) of the UVB irradiation reaching the 7-dehydrocholesterol deep in the stratum basale and stratum spinosum (PMID: 9625080). 7-DHC is also found in the milk of several mammalian species, including cows (PMID: 10999630; PMID: 225459). It was discovered by Nobel-laureate organic chemist Adolf Windaus. 7-DHC can be produced by animals and plants via different pathways (PMID: 23717318). It is not produced by fungi in significant amounts. 7-DHC is made by some algae and can also be produced by some bacteria. | ChEBI: A Delta(5),Delta(7)-sterol that has formula C27H44O."
        ],
        [
         "22",
         "BMG_MT000023",
         "HMDB: Carnosine, which is also known as beta-alanyl-L-histidine) is a dipeptide consisting of the amino acids beta-alanine and histidine. It is found exclusively in animal tissues and is naturally produced in the body by the liver. Carnosine has a pKa value of 6.83, making it a good buffer for the pH range of animal muscles.  Since beta-alanine is a non-proteogenic amino acid and is not incorporated into proteins, carnosine can be stored at relatively high concentrations (millimolar) in muscles, with concentrations as high as 17â€šÃ„Ã¬25 mmol/kg (dry muscle). Carnosine is also highly concentrated in brain tissues. Carnosine has been shown to scavenge reactive oxygen species (ROS) as well as alpha-beta unsaturated aldehydes formed from peroxidation of fatty acids during oxidative stress. The antioxidant mechanism of carnosine is attributed to its chelating effect against divalent metal ions, superoxide dismutase (SOD)-like activity, as well as its ROS and free radicals scavenging ability (PMID: 16406688). Carnosine also buffers muscle cells, and acts as a neurotransmitter in the brain. Carnosine has the potential to suppress many of the biochemical changes that accompany ageing (e.g. protein oxidation, glycation, AGE formation, and cross-linking) and associated pathologies (PMID: 16804013). Some autistic patients take carnosine as a dietary supplement and attribute an improvement in their condition to it. Supplemental carnosine may increase corticosterone levels. This may explain the \"hyperactivity\" seen in autistic subjects at higher doses. A positive association between muscle tissue carnosine concentration and exercise performance has been found. Å’â‰¤-Alanine supplementation is thought increase exercise performance by promoting carnosine production in muscle. Exercise has conversely been found to increase muscle carnosine concentrations, and muscle carnosine content is higher in athletes engaging in anaerobic exercise. Carnosine is also a biomarker for the consumption of meat. Elevated levels of urinary and plasma carnosine are associated with carnosinuria (also known as carnosinemia), which is an inborn error of metabolism. caused by a deficiency of the enzyme carnosinase. Carnosinas cleaves carnosine into its constituent amino acids: Å’â‰¤-Alanine and histidine. Carnonsinemia results in an excess of carnosine in the urine, cerebrospinal fluid, blood, and nervous tissue. A variety of neurological symptoms have been associated with carnosinemia. They include: hypotonia, developmental delay, mental retardation, degeneration of axons, sensory neuropathy, tremors, demyelinization, gray matter anomalies, myoclonic seizures, and loss of purkinje fibers. | ChEBI: A dipeptide that is the N-(beta-alanyl) derivative of L-histidine."
        ],
        [
         "23",
         "BMG_MT000024",
         "HMDB: Adenine is a purine base. Adenine is found in both DNA and RNA. Adenine is a fundamental component of adenine nucleotides. Adenine forms adenosine, a nucleoside, when attached to ribose, and deoxyadenosine when attached to deoxyribose; it forms adenosine triphosphate (ATP), a nucleotide, when three phosphate groups are added to adenosine. Adenosine triphosphate is used in cellular metabolism as one of the basic methods of transferring chemical energy between chemical reactions. Purine inborn errors of metabolism (IEM) are serious hereditary disorders, which should be suspected in any case of neonatal fitting, failure to thrive, recurrent infections, neurological deficit, renal disease, self-mutilation and other manifestations. Investigation usually starts with uric acid (UA) determination in urine and plasma. (OMIM 300322, 229600, 603027, 232400, 232600, 232800, 201450, 220150, 232200, 162000, 164050, 278300). (PMID: 17052198, 17520339). | ChEBI: The parent compound of the 6-aminopurines, composed of a purine having an amino group at C-6."
        ],
        [
         "24",
         "BMG_MT000025",
         "HMDB: Taurocholic acid is a bile acid and is the product of the conjugation of cholic acid with taurine. Its sodium salt is the chief ingredient of the bile of carnivorous animals. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Taurocholic acid, as with all bile acids, acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as a cholagogue and choleretic (a bile purging agent). Hydrolysis of taurocholic acid yields taurine, a nonessential amino acid. Taurocholic acid is one of the main components of urinary nonsulfated bile acids in biliary atresia. Raised levels of taurocholate in fetal serum in obstetric cholestasis may result in the development of a fetal dysrhythmia and sudden intra-uterine death (PMID: 3944741, 11256973). | ChEBI: A bile acid taurine conjugate of  cholic acid that usually occurs as the sodium salt of bile in mammals."
        ],
        [
         "25",
         "BMG_MT000026",
         "HMDB: Aldosterone is a steroid hormone produced by the adrenal cortex in the adrenal gland to regulate sodium and potassium balance in the blood. Specifically, it regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. It is synthesized from cholesterol by aldosterone synthase, which is absent in other sections of the adrenal gland. It is the sole endogenous member of the class of mineralocorticoids. Aldosterone increases the permeability of the apical (luminal) membrane of the kidney's collecting ducts to potassium and sodium and activates their basolateral Na+/K+ pumps, stimulating ATP hydrolysis, reabsorbing sodium (Na+) ions and water into the blood, and excreting potassium (K+) ions into the urine. | ChEBI: A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney."
        ],
        [
         "26",
         "BMG_MT000027",
         "HMDB: Dihydrobiopterin, also known as BH2, 7,8-dihydrobiopterin, L-erythro-7,8-dihydrobiopterin, quinonoid dihydrobiopterin or q-BH2, belongs to the class of organic compounds known as biopterins and derivatives. These are coenzymes containing a 2-amino-pteridine-4-one derivative. Dihydrobiopterin is also classified as a pteridine. Pteridines are aromatic compounds composed of fused pyrimidine and pyrazine rings. Dihydrobiopterin is produced during the synthesis of neurotransmitters L-DOPA, dopamine, norepinephrine and epinephrine. It is restored to the required cofactor tetrahydrobiopterin via the NADPH-dependant reduction of dihydrobiopterin reductase. Dihydrobiopterin can also be converted to tetrahydrobiopterin by nitric oxide synthase (NOS) which is catalyzed by the flavoprotein \"diaphorase\" activity of NOS. This activity is located on the reductase (C-terminal) domain of NOS, whereas the high affinity tetrahydrobiopterin site involved in NOS activation is located on the oxygenase (N-terminal) domain (PMID: 8626754). Sepiapterin reductase (SPR) is another enzyme that plays a role in the production of dihydrobiopterin. SPR catalyzes the reduction of sepiapterin to dihydrobiopterin (BH2), the precursor for tetrahydrobiopterin (BH4). BH4 is a cofactor critical for nitric oxide biosynthesis and alkylglycerol and aromatic amino acid metabolism (PMID: 25550200). Dihydrobiopterin is known to be synthesized in several parts of the body, including the pineal gland. Dihydrobiopterin exists in all eukaryotes, ranging from yeast to humans. In humans, dihydrobiopterin is involved in several metabolic disorders including dihydropteridine reductase (DHPR) deficiency. DHPR deficiency is a severe form of hyperphenylalaninemia (HPA) due to impaired regeneration of tetrahydrobiopterin (BH4) leading to decreased levels of neurotransmitters (dopamine, serotonin) and folate in cerebrospinal fluid, and causing neurological symptoms such as psychomotor delay, hypotonia, seizures, abnormal movements, hypersalivation, and swallowing difficulties. Dihydrobiopterin is also associated with another metabolic disorder known as sepiapterin reductase deficiency (SRD). Sepiapterin reductase catalyzes the (NADP-dependent) reduction of carbonyl derivatives, including pteridines, and plays an important role in tetrahydrobiopterin biosynthesis. Low dihydrofolate reductase activity in the brain leads to the accumulation of dihydrobiopterin, which in turn, inhibits tyrosine and tryptophan hydroxylases. This uncouples neuronal nitric oxide synthase, leading to neurotransmitter deficiencies and neuronal cell death. SRD is characterized by low cerebrospinal fluid neurotransmitter levels and the presence of elevated cerebrospinal fluid dihydrobiopterin. SRD is characterized by motor delay, axial hypotonia, language delay, diurnal fluctuation of symptoms, dystonia, weakness, oculogyric crises, dysarthria, parkinsonian signs and hyperreflexia. | ChEBI: A 7,8-dihydrobiopterin in which the 1,2-dihydroxypropyl group has (1R,2S)-configuration; naturally occurring form."
        ],
        [
         "27",
         "BMG_MT000028",
         "HMDB: Butyric acid is a short-chain fatty acid (SCFA) formed in the mammalian colon by bacterial fermentation of carbohydrates (including dietary fibre). It is a straight-chain alkyl carboxylic acid that appears as an oily, colorless liquid with an unpleasant (rancid butter) odor. The name butyric acid comes from the Greek word for \"butter\", the substance in which it was first found. Triglycerides of butyric acid constitute 3â€šÃ„Ã¬4% of butter. When butter goes rancid, butyric acid is liberated from the short-chain triglycerides via hydrolysis. Butyric acid is a widely distributed SCFA and is found in all organisms ranging from bacteria to plants to animals. It is present in animal fat and plant oils, bovine milk, breast milk, butter, parmesan cheese, body odor and vomit. While butyric acid has an unpleasant odor, it does have a pleasant buttery taste. As a result, butyric acid is used as a flavoring agent in food manufacturing. Low-molecular-weight esters of butyric acid, such as methyl butyrate, also have very pleasant aromas or tastes. As a result, several butyrate esters are used as food and perfume additives. Butyrate is naturally produced by fermentation processes performed by obligate anaerobic bacteria found in the mammalian gut. It is a metabolite of several bacterial genera including Anaerostipes, Coprococcus, Eubacterium, Faecalibacterium and Roseburia (PMID: 12324374; PMID: 27446020). Highly-fermentable fiber residues, such as those from resistant starch, oat bran, pectin, and guar can be transformed by colonic bacteria into butyrate. One study found that resistant starch consistently produces more butyrate than other types of dietary fibre (PMID: 14747692). The production of butyrate from fibres in ruminant animals such as cattle is responsible for the butyrate content of milk and butter. Butyrate has a number of important biological functions and binds to several specific receptors. In humans, butyric acid is one of two primary endogenous agonists of human hydroxycarboxylic acid receptor 2 (HCA2), a G protein-coupled receptor. Like other SCFAs, butyrate is also an agonist at the free fatty acid receptors FFAR2 and FFAR3, which function as nutrient sensors that facilitate the homeostatic control of energy balance. Butyrate is essential to host immune homeostasis (PMID: 25875123). Butyrate's effects on the immune system are mediated through the inhibition of class I histone deacetylases (specifically, HDAC1, HDAC2, HDAC3, and HDAC8) and activation of its G-protein coupled receptor targets including HCA2, FFAR2 and FFAR3. Among the short-chain fatty acids, butyrate is the most potent promoter of intestinal regulatory T cells in vitro and the only SCFA that is an HCA2 ligand (PMID: 25741338). Butyrate has been shown to be a critical mediator of the colonic inflammatory response. It possesses both preventive and therapeutic potential to counteract inflammation-mediated ulcerative colitis and colorectal cancer. As a short-chain fatty acid, butyrate is metabolized by mitochondria as an energy source through fatty acid metabolism. In particular, it is an important energy source for cells lining the mammalian colon (colonocytes). Without butyrate, colon cells undergo autophagy (i.e., self-digestion) and die. | ChEBI: A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group."
        ],
        [
         "28",
         "BMG_MT000029",
         "HMDB: Acetic acid is a two-carbon, straight-chain fatty acid. It is the smallest short-chain fatty acid (SCFA) and one of the simplest carboxylic acids. is an acidic, colourless liquid and is the main component in vinegar. Acetic acid has a sour taste and pungent smell. It is an important chemical reagent and industrial chemical that is used in the production of plastic soft drink bottles, photographic film; and polyvinyl acetate for wood glue, as well as many synthetic fibres and fabrics. In households diluted acetic acid is often used as a cleaning agent. In the food industry acetic acid is used as an acidity regulator. Acetic acid is found in all organisms, from bacteria to plants to humans. The acetyl group, derived from acetic acid, is fundamental to the biochemistry of virtually all forms of life. When bound to coenzyme A (to form acetylCoA) it is central to the metabolism of carbohydrates and fats. However, the concentration of free acetic acid in cells is kept at a low level to avoid disrupting the control of the pH of the cell contents. Acetic acid is produced and excreted in large amounts by certain acetic acid bacteria, notably the Acetobacter genus and Clostridium acetobutylicum. These bacteria are found universally in foodstuffs, water, and soil. Due to their widespread presence on fruit, acetic acid is produced naturally as fruits and many other sugar-rich foods spoil. Several species of anaerobic bacteria, including members of the genus Clostridium and Acetobacterium can convert sugars to acetic acid directly. However, Clostridium bacteria are less acid-tolerant than Acetobacter. Even the most acid-tolerant Clostridium strains can produce acetic acid in concentrations of only a few per cent, compared to Acetobacter strains that can produce acetic acid in concentrations up to 20%. Acetic acid is also a component of the vaginal lubrication of humans and other primates, where it appears to serve as a mild antibacterial agent. Acetic acid can be found in other biofluids such as urine at low concentrations. Urinary acetic acid is produced by bacteria such as Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumonia, Enterobacter, Acinetobacter, Proteus mirabilis, Citrobacter frundii, Enterococcus faecalis, Streptococcus group B, Staphylococcus saprophyticus (PMID: 22292465). Acetic acid concentrations greater than 30 uM/mM creatinine in the urine can indicate a urinary tract infection, which typically suggests the presence of E. coli or Klebshiella pneumonia in the urinary tract. (PMID: 24909875) Acetic acid is also produced by other bacteria such as Akkermansia, Bacteroidetes, Bifidobacterium, Prevotella and Ruminococcus (PMID: 20444704; PMID: 22292465). | ChEBI: A simple monocarboxylic acid containing two carbons."
        ],
        [
         "29",
         "BMG_MT000030",
         "HMDB: Betaine (CAS: 107-43-7), also known as N,N,N-trimethylglycine, was named after its discovery in sugar beet (Beta vulgaris) in the 19th century. It is a small N-trimethylated amino acid, existing in zwitterionic form at neutral pH. It is now often called glycine betaine to distinguish it from other betaines that are widely distributed in microorganisms, plants, and animals. Many naturally occurring betaines serve as organic osmolytes, substances synthesized or taken up from the environment by cells for protection against osmotic stress, drought, high salinity, or high temperature. Intracellular accumulation of betaines permits water retention in cells, thus protecting from the effects of dehydration (Wikipedia). Betaine functions as a methyl donor in that it carries and donates methyl functional groups to facilitate necessary chemical processes. In particular, it methylates homocysteine to methionine, also producing N,N-dimethylglycine. The donation of methyl groups is important to proper liver function, cellular replication, and detoxification reactions. Betaine also plays a role in the manufacture of carnitine and serves to protect the kidneys from damage. Betaine comes from either the diet or by the oxidation of choline. Betaine insufficiency is associated with metabolic syndrome, lipid disorders, and diabetes, and may have a role in vascular and other diseases (PMID: 20346934). Betaine is important in development, from the pre-implantation embryo to infancy. Betaine is also widely regarded as an anti-oxidant. Betaine has been shown to have an inhibitory effect on NO release in activated microglial cells and may be an effective therapeutic component to control neurological disorders (PMID: 22801281). As a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. Betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances (Martindale, The Extra Pharmacopoeia, 30th Ed, p1341). | ChEBI: A quaternary ammonium ion in which the substituents on nitrogen are methyl (three) and carboxymethyl."
        ],
        [
         "30",
         "BMG_MT000031",
         "HMDB: Ascorbic acid is found naturally in citrus fruits and many vegetables and is an essential nutrient in human diets. It is necessary to maintain connective tissue and bone. The biologically active form of ascorbic acid is vitamin C. Vitamin C is a water soluble vitamin. Primates (including humans) and a few other species in all divisions of the animal kingdom, notably the guinea pig, have lost the ability to synthesize ascorbic acid and must obtain it in their food. Vitamin C functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant (PubChem). Ascorbic acid is an electron donor for enzymes involved in collagen hydroxylation, biosynthesis of carnitine and norepinephrine, tyrosine metabolism, and amidation of peptide hormones. Ascrobic acid (vitamin C) deficiency causes scurvy. The amount of vitamin C necessary to prevent scurvy may not be adequate to maintain optimal health. The ability of vitamin C to donate electrons also makes it a potent water-soluble antioxidant that readily scavenges free radicals such as molecular oxygen, superoxide, hydroxyl radical, and hypochlorous acid. In this setting, several mechanisms could account for a link between vitamin C and heart disease. One is the relation between LDL oxidation and vitamins C and E. Vitamin C in vitro can recycle vitamin E, which can donate electrons to prevent LDL oxidation in vitro. As the lipid-phase vitamin E is oxidized, it can be regenerated by aqueous vitamin C. Other possibilities are that vitamin C could decrease cholesterol by mechanisms not well characterized, or could improve vasodilatation and vascular reactivity, perhaps by decreasing the interactions of nitric oxide with oxidants (PMID: 10799361). Moreover, ascorbic acid is found to be associated with hyperoxalemia, which is an inborn error of metabolism. Ascorbic acid is also a microbial metabolite produced by Ketogulonicigenium (PMID: 15785002). | ChEBI: The L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate."
        ],
        [
         "31",
         "BMG_MT000032",
         "HMDB: Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP can be produced during ATP synthesis by the enzyme adenylate kinase. AMP has recently been approved as a 'Bitter Blocker' additive to foodstuffs. When AMP is added to bitter foods or foods with a bitter aftertaste it makes them seem 'sweeter'. This potentially makes lower calorie food products more palatable. | ChEBI: A purine ribonucleoside 5'-monophosphate having adenine as the nucleobase. | ChEBI: A nucleoside 5'-monophosphate(2-) that results from the removal of two protons from the phosphate group of adenosine 5'-monophosphate (AMP)."
        ],
        [
         "32",
         "BMG_MT000033",
         "HMDB: Melibiose (CAS: 585-99-9) is a disaccharide consisting of one galactose and one glucose moiety in an alpha (1-6) glycosidic linkage. This sugar is produced and metabolized only by enteric and lactic acid bacteria and other microbes, such as Dickeya dadantii, Escherichia, Leuconostoc, and Saccharomyces (PMID: 19734309, 28453942). It is not an endogenous metabolite but may be obtained from the consumption of partially fermented molasses, brown sugar, or honey. Antibodies to melibiose will appear in individuals affected by Chagas' disease (Trypanosoma cruzi infection). Melibiose is not metabolized by humans but can be broken down by gut microflora, such as E. coli. In fact, E. coli is able to utilize melibiose as a sole source of carbon. Melibiose is first imported by the melibiose permease, MelB and then converted into Î²-D-glucose and Î²-D-galactose by the Î±-galactosidase encoded by melA. Because of its poor digestibility, melibiose (along with rhamnose) can be used together for noninvasive intestinal mucosa barrier testing. This test can be used to assess malabsorption or impairment of intestinal permeability. Recent studies with dietary melibiose have shown that it can strongly affect the Th cell responses to an ingested antigen. It has been suggested that melibiose could be used to enhance the induction of oral tolerance (PMID: 17986780)."
        ],
        [
         "33",
         "BMG_MT000034",
         "HMDB: Adenosine is a nucleoside that is composed of adenine and D-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. For instance, adenosine plays an important role in energy transfer as adenosine triphosphate (ATP) and adenosine diphosphate (ADP). It also plays a role in signal transduction as cyclic adenosine monophosphate (cAMP). Adenosine itself is both a neurotransmitter and potent vasodilator. When administered intravenously adenosine causes transient heart block in the AV node. Due to the effects of adenosine on AV node-dependent supraventricular tachycardia, adenosine is considered a class V antiarrhythmic agent. Overdoses of adenosine intake (as a drug) can lead to several side effects including chest pain, feeling faint, shortness of breath, and tingling of the senses. Serious side effects include a worsening dysrhythmia and low blood pressure. When present in sufficiently high levels, adenosine can act as an immunotoxin and a metabotoxin. An immunotoxin disrupts, limits the function, or destroys immune cells. A metabotoxin is an endogenous metabolite that causes adverse health effects at chronically high levels. Chronically high levels of adenosine are associated with adenosine deaminase deficiency. Adenosine is a precursor to deoxyadenosine, which is a precursor to dATP. A buildup of dATP in cells inhibits ribonucleotide reductase and prevents DNA synthesis, so cells are unable to divide. Since developing T cells and B cells are some of the most mitotically active cells, they are unable to divide and propagate to respond to immune challenges. High levels of deoxyadenosine also lead to an increase in S-adenosylhomocysteine, which is toxic to immature lymphocytes. | ChEBI: A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond."
        ],
        [
         "34",
         "BMG_MT000035",
         "HMDB: Ammonia is a colourless alkaline gas and is one of the most abundant nitrogen-containing compounds in the atmosphere. It is an irritant with a characteristic pungent odor that is widely used in industry. Inasmuch as ammonia is highly soluble in water and, upon inhalation, is deposited in the upper airways, occupational exposures to ammonia have commonly been associated with sinusitis, upper airway irritation, and eye irritation. Acute exposures to high levels of ammonia have also been associated with diseases of the lower airways and interstitial lung. Small amounts of ammonia are naturally formed in nearly all tissues and organs of the vertebrate organism. Ammonia is both a neurotoxin and a metabotoxin. In fact, it is the most common endogenous neurotoxin. A neurotoxin is a compound that causes damage to neural tissue and neural cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Ammonia is recognized to be central in the pathogenesis of a brain condition known as hepatic encephalopathy, which arises from various liver diseases and leads to a build up ammonia in the blood (hyperammonemia). More than 40% of people with cirrhosis develop hepatic encephalopathy. Part of the neurotoxicity of ammonia arises from the fact that it easily crosses the blood-brain barrier and is absorbed and metabolized by the astrocytes, a population of cells in the brain that constitutes 30% of the cerebral cortex. Astrocytes use ammonia when synthesizing glutamine from glutamate. The increased levels of glutamine lead to an increase in osmotic pressure in the astrocytes, which become swollen. There is increased activity of the inhibitory gamma-aminobutyric acid (GABA) system, and the energy supply to other brain cells is decreased. This can be thought of as an example of brain edema. The source of the ammonia leading to hepatic encaphlopahy is not entirely clear. The gut produces ammonia, which is metabolized in the liver, and almost all organ systems are involved in ammonia metabolism. Colonic bacteria produce ammonia by splitting urea and other amino acids, however this does not fully explain hyperammonemia and hepatic encephalopathy. The alternative explanation is that hyperammonemia is the result of intestinal breakdown of amino acids, especially glutamine. The intestines have significant glutaminase activity, predominantly located in the enterocytes. On the other hand, intestinal tissues only have a little glutamine synthetase activity, making it a major glutamine-consuming organ. In addition to the intestine, the kidney is an important source of blood ammonia in patients with liver disease. Ammonia is also taken up by the muscle and brain in hepatic coma, and there is confirmation that ammonia is metabolized in muscle. Excessive formation of ammonia in the brains of Alzheimer's disease patients has also been demonstrated, and it has been shown that some Alzheimer's disease patients exhibit elevated blood ammonia concentrations. Ammonia is the most important natural modulator of lysosomal protein processing. Indeed, there is strong evidence for the involvement of aberrant lysosomal processing of beta-amyloid precursor protein (beta-APP) in the formation of amyloid deposits. Inflammatory processes and activation of microglia are widely believed to be implicated in the pathology of Alzheimer's disease. Ammonia is able to affect the characteristic functions of microglia, such as endocytosis, and cytokine production. Based on these facts, an ammonia-based hypothesis for Alzheimer's disease has been suggested (PMID: 17006913, 16167195, 15377862, 15369278). Chronically high levels of ammonia in the blood are associated with nearly twenty different inborn errors of metabolism including: 3-hydroxy-3-methylglutaryl-CoA lyase deficiency, 3-methyl-crotonylglycinuria, argininemia, argininosuccinic aciduria, beta-ketothiolase deficiency, biotinidase deficiency, carbamoyl phosphate synthetase deficiency, carnitine-acylcarnitine translocase deficiency, citrullinemia type I, hyperinsulinism-hyperammonemia syndrome, hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, isovaleric aciduria, lysinuric protein intolerance, malonic aciduria, methylmalonic aciduria, methylmalonic aciduria due to cobalamin-related disorders, propionic acidemia, pyruvate carboxylase deficiency, and short chain acyl CoA dehydrogenase deficiency (SCAD deficiency). Many of these inborn errors of metabolism are associated with urea cycle disorders or impairment to amino acid metabolism. High levels of ammonia in the blood (hyperammonemia) lead to the activation of NMDA receptors in the brain. This results in the depletion of brain ATP, which in turn leads to release of glutamate. Ammonia also leads to the impairment of mitochondrial function and calcium homeostasis, thereby decreasing ATP synthesis. Excess ammonia also increases the formation of nitric oxide (NO), which in turn reduces the activity of glutamine synthetase, and thereby decreases the elimination of ammonia in the brain (PMID: 12020609). As a neurotoxin, ammonia predominantly affects astrocytes. Disturbed mitochondrial function and oxidative stress, factors implicated in the induction of the mitochondrial permeability transition, appear to be involved in the mechanism of ammonia neurotoxicity. Ammonia can also affect the glutamatergic and GABAergic neuronal systems, the two prevailing neuronal systems of the cortical structures. All of these effects can lead to irreversible brain damage, coma, and/or death. Infants with urea cycle disorders and hyperammonia initially exhibit vomiting and increasing lethargy. If untreated, seizures, hypotonia (poor muscle tone, floppiness), respiratory distress (respiratory alkalosis), and coma can occur. Adults with urea cycle disorders and hyperammonia will exhibit episodes of disorientation, confusion, slurred speech, unusual and extreme combativeness or agitation, stroke-like symptoms, lethargy, and delirium. Ammonia also has toxic effects when an individual is exposed to ammonia solutions. Acute exposure to high levels of ammonia in air may be irritating to skin, eyes, throat, and lungs and cause coughing and burns. Lung damage and death may occur after exposure to very high concentrations of ammonia. Swallowing concentrated solutions of ammonia can cause burns in the mouth, throat, and stomach. Splashing ammonia into eyes can cause burns and even blindness. | ChEBI: An azane that consists of a single nitrogen atom covelently bonded to three hydrogen atoms."
        ],
        [
         "35",
         "BMG_MT000036",
         "HMDB: Arginosuccinic acid is a basic amino acid. Some cells synthesize it from citrulline, aspartic acid and use it as a precursor for arginine in the urea cycle or Citrulline-NO cycle. The enzyme that catalyzes the reaction is argininosuccinate synthetase. Argininosuccinic acid is a precursor to fumarate in the citric acid cycle via argininosuccinate lyase. Defects in the argininosuccinate lyase enzyme can lead to argininosuccinate lyase deficiency, which is an inborn error of metabolism. Argininosuccinate (ASA) lyase deficiency results in defective cleavage of ASA. This leads to an accumulation of ASA in cells and an excessive excretion of ASA in urine (argininosuccinic aciduria). In virtually all respects, this disorder shares the characteristics of other urea cycle defects. The most important characteristic of ASA lyase deficiency is its propensity to cause hyperammonemia in affected individuals. ASA in affected individuals is excreted by the kidney at a rate practically equivalent to the glomerular filtration rate (GFR). Whether ASA itself causes a degree of toxicity due to hepatocellular accumulation is unknown; such an effect could help explain hyperammonemia development in affected individuals. Regardless, the name of the disease is derived from the rapid clearance of ASA in urine, although elevated levels of ASA can be found in plasma. ASA lyase deficiency is associated with high mortality and morbidity rates. Symptoms of ASA lyase deficiency include anorexia, irritability rapid breathing, lethargy and vomiting. Extreme symptoms include coma and cerebral edema. | ChEBI: A L-arginine derivative that has formula C10H18N4O6."
        ],
        [
         "36",
         "BMG_MT000037",
         "HMDB: Androstenedione is a delta-4 19-carbon steroid that is produced not only in the testis, but also in the ovary and the adrenal cortex. Depending on the tissue type, androstenedione can serve as a precursor to testosterone as well as estrone and estradiol. It is the common precursor of male and female sex hormones. Some androstenedione is also secreted into the plasma and may be converted in peripheral tissues to testosterone and estrogens. Androstenedione originates either from the conversion of dehydroepiandrosterone or from 17-hydroxyprogesterone. It is further converted to either testosterone or estrone. The production of adrenal androstenedione is governed by ACTH, while the production of gonadal androstenedione is under control by gonadotropins. | ChEBI: A 3-oxo Delta(4)-steroid that is androst-4-ene substituted by oxo groups at positions 3 and 17. It is a steroid hormone synthesized in the adrenal glands and gonads."
        ],
        [
         "37",
         "BMG_MT000038",
         "HMDB: Bilirubin is a yellow bile pigment that is a degradation product of heme. It occurs in the normal catabolic pathway that breaks down heme in vertebrates. This catabolism is a necessary process in the body's clearance of waste products that arise from the destruction of aged or abnormal red blood cells. Bilirubin has been found in all vertebrates and in certain plants including Strelitzia nicolai (PMID: 28573242). Bilirubin levels in humans are elevated in certain diseases such as jaundice and liver disease and it is responsible for the yellow color of bruises and the yellow discoloration in jaundice. Bilirubin breakdown products, such as stercobilin, cause the brown color of feces. A different breakdown product, urobilin, is the main component of the straw-yellow color in urine. Bilirubin consists of an open chain of four pyrroles (tetrapyrrole). It is formed by oxidative cleavage of a porphyrin in heme, which leads to biliverdin, a green tetrapyrrolic bile pigment that is also a product of heme catabolism. Biliverdin is then reduced to bilirubin via biliverdin reductase. After conjugation with glucuronic acid, bilirubin can be excreted in the urine. Bilirubin is structurally similar to the pigment phycobilin used by certain algae to capture light energy, and to the pigment phytochrome used by plants to sense light. Elevated bilirubin levels in humans are associated with Crigler-Najjar syndrome type I, which is an inborn error of metabolism. Crigler-Najjar syndrome is a rare genetic disorder characterized by an inability to properly convert and clear bilirubin from the body. Affected individuals cannot convert unconjugated bilirubin to the conjugated form because they lack a specific liver enzyme required to break down (metabolize) bilirubin. Since they cannot convert bilirubin, they develop abnormally high levels of unconjugated bilirubin in the blood (hyperbilirubinemia). Crigler-Najjar syndrome is caused by mutations in the UGT1A1 gene. The hallmark finding of Crigler-Najjar syndrome is a persistent yellowing of the skin, mucous membranes and whites of the eyes (jaundice). Elevation of both alanine aminotransferase and bilirubin levels in serum or plasma can be indicative of serious liver injury. High levels of bilirubin are indicative of jaundice, which is easily recognizable due to a yellowing of the skin and eyes.  Bilirubin is also an antioxidant. Bilirubin's antioxidant activity may be particularly important in the brain, where it prevents excitotoxicity and neuronal death by scavenging superoxide during N-methyl-D-aspartic acid neurotransmission (PMID: 31353321). | ChEBI: A member of the class of  biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin."
        ],
        [
         "38",
         "BMG_MT000039",
         "HMDB: Cellobiose, also known as GLCB1-4GLCB or cellose, is a disaccharide. It is also classified as a reducing sugar. In terms of its chemical structure, it is derived from the condensation of a pair beta-glucose molecules creating a beta (1â€šÃœÃ­4) bond. It belongs to the class of organic compounds known as O-glycosyl compounds. These are glycosides in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Cellobiose can be obtained by enzymatic hydrolysis of cellulose and cellulose-rich materials such as cotton, jute, or paper. Cellobiose is a plant metabolite found in flowering plants, conifers and other gymnosperms. Cellobiose can also be found in vertebrates that have consumed plant foods. It has been detected, but not quantified in, several different foods, such as okra, common chokecherries, cherry tomatoes, and welsh onions. Cellobiose can be used as an indicator carbohydrate for Crohn's disease and malabsorption syndrome. Intestinal permeability to detect Crohn's disease and malabsorption syndrome can be measured by the sugar absorption test. This test is based on determining the ratio of the urinary excretion of a large (a disaccharide such as cellobiose) and a small carbohydrate (a monosaccharide such as lactulose or rhamnose) after oral administration. Patients with Crohn's disease or with ulcerative colitis have increased permeability indices in comparison to healthy controls (PMID: 15546811). | ChEBI: A cellobiose with beta configuration at the reducing-end glucose residue."
        ],
        [
         "39",
         "BMG_MT000040",
         "HMDB: beta-Alanine is the only naturally occurring beta-amino acid - an amino acid in which the amino group is at the beta-position from the carboxylate group. It is formed in vivo by the degradation of dihydrouracil and carnosine. It is a component of the naturally occurring peptides carnosine and anserine and also of pantothenic acid (vitamin B-5), which itself is a component of coenzyme A. Under normal conditions, beta-alanine is metabolized into acetic acid. beta-Alanine can undergo a transanimation reaction with pyruvate to form malonate-semialdehyde and L-alanine. The malonate semialdehyde can then be converted into malonate via malonate-semialdehyde dehydrogenase. Malonate is then converted into malonyl-CoA and enter fatty acid biosynthesis. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, beta-alanine may act as a false transmitter replacing gamma-aminobutyric acid. When present in sufficiently high levels, beta-alanine can act as a neurotoxin, a mitochondrial toxin, and a metabotoxin. A neurotoxin is a compound that damages the brain or nerve tissue. A mitochondrial toxin is a compound that damages mitochondria and reduces cellular respiration as well as oxidative phosphorylation. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of beta-alanine are associated with at least three inborn errors of metabolism, including GABA-transaminase deficiency, hyper-beta-alaninemia, and methylmalonate semialdehyde dehydrogenase deficiency. beta-Alanine is a central nervous system (CNS) depressant and is an inhibitor of GABA transaminase. The associated inhibition of GABA transaminase and displacement of GABA from CNS binding sites can also lead to GABAuria (high levels of GABA in the urine) and convulsions. In addition to its neurotoxicity, beta-alanine reduces cellular levels of taurine, which are required for normal respiratory chain function. Cellular taurine depletion is known to reduce respiratory function and elevate mitochondrial superoxide generation, which damages mitochondria and increases oxidative stress (PMID: 27023909). Individuals suffering from mitochondrial defects or mitochondrial toxicity typically develop neurotoxicity, hypotonia, respiratory distress, and cardiac failure. beta-Alanine is a biomarker for the consumption of meat, especially red meat. | ChEBI: A naturally-occurring beta-amino acid comprising propionic acid with the amino group in the 3-position."
        ],
        [
         "40",
         "BMG_MT000041",
         "HMDB: Cyclic AMP (cAMP) or cyclic adenosine monophosphate is an adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. cAMP is found in all organisms ranging from bacteria to plants to animals. In humans and other mammals it is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon and ACTH. cAMP is synthesized from ATP by adenylate cyclase. Adenylate cyclase is located at the inner side of cell membranes. Adenylate cyclase is activated by the hormones glucagon and adrenaline and by G protein. Liver adenylate cyclase responds more strongly to glucagon, and muscle adenylate cyclase responds more strongly to adrenaline. cAMP decomposition into AMP is catalyzed by the enzyme phosphodiesterase. cAMP is primarily used for intracellular signal transduction, such as transferring into cells the effects of hormones like glucagon and adrenaline, which cannot pass through the plasma membrane. cAMP is also involved in the activation of protein kinases. In addition, cAMP binds to and regulates the function of ion channels such as the HCN channels. Hyperpolarization-activated cyclic nucleotideâ€šÃ„Ã¬gated (HCN) channels are integral membrane proteins that serve as nonselective voltage-gated cation channels in the plasma membranes of heart and brain cells. HCN channels are sometimes referred to as pacemaker channels because they help to generate rhythmic activity within groups of heart and brain cells. | ChEBI: A 3',5'-cyclic purine nucleotide having having adenine as the nucleobase."
        ],
        [
         "41",
         "BMG_MT000042",
         "HMDB: Acetoacetic acid (AcAc) is a weak organic acid that can be produced in the human liver under certain conditions of poor metabolism leading to excessive fatty acid breakdown (diabetes mellitus leading to diabetic ketoacidosis). It is then partially converted into acetone by decarboxylation and excreted either in urine or through respiration. Persistent mild hyperketonemia is a common finding in newborns. Ketone bodies serve as an indispensable source of energy for extrahepatic tissues, especially the brain and lung of developing rats. Another important function of ketone bodies is to provide acetoacetyl-CoA and acetyl-CoA for synthesis of cholesterol, fatty acids, and complex lipids. During the early postnatal period, acetoacetate and beta-hydroxybutyrate are preferred over glucose as substrates for synthesis of phospholipids and sphingolipids in accord with requirements for brain growth and myelination. Thus, during the first two weeks of postnatal development, when the accumulation of cholesterol and phospholipids accelerates, the proportion of ketone bodies incorporated into these lipids increases. On the other hand, an increased proportion of ketone bodies are utilized for cerebroside synthesis during the period of active myelination. In the lung, AcAc serves better than glucose as a precursor for the synthesis of lung phospholipids. The synthesized lipids, particularly dipalmityl phosphatidylcholine, are incorporated into surfactant, and thus have a potential role in supplying adequate surfactant lipids to maintain lung function during the early days of life (PMID: 3884391). The acid is also present in the metabolism of those undergoing starvation or prolonged physical exertion as part of gluconeogenesis. When ketone bodies are measured by way of urine concentration, acetoacetic acid, along with beta-hydroxybutyric acid or acetone, is what is detected. | ChEBI: A 3-oxo monocarboxylic acid that is butyric acid bearing a 3-oxo substituent."
        ],
        [
         "42",
         "BMG_MT000043",
         "HMDB: Adenosine 3', 5'-diphosphate or PAP is a nucleotide that is closely related to ADP. It has two phosphate groups attached to the 5' and 3' positions of the pentose sugar ribose (instead of pyrophosphoric acid at the 5' position, as found in ADP), and the nucleobase adenine. PAP is converted to PAPS by Sulfotransferase and then back to PAP after the sulfotransferase reaction. Sulfotransferase (STs) catalyze the transfer reaction of the sulfate group from the ubiquitous donor 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to an acceptor group of numerous substrates. This reaction, often referred to as sulfuryl transfer, sulfation, or sulfonation, is widely observed from bacteria to humans and plays a key role in various biological processes such as cell communication, growth and development, and defense. PAP also appears to a role in bipolar depression. Phosphatases converting 3'-phosphoadenosine 5'-phosphate (PAP) into adenosine 5'-phosphate are of fundamental importance in living cells as the accumulation of PAP is toxic to several cellular systems. These enzymes are lithium-sensitive and we have characterized a human PAP phosphatase as a potential target of lithium therapy. | ChEBI: An adenosine bisphosphate having two monophosphate groups at the 3'- and 5'-positions."
        ],
        [
         "43",
         "BMG_MT000044",
         "HMDB: Carnitine is a non-essential amino acid and a quaternary ammonium compound. Carnitine is also classified as an alcohol (specifically, a trimethylated carboxy-alcohol). Carnitine exists as one of two stereoisomers (the two enantiomers D-carnitine and L-carnitine. Both are biologically active, but only L-carnitine naturally occurs in animals, and D-carnitine is toxic as it inhibits the activity of the L-form. Carnitine is involved in the metabolism in most mammals, plants, and some bacteria.  Carnitine plays a key role in lipid metabolism and beta-oxidation. It is used to transport long-chain fatty acids into the mitochondria to be oxidized for energy production. This is done by forming a long chain acetylcarnitine esters which are then transported by carnitine palmitoyltransferase I and carnitine palmitoyltransferase II. Carnitine also participates in removing products of metabolism from cells. Given its key metabolic roles, carnitine is concentrated in skeletal and cardiac muscle as well as other tissues that metabolize fatty acids as an energy source. A normal 70 kilogram person typically produces 11â€šÃ„Ã¬34 mg of carnitine per day. Adults eating mixed diets of red meat and other animal products ingest 60â€šÃ„Ã¬180 mg of carnitine per day, while vegans consume about 10â€šÃ„Ã¬12 mg per day. Most carnitine obtained from the diet is absorbed in the small intestine before entering the blood.[3] The total body content of carnitine is about 20 grams in a person weighing 70 kilograms, with nearly all of it contained within skeletal muscle cells. Carnitine is so important in providing energy to muscles (including the heart) that some researchers are now recommending carnitine supplements in the diet, particularly for people who do not consume much red meat (the main food source for carnitine). Carnitine has been described as a vitamin, an amino acid, or a metabimin (i.e. an essential metabolite). Like the B vitamins, carnitine contains nitrogen and is very soluble in water. However, most animals, including humans, make their own carnitine; thus, carnitine cannot be considered to be a vitamin. In certain circumstances, such as methionine deficiency, lysine deficiency, vitamin C deficiency or kidney dialysis, carnitine shortages can develop. Under these conditions, carnitine must be absorbed from food, and for this reason, it is sometimes referred to as a \"metabimin\" or a conditionally essential metabolite. In humans, about 25% of carnitine is synthesized in the liver, kidney, and brain from lysine and methionine. Most of the carnitine in the body comes from dietary sources such as red meat and dairy products. Inborn errors of carnitine metabolism such as Reyeâ€šÃ„Ã´s syndrome can lead to brain deterioration gradually worsening muscle weakness, Duchenne-like muscular dystrophy, and extreme muscle weakness with fat accumulation in muscles. Carnitine is an essential nutrient for pre-term babies and individuals who are unable to eat a normal diet (e.g. non-ketotic hypoglycemics, kidney dialysis patients) (PMID: 115309). In conditions such as kwashiorkor, cirrhosis, and heart muscle disease (cardiomyopathy) as well as in inborn errors of metabolism such as type IV hyperlipidemia and propionic aciduria, carnitine is essential to life and carnitine supplements are critically important. Carnitine therapy may also be useful in a wide variety of clinical conditions. Carnitine supplementation has improved some patients who have angina secondary to coronary artery disease. Carnitine supplements may also be useful in many forms of metabolic liver diseases and heart muscle disease. Hearts undergoing severe arrhythmia quickly deplete their stores of carnitine. Athletes, particularly in Europe, have used carnitine supplements for improved endurance. Carnitine may improve muscle building by improving fat utilization and may even be useful in treating obesity. Carnitine may be of value in treating pregnant women, hypothyroid individuals, and male infertility due to the low motility of sperm. Carnitine deficiency is noted in abnormal liver function, renal dialysis patients, and severe to moderate muscular weakness with associated anorexia. Carnitine is a biomarker for the consumption of meat. In fact, carnitine was first extracted from meat extracts in 1905, leading to its name from Latin, \"caro/carnis\" or flesh. | ChEBI: The (R)-enantiomer of carnitine."
        ],
        [
         "44",
         "BMG_MT000045",
         "HMDB: Cortisol is the main glucocorticoid secreted by the adrenal cortex and it is involved in the stress response. Its synthetic counterpart hydrocortisone is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Hydrocortisone is synthesized from pregnenolone and is used as an immunosuppressive drug given by injection in the treatment of severe allergic reactions such as anaphylaxis and angioedema, in place of prednisolone in patients who need steroid treatment but cannot take oral medication, and peri-operatively in patients on long-term steroid treatment to prevent an Addisonian crisis. Cortisol increases blood pressure, blood sugar levels, may cause infertility in women, and suppresses the immune system. The amount of cortisol present in the serum undergoes diurnal variation, with the highest levels present in the early morning and lower levels in the evening, several hours after the onset of sleep. Cortisol is found to be associated with ACTH deficiency and glucocorticoid deficiency, which are inborn errors of metabolism. Cortisol binds to the cytosolic glucocorticoid receptor. After binding the receptor, the newly formed receptor-ligand complex translocates itself into the cell nucleus where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA-bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically, glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes and prevents phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In other words, the two main products of inflammation, prostaglandins and leukotrienes, are inhibited by the action of glucocorticoids. Glucocorticoids also stimulate the escape of lipocortin-1 into the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst, and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines, etc.) from neutrophils, macrophages, and mastocytes. Additionally, the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. | ChEBI: A 17alpha-hydroxy-C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the \\stress hormone\\ as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses."
        ],
        [
         "45",
         "BMG_MT000046",
         "HMDB: Creatine, is a naturally occurring non-protein compound. It belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. Creatine is found in all vertebrates where it facilitates recycling of adenosine triphosphate (ATP). Its primary metabolic role is to combine with a phosphoryl group, via the enzyme creatine kinase, to generate phosphocreatine, which is used to regenerate ATP. Most of the human body's total creatine and phosphocreatine stores are found in skeletal muscle (95%), while the remainder is distributed in the blood, brain, testes, and other tissues. Creatine is not an essential nutrient as it is naturally produced in the human body from the amino acids glycine and arginine, with an additional requirement for methionine to catalyze the transformation of guanidinoacetate to creatine. In the first step of its biosynthesis glycine and arginine are combined by the enzyme arginine:glycine amidinotransferase (AGAT) to form guanidinoacetate, which is then methylated by guanidinoacetate N-methyltransferase (GAMT), using S-adenosyl methionine as the methyl donor. Creatine can also be obtained through the diet at a rate of about 1 gram per day from an omnivorous diet. A cyclic form of creatine, called creatinine, exists in equilibrium with its tautomer and with creatine. Clinically, there are three distinct disorders of creatine metabolism. Deficiencies in the two synthesis enzymes (AGAT and GAMT) can cause L-arginine:glycine amidinotransferase deficiency (caused by variants in AGAT) and guanidinoacetate methyltransferase deficiency (caused by variants in GAMT). Both disorders are inherited in an autosomal recessive manner. A third defect, creatine transporter defect, is caused by mutations in SLC6A8 and inherited in a X-linked manner. Creatine is widely used as a supplement by athletes. Its use can increase maximum power and performance in high-intensity anaerobic repetitive work (periods of work and rest) by 5 to 15% (PMID: 24688272). Creatine has no significant effect on aerobic endurance, although it will increase power during short sessions of high-intensity aerobic exercise (PMID: 9662683). | ChEBI: A glycine derivative having methyl and amidino groups attached to the nitrogen."
        ],
        [
         "46",
         "BMG_MT000047",
         "HMDB: Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues and transported in the blood plasma of all animals. The name originates from the Greek chole- (bile) and stereos (solid), and the chemical suffix -ol for an alcohol. This is because researchers first identified cholesterol in solid form in gallstones in 1784. In the body, cholesterol can exist in either the free form or as an ester with a single fatty acid (of 10-20 carbons in length) covalently attached to the hydroxyl group at position 3 of the cholesterol ring. Due to the mechanism of synthesis, plasma cholesterol esters tend to contain relatively high proportions of polyunsaturated fatty acids. Most of the cholesterol consumed as a dietary lipid exists as cholesterol esters. Cholesterol esters have a lower solubility in water than cholesterol and are more hydrophobic. They are hydrolyzed by the pancreatic enzyme cholesterol esterase to produce cholesterol and free fatty acids. Cholesterol has vital structural roles in membranes and in lipid metabolism in general. It is a biosynthetic precursor of bile acids, vitamin D, and steroid hormones (glucocorticoids, estrogens, progesterones, androgens and aldosterone). In addition, it contributes to the development and functioning of the central nervous system, and it has major functions in signal transduction and sperm development. Cholesterol is a ubiquitous component of all animal tissues where much of it is located in the membranes, although it is not evenly distributed. The highest proportion of unesterified cholesterol is in the plasma membrane (roughly 30-50% of the lipid in the membrane or 60-80% of the cholesterol in the cell), while mitochondria and the endoplasmic reticulum have very low cholesterol contents. Cholesterol is also enriched in early and recycling endosomes, but not in late endosomes. The brain contains more cholesterol than any other organ where it comprises roughly a quarter of the total free cholesterol in the human body. Of all the organic constituents of blood, only glucose is present in a higher molar concentration than cholesterol. Cholesterol esters appear to be the preferred form for transport in plasma and as a biologically inert storage (de-toxified) form. They do not contribute to membranes but are packed into intracellular lipid particles. Cholesterol molecules (i.e. cholesterol esters) are transported throughout the body via lipoprotein particles. The largest lipoproteins, which primarily transport fats from the intestinal mucosa to the liver, are called chylomicrons. They carry mostly triglyceride fats and cholesterol that are from food, especially internal cholesterol secreted by the liver into the bile. In the liver, chylomicron particles give up triglycerides and some cholesterol. They are then converted into low-density lipoprotein (LDL) particles, which carry triglycerides and cholesterol on to other body cells. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. (Lack of information on LDL particle number and size is one of the major problems of conventional lipid tests.). In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. There is a worldwide trend to believe that lower total cholesterol levels tend to correlate with lower atherosclerosis event rates (though some studies refute this idea). As a result, cholesterol has become a very large focus for the scientific community trying to determine the proper amount of cholesterol needed in a healthy diet. However, the primary association of atherosclerosis with cholesterol has always been specifically with cholesterol transport patterns, not total cholesterol per se. For example, total cholesterol can be low, yet made up primarily of small LDL and small HDL particles and atheroma growth rates are high. In contrast, however, if LDL particle number is low (mostly large particles) and a large percentage of the HDL particles are large (HDL is actively reverse transporting cholesterol), then atheroma growth rates are usually low, even negative, for any given total cholesterol concentration. These effects are further complicated by the relative concentration of asymmetric dimethylarginine (ADMA) in the endothelium since ADMA down-regulates production of nitric oxide, a relaxant of the endothelium. Thus, high levels of ADMA, associated with highly oxidized levels of LDL, pose a heightened risk factor for vascular disease. Chronically high levels of cholesterol are associated with at least five inborn errors of metabolism, including cerebrotendinous xanthomatosis, cholesteryl ester storage disease, congenital lipoid adrenal hyperplasia, hypercholesterolemia, and Zellweger syndrome. In chronically high levels, cholesterol can function as an atherogen (causes atherosclerosis and cardiovascular disease). Specifically, chronically high levels (from diet or from genetic predisposition or from diseases such as hyperlipidemia) of cholesterol and cholesterol esters lead to an excess of low-density lipoprotein (LDL) particles. In healthy individuals, the LDL particles are large and relatively few in number. In contrast, large numbers of small LDL particles are strongly associated with promoting atheromatous disease within the arteries. In conditions with elevated concentrations of oxidized LDL particles, especially small LDL particles, cholesterol promotes atheroma plaque deposits in the walls of arteries, a condition known as atherosclerosis, which is a major contributor to coronary heart disease and other forms of cardiovascular disease. Resistin, a protein secreted by fat tissue, has been shown to increase the production of LDL in human liver cells and also degrades LDL receptors in the liver. As a result, the liver is less able to clear cholesterol from the bloodstream. Resistin accelerates the accumulation of LDL in arteries, increasing the risk of heart disease. Cholesterol is considered to be practically insoluble (in water) and basic. | ChEBI: A cholestanoid consisting of cholestane having a double bond at the 5,6-position as well as a 3beta-hydroxy group."
        ],
        [
         "47",
         "BMG_MT000048",
         "HMDB: Epinephrine is a catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine and tyrosine. It is the active sympathomimetic hormone secreted from the adrenal medulla in most species. It stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels. It is used in asthma and cardiac failure and to delay absorption of local anesthetics. Epinephrine also constricts arterioles in the skin and gut while dilating arterioles in leg muscles. It elevates the blood sugar level by increasing hydrolysis of glycogen to glucose in the liver, and at the same time begins the breakdown of lipids in adipocytes. Epinephrine has a suppressive effect on the immune system. | ChEBI: The R-enantiomer of adrenaline. It is a hormone secreted by the adrenal glands resulting in the 'fight-or-flight' response."
        ],
        [
         "48",
         "BMG_MT000049",
         "HMDB: Pipecolic acid is a metabolite of lysine found in human physiological fluids such as urine, plasma and CSF. However, it is uncertain if pipecolic acid originates directly from food intake or from mammalian or intestinal bacterial enzyme metabolism. Recent studies suggest that plasma pipecolic acid, particularly the D-isomer, originates mainly from the catabolism of dietary lysine by intestinal bacteria rather than by direct food intake. In classic Zellweger syndrome (a cerebro-hepato-renal genetic disorder, OMIM 214100) pipecolic acid accumulate in the plasma of the patients. It is known that plasma pipecolic acid levels are also elevated in patients with chronic liver diseases. Pipecolic acid is moderately elevated in patients with pyridoxine-dependent seizures and might therefore be a possible biochemical marker for selecting candidates for pyridoxine therapy (Plecko et al 2000). Pipecolic acid was also elevated in CSF in these vitamin B6-responsive patients (PMID 12705501). Pipecolic acid is found to be associated with adrenoleukodystrophy, infantile Refsum disease, and peroxisomal biogenesis defect, which are also inborn errors of metabolism. Pipecolic acid is a biomarker for the consumption of dried and cooked beans. | ChEBI: A piperidinemonocarboxylic acid in which the carboxy group is located at position C-2."
        ],
        [
         "49",
         "BMG_MT000050",
         "HMDB: Deoxyinosine is a nucleoside that is formed when hypoxanthine is attached to a deoxyribose ring (also known as a ribofuranose) via a beta-N9-glycosidic bond. Deoxyinosine is found in DNA while inosine is found in RNA. Inosine is a nucleic acid important for RNA editing. Adenosine deaminase (ADA) catalyzes the conversion of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. ADA-deficient individuals suffer from severe combined immunodeficiency (SCID) and are unable to produce significant numbers of mature T or B lymphocytes. This occurs as a consequence of the accumulation of ADA substrates or their metabolites. Inosine is also an intermediate in a chain of purine nucleotides reactions required for muscle movements. Moreover, deoxyinosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism. | ChEBI: A purine 2'-deoxyribonucleoside that is inosine in which the hydroxy group at position 2' is replaced by a hydrogen."
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>Description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>HMDB: 1-Methylhistidine, also known as 1-MHis ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>HMDB: 1,3-Diaminopropane, also known as DAP or...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>HMDB: 2-Ketobutyric acid, also known as alpha-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>HMDB: 2-Hydroxybutyric acid (CAS: 600-15-7), a...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>HMDB: 2-Methoxyestrone (or 2-ME1) belongs to t...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>ChEBI: A hydrochloride obtained by combining L...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>ChEBI: A hydrate that is the monohydrate form ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>ChEBI: An organic sodium salt that is the mono...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>ChEBI: An HPODE (hydroperoxyoctadecadienoic ac...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>ChEBI: A member of the class of pyrrolidin-2-o...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID                                        Description\n",
       "0           BMG_MT000001  HMDB: 1-Methylhistidine, also known as 1-MHis ...\n",
       "1           BMG_MT000002  HMDB: 1,3-Diaminopropane, also known as DAP or...\n",
       "2           BMG_MT000003  HMDB: 2-Ketobutyric acid, also known as alpha-...\n",
       "3           BMG_MT000004  HMDB: 2-Hydroxybutyric acid (CAS: 600-15-7), a...\n",
       "4           BMG_MT000005  HMDB: 2-Methoxyestrone (or 2-ME1) belongs to t...\n",
       "...                  ...                                                ...\n",
       "218330      BMG_MT218331  ChEBI: A hydrochloride obtained by combining L...\n",
       "218331      BMG_MT218332  ChEBI: A hydrate that is the monohydrate form ...\n",
       "218332      BMG_MT218333  ChEBI: An organic sodium salt that is the mono...\n",
       "218333      BMG_MT218334  ChEBI: An HPODE (hydroperoxyoctadecadienoic ac...\n",
       "218334      BMG_MT218335  ChEBI: A member of the class of pyrrolidin-2-o...\n",
       "\n",
       "[218335 rows x 2 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "comb_description = metabolite_description.copy()\n",
    "\n",
    "# add the column name at the beginning of the string\n",
    "# first, we need to get the column names\n",
    "column_names = comb_description.columns.tolist()\n",
    "column_names = [col for col in column_names if col != 'BioMedGraphica_ID']\n",
    "# then we can apply the function to each column\n",
    "for col in column_names:\n",
    "    comb_description[col] = comb_description[col].apply(lambda x: ' | '.join([f\"{col}: {i}\" for i in x.split(' | ')]) if pd.notna(x) else x)\n",
    "\n",
    "# now we can merge the columns into one\n",
    "comb_description['Description'] = comb_description[column_names].apply(lambda x: ' | '.join(x.dropna()), axis=1)\n",
    "comb_description = comb_description[['BioMedGraphica_ID', 'Description']]\n",
    "comb_description"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data has been saved to D:\\RA\\BMG\\BioMedGraphica\\Entity\\Metabolite\\BioMedGraphica_Metabolite_Description_Combined.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "# get the current working directory\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "\n",
    "# get the output directory\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "\n",
    "target_folder = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite'\n",
    "if not target_folder.exists():\n",
    "    target_folder.mkdir(parents=True)\n",
    "    print(f\"Folder {target_folder} has been created.\")\n",
    "\n",
    "output_file_path = target_folder / 'BioMedGraphica_Metabolite_Description_Combined.csv'\n",
    "comb_description.to_csv(output_file_path, index=False)\n",
    "print(f\"Data has been saved to {output_file_path}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## 6. File Generation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "target_dir = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite' / 'BioMedGraphica_Metabolite.csv'\n",
    "biomedgraphica_metabolite = pd.read_csv(target_dir, dtype=str)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 6.1 BioChem"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "SMILES",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "InChI",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "InChIKey",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "34e3e9a0-5358-4096-85f4-ed8c28b03ae0",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "CN1C=NC(C[C@H](N)C(O)=O)=C1",
         "InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1",
         "BRMWTNUJHUMWMS-LURJTMIESA-N"
        ],
        [
         "1",
         "BMG_MT000002",
         "NCCCN",
         "InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2",
         "XFNJVJPLKCPIBV-UHFFFAOYSA-N"
        ],
        [
         "2",
         "BMG_MT000003",
         "CCC(=O)C(O)=O",
         "InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)",
         "TYEYBOSBBBHJIV-UHFFFAOYSA-N"
        ],
        [
         "3",
         "BMG_MT000004",
         "CC[C@H](O)C(O)=O",
         "InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1",
         "AFENDNXGAFYKQO-VKHMYHEASA-N"
        ],
        [
         "4",
         "BMG_MT000005",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C(OC)=C3",
         "InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,20H,3-8H2,1-2H3/t12-,13+,15-,19-/m0/s1",
         "WHEUWNKSCXYKBU-QPWUGHHJSA-N"
        ],
        [
         "5",
         "BMG_MT000006",
         "C[C@@H](O)CC(O)=O",
         "InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1",
         "WHBMMWSBFZVSSR-GSVOUGTGSA-N"
        ],
        [
         "6",
         "BMG_MT000007",
         "OC[C@H]1O[C@H](C[C@@H]1O)N1C=CC(=O)NC1=O",
         "InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1",
         "MXHRCPNRJAMMIM-SHYZEUOFSA-N"
        ],
        [
         "7",
         "BMG_MT000008",
         "NC1=NC(=O)N(C=C1)[C@H]1C[C@H](O)[C@@H](CO)O1",
         "InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",
         "CKTSBUTUHBMZGZ-SHYZEUOFSA-N"
        ],
        [
         "8",
         "BMG_MT000009",
         "[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1",
         "WHBHBVVOGNECLV-OBQKJFGGSA-N"
        ],
        [
         "9",
         "BMG_MT000010",
         "[H][C@@]12CC[C@H](C(=O)CO)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1",
         "ZESRJSPZRDMNHY-YFWFAHHUSA-N"
        ],
        [
         "10",
         "BMG_MT000011",
         "CC1=NC=C(CO)C(C(O)=O)=C1O",
         "InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)",
         "HXACOUQIXZGNBF-UHFFFAOYSA-N"
        ],
        [
         "11",
         "BMG_MT000012",
         "CC(C)C(=O)C(O)=O",
         "InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8)",
         "QHKABHOOEWYVLI-UHFFFAOYSA-N"
        ],
        [
         "12",
         "BMG_MT000013",
         "OC(=O)CC1=CC=C(O)C=C1",
         "InChI=1S/C8H8O3/c9-7-3-1-6(2-4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)",
         "XQXPVVBIMDBYFF-UHFFFAOYSA-N"
        ],
        [
         "13",
         "BMG_MT000014",
         "N[C@@H](CC1=CC=C(O)C(I)=C1)C(O)=O",
         "InChI=1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1",
         "UQTZMGFTRHFAAM-ZETCQYMHSA-N"
        ],
        [
         "14",
         "BMG_MT000015",
         "COC1=C(O)C=CC(CCN)=C1",
         "InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3",
         "DIVQKHQLANKJQO-UHFFFAOYSA-N"
        ],
        [
         "15",
         "BMG_MT000016",
         "C[C@@H](CO)C(O)=O",
         "InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1",
         "DBXBTMSZEOQQDU-VKHMYHEASA-N"
        ],
        [
         "16",
         "BMG_MT000017",
         "[H][C@@](CO[C@@H]1O[C@H](CO)[C@H](O)C(OS(O)(=O)=O)C1O)(NC(=O)CCCCCCCCCCCCCCCCCCCCCCC)[C@]([H])(O)\\C=C\\CCCCCCCCCCCCC",
         "InChI=1S/C48H93NO11S/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2)40-58-48-46(54)47(60-61(55,56)57)45(53)43(39-50)59-48/h35,37,41-43,45-48,50-51,53-54H,3-34,36,38-40H2,1-2H3,(H,49,52)(H,55,56,57)/b37-35+/t41-,42+,43+,45-,46?,47?,48+/m0/s1",
         "MEAZTWJVOWHKJM-YQTIZROBSA-N"
        ],
        [
         "17",
         "BMG_MT000018",
         "NC(=O)NCCC(O)=O",
         "InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9)",
         "JSJWCHRYRHKBBW-UHFFFAOYSA-N"
        ],
        [
         "18",
         "BMG_MT000019",
         "[H][C@@]1(CNC2=C(N1)C(=O)N=C(N)N2)[C@@H](O)[C@H](C)O",
         "InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1",
         "FNKQXYHWGSIFBK-RPDRRWSUSA-N"
        ],
        [
         "19",
         "BMG_MT000020",
         "[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2",
         "InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",
         "YBJHBAHKTGYVGT-ZKWXMUAHSA-N"
        ],
        [
         "20",
         "BMG_MT000021",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](O)CC[C@]12C",
         "InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,18-,19-/m0/s1",
         "QGXBDMJGAMFCBF-HLUDHZFRSA-N"
        ],
        [
         "21",
         "BMG_MT000022",
         "[H][C@@]1(CC[C@@]2([H])C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C",
         "InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1",
         "UCTLRSWJYQTBFZ-DDPQNLDTSA-N"
        ],
        [
         "22",
         "BMG_MT000023",
         "NCCC(=O)N[C@@H](CC1=CN=CN1)C(O)=O",
         "InChI=1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1",
         "CQOVPNPJLQNMDC-ZETCQYMHSA-N"
        ],
        [
         "23",
         "BMG_MT000024",
         "NC1=C2NC=NC2=NC=N1",
         "InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)",
         "GFFGJBXGBJISGV-UHFFFAOYSA-N"
        ],
        [
         "24",
         "BMG_MT000025",
         "[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O",
         "InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1",
         "WBWWGRHZICKQGZ-HZAMXZRMSA-N"
        ],
        [
         "25",
         "BMG_MT000026",
         "[H][C@@]12CC[C@H](C(=O)CO)[C@]1(C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C)C=O",
         "InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",
         "PQSUYGKTWSAVDQ-ZVIOFETBSA-N"
        ],
        [
         "26",
         "BMG_MT000027",
         "C[C@H](O)[C@H](O)C1=NC2=C(NC1)NC(N)=NC2=O",
         "InChI=1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3,6,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,6-/m0/s1",
         "FEMXZDUTFRTWPE-DZSWIPIPSA-N"
        ],
        [
         "27",
         "BMG_MT000028",
         "CCCC(O)=O",
         "InChI=1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6)",
         "FERIUCNNQQJTOY-UHFFFAOYSA-N"
        ],
        [
         "28",
         "BMG_MT000029",
         "CC(O)=O",
         "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)",
         "QTBSBXVTEAMEQO-UHFFFAOYSA-N"
        ],
        [
         "29",
         "BMG_MT000030",
         "C[N+](C)(C)CC(O)=O",
         "InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3/p+1",
         "KWIUHFFTVRNATP-UHFFFAOYSA-O"
        ],
        [
         "30",
         "BMG_MT000031",
         "[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO",
         "InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1",
         "CIWBSHSKHKDKBQ-JLAZNSOCSA-N"
        ],
        [
         "31",
         "BMG_MT000032",
         "NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
         "UDMBCSSLTHHNCD-KQYNXXCUSA-N"
        ],
        [
         "32",
         "BMG_MT000033",
         "OC[C@H]1O[C@H](OC[C@H]2O[C@H](O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O",
         "InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2/t3-,4-,5+,6-,7+,8+,9-,10-,11+,12+/m1/s1",
         "DLRVVLDZNNYCBX-CQHUIXDMSA-N"
        ],
        [
         "33",
         "BMG_MT000034",
         "NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
         "OIRDTQYFTABQOQ-KQYNXXCUSA-N"
        ],
        [
         "34",
         "BMG_MT000035",
         "N",
         "InChI=1S/H3N/h1H3",
         "QGZKDVFQNNGYKY-UHFFFAOYSA-N"
        ],
        [
         "35",
         "BMG_MT000036",
         "N[C@@H](CCCNC(=N)N[C@@H](CC(O)=O)C(O)=O)C(O)=O",
         "InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/t5-,6-/m0/s1",
         "KDZOASGQNOPSCU-WDSKDSINSA-N"
        ],
        [
         "36",
         "BMG_MT000037",
         "[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",
         "AEMFNILZOJDQLW-QAGGRKNESA-N"
        ],
        [
         "37",
         "BMG_MT000038",
         "CC1=C(C=C)\\C(NC1=O)=C\\C1=C(C)C(CCC(O)=O)=C(CC2=C(CCC(O)=O)C(C)=C(N2)\\C=C2/NC(=O)C(C=C)=C2C)N1",
         "InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-",
         "BPYKTIZUTYGOLE-IFADSCNNSA-N"
        ],
        [
         "38",
         "BMG_MT000039",
         "OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O",
         "InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11-,12+/m1/s1",
         "GUBGYTABKSRVRQ-QRZGKKJRSA-N"
        ],
        [
         "39",
         "BMG_MT000040",
         "NCCC(O)=O",
         "InChI=1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6)",
         "UCMIRNVEIXFBKS-UHFFFAOYSA-N"
        ],
        [
         "40",
         "BMG_MT000041",
         "[H][C@@]12COP(O)(=O)O[C@@]1([H])[C@@H](O)[C@@H](O2)N1C=NC2=C1N=CN=C2N",
         "InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
         "IVOMOUWHDPKRLL-KQYNXXCUSA-N"
        ],
        [
         "41",
         "BMG_MT000042",
         "CC(=O)CC(O)=O",
         "InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7)",
         "WDJHALXBUFZDSR-UHFFFAOYSA-N"
        ],
        [
         "42",
         "BMG_MT000043",
         "NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1",
         "InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1",
         "WHTCPDAXWFLDIH-KQYNXXCUSA-N"
        ],
        [
         "43",
         "BMG_MT000044",
         "C[N+](C)(C)C[C@H](O)CC(O)=O",
         "InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/p+1/t6-/m1/s1",
         "PHIQHXFUZVPYII-ZCFIWIBFSA-O"
        ],
        [
         "44",
         "BMG_MT000045",
         "[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C",
         "InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",
         "JYGXADMDTFJGBT-VWUMJDOOSA-N"
        ],
        [
         "45",
         "BMG_MT000046",
         "CN(CC(O)=O)C(N)=N",
         "InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9)",
         "CVSVTCORWBXHQV-UHFFFAOYSA-N"
        ],
        [
         "46",
         "BMG_MT000047",
         "[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C",
         "InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1",
         "HVYWMOMLDIMFJA-DPAQBDIFSA-N"
        ],
        [
         "47",
         "BMG_MT000048",
         "CNC[C@H](O)C1=CC(O)=C(O)C=C1",
         "InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",
         "UCTWMZQNUQWSLP-VIFPVBQESA-N"
        ],
        [
         "48",
         "BMG_MT000049",
         "OC(=O)C1CCCCN1",
         "InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)",
         "HXEACLLIILLPRG-UHFFFAOYSA-N"
        ],
        [
         "49",
         "BMG_MT000050",
         "OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC2=O",
         "InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1",
         "VGONTNSXDCQUGY-RRKCRQDMSA-N"
        ]
       ],
       "shape": {
        "columns": 4,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>SMILES</th>\n",
       "      <th>InChI</th>\n",
       "      <th>InChIKey</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>CN1C=NC(C[C@H](N)C(O)=O)=C1</td>\n",
       "      <td>InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11...</td>\n",
       "      <td>BRMWTNUJHUMWMS-LURJTMIESA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>NCCCN</td>\n",
       "      <td>InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2</td>\n",
       "      <td>XFNJVJPLKCPIBV-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>CCC(=O)C(O)=O</td>\n",
       "      <td>InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)</td>\n",
       "      <td>TYEYBOSBBBHJIV-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>CC[C@H](O)C(O)=O</td>\n",
       "      <td>InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(...</td>\n",
       "      <td>AFENDNXGAFYKQO-VKHMYHEASA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[...</td>\n",
       "      <td>InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18...</td>\n",
       "      <td>WHEUWNKSCXYKBU-QPWUGHHJSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID                                             SMILES  \\\n",
       "0           BMG_MT000001                        CN1C=NC(C[C@H](N)C(O)=O)=C1   \n",
       "1           BMG_MT000002                                              NCCCN   \n",
       "2           BMG_MT000003                                      CCC(=O)C(O)=O   \n",
       "3           BMG_MT000004                                   CC[C@H](O)C(O)=O   \n",
       "4           BMG_MT000005  [H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[...   \n",
       "...                  ...                                                ...   \n",
       "218330      BMG_MT218331                                                NaN   \n",
       "218331      BMG_MT218332                                                NaN   \n",
       "218332      BMG_MT218333                                                NaN   \n",
       "218333      BMG_MT218334                                                NaN   \n",
       "218334      BMG_MT218335                                                NaN   \n",
       "\n",
       "                                                    InChI  \\\n",
       "0       InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11...   \n",
       "1                      InChI=1S/C3H10N2/c4-2-1-3-5/h1-5H2   \n",
       "2         InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)   \n",
       "3       InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(...   \n",
       "4       InChI=1S/C19H24O3/c1-19-8-7-12-13(15(19)5-6-18...   \n",
       "...                                                   ...   \n",
       "218330                                                NaN   \n",
       "218331                                                NaN   \n",
       "218332                                                NaN   \n",
       "218333                                                NaN   \n",
       "218334                                                NaN   \n",
       "\n",
       "                           InChIKey  \n",
       "0       BRMWTNUJHUMWMS-LURJTMIESA-N  \n",
       "1       XFNJVJPLKCPIBV-UHFFFAOYSA-N  \n",
       "2       TYEYBOSBBBHJIV-UHFFFAOYSA-N  \n",
       "3       AFENDNXGAFYKQO-VKHMYHEASA-N  \n",
       "4       WHEUWNKSCXYKBU-QPWUGHHJSA-N  \n",
       "...                             ...  \n",
       "218330                          NaN  \n",
       "218331                          NaN  \n",
       "218332                          NaN  \n",
       "218333                          NaN  \n",
       "218334                          NaN  \n",
       "\n",
       "[218335 rows x 4 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "biochem = biomedgraphica_metabolite[['BioMedGraphica_ID','SMILES','InChI','InChIKey']]\n",
    "biochem"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data has been saved to D:\\RA\\BMG\\BioMedGraphica\\Entity\\Metabolite\\BioMedGraphica_Metabolite_BioChem.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "# get the current working directory\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "\n",
    "# get the output directory\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "\n",
    "target_folder = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite'\n",
    "if not target_folder.exists():\n",
    "    target_folder.mkdir(parents=True)\n",
    "    print(f\"Folder {target_folder} has been created.\")\n",
    "\n",
    "output_file_path = target_folder / 'BioMedGraphica_Metabolite_BioChem.csv'\n",
    "biochem.to_csv(output_file_path, index=False)\n",
    "print(f\"Data has been saved to {output_file_path}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 6.2 Name and ID"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "GUI Name"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Metabolite_Name_List",
         "rawType": "object",
         "type": "string"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "8c22af30-8348-439b-bf25-6c8d69efd69b",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "1-Methylhistidine | N(tele)-methyl-L-histidine | (2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid"
        ],
        [
         "1",
         "BMG_MT000002",
         "1,3-Diaminopropane | propane-1,3-diamine | trimethylenediamine"
        ],
        [
         "2",
         "BMG_MT000003",
         "2-oxobutanoic acid | 2-Ketobutyric acid | 2-oxobutanoate"
        ],
        [
         "3",
         "BMG_MT000004",
         "2-hydroxybutyric acid | (2S)-2-hydroxybutanoic acid | 2-Hydroxybutyric acid"
        ],
        [
         "4",
         "BMG_MT000005",
         "2-methoxyestrone | (1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one | 2-Methoxyestrone"
        ],
        [
         "5",
         "BMG_MT000006",
         "(R)-3-hydroxybutyric acid | (3R)-3-hydroxybutanoic acid | 3-Hydroxybutyric acid"
        ],
        [
         "6",
         "BMG_MT000007",
         "Deoxyuridine | 2'-deoxyuridine | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione"
        ],
        [
         "7",
         "BMG_MT000008",
         "2'-deoxycytidine | Deoxycytidine | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one"
        ],
        [
         "8",
         "BMG_MT000009",
         "Cortexolone | (1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one | 11-deoxycortisol"
        ],
        [
         "9",
         "BMG_MT000010",
         "(1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one | 11-deoxycorticosterone | Deoxycorticosterone"
        ],
        [
         "10",
         "BMG_MT000011",
         "3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid | 4-pyridoxic acid | 4-Pyridoxic acid"
        ],
        [
         "11",
         "BMG_MT000012",
         "alpha-Ketoisovaleric acid | 3-methyl-2-oxobutanoic acid"
        ],
        [
         "12",
         "BMG_MT000013",
         "4-hydroxyphenylacetic acid | 2-(4-hydroxyphenyl)acetic acid | p-Hydroxyphenylacetic acid"
        ],
        [
         "13",
         "BMG_MT000014",
         "Iodotyrosine | (2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid | 3-iodo-L-tyrosine"
        ],
        [
         "14",
         "BMG_MT000015",
         "3-Methoxytyramine | 4-(2-aminoethyl)-2-methoxyphenol | 3-methoxytyramine"
        ],
        [
         "15",
         "BMG_MT000016",
         "(S)-3-Hydroxyisobutyric acid | (2S)-3-hydroxy-2-methylpropanoic acid"
        ],
        [
         "16",
         "BMG_MT000017",
         "[(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid | 3-O-Sulfogalactosylceramide (d18:1/24:0)"
        ],
        [
         "17",
         "BMG_MT000018",
         "Ureidopropionic acid | 3-(carbamoylamino)propanoic acid"
        ],
        [
         "18",
         "BMG_MT000019",
         "sapropterin | (6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,5,6,7,8-hexahydropteridin-4-one | Tetrahydrobiopterin"
        ],
        [
         "19",
         "BMG_MT000020",
         "5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid | biotin | Biotin"
        ],
        [
         "20",
         "BMG_MT000021",
         "androsterone | Androsterone | (1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one"
        ],
        [
         "21",
         "BMG_MT000022",
         "cholesta-5,7-dien-3beta-ol | (1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,9-dien-5-ol | 7-Dehydrocholesterol"
        ],
        [
         "22",
         "BMG_MT000023",
         "carnosine | (2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid | Carnosine"
        ],
        [
         "23",
         "BMG_MT000024",
         "7H-purin-6-amine | adenine | Adenine"
        ],
        [
         "24",
         "BMG_MT000025",
         "2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid | Taurocholic acid | taurocholic acid"
        ],
        [
         "25",
         "BMG_MT000026",
         "(1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde | Aldosterone | aldosterone"
        ],
        [
         "26",
         "BMG_MT000027",
         "Dihydrobiopterin | 2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,7,8-tetrahydropteridin-4-one"
        ],
        [
         "27",
         "BMG_MT000028",
         "butanoic acid | Butyric acid | butyric acid"
        ],
        [
         "28",
         "BMG_MT000029",
         "Acetic acid | acetic acid"
        ],
        [
         "29",
         "BMG_MT000030",
         "Betaine | (carboxymethyl)trimethylazanium"
        ],
        [
         "30",
         "BMG_MT000031",
         "Ascorbic acid | (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one"
        ],
        [
         "31",
         "BMG_MT000032",
         "Adenosine monophosphate | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | adenosine 5'-monophosphate(2-)"
        ],
        [
         "32",
         "BMG_MT000033",
         "Melibiose | (2S,3R,4S,5S,6R)-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol"
        ],
        [
         "33",
         "BMG_MT000034",
         "(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | adenosine | Adenosine"
        ],
        [
         "34",
         "BMG_MT000035",
         "ammonia | Ammonia"
        ],
        [
         "35",
         "BMG_MT000036",
         "(2S)-2-{N'-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid | Argininosuccinic acid"
        ],
        [
         "36",
         "BMG_MT000037",
         "androst-4-ene-3,17-dione | (1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,14-dione | Androstenedione"
        ],
        [
         "37",
         "BMG_MT000038",
         "Bilirubin | 3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid | bilirubin IXalpha"
        ],
        [
         "38",
         "BMG_MT000039",
         "Cellobiose | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol"
        ],
        [
         "39",
         "BMG_MT000040",
         "beta-Alanine | beta-alanine | 3-aminopropanoic acid"
        ],
        [
         "40",
         "BMG_MT000041",
         "3',5'-cyclic AMP | (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one | Cyclic AMP"
        ],
        [
         "41",
         "BMG_MT000042",
         "Acetoacetic acid | 3-oxobutanoic acid"
        ],
        [
         "42",
         "BMG_MT000043",
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}phosphonic acid | Adenosine 3',5'-diphosphate"
        ],
        [
         "43",
         "BMG_MT000044",
         "L-Carnitine | (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate | (R)-carnitine"
        ],
        [
         "44",
         "BMG_MT000045",
         "cortisol | Cortisol | (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one"
        ],
        [
         "45",
         "BMG_MT000046",
         "Creatine | 2-(N-methylcarbamimidamido)acetic acid | creatine"
        ],
        [
         "46",
         "BMG_MT000047",
         "cholesterol | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol | Cholesterol"
        ],
        [
         "47",
         "BMG_MT000048",
         "Epinephrine | 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol"
        ],
        [
         "48",
         "BMG_MT000049",
         "Pipecolic acid | piperidine-2-carboxylic acid"
        ],
        [
         "49",
         "BMG_MT000050",
         "2'-deoxyinosine | 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-ol | Deoxyinosine"
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>Metabolite_Name_List</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>1-Methylhistidine | N(tele)-methyl-L-histidine...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>1,3-Diaminopropane | propane-1,3-diamine | tri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>2-oxobutanoic acid | 2-Ketobutyric acid | 2-ox...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>2-hydroxybutyric acid | (2S)-2-hydroxybutanoic...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>2-methoxyestrone | (1S,10R,11S,15S)-5-hydroxy-...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>L-cysteine hydrochloride</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>L-cysteine hydrochloride hydrate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>sodium glyoxylate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>13-HPODE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>tenuazonic acid</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID                               Metabolite_Name_List\n",
       "0           BMG_MT000001  1-Methylhistidine | N(tele)-methyl-L-histidine...\n",
       "1           BMG_MT000002  1,3-Diaminopropane | propane-1,3-diamine | tri...\n",
       "2           BMG_MT000003  2-oxobutanoic acid | 2-Ketobutyric acid | 2-ox...\n",
       "3           BMG_MT000004  2-hydroxybutyric acid | (2S)-2-hydroxybutanoic...\n",
       "4           BMG_MT000005  2-methoxyestrone | (1S,10R,11S,15S)-5-hydroxy-...\n",
       "...                  ...                                                ...\n",
       "218330      BMG_MT218331                           L-cysteine hydrochloride\n",
       "218331      BMG_MT218332                   L-cysteine hydrochloride hydrate\n",
       "218332      BMG_MT218333                                  sodium glyoxylate\n",
       "218333      BMG_MT218334                                           13-HPODE\n",
       "218334      BMG_MT218335                                    tenuazonic acid\n",
       "\n",
       "[218335 rows x 2 columns]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "def merge_string_columns(df, columns, merge_name, separator=' | '):\n",
    "    def merge_strings(row):\n",
    "        combined = set()\n",
    "        for column in columns:\n",
    "            if pd.notnull(row[column]):\n",
    "                combined.update(row[column].split(separator))\n",
    "        return separator.join(combined)\n",
    "    \n",
    "    # Apply the function to each row and create a new column\n",
    "    combined_column_name = merge_name\n",
    "    df[combined_column_name] = df.apply(merge_strings, axis=1)\n",
    "    df.drop(columns=columns, inplace=True)\n",
    "    \n",
    "    return df\n",
    "\n",
    "gui_name = biomedgraphica_metabolite.copy()\n",
    "gui_name = merge_string_columns(gui_name, ['HMDB_Name', 'ChEBI_Name', 'IUPAC_Name'], 'Metabolite_Name_List')\n",
    "gui_name = gui_name[['BioMedGraphica_ID', 'Metabolite_Name_List']]\n",
    "gui_name"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data has been saved to D:\\RA\\BMG\\BioMedGraphica\\Entity\\Metabolite\\BioMedGraphica_Metabolite_GUI_Name.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "# get the current working directory\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "\n",
    "# get the output directory\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "\n",
    "target_folder = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite'\n",
    "if not target_folder.exists():\n",
    "    target_folder.mkdir(parents=True)\n",
    "    print(f\"Folder {target_folder} has been created.\")\n",
    "\n",
    "output_file_path = target_folder / 'BioMedGraphica_Metabolite_GUI_Name.csv'\n",
    "gui_name.to_csv(output_file_path, index=False)\n",
    "print(f\"Data has been saved to {output_file_path}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "LLM Name and ID"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "IUPAC_Name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "HMDB_Name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "HMDB_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PubChem_CID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ChemSpider_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "CAS_RN",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ChEBI_Name",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "ChEBI_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "KEGG_ID",
         "rawType": "object",
         "type": "unknown"
        },
        {
         "name": "PDB_ID",
         "rawType": "object",
         "type": "unknown"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "239891e2-4152-496d-a32a-900348574e20",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid",
         "1-Methylhistidine",
         "HMDB ID:HMDB0000001",
         "PubChem CID:92105",
         "ChemSpider ID:83153",
         "CAS RN:332-80-9",
         "N(tele)-methyl-L-histidine",
         "ChEBI ID:50599",
         "KEGG ID:C01152",
         null
        ],
        [
         "1",
         "BMG_MT000002",
         "propane-1,3-diamine",
         "1,3-Diaminopropane",
         "HMDB ID:HMDB0000002",
         "PubChem CID:428",
         "ChemSpider ID:415",
         "CAS RN:109-76-2",
         "trimethylenediamine",
         "ChEBI ID:15725",
         "KEGG ID:C00986",
         null
        ],
        [
         "2",
         "BMG_MT000003",
         "2-oxobutanoic acid",
         "2-Ketobutyric acid",
         "HMDB ID:HMDB0000005",
         "PubChem CID:58",
         "ChemSpider ID:57",
         "CAS RN:600-18-0",
         "2-oxobutanoate",
         "ChEBI ID:30831 | ChEBI ID:16763",
         "KEGG ID:C00109",
         null
        ],
        [
         "3",
         "BMG_MT000004",
         "(2S)-2-hydroxybutanoic acid",
         "2-Hydroxybutyric acid",
         "HMDB ID:HMDB0000008",
         "PubChem CID:440864",
         "ChemSpider ID:389701",
         "CAS RN:600-15-7 | CAS RN:3347-90-8",
         "2-hydroxybutyric acid",
         "ChEBI ID:1148 | ChEBI ID:50613",
         "KEGG ID:C05984",
         null
        ],
        [
         "4",
         "BMG_MT000005",
         "(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one",
         "2-Methoxyestrone",
         "HMDB ID:HMDB0000010",
         "PubChem CID:440624",
         "ChemSpider ID:389515",
         "CAS RN:362-08-3",
         "2-methoxyestrone",
         "ChEBI ID:1189",
         "KEGG ID:C05299",
         null
        ],
        [
         "5",
         "BMG_MT000006",
         "(3R)-3-hydroxybutanoic acid",
         "3-Hydroxybutyric acid",
         "HMDB ID:HMDB0000011",
         "PubChem CID:92135",
         "ChemSpider ID:83181",
         "CAS RN:625-72-9",
         "(R)-3-hydroxybutyric acid",
         "ChEBI ID:17066",
         "KEGG ID:C01089",
         null
        ],
        [
         "6",
         "BMG_MT000007",
         "1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione",
         "Deoxyuridine",
         "HMDB ID:HMDB0000012",
         "PubChem CID:13712",
         "ChemSpider ID:13118",
         "CAS RN:951-78-0",
         "2'-deoxyuridine",
         "ChEBI ID:16450",
         "KEGG ID:C00526",
         null
        ],
        [
         "7",
         "BMG_MT000008",
         "4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",
         "Deoxycytidine",
         "HMDB ID:HMDB0000014",
         "PubChem CID:13711",
         "ChemSpider ID:13117",
         "CAS RN:951-77-9",
         "2'-deoxycytidine",
         "ChEBI ID:15698",
         "KEGG ID:C00881",
         null
        ],
        [
         "8",
         "BMG_MT000009",
         "(1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "Cortexolone",
         "HMDB ID:HMDB0000015",
         "PubChem CID:440707",
         "ChemSpider ID:389582",
         "CAS RN:152-58-9",
         "11-deoxycortisol",
         "ChEBI ID:28324",
         "KEGG ID:C05488",
         null
        ],
        [
         "9",
         "BMG_MT000010",
         "(1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "Deoxycorticosterone",
         "HMDB ID:HMDB0000016",
         "PubChem CID:6166",
         "ChemSpider ID:5932",
         "CAS RN:64-85-7",
         "11-deoxycorticosterone",
         "ChEBI ID:16973",
         "KEGG ID:C03205",
         null
        ],
        [
         "10",
         "BMG_MT000011",
         "3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid",
         "4-Pyridoxic acid",
         "HMDB ID:HMDB0000017",
         "PubChem CID:6723",
         "ChemSpider ID:6467",
         "CAS RN:82-82-6",
         "4-pyridoxic acid",
         "ChEBI ID:17405",
         "KEGG ID:C00847",
         null
        ],
        [
         "11",
         "BMG_MT000012",
         "3-methyl-2-oxobutanoic acid",
         "alpha-Ketoisovaleric acid",
         "HMDB ID:HMDB0000019",
         "PubChem CID:49",
         "ChemSpider ID:48",
         "CAS RN:759-05-7",
         "3-methyl-2-oxobutanoic acid",
         "ChEBI ID:16530",
         "KEGG ID:C00141",
         null
        ],
        [
         "12",
         "BMG_MT000013",
         "2-(4-hydroxyphenyl)acetic acid",
         "p-Hydroxyphenylacetic acid",
         "HMDB ID:HMDB0000020",
         "PubChem CID:127",
         "ChemSpider ID:124",
         "CAS RN:156-38-7",
         "4-hydroxyphenylacetic acid",
         "ChEBI ID:18101",
         "KEGG ID:C00642",
         null
        ],
        [
         "13",
         "BMG_MT000014",
         "(2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid",
         "Iodotyrosine",
         "HMDB ID:HMDB0000021",
         "PubChem CID:439744",
         "ChemSpider ID:388804",
         "CAS RN:70-78-0",
         "3-iodo-L-tyrosine",
         "ChEBI ID:27847",
         "KEGG ID:C02515",
         null
        ],
        [
         "14",
         "BMG_MT000015",
         "4-(2-aminoethyl)-2-methoxyphenol",
         "3-Methoxytyramine",
         "HMDB ID:HMDB0000022",
         "PubChem CID:1669",
         "ChemSpider ID:1606",
         "CAS RN:554-52-9",
         "3-methoxytyramine",
         "ChEBI ID:1582 | ChEBI ID:742324",
         "KEGG ID:C05587",
         null
        ],
        [
         "15",
         "BMG_MT000016",
         "(2S)-3-hydroxy-2-methylpropanoic acid",
         "(S)-3-Hydroxyisobutyric acid",
         "HMDB ID:HMDB0000023",
         "PubChem CID:440873",
         "ChemSpider ID:389707",
         "CAS RN:26543-05-5",
         null,
         "ChEBI ID:37373",
         "KEGG ID:C06001",
         null
        ],
        [
         "16",
         "BMG_MT000017",
         "[(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid",
         "3-O-Sulfogalactosylceramide (d18:1/24:0)",
         "HMDB ID:HMDB0000024",
         "PubChem CID:24779585",
         "ChemSpider ID:24823255",
         "CAS RN:151122-71-3",
         null,
         null,
         null,
         null
        ],
        [
         "17",
         "BMG_MT000018",
         "3-(carbamoylamino)propanoic acid",
         "Ureidopropionic acid",
         "HMDB ID:HMDB0000026",
         null,
         "ChemSpider ID:109",
         "CAS RN:462-88-4",
         null,
         "ChEBI ID:18261",
         "KEGG ID:C02642",
         null
        ],
        [
         "18",
         "BMG_MT000019",
         "(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,5,6,7,8-hexahydropteridin-4-one",
         "Tetrahydrobiopterin",
         "HMDB ID:HMDB0000027",
         "PubChem CID:44257",
         "ChemSpider ID:40270",
         "CAS RN:27070-47-9 | CAS RN:17528-72-2 | CAS RN:62989-33-7",
         "sapropterin",
         "ChEBI ID:59560",
         "KEGG ID:C00272",
         null
        ],
        [
         "19",
         "BMG_MT000020",
         "5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid",
         "Biotin",
         "HMDB ID:HMDB0000030",
         "PubChem CID:171548",
         "ChemSpider ID:149962",
         "CAS RN:58-85-5",
         "biotin",
         "ChEBI ID:15956",
         "KEGG ID:C00120",
         null
        ],
        [
         "20",
         "BMG_MT000021",
         "(1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one",
         "Androsterone",
         "HMDB ID:HMDB0000031",
         "PubChem CID:5879",
         "ChemSpider ID:5668",
         "CAS RN:53-41-8",
         "androsterone",
         "ChEBI ID:16032",
         "KEGG ID:C00523",
         null
        ],
        [
         "21",
         "BMG_MT000022",
         "(1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,9-dien-5-ol",
         "7-Dehydrocholesterol",
         "HMDB ID:HMDB0000032",
         "PubChem CID:439423",
         null,
         "CAS RN:434-16-2",
         "cholesta-5,7-dien-3beta-ol",
         "ChEBI ID:17759",
         "KEGG ID:C01164",
         null
        ],
        [
         "22",
         "BMG_MT000023",
         "(2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid",
         "Carnosine",
         "HMDB ID:HMDB0000033",
         "PubChem CID:439224",
         "ChemSpider ID:388363",
         "CAS RN:305-84-0",
         "carnosine",
         "ChEBI ID:15727",
         "KEGG ID:C00386",
         null
        ],
        [
         "23",
         "BMG_MT000024",
         "7H-purin-6-amine",
         "Adenine",
         "HMDB ID:HMDB0000034",
         "PubChem CID:190",
         "ChemSpider ID:185",
         "CAS RN:73-24-5",
         "adenine",
         "ChEBI ID:16708",
         "KEGG ID:C00147",
         null
        ],
        [
         "24",
         "BMG_MT000025",
         "2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid",
         "Taurocholic acid",
         "HMDB ID:HMDB0000036",
         "PubChem CID:6675",
         "ChemSpider ID:6423",
         "CAS RN:81-24-3",
         "taurocholic acid",
         "ChEBI ID:28865",
         "KEGG ID:C05122",
         null
        ],
        [
         "25",
         "BMG_MT000026",
         "(1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde",
         "Aldosterone",
         "HMDB ID:HMDB0000037",
         "PubChem CID:5839",
         "ChemSpider ID:5633",
         "CAS RN:52-39-1",
         "aldosterone",
         "ChEBI ID:27584",
         "KEGG ID:C01780",
         null
        ],
        [
         "26",
         "BMG_MT000027",
         "2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,7,8-tetrahydropteridin-4-one",
         "Dihydrobiopterin",
         "HMDB ID:HMDB0000038",
         "PubChem CID:119055",
         "ChemSpider ID:106382",
         "CAS RN:6779-87-9",
         null,
         "ChEBI ID:43029",
         "KEGG ID:C02953",
         null
        ],
        [
         "27",
         "BMG_MT000028",
         "butanoic acid",
         "Butyric acid",
         "HMDB ID:HMDB0000039",
         "PubChem CID:264",
         "ChemSpider ID:259",
         "CAS RN:107-92-6",
         "butyric acid",
         "ChEBI ID:30772",
         "KEGG ID:C00246",
         null
        ],
        [
         "28",
         "BMG_MT000029",
         "acetic acid",
         "Acetic acid",
         "HMDB ID:HMDB0000042",
         "PubChem CID:176",
         "ChemSpider ID:171",
         "CAS RN:64-19-7",
         null,
         "ChEBI ID:15366",
         "KEGG ID:C00033",
         null
        ],
        [
         "29",
         "BMG_MT000030",
         "(carboxymethyl)trimethylazanium",
         "Betaine",
         "HMDB ID:HMDB0000043",
         "PubChem CID:248",
         "ChemSpider ID:243",
         "CAS RN:6915-17-9",
         null,
         "ChEBI ID:41139",
         null,
         null
        ],
        [
         "30",
         "BMG_MT000031",
         "(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one",
         "Ascorbic acid",
         "HMDB ID:HMDB0000044",
         null,
         "ChemSpider ID:10189562",
         "CAS RN:50-81-7",
         null,
         "ChEBI ID:29073",
         "KEGG ID:C01041",
         null
        ],
        [
         "31",
         "BMG_MT000032",
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid",
         "Adenosine monophosphate",
         "HMDB ID:HMDB0000045",
         "PubChem CID:6083",
         "ChemSpider ID:5858",
         "CAS RN:61-19-8",
         "adenosine 5'-monophosphate(2-)",
         "ChEBI ID:16027 | ChEBI ID:456215",
         "KEGG ID:C00020",
         null
        ],
        [
         "32",
         "BMG_MT000033",
         "(2S,3R,4S,5S,6R)-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol",
         "Melibiose",
         "HMDB ID:HMDB0000048",
         "PubChem CID:6602503",
         null,
         "CAS RN:13299-20-2",
         null,
         null,
         null,
         null
        ],
        [
         "33",
         "BMG_MT000034",
         "(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",
         "Adenosine",
         "HMDB ID:HMDB0000050",
         "PubChem CID:60961",
         "ChemSpider ID:54923",
         "CAS RN:58-61-7",
         "adenosine",
         "ChEBI ID:16335",
         "KEGG ID:C00212",
         null
        ],
        [
         "34",
         "BMG_MT000035",
         "ammonia",
         "Ammonia",
         "HMDB ID:HMDB0000051",
         "PubChem CID:222",
         "ChemSpider ID:217",
         "CAS RN:7664-41-7",
         null,
         "ChEBI ID:16134",
         "KEGG ID:C00014",
         null
        ],
        [
         "35",
         "BMG_MT000036",
         "(2S)-2-{N'-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid",
         "Argininosuccinic acid",
         "HMDB ID:HMDB0000052",
         "PubChem CID:16950",
         "ChemSpider ID:16059",
         "CAS RN:2387-71-5",
         null,
         "ChEBI ID:15682",
         "KEGG ID:C03406",
         null
        ],
        [
         "36",
         "BMG_MT000037",
         "(1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,14-dione",
         "Androstenedione",
         "HMDB ID:HMDB0000053",
         "PubChem CID:6128",
         "ChemSpider ID:5898",
         "CAS RN:63-05-8",
         "androst-4-ene-3,17-dione",
         "ChEBI ID:16422",
         "KEGG ID:C00280",
         null
        ],
        [
         "37",
         "BMG_MT000038",
         "3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid",
         "Bilirubin",
         "HMDB ID:HMDB0000054",
         "PubChem CID:5280352",
         "ChemSpider ID:4444055",
         "CAS RN:635-65-4",
         "bilirubin IXalpha",
         "ChEBI ID:16990",
         "KEGG ID:C00486",
         null
        ],
        [
         "38",
         "BMG_MT000039",
         "(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol",
         "Cellobiose",
         "HMDB ID:HMDB0000055",
         "PubChem CID:10712",
         "ChemSpider ID:10261",
         "CAS RN:528-50-7",
         null,
         "ChEBI ID:36217",
         "KEGG ID:C06422",
         null
        ],
        [
         "39",
         "BMG_MT000040",
         "3-aminopropanoic acid",
         "beta-Alanine",
         "HMDB ID:HMDB0000056",
         "PubChem CID:239",
         "ChemSpider ID:234",
         "CAS RN:107-95-9",
         "beta-alanine",
         "ChEBI ID:16958",
         "KEGG ID:C00099",
         null
        ],
        [
         "40",
         "BMG_MT000041",
         "(4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one",
         "Cyclic AMP",
         "HMDB ID:HMDB0000058",
         "PubChem CID:6076",
         "ChemSpider ID:5851",
         "CAS RN:60-92-4",
         "3',5'-cyclic AMP",
         "ChEBI ID:17489",
         "KEGG ID:C00575",
         null
        ],
        [
         "41",
         "BMG_MT000042",
         "3-oxobutanoic acid",
         "Acetoacetic acid",
         "HMDB ID:HMDB0000060",
         "PubChem CID:96",
         "ChemSpider ID:94",
         "CAS RN:541-50-4",
         null,
         "ChEBI ID:15344",
         "KEGG ID:C00164",
         null
        ],
        [
         "42",
         "BMG_MT000043",
         "{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}phosphonic acid",
         "Adenosine 3',5'-diphosphate",
         "HMDB ID:HMDB0000061",
         "PubChem CID:159296",
         "ChemSpider ID:140102",
         "CAS RN:1053-73-2",
         null,
         "ChEBI ID:17985",
         "KEGG ID:C00054",
         null
        ],
        [
         "43",
         "BMG_MT000044",
         "(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate",
         "L-Carnitine",
         "HMDB ID:HMDB0000062",
         "PubChem CID:10917",
         "ChemSpider ID:2006614",
         "CAS RN:541-15-1",
         "(R)-carnitine",
         "ChEBI ID:16347",
         "KEGG ID:C00318",
         null
        ],
        [
         "44",
         "BMG_MT000045",
         "(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one",
         "Cortisol",
         "HMDB ID:HMDB0000063",
         "PubChem CID:5754",
         null,
         "CAS RN:50-23-7",
         "cortisol",
         "ChEBI ID:17650",
         "KEGG ID:C00735",
         null
        ],
        [
         "45",
         "BMG_MT000046",
         "2-(N-methylcarbamimidamido)acetic acid",
         "Creatine",
         "HMDB ID:HMDB0000064",
         "PubChem CID:586",
         "ChemSpider ID:566",
         "CAS RN:57-00-1",
         "creatine",
         "ChEBI ID:16919",
         "KEGG ID:C00300",
         null
        ],
        [
         "46",
         "BMG_MT000047",
         "(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",
         "Cholesterol",
         "HMDB ID:HMDB0000067",
         "PubChem CID:5997",
         null,
         "CAS RN:57-88-5",
         "cholesterol",
         "ChEBI ID:16113",
         "KEGG ID:C00187",
         null
        ],
        [
         "47",
         "BMG_MT000048",
         "4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol",
         "Epinephrine",
         "HMDB ID:HMDB0000068",
         "PubChem CID:5816",
         "ChemSpider ID:5611",
         "CAS RN:51-43-4",
         null,
         "ChEBI ID:28918",
         "KEGG ID:C00788",
         null
        ],
        [
         "48",
         "BMG_MT000049",
         "piperidine-2-carboxylic acid",
         "Pipecolic acid",
         "HMDB ID:HMDB0000070",
         "PubChem CID:849",
         "ChemSpider ID:826",
         "CAS RN:535-75-1",
         null,
         "ChEBI ID:17964",
         "KEGG ID:C00408",
         null
        ],
        [
         "49",
         "BMG_MT000050",
         "9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-ol",
         "Deoxyinosine",
         "HMDB ID:HMDB0000071",
         "PubChem CID:65058",
         "ChemSpider ID:58569",
         "CAS RN:890-38-0",
         "2'-deoxyinosine",
         "ChEBI ID:28997",
         "KEGG ID:C05512",
         null
        ]
       ],
       "shape": {
        "columns": 11,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>IUPAC_Name</th>\n",
       "      <th>HMDB_Name</th>\n",
       "      <th>HMDB_ID</th>\n",
       "      <th>PubChem_CID</th>\n",
       "      <th>ChemSpider_ID</th>\n",
       "      <th>CAS_RN</th>\n",
       "      <th>ChEBI_Name</th>\n",
       "      <th>ChEBI_ID</th>\n",
       "      <th>KEGG_ID</th>\n",
       "      <th>PDB_ID</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...</td>\n",
       "      <td>1-Methylhistidine</td>\n",
       "      <td>HMDB ID:HMDB0000001</td>\n",
       "      <td>PubChem CID:92105</td>\n",
       "      <td>ChemSpider ID:83153</td>\n",
       "      <td>CAS RN:332-80-9</td>\n",
       "      <td>N(tele)-methyl-L-histidine</td>\n",
       "      <td>ChEBI ID:50599</td>\n",
       "      <td>KEGG ID:C01152</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>propane-1,3-diamine</td>\n",
       "      <td>1,3-Diaminopropane</td>\n",
       "      <td>HMDB ID:HMDB0000002</td>\n",
       "      <td>PubChem CID:428</td>\n",
       "      <td>ChemSpider ID:415</td>\n",
       "      <td>CAS RN:109-76-2</td>\n",
       "      <td>trimethylenediamine</td>\n",
       "      <td>ChEBI ID:15725</td>\n",
       "      <td>KEGG ID:C00986</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>2-oxobutanoic acid</td>\n",
       "      <td>2-Ketobutyric acid</td>\n",
       "      <td>HMDB ID:HMDB0000005</td>\n",
       "      <td>PubChem CID:58</td>\n",
       "      <td>ChemSpider ID:57</td>\n",
       "      <td>CAS RN:600-18-0</td>\n",
       "      <td>2-oxobutanoate</td>\n",
       "      <td>ChEBI ID:30831 | ChEBI ID:16763</td>\n",
       "      <td>KEGG ID:C00109</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>(2S)-2-hydroxybutanoic acid</td>\n",
       "      <td>2-Hydroxybutyric acid</td>\n",
       "      <td>HMDB ID:HMDB0000008</td>\n",
       "      <td>PubChem CID:440864</td>\n",
       "      <td>ChemSpider ID:389701</td>\n",
       "      <td>CAS RN:600-15-7 | CAS RN:3347-90-8</td>\n",
       "      <td>2-hydroxybutyric acid</td>\n",
       "      <td>ChEBI ID:1148 | ChEBI ID:50613</td>\n",
       "      <td>KEGG ID:C05984</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>(1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyl...</td>\n",
       "      <td>2-Methoxyestrone</td>\n",
       "      <td>HMDB ID:HMDB0000010</td>\n",
       "      <td>PubChem CID:440624</td>\n",
       "      <td>ChemSpider ID:389515</td>\n",
       "      <td>CAS RN:362-08-3</td>\n",
       "      <td>2-methoxyestrone</td>\n",
       "      <td>ChEBI ID:1189</td>\n",
       "      <td>KEGG ID:C05299</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CAS RN:52-89-1</td>\n",
       "      <td>L-cysteine hydrochloride</td>\n",
       "      <td>ChEBI ID:91247</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CAS RN:7048-04-6</td>\n",
       "      <td>L-cysteine hydrochloride hydrate</td>\n",
       "      <td>ChEBI ID:91248</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CAS RN:2706-75-4</td>\n",
       "      <td>sodium glyoxylate</td>\n",
       "      <td>ChEBI ID:91251</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CAS RN:23017-93-8</td>\n",
       "      <td>13-HPODE</td>\n",
       "      <td>ChEBI ID:91272</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CAS RN:27778-66-1</td>\n",
       "      <td>tenuazonic acid</td>\n",
       "      <td>ChEBI ID:9440</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID                                         IUPAC_Name  \\\n",
       "0           BMG_MT000001  (2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...   \n",
       "1           BMG_MT000002                                propane-1,3-diamine   \n",
       "2           BMG_MT000003                                 2-oxobutanoic acid   \n",
       "3           BMG_MT000004                        (2S)-2-hydroxybutanoic acid   \n",
       "4           BMG_MT000005  (1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyl...   \n",
       "...                  ...                                                ...   \n",
       "218330      BMG_MT218331                                                NaN   \n",
       "218331      BMG_MT218332                                                NaN   \n",
       "218332      BMG_MT218333                                                NaN   \n",
       "218333      BMG_MT218334                                                NaN   \n",
       "218334      BMG_MT218335                                                NaN   \n",
       "\n",
       "                    HMDB_Name              HMDB_ID         PubChem_CID  \\\n",
       "0           1-Methylhistidine  HMDB ID:HMDB0000001   PubChem CID:92105   \n",
       "1          1,3-Diaminopropane  HMDB ID:HMDB0000002     PubChem CID:428   \n",
       "2          2-Ketobutyric acid  HMDB ID:HMDB0000005      PubChem CID:58   \n",
       "3       2-Hydroxybutyric acid  HMDB ID:HMDB0000008  PubChem CID:440864   \n",
       "4            2-Methoxyestrone  HMDB ID:HMDB0000010  PubChem CID:440624   \n",
       "...                       ...                  ...                 ...   \n",
       "218330                    NaN                  NaN                 NaN   \n",
       "218331                    NaN                  NaN                 NaN   \n",
       "218332                    NaN                  NaN                 NaN   \n",
       "218333                    NaN                  NaN                 NaN   \n",
       "218334                    NaN                  NaN                 NaN   \n",
       "\n",
       "               ChemSpider_ID                              CAS_RN  \\\n",
       "0        ChemSpider ID:83153                     CAS RN:332-80-9   \n",
       "1          ChemSpider ID:415                     CAS RN:109-76-2   \n",
       "2           ChemSpider ID:57                     CAS RN:600-18-0   \n",
       "3       ChemSpider ID:389701  CAS RN:600-15-7 | CAS RN:3347-90-8   \n",
       "4       ChemSpider ID:389515                     CAS RN:362-08-3   \n",
       "...                      ...                                 ...   \n",
       "218330                   NaN                      CAS RN:52-89-1   \n",
       "218331                   NaN                    CAS RN:7048-04-6   \n",
       "218332                   NaN                    CAS RN:2706-75-4   \n",
       "218333                   NaN                   CAS RN:23017-93-8   \n",
       "218334                   NaN                   CAS RN:27778-66-1   \n",
       "\n",
       "                              ChEBI_Name                         ChEBI_ID  \\\n",
       "0             N(tele)-methyl-L-histidine                   ChEBI ID:50599   \n",
       "1                    trimethylenediamine                   ChEBI ID:15725   \n",
       "2                         2-oxobutanoate  ChEBI ID:30831 | ChEBI ID:16763   \n",
       "3                  2-hydroxybutyric acid   ChEBI ID:1148 | ChEBI ID:50613   \n",
       "4                       2-methoxyestrone                    ChEBI ID:1189   \n",
       "...                                  ...                              ...   \n",
       "218330          L-cysteine hydrochloride                   ChEBI ID:91247   \n",
       "218331  L-cysteine hydrochloride hydrate                   ChEBI ID:91248   \n",
       "218332                 sodium glyoxylate                   ChEBI ID:91251   \n",
       "218333                          13-HPODE                   ChEBI ID:91272   \n",
       "218334                   tenuazonic acid                    ChEBI ID:9440   \n",
       "\n",
       "               KEGG_ID PDB_ID  \n",
       "0       KEGG ID:C01152    NaN  \n",
       "1       KEGG ID:C00986    NaN  \n",
       "2       KEGG ID:C00109    NaN  \n",
       "3       KEGG ID:C05984    NaN  \n",
       "4       KEGG ID:C05299    NaN  \n",
       "...                ...    ...  \n",
       "218330             NaN    NaN  \n",
       "218331             NaN    NaN  \n",
       "218332             NaN    NaN  \n",
       "218333             NaN    NaN  \n",
       "218334             NaN    NaN  \n",
       "\n",
       "[218335 rows x 11 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "llm_name_id = biomedgraphica_metabolite.copy()\n",
    "\n",
    "llm_name_id['HMDB_ID'] = llm_name_id['HMDB_ID'].apply(\n",
    "    lambda x: ' | '.join(f\"HMDB ID:{id}\" for id in x.split(';')) if pd.notna(x) and x != '' else x\n",
    ")\n",
    "\n",
    "llm_name_id['PubChem_CID'] = llm_name_id['PubChem_CID'].apply(\n",
    "    lambda x: ' | '.join(f\"PubChem CID:{id}\" for id in x.split(';')) if pd.notna(x) and x != '' else x\n",
    ")\n",
    "\n",
    "llm_name_id['CAS_RN'] = llm_name_id['CAS_RN'].apply(\n",
    "    lambda x: ' | '.join(f\"CAS RN:{id}\" for id in x.split(';')) if pd.notna(x) and x != '' else x\n",
    ")\n",
    "\n",
    "llm_name_id['ChemSpider_ID'] = llm_name_id['ChemSpider_ID'].apply(\n",
    "    lambda x: ' | '.join(f\"ChemSpider ID:{id}\" for id in x.split(';')) if pd.notna(x) and x != '' else x\n",
    ")\n",
    "\n",
    "llm_name_id['PDB_ID'] = llm_name_id['PDB_ID'].apply(\n",
    "    lambda x: ' | '.join(f\"PDB ID:{id}\" for id in x.split(';')) if pd.notna(x) and x != '' else x\n",
    ")\n",
    "\n",
    "llm_name_id['ChEBI_ID'] = llm_name_id['ChEBI_ID'].apply(\n",
    "    lambda x: ' | '.join(f\"ChEBI ID:{id}\" for id in x.split(';')) if pd.notna(x) and x != '' else x\n",
    ")\n",
    "\n",
    "llm_name_id['KEGG_ID'] = llm_name_id['KEGG_ID'].apply(\n",
    "    lambda x: ' | '.join(f\"KEGG ID:{id}\" for id in x.split(';')) if pd.notna(x) and x != '' else x\n",
    ")\n",
    "\n",
    "column_order = ['BioMedGraphica_ID', 'IUPAC_Name', 'HMDB_Name', 'HMDB_ID', 'PubChem_CID', 'ChemSpider_ID', 'CAS_RN', 'ChEBI_Name', 'ChEBI_ID', 'KEGG_ID', 'PDB_ID']\n",
    "llm_name_id = llm_name_id[column_order]\n",
    "llm_name_id"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data has been saved to D:\\RA\\BMG\\BioMedGraphica\\Entity\\Metabolite\\BioMedGraphica_Metabolite_LLM_Name_ID.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "# get the current working directory\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "\n",
    "# get the output directory\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "\n",
    "target_folder = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite'\n",
    "if not target_folder.exists():\n",
    "    target_folder.mkdir(parents=True)\n",
    "    print(f\"Folder {target_folder} has been created.\")\n",
    "\n",
    "output_file_path = target_folder / 'BioMedGraphica_Metabolite_LLM_Name_ID.csv'\n",
    "llm_name_id.to_csv(output_file_path, index=False)\n",
    "print(f\"Data has been saved to {output_file_path}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "LLM Name and ID Combined"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "Names_and_IDs",
         "rawType": "object",
         "type": "string"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "aa70d605-cf36-4f2d-965e-9ae9483566b6",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)propanoic acid | CAS RN:332-80-9 | KEGG ID:C01152 | PubChem CID:92105 | 1-Methylhistidine | ChEBI ID:50599 | N(tele)-methyl-L-histidine | HMDB ID:HMDB0000001 | ChemSpider ID:83153"
        ],
        [
         "1",
         "BMG_MT000002",
         "PubChem CID:428 | KEGG ID:C00986 | ChEBI ID:15725 | trimethylenediamine | CAS RN:109-76-2 | ChemSpider ID:415 | 1,3-Diaminopropane | propane-1,3-diamine | HMDB ID:HMDB0000002"
        ],
        [
         "2",
         "BMG_MT000003",
         "KEGG ID:C00109 | 2-oxobutanoic acid | 2-Ketobutyric acid | 2-oxobutanoate | CAS RN:600-18-0 | ChEBI ID:16763 | ChemSpider ID:57 | ChEBI ID:30831 | PubChem CID:58 | HMDB ID:HMDB0000005"
        ],
        [
         "3",
         "BMG_MT000004",
         "HMDB ID:HMDB0000008 | ChEBI ID:1148 | ChEBI ID:50613 | CAS RN:3347-90-8 | KEGG ID:C05984 | (2S)-2-hydroxybutanoic acid | 2-hydroxybutyric acid | PubChem CID:440864 | ChemSpider ID:389701 | CAS RN:600-15-7 | 2-Hydroxybutyric acid"
        ],
        [
         "4",
         "BMG_MT000005",
         "HMDB ID:HMDB0000010 | PubChem CID:440624 | KEGG ID:C05299 | ChEBI ID:1189 | ChemSpider ID:389515 | (1S,10R,11S,15S)-5-hydroxy-4-methoxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-14-one | CAS RN:362-08-3 | 2-methoxyestrone | 2-Methoxyestrone"
        ],
        [
         "5",
         "BMG_MT000006",
         "ChemSpider ID:83181 | KEGG ID:C01089 | HMDB ID:HMDB0000011 | PubChem CID:92135 | ChEBI ID:17066 | 3-Hydroxybutyric acid | (3R)-3-hydroxybutanoic acid | (R)-3-hydroxybutyric acid | CAS RN:625-72-9"
        ],
        [
         "6",
         "BMG_MT000007",
         "Deoxyuridine | CAS RN:951-78-0 | KEGG ID:C00526 | PubChem CID:13712 | 2'-deoxyuridine | HMDB ID:HMDB0000012 | ChemSpider ID:13118 | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione | ChEBI ID:16450"
        ],
        [
         "7",
         "BMG_MT000008",
         "CAS RN:951-77-9 | 2'-deoxycytidine | HMDB ID:HMDB0000014 | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one | KEGG ID:C00881 | ChemSpider ID:13117 | ChEBI ID:15698 | PubChem CID:13711 | Deoxycytidine"
        ],
        [
         "8",
         "BMG_MT000009",
         "11-deoxycortisol | ChemSpider ID:389582 | PubChem CID:440707 | Cortexolone | HMDB ID:HMDB0000015 | ChEBI ID:28324 | KEGG ID:C05488 | CAS RN:152-58-9 | (1S,2R,10R,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one"
        ],
        [
         "9",
         "BMG_MT000010",
         "KEGG ID:C03205 | HMDB ID:HMDB0000016 | Deoxycorticosterone | (1S,2R,10S,11S,14S,15S)-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one | ChEBI ID:16973 | 11-deoxycorticosterone | ChemSpider ID:5932 | CAS RN:64-85-7 | PubChem CID:6166"
        ],
        [
         "10",
         "BMG_MT000011",
         "KEGG ID:C00847 | CAS RN:82-82-6 | 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid | ChemSpider ID:6467 | 4-pyridoxic acid | HMDB ID:HMDB0000017 | PubChem CID:6723 | 4-Pyridoxic acid | ChEBI ID:17405"
        ],
        [
         "11",
         "BMG_MT000012",
         "PubChem CID:49 | 3-methyl-2-oxobutanoic acid | ChemSpider ID:48 | HMDB ID:HMDB0000019 | KEGG ID:C00141 | CAS RN:759-05-7 | ChEBI ID:16530 | alpha-Ketoisovaleric acid"
        ],
        [
         "12",
         "BMG_MT000013",
         "4-hydroxyphenylacetic acid | ChemSpider ID:124 | ChEBI ID:18101 | CAS RN:156-38-7 | PubChem CID:127 | KEGG ID:C00642 | 2-(4-hydroxyphenyl)acetic acid | HMDB ID:HMDB0000020 | p-Hydroxyphenylacetic acid"
        ],
        [
         "13",
         "BMG_MT000014",
         "ChEBI ID:27847 | 3-iodo-L-tyrosine | HMDB ID:HMDB0000021 | KEGG ID:C02515 | PubChem CID:439744 | ChemSpider ID:388804 | CAS RN:70-78-0 | Iodotyrosine | (2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid"
        ],
        [
         "14",
         "BMG_MT000015",
         "PubChem CID:1669 | CAS RN:554-52-9 | ChEBI ID:742324 | KEGG ID:C05587 | 3-Methoxytyramine | 4-(2-aminoethyl)-2-methoxyphenol | ChEBI ID:1582 | HMDB ID:HMDB0000022 | 3-methoxytyramine | ChemSpider ID:1606"
        ],
        [
         "15",
         "BMG_MT000016",
         "(2S)-3-hydroxy-2-methylpropanoic acid | HMDB ID:HMDB0000023 | PubChem CID:440873 | ChemSpider ID:389707 | ChEBI ID:37373 | CAS RN:26543-05-5 | (S)-3-Hydroxyisobutyric acid | KEGG ID:C06001"
        ],
        [
         "16",
         "BMG_MT000017",
         "[(2R,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-tetracosanamidooctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid | CAS RN:151122-71-3 | PubChem CID:24779585 | HMDB ID:HMDB0000024 | 3-O-Sulfogalactosylceramide (d18:1/24:0) | ChemSpider ID:24823255"
        ],
        [
         "17",
         "BMG_MT000018",
         "ChemSpider ID:109 | CAS RN:462-88-4 | HMDB ID:HMDB0000026 | 3-(carbamoylamino)propanoic acid | KEGG ID:C02642 | ChEBI ID:18261 | Ureidopropionic acid"
        ],
        [
         "18",
         "BMG_MT000019",
         "(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,5,6,7,8-hexahydropteridin-4-one | HMDB ID:HMDB0000027 | ChEBI ID:59560 | CAS RN:27070-47-9 | Tetrahydrobiopterin | CAS RN:17528-72-2 | CAS RN:62989-33-7 | KEGG ID:C00272 | sapropterin | ChemSpider ID:40270 | PubChem CID:44257"
        ],
        [
         "19",
         "BMG_MT000020",
         "KEGG ID:C00120 | CAS RN:58-85-5 | 5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoic acid | ChemSpider ID:149962 | ChEBI ID:15956 | biotin | PubChem CID:171548 | HMDB ID:HMDB0000030 | Biotin"
        ],
        [
         "20",
         "BMG_MT000021",
         "ChEBI ID:16032 | HMDB ID:HMDB0000031 | ChemSpider ID:5668 | androsterone | Androsterone | (1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one | KEGG ID:C00523 | CAS RN:53-41-8 | PubChem CID:5879"
        ],
        [
         "21",
         "BMG_MT000022",
         "HMDB ID:HMDB0000032 | KEGG ID:C01164 | cholesta-5,7-dien-3beta-ol | CAS RN:434-16-2 | ChEBI ID:17759 | 7-Dehydrocholesterol | (1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,9-dien-5-ol | PubChem CID:439423"
        ],
        [
         "22",
         "BMG_MT000023",
         "ChemSpider ID:388363 | carnosine | ChEBI ID:15727 | KEGG ID:C00386 | HMDB ID:HMDB0000033 | CAS RN:305-84-0 | PubChem CID:439224 | (2S)-2-(3-aminopropanamido)-3-(1H-imidazol-5-yl)propanoic acid | Carnosine"
        ],
        [
         "23",
         "BMG_MT000024",
         "ChemSpider ID:185 | CAS RN:73-24-5 | KEGG ID:C00147 | 7H-purin-6-amine | ChEBI ID:16708 | PubChem CID:190 | HMDB ID:HMDB0000034 | Adenine | adenine"
        ],
        [
         "24",
         "BMG_MT000025",
         "HMDB ID:HMDB0000036 | ChEBI ID:28865 | 2-[(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanamido]ethane-1-sulfonic acid | taurocholic acid | PubChem CID:6675 | CAS RN:81-24-3 | KEGG ID:C05122 | ChemSpider ID:6423 | Taurocholic acid"
        ],
        [
         "25",
         "BMG_MT000026",
         "(1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde | PubChem CID:5839 | ChemSpider ID:5633 | HMDB ID:HMDB0000037 | Aldosterone | KEGG ID:C01780 | ChEBI ID:27584 | CAS RN:52-39-1 | aldosterone"
        ],
        [
         "26",
         "BMG_MT000027",
         "KEGG ID:C02953 | PubChem CID:119055 | Dihydrobiopterin | HMDB ID:HMDB0000038 | 2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4,7,8-tetrahydropteridin-4-one | ChemSpider ID:106382 | CAS RN:6779-87-9 | ChEBI ID:43029"
        ],
        [
         "27",
         "BMG_MT000028",
         "butanoic acid | PubChem CID:264 | Butyric acid | ChemSpider ID:259 | ChEBI ID:30772 | HMDB ID:HMDB0000039 | butyric acid | KEGG ID:C00246 | CAS RN:107-92-6"
        ],
        [
         "28",
         "BMG_MT000029",
         "KEGG ID:C00033 | ChemSpider ID:171 | PubChem CID:176 | acetic acid | CAS RN:64-19-7 | HMDB ID:HMDB0000042 | Acetic acid | ChEBI ID:15366"
        ],
        [
         "29",
         "BMG_MT000030",
         "HMDB ID:HMDB0000043 | PubChem CID:248 | ChEBI ID:41139 | ChemSpider ID:243 | (carboxymethyl)trimethylazanium | Betaine | CAS RN:6915-17-9"
        ],
        [
         "30",
         "BMG_MT000031",
         "HMDB ID:HMDB0000044 | Ascorbic acid | ChEBI ID:29073 | ChemSpider ID:10189562 | CAS RN:50-81-7 | KEGG ID:C01041 | (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2,5-dihydrofuran-2-one"
        ],
        [
         "31",
         "BMG_MT000032",
         "ChemSpider ID:5858 | KEGG ID:C00020 | PubChem CID:6083 | ChEBI ID:16027 | CAS RN:61-19-8 | HMDB ID:HMDB0000045 | ChEBI ID:456215 | Adenosine monophosphate | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | adenosine 5'-monophosphate(2-)"
        ],
        [
         "32",
         "BMG_MT000033",
         "(2S,3R,4S,5S,6R)-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-2,3,4,5-tetrol | PubChem CID:6602503 | HMDB ID:HMDB0000048 | Melibiose | CAS RN:13299-20-2"
        ],
        [
         "33",
         "BMG_MT000034",
         "(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | ChemSpider ID:54923 | Adenosine | adenosine | KEGG ID:C00212 | HMDB ID:HMDB0000050 | CAS RN:58-61-7 | ChEBI ID:16335 | PubChem CID:60961"
        ],
        [
         "34",
         "BMG_MT000035",
         "HMDB ID:HMDB0000051 | ChemSpider ID:217 | PubChem CID:222 | CAS RN:7664-41-7 | ammonia | KEGG ID:C00014 | Ammonia | ChEBI ID:16134"
        ],
        [
         "35",
         "BMG_MT000036",
         "ChEBI ID:15682 | Argininosuccinic acid | KEGG ID:C03406 | (2S)-2-{N'-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid | CAS RN:2387-71-5 | HMDB ID:HMDB0000052 | ChemSpider ID:16059 | PubChem CID:16950"
        ],
        [
         "36",
         "BMG_MT000037",
         "(1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-5,14-dione | ChemSpider ID:5898 | KEGG ID:C00280 | androst-4-ene-3,17-dione | Androstenedione | HMDB ID:HMDB0000053 | PubChem CID:6128 | ChEBI ID:16422 | CAS RN:63-05-8"
        ],
        [
         "37",
         "BMG_MT000038",
         "KEGG ID:C00486 | Bilirubin | bilirubin IXalpha | PubChem CID:5280352 | 3-(2-{[3-(2-carboxyethyl)-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-2-yl]methyl}-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl}-4-methyl-1H-pyrrol-3-yl)propanoic acid | ChemSpider ID:4444055 | CAS RN:635-65-4 | HMDB ID:HMDB0000054 | ChEBI ID:16990"
        ],
        [
         "38",
         "BMG_MT000039",
         "ChEBI ID:36217 | Cellobiose | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxane-3,4,5-triol | PubChem CID:10712 | ChemSpider ID:10261 | CAS RN:528-50-7 | KEGG ID:C06422 | HMDB ID:HMDB0000055"
        ],
        [
         "39",
         "BMG_MT000040",
         "ChEBI ID:16958 | PubChem CID:239 | KEGG ID:C00099 | 3-aminopropanoic acid | beta-Alanine | beta-alanine | CAS RN:107-95-9 | HMDB ID:HMDB0000056 | ChemSpider ID:234"
        ],
        [
         "40",
         "BMG_MT000041",
         "ChEBI ID:17489 | HMDB ID:HMDB0000058 | ChemSpider ID:5851 | CAS RN:60-92-4 | 3',5'-cyclic AMP | PubChem CID:6076 | (4aR,6R,7R,7aS)-6-(6-amino-9H-purin-9-yl)-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one | KEGG ID:C00575 | Cyclic AMP"
        ],
        [
         "41",
         "BMG_MT000042",
         "ChemSpider ID:94 | 3-oxobutanoic acid | ChEBI ID:15344 | PubChem CID:96 | CAS RN:541-50-4 | HMDB ID:HMDB0000060 | Acetoacetic acid | KEGG ID:C00164"
        ],
        [
         "42",
         "BMG_MT000043",
         "CAS RN:1053-73-2 | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}phosphonic acid | Adenosine 3',5'-diphosphate | HMDB ID:HMDB0000061 | ChEBI ID:17985 | ChemSpider ID:140102 | KEGG ID:C00054 | PubChem CID:159296"
        ],
        [
         "43",
         "BMG_MT000044",
         "ChEBI ID:16347 | ChemSpider ID:2006614 | HMDB ID:HMDB0000062 | (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate | PubChem CID:10917 | KEGG ID:C00318 | (R)-carnitine | L-Carnitine | CAS RN:541-15-1"
        ],
        [
         "44",
         "BMG_MT000045",
         "HMDB ID:HMDB0000063 | PubChem CID:5754 | ChEBI ID:17650 | KEGG ID:C00735 | cortisol | CAS RN:50-23-7 | (1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one | Cortisol"
        ],
        [
         "45",
         "BMG_MT000046",
         "Creatine | creatine | 2-(N-methylcarbamimidamido)acetic acid | ChEBI ID:16919 | ChemSpider ID:566 | HMDB ID:HMDB0000064 | CAS RN:57-00-1 | KEGG ID:C00300 | PubChem CID:586"
        ],
        [
         "46",
         "BMG_MT000047",
         "CAS RN:57-88-5 | KEGG ID:C00187 | Cholesterol | cholesterol | HMDB ID:HMDB0000067 | ChEBI ID:16113 | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol | PubChem CID:5997"
        ],
        [
         "47",
         "BMG_MT000048",
         "Epinephrine | KEGG ID:C00788 | PubChem CID:5816 | CAS RN:51-43-4 | ChemSpider ID:5611 | ChEBI ID:28918 | 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol | HMDB ID:HMDB0000068"
        ],
        [
         "48",
         "BMG_MT000049",
         "PubChem CID:849 | Pipecolic acid | HMDB ID:HMDB0000070 | KEGG ID:C00408 | ChEBI ID:17964 | ChemSpider ID:826 | piperidine-2-carboxylic acid | CAS RN:535-75-1"
        ],
        [
         "49",
         "BMG_MT000050",
         "KEGG ID:C05512 | CAS RN:890-38-0 | PubChem CID:65058 | ChemSpider ID:58569 | ChEBI ID:28997 | 2'-deoxyinosine | 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-ol | HMDB ID:HMDB0000071 | Deoxyinosine"
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>Names_and_IDs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>(2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>PubChem CID:428 | KEGG ID:C00986 | ChEBI ID:15...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>KEGG ID:C00109 | 2-oxobutanoic acid | 2-Ketobu...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>HMDB ID:HMDB0000008 | ChEBI ID:1148 | ChEBI ID...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>HMDB ID:HMDB0000010 | PubChem CID:440624 | KEG...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>ChEBI ID:91247 | L-cysteine hydrochloride | CA...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>CAS RN:7048-04-6 | L-cysteine hydrochloride hy...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>ChEBI ID:91251 | sodium glyoxylate | CAS RN:27...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>13-HPODE | CAS RN:23017-93-8 | ChEBI ID:91272</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>CAS RN:27778-66-1 | tenuazonic acid | ChEBI ID...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID                                      Names_and_IDs\n",
       "0           BMG_MT000001  (2S)-2-amino-3-(1-methyl-1H-imidazol-4-yl)prop...\n",
       "1           BMG_MT000002  PubChem CID:428 | KEGG ID:C00986 | ChEBI ID:15...\n",
       "2           BMG_MT000003  KEGG ID:C00109 | 2-oxobutanoic acid | 2-Ketobu...\n",
       "3           BMG_MT000004  HMDB ID:HMDB0000008 | ChEBI ID:1148 | ChEBI ID...\n",
       "4           BMG_MT000005  HMDB ID:HMDB0000010 | PubChem CID:440624 | KEG...\n",
       "...                  ...                                                ...\n",
       "218330      BMG_MT218331  ChEBI ID:91247 | L-cysteine hydrochloride | CA...\n",
       "218331      BMG_MT218332  CAS RN:7048-04-6 | L-cysteine hydrochloride hy...\n",
       "218332      BMG_MT218333  ChEBI ID:91251 | sodium glyoxylate | CAS RN:27...\n",
       "218333      BMG_MT218334      13-HPODE | CAS RN:23017-93-8 | ChEBI ID:91272\n",
       "218334      BMG_MT218335  CAS RN:27778-66-1 | tenuazonic acid | ChEBI ID...\n",
       "\n",
       "[218335 rows x 2 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "llm_combined = llm_name_id.copy()\n",
    "\n",
    "def merge_string_columns(df, columns, merge_name, separator=' | '):\n",
    "    def merge_strings(row):\n",
    "        combined = set()\n",
    "        for column in columns:\n",
    "            if pd.notnull(row[column]):\n",
    "                combined.update(row[column].split(separator))\n",
    "        return separator.join(combined)\n",
    "    \n",
    "    # Apply the function to each row and create a new column\n",
    "    combined_column_name = merge_name\n",
    "    df[combined_column_name] = df.apply(merge_strings, axis=1)\n",
    "    df.drop(columns=columns, inplace=True)\n",
    "    \n",
    "    return df\n",
    "\n",
    "llm_combined = merge_string_columns(llm_combined, llm_combined.columns[llm_combined.columns != 'BioMedGraphica_ID'], 'Names_and_IDs')\n",
    "llm_combined"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data has been saved to D:\\RA\\BMG\\BioMedGraphica\\Entity\\Metabolite\\BioMedGraphica_Metabolite_LLM_Name_ID_Combined.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "# get the current working directory\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "\n",
    "# get the output directory\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "\n",
    "target_folder = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite'\n",
    "if not target_folder.exists():\n",
    "    target_folder.mkdir(parents=True)\n",
    "    print(f\"Folder {target_folder} has been created.\")\n",
    "\n",
    "output_file_path = target_folder / 'BioMedGraphica_Metabolite_LLM_Name_ID_Combined.csv'\n",
    "llm_combined.to_csv(output_file_path, index=False)\n",
    "print(f\"Data has been saved to {output_file_path}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Display Name"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.microsoft.datawrangler.viewer.v0+json": {
       "columns": [
        {
         "name": "index",
         "rawType": "int64",
         "type": "integer"
        },
        {
         "name": "BioMedGraphica_ID",
         "rawType": "object",
         "type": "string"
        },
        {
         "name": "BMG_Metabolite_Name",
         "rawType": "object",
         "type": "string"
        }
       ],
       "conversionMethod": "pd.DataFrame",
       "ref": "344a2e4f-89cb-4ff9-a109-d5636281e97d",
       "rows": [
        [
         "0",
         "BMG_MT000001",
         "1-Methylhistidine"
        ],
        [
         "1",
         "BMG_MT000002",
         "1,3-Diaminopropane"
        ],
        [
         "2",
         "BMG_MT000003",
         "2-Ketobutyric acid"
        ],
        [
         "3",
         "BMG_MT000004",
         "2-Hydroxybutyric acid"
        ],
        [
         "4",
         "BMG_MT000005",
         "2-Methoxyestrone"
        ],
        [
         "5",
         "BMG_MT000006",
         "3-Hydroxybutyric acid"
        ],
        [
         "6",
         "BMG_MT000007",
         "Deoxyuridine"
        ],
        [
         "7",
         "BMG_MT000008",
         "Deoxycytidine"
        ],
        [
         "8",
         "BMG_MT000009",
         "Cortexolone"
        ],
        [
         "9",
         "BMG_MT000010",
         "Deoxycorticosterone"
        ],
        [
         "10",
         "BMG_MT000011",
         "4-Pyridoxic acid"
        ],
        [
         "11",
         "BMG_MT000012",
         "alpha-Ketoisovaleric acid"
        ],
        [
         "12",
         "BMG_MT000013",
         "p-Hydroxyphenylacetic acid"
        ],
        [
         "13",
         "BMG_MT000014",
         "Iodotyrosine"
        ],
        [
         "14",
         "BMG_MT000015",
         "3-Methoxytyramine"
        ],
        [
         "15",
         "BMG_MT000016",
         "(S)-3-Hydroxyisobutyric acid"
        ],
        [
         "16",
         "BMG_MT000017",
         "3-O-Sulfogalactosylceramide (d18:1/24:0)"
        ],
        [
         "17",
         "BMG_MT000018",
         "Ureidopropionic acid"
        ],
        [
         "18",
         "BMG_MT000019",
         "Tetrahydrobiopterin"
        ],
        [
         "19",
         "BMG_MT000020",
         "Biotin"
        ],
        [
         "20",
         "BMG_MT000021",
         "Androsterone"
        ],
        [
         "21",
         "BMG_MT000022",
         "7-Dehydrocholesterol"
        ],
        [
         "22",
         "BMG_MT000023",
         "Carnosine"
        ],
        [
         "23",
         "BMG_MT000024",
         "Adenine"
        ],
        [
         "24",
         "BMG_MT000025",
         "Taurocholic acid"
        ],
        [
         "25",
         "BMG_MT000026",
         "Aldosterone"
        ],
        [
         "26",
         "BMG_MT000027",
         "Dihydrobiopterin"
        ],
        [
         "27",
         "BMG_MT000028",
         "Butyric acid"
        ],
        [
         "28",
         "BMG_MT000029",
         "Acetic acid"
        ],
        [
         "29",
         "BMG_MT000030",
         "Betaine"
        ],
        [
         "30",
         "BMG_MT000031",
         "Ascorbic acid"
        ],
        [
         "31",
         "BMG_MT000032",
         "Adenosine monophosphate"
        ],
        [
         "32",
         "BMG_MT000033",
         "Melibiose"
        ],
        [
         "33",
         "BMG_MT000034",
         "Adenosine"
        ],
        [
         "34",
         "BMG_MT000035",
         "Ammonia"
        ],
        [
         "35",
         "BMG_MT000036",
         "Argininosuccinic acid"
        ],
        [
         "36",
         "BMG_MT000037",
         "Androstenedione"
        ],
        [
         "37",
         "BMG_MT000038",
         "Bilirubin"
        ],
        [
         "38",
         "BMG_MT000039",
         "Cellobiose"
        ],
        [
         "39",
         "BMG_MT000040",
         "beta-Alanine"
        ],
        [
         "40",
         "BMG_MT000041",
         "Cyclic AMP"
        ],
        [
         "41",
         "BMG_MT000042",
         "Acetoacetic acid"
        ],
        [
         "42",
         "BMG_MT000043",
         "Adenosine 3',5'-diphosphate"
        ],
        [
         "43",
         "BMG_MT000044",
         "L-Carnitine"
        ],
        [
         "44",
         "BMG_MT000045",
         "Cortisol"
        ],
        [
         "45",
         "BMG_MT000046",
         "Creatine"
        ],
        [
         "46",
         "BMG_MT000047",
         "Cholesterol"
        ],
        [
         "47",
         "BMG_MT000048",
         "Epinephrine"
        ],
        [
         "48",
         "BMG_MT000049",
         "Pipecolic acid"
        ],
        [
         "49",
         "BMG_MT000050",
         "Deoxyinosine"
        ]
       ],
       "shape": {
        "columns": 2,
        "rows": 218335
       }
      },
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>BioMedGraphica_ID</th>\n",
       "      <th>BMG_Metabolite_Name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>BMG_MT000001</td>\n",
       "      <td>1-Methylhistidine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>BMG_MT000002</td>\n",
       "      <td>1,3-Diaminopropane</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMG_MT000003</td>\n",
       "      <td>2-Ketobutyric acid</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>BMG_MT000004</td>\n",
       "      <td>2-Hydroxybutyric acid</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>BMG_MT000005</td>\n",
       "      <td>2-Methoxyestrone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218330</th>\n",
       "      <td>BMG_MT218331</td>\n",
       "      <td>L-cysteine hydrochloride</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218331</th>\n",
       "      <td>BMG_MT218332</td>\n",
       "      <td>L-cysteine hydrochloride hydrate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218332</th>\n",
       "      <td>BMG_MT218333</td>\n",
       "      <td>sodium glyoxylate</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218333</th>\n",
       "      <td>BMG_MT218334</td>\n",
       "      <td>13-HPODE</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218334</th>\n",
       "      <td>BMG_MT218335</td>\n",
       "      <td>tenuazonic acid</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>218335 rows Ã— 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       BioMedGraphica_ID               BMG_Metabolite_Name\n",
       "0           BMG_MT000001                 1-Methylhistidine\n",
       "1           BMG_MT000002                1,3-Diaminopropane\n",
       "2           BMG_MT000003                2-Ketobutyric acid\n",
       "3           BMG_MT000004             2-Hydroxybutyric acid\n",
       "4           BMG_MT000005                  2-Methoxyestrone\n",
       "...                  ...                               ...\n",
       "218330      BMG_MT218331          L-cysteine hydrochloride\n",
       "218331      BMG_MT218332  L-cysteine hydrochloride hydrate\n",
       "218332      BMG_MT218333                 sodium glyoxylate\n",
       "218333      BMG_MT218334                          13-HPODE\n",
       "218334      BMG_MT218335                   tenuazonic acid\n",
       "\n",
       "[218335 rows x 2 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "display_name = biomedgraphica_metabolite.copy()\n",
    "\n",
    "display_name['BMG_Metabolite_Name'] = display_name['HMDB_Name'].fillna(display_name['IUPAC_Name']).fillna(display_name['ChEBI_Name'])\n",
    "display_name = display_name[['BioMedGraphica_ID', 'BMG_Metabolite_Name']]\n",
    "display_name"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Data has been saved to D:\\RA\\BMG\\BioMedGraphica\\Entity\\Metabolite\\BioMedGraphica_Metabolite_Display_Name.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "# get the current working directory\n",
    "current_working_dir = Path(os.getcwd()).resolve()\n",
    "\n",
    "# get the output directory\n",
    "grandparent_dir = current_working_dir.parent.parent.parent\n",
    "\n",
    "target_folder = grandparent_dir / 'BioMedGraphica' / 'Entity' / 'Metabolite'\n",
    "if not target_folder.exists():\n",
    "    target_folder.mkdir(parents=True)\n",
    "    print(f\"Folder {target_folder} has been created.\")\n",
    "\n",
    "output_file_path = target_folder / 'BioMedGraphica_Metabolite_Display_Name.csv'\n",
    "display_name.to_csv(output_file_path, index=False)\n",
    "print(f\"Data has been saved to {output_file_path}\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.19"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
